If you do not want to miss anything about research at IVIRMA Global Research Alliance, stay tuned to this section for upcoming news. You will find updates on the more than 300 studies that are being conducted and many others that are being launched. IVIRMA has more than thirty publications each quarter and you will be able to find our recent publications here. Moreover, if you need further information, please don’t hesitate to contact the investigator directly.
| Names | Title | Area | Year | Area |
|---|---|---|---|---|
| Title | Area | Year | Area | |
|
Addition of rapamycin or co-culture with cumulus cells from younger reproductive age women does not improve rescue in vitro oocyte maturation or euploidy rates in older reproductive age women. | 2024 | ||
|
Oocyte vitrification for fertility preservation, an evolving practice requiring a new mindset: societal, technical, clinical aspects and basic science-driven evolutions. | 2024 | ||
|
Role of thyroid stimulating hormone in the maintenance and functioning of the human corpus luteum. | 2024 | ||
|
Transcriptome analysis of adenomyosis eutopic endometrium reveals molecular mechanisms involved in adenomyosis-related implantation failure and pregnancy disorders. | 2024 | ||
|
Views and reviews: Fertility preservation from different perspectives. | 2024 | ||
|
The use of non-apoptotic sperm selected by Magnetic activated cell sorting (MACS) to enhance reproductive outcomes: what the evidence says | 2024 | ||
|
Sequential-contingent strategy for fallopian tube evaluation using hysterosalpingo foam sonography: a cost analysis. | 2024 | ||
|
A miniaturized stir bar sorptive dispersive microextraction method for the determination of bisphenols in follicular fluid using a magnetic covalent organic framework | 2024 | ||
|
Proteomic Profiling Identifies Candidate Diagnostic Biomarkers of Hydrosalpinx in Endometrial Fluid: A Pilot Study. | 2024 | ||
|
Corrigendum to 'Medroxyprogesterone acetate: an alternative to GnRH-antagonist in oocyte vitrification for social fertility preservation and preimplantation genetic testing for aneuploidy' Reproductive Biomedicine Online. 2023 Aug;47(2):103222. | 2024 | ||
|
Reply of the Authors: Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial. | 2024 | ||
|
Detecting partial premature ovulation during follicular aspiration compromises the quantity, but not the quality, of the oocytes retrieved in stimulated in vitro fertilization (IVF) cycles. | 2024 | ||
|
An update on the current indications for in vitro maturation. | 2024 | ||
|
Progestin-primed ovarian stimulation. | 2024 | ||
|
The ovarian stimulation regimen does not affect aneuploidy or blastocyst rate | 2024 | ||
|
Trophectoderm cells of human mosaic embryos display increased apoptotic levels and impaired differentiation capacity: a molecular clue regarding their reproductive fate? | 2024 | ||
|
Identification of miR-30c-5p microRNA in Serum as a Candidate Biomarker to Diagnose Endometriosis | 2024 | ||
|
Changes in environmental exposures over decades may influence the genetic architecture of severe spermatogenic failure. | 2024 | ||
|
Towards a more sustainable balance between optimal live birth rate and supernumerary embryos in ART treatments. | 2024 | ||
|
Mitochondrial Unfolded Protein Response Gene Clpp Is Required for Oocyte Function and Female Fertility. | 2024 | ||
|
Disruption of mitochondrial unfolded protein response results in telomere shortening in mouse oocytes and somatic cells. | 2024 | ||
|
A call for new theories on the pathogenesis and pathophysiology of endometriosis. | 2024 | ||
|
ESHRE guideline: number of embryos to transfer during IVF/ICSI†. | 2024 | ||
|
No additional risk of congenital anomalies after first-trimester dydrogesterone use: a systematic review and meta-analysis. | 2024 | ||
|
Centromeric AA motif in KIR as an optimal surrogate marker for precision definition of alloimmune reproductive failure. | 2024 | ||
|
Semen cryopreservation for an oncological reason: a retrospective study | 2024 | ||
|
Cumulative live birth rate following progestin-primed ovarian stimulation: controversial results with own and donated oocytes | 2024 | ||
|
Prediction of pregnancy-related complications in women undergoing assisted reproduction, using machine learning methods | 2024 | ||
|
Preimplantation genetic testing for aneuploidy: predictive embryonic factors. | 2024 | ||
|
Safety of Plasma Rich in Growth Factors (PRGF) as additive to healthy human sperm samples: a pilot study. | 2024 | ||
|
An artificial intelligence tool predicts blastocyst development from static images of fresh mature oocytes | 2024 | ||
|
Utilization of Cryopreserved Oocytes in Patients With Poor Ovarian Response After Planned Oocyte Cryopreservation. | 2024 | ||
|
Metabolic imaging of human embryos is predictive of ploidy status but is not associated with clinical pregnancy outcomes: a pilot trial. | 2024 | ||
|
Iatrogenic and Demographic Determinants of the National Plural Birth Increase. | 2024 | ||
|
Estimating the number of oocytes to expose to sperm in assisted reproductive technology treatment. | 2024 | ||
|
The role of mitochondrial dynamics in oocyte and early embryo development. | 2024 | ||
|
Does recurrent implantation failure exist? Prevalence and outcomes of five consecutive euploid blastocyst transfers in 123 987 patients | 2024 | ||
|
Deciphering the role of PGRMC2 in the human endometrium during the menstrual cycle and in vitro decidualization using an in vitro approach | 2024 | ||
|
High impact journal publishing: the devil is in the detail! | 2024 | ||
|
The metrics maze in science: navigating academic evaluation without journalistic pressures | 2024 | ||
|
Factsheet on environmental exposure and offspring health | 2024 | ||
|
Environmental exposure, fertility and reproductive health | 2024 | ||
|
Factsheet on environmental exposure and male reproductive health | 2024 | ||
|
Factsheet on environmental exposure and female reproductive health | 2024 | ||
|
Factsheet on air pollution, climate change and reproductive health | 2024 | ||
|
A novel machine-learning framework based on early embryo morphokinetics identifies a feature signature associated with blastocyst development. | 2024 | ||
|
Predicting risk of endometrial failure: a biomarker signature that identifies a novel disruption independent of endometrial timing in patients undergoing hormonal replacement cycles | 2024 | ||
|
Embryo long-term storage does not affect ART outcome: analysis of 58001 vitrified blastocysts over an 11-year period. | 2024 | ||
|
Current Updates on Involvement of Artificial Intelligence and Machine Learning in Semen Analysis. | 2024 | ||
|
Decision-making in women considering planned oocyte cryopreservation: decision satisfaction or regret? | 2024 | ||
|
Natural proliferative phase frozen embryo transfer-a new approach which may facilitate scheduling without hindering pregnancy outcomes. | 2024 | ||
|
Understanding and addressing unexplained infertility: from diagnosis to treatment. | 2024 | ||
|
185. Comparison of the Administration of 150 or 75 IU of Recombinant LH in Agonist ICSI Cycles Stimulated with Recombinant FSH in Women Aged 35-39: A Comparative Study. | 2023 | ||
|
New insights into decidualization: immunological and genetic factors. | 2023 | ||
|
Single-cell multi-omic analysis profiles defective genome activation and epigenetic reprogramming associated with human pre-implantation embryo arrest. | 2023 | ||
|
First pilot study of maternal spindle transfer for the treatment of repeated in vitro fertilization failures in couples with idiopathic infertility. | 2023 | ||
|
Correlations between a deep learning-based algorithm for embryo evaluation with number of cells and degree of fragmentation on day 2 and 3 | 2023 | ||
|
Early Spontaneous Twinning Recorded By Time-Lapse. | 2023 | ||
|
Deciphering reproductive aging in women using a NOD/SCID mouse model for distinct physiological ovarian phenotypes | 2023 | ||
|
Borderline blastocysts. A multifaceted dilemma | 2023 | ||
|
The effect of vitrification on blastocyst mitochondrial DNA dynamics and gene expression profiles. | 2023 | ||
|
Aneuploidy in oocytes from women of advanced maternal age: analysis of the causal meiotic errors andimpact on embryo development. | 2023 | ||
|
Frequency of diminished ovarian reserve in women with multiple sclerosis in Chile: An exploratory study. | 2023 | ||
|
Automatic Ploidy Prediction and Quality Assessment of Human Blastocyst Using Time-Lapse Imaging | 2023 | ||
|
Erratum to ‘Cumulative live birth rates in ICSI cycles with donated oocytes are not improved by magnetic-activated cell sorting: A retrospective study in unselected males’ [Reproductive BioMedicine Journal 44/4 (2022) 677-684] | 2023 | ||
|
Frequency, morbidity and equity - the case for increased research on male fertility. | 2023 | ||
|
Luteal phase support with micronised vaginal progesterone in the form of pessaries or capsules in artificial cycles: is there any difference? | 2023 | ||
|
Elevated Sperm DNA Damage in IVF–ICSI Treatments Is Not Related to Pregnancy Complications and Adverse Neonatal Outcomes | 2023 | ||
|
APHRODITE criteria: Addressing male patients with hypogonadism and/or infertility owing to altered idiopathic testicular function | 2023 | ||
|
Innovative Strategies for Fertility Preservation in Female Cancer Survivors: New Hope from Artificial Ovary Construction and Stem Cell-Derived Neo-Folliculogenesis. | 2023 | ||
|
No major differences in perinatal and maternal outcomes between uninterrupted embryo culture in time-lapse system and conventional embryo culture. | 2023 | ||
|
Unpacking the artificial intelligence toolbox for embryo ploidy prediction. | 2023 | ||
|
Addressing Key Questions in Organoid Models: Who, Where, How, and Why? | 2023 | ||
|
To transfer or not to transfer: the dilemma of mosaic embryos – a narrative review | 2023 | ||
|
Considerations for future modification of The Association for the Study of Reproductive Biology embryo grading system incorporating time-lapse observations | 2023 | ||
|
Editorial: Single cell analysis in endocrinology, reproduction, and metabolism. | 2023 | ||
|
Chromosome ends and the theory of marginotomy: implications for reproduction. | 2023 | ||
|
Oocyte Cryopreservation in Women with Ovarian Endometriosis. | 2023 | ||
|
Leukocyte telomere length and DNA methylome as biomarkers of ovarian reserve and embryo aneuploidy: The intricate relationship between somatic and reproductive aging. | 2023 | ||
|
Factors that influence natural fecundity in fertile couples assessed by means of a survey carried out on puerperae and their partners | 2023 | ||
|
Hybrid Endometrial-Derived Hydrogels: Human Organoid Culture Models and In Vivo Perspectives. | 2023 | ||
|
Effect of L. crispatus M247 Administration on Pregnancy Outcomes in Women Undergoing IVF: A Controlled, Retrospective, Observational, and Open-Label Study. | 2023 | ||
|
Day7 and low-quality blastocysts: opt in or opt out? A dilemma with important clinical implications. | 2023 | ||
|
Analysis of New Colposcopy Techniques in the Diagnosis and Evolution of SIL/CIN: Comparison of Colposcopy with the DSI System (COLPO-DSI Study). | 2023 | ||
|
The adenomyosis/endometriosis IVF patient – call for clinical focus | 2023 | ||
|
Microfluidic sperm sorting improves ICSI outcomes in patients with increased values of Double-Strand Breaks in sperm DNA | 2023 | ||
|
Serum progesterone is lower in ovarian stimulation with highly purified HMG compared to recombinant FSH owing to a different regulation of follicular steroidogenesis: a randomized controlled trial. | 2023 | ||
|
Impact of adenomyosis on IVF outcomes in women undergoing donor oocyte transfers: a prospective observational study. | 2023 | ||
|
If recurrent implantation failure (RIF) is rare, what could be the cause of repeat unsuccessful ARTs ? | 2023 | ||
|
No matter how you slice it, increasing BMI is associated with a lower probability of live birth…or is it? | 2023 | ||
|
INvestigational Study Into Transplantation of the Uterus (INSITU): a cross-sectional survey among women with uterine factor infertility in the UK assessing background, motivations and suitability. | 2023 | ||
|
Systemic changes induced by autologous stem cell ovarian transplant in plasma proteome of women with impaired ovarian reserves | 2023 | ||
|
First case of dichorionic diamniotic triplet pregnancy after single blastocyst transfer. | 2023 | ||
|
Correction to: The HERA (Hyper‑response Risk Assessment) Delphi consensus for the management of hyper‑responders in in vitro fertilization. | 2023 | ||
|
Oocyte competence is comparable between progestin primed ovarian stimulation with Norethisterone acetate (NETA-PPOS) and GnRH-antagonist protocols: A matched case-control study in PGT-A cycles | 2023 | ||
|
IVF stimulation protocols and outcomes in women with endometriosis. | 2023 | ||
|
Real-world practices of hormone monitoring during ovarian stimulation in assisted reproductive technology: a global online survey. | 2023 | ||
|
Modified natural cycle allows a window of seven days for frozen embryo transfer planning | 2023 | ||
|
Microbiome preterm birth DREAM challenge: Crowdsourcing machine learning approaches to advance preterm birth research | 2023 | ||
|
The effectiveness of cervical cerclage in twin pregnancies with a mid-trimester short cervix: A retrospective cohort study | 2023 | ||
|
A biomechanical assessment of tissue-engineered polymer neo-uteri after orthotopic implantation. | 2023 | ||
|
Study protocol of a clinical randomized controlled trial on the efficacy of an innovative Digital thErapy to proMote wEighT loss in patients with obesity by incReasing their Adherence to treatment: the DEMETRA study. | 2023 | ||
|
Altered ureido protein modification profiles in seminal plasma extracellular vesicles of non-normozoospermic men. | Male Fertility | 2023 | Male Fertility |
|
Biomechanical forces and signals operating in the ovary during folliculogenesis and their dysregulation: implications for fertility. | 2023 | ||
|
Can probiotics enhance fertility outcome? Capacity of probiotics as a single intervention to improve the feminine genital tract microbiota in non-symptomatic reproductive-aged women. | 2023 | ||
|
Clinical and laboratory key performance indicators in IVF: A consensus between the Italian Society of Fertility and Sterility and Reproductive Medicine (SIFES-MR) and the Italian Society of Embryology, Reproduction and Research (SIERR). | IVF Clinical | 2023 | IVF Clinical;IVF Laboratory |
|
Cryostorage management of reproductive cells and tissues in ART: status, needs, opportunities, and potential new challenges | cryobiology | 2023 | cryobiology |
|
Diabetes and erectile dysfunction: The relationships with health literacy, treatment adherence, unrealistic optimism, and glycaemic control. | 2023 | ||
|
Double stimulation for the management of poor-prognosis patients: where are we going? | 2023 | ||
|
Endometriosis affects the number of retrieved oocytes but not early embryonic development and live birth: a retrospective analysis of 716 IVF cycles. | Reproductive disorders | 2023 | Reproductive disorders |
|
ESHRE good practice recommendations on recurrent implantation failure. | IVF Clinical | 2023 | IVF Clinical;Other |
|
Female couples undergoing assisted reproduction - choices and the importance of pregnancy and genetics. | Female fertility | 2023 | Female fertility;Other |
|
From a cycle-by-cycle to a multi-cycle treatment planning: the next relevant shift in perspective needed in ART? | IVF Clinical | 2023 | IVF Clinical |
|
How should the best human embryo in vitro be? Current and future challenges for embryo selection. | IVF Laboratory | 2023 | IVF Laboratory;Other |
|
Humidified atmosphere in a time-lapse embryo culture system does not improve ongoing pregnancy rate: a retrospective propensity score model study derived from 496 first ICSI cycles. | IVF Laboratory | 2023 | IVF Laboratory |
|
Improved clinical utility of preimplantation genetic testing through the integration of ploidy and common pathogenic microdeletions analyses. | 2023 | ||
|
Incidental Finding of a Müllerian Malformation on Two-dimensional Ultrasound: What Now? | Reproductive disorders | 2023 | Reproductive disorders |
|
Intra-individual variation of sperm DNA fragmentation in the Human ejaculate. | 2023 | ||
|
Low-quality evidence from a randomized controlled trial due to an inappropriate IVF setting to challenge Dual Stimulation strategy. | IVF Clinical | 2023 | IVF Clinical;Female Fertility |
|
Luteal phase support in assisted reproductive technology centers: Italian survey. | Female fertility | 2023 | Female fertility;IVF Clinical |
|
Male factor infertility and assisted reproductive technologies: indications, minimum access criteria and outcomes. | 2023 | ||
|
Maternal age affects pronuclear and chromatin dynamics, morula compaction and cell polarity, and blastulation of human embryos. | 2023 | ||
|
Oocyte and embryo cryopreservation in ART: past achievements and current challenges | Cryobiology | 2023 | Cryobiology |
|
Opening the black box: why do euploid blastocysts fail to implant? A systematic review and meta-analysis. | Pre-Implantation genetics | 2023 | Pre-Implantation genetics |
|
Polymorphic Rearrangements of Human Chromosome 9 and Male Infertility: New Evidence and Impact on Spermatogenesis. | Male Fertility | 2023 | Male Fertility |
|
Reproductive plans and knowledge of assisted reproductive techniques among lesbian women: an international survey study. | IVF Clinical | 2023 | IVF Clinical;Female fertility |
|
The combined effect of BMI and age on ART outcomes. | 2023 | ||
|
The first mitotic division: a perilous bridge connecting the zygote and the early embryo. | Other | 2023 | Other;Female Fertility |
|
The time has come for harmonized international ART registration | 2023 | ||
|
Towards Automation in IVF: Pre-Clinical Validation of a Deep Learning-Based Embryo Grading System during PGT-A Cycles. | 2023 | ||
|
University students' opinion on gamete donor identification regimes. | Other | 2023 | Other |
|
11. Third Party Reproduction. A Treatment that Grows with Societal Changes. | IVF Clinical o Other | 2023 | IVF Clinical o Other |
|
A comparison between the Felix™ electrophoretic system of sperm isolation and conventional density gradient centrifugation: a multicentre analysis. | 2023 | ||
|
A Novel Nonsense Pathogenic TTN Variant Identified in a Patient with Severe Dilated Cardiomyopathy. | Other | 2023 | Other |
|
A Randomized Controlled Intervention Trial with Danazol to Improve Telomeric and Fertility Parameters in Women with Diminished Ovarian Reserve: A Pilot Study. | Aging and rejuvenation | 2023 | Aging and rejuvenation;Female Fertility |
|
Advanced Paternal Age Does Not Affect Medically-Relevant Obstetrical and Perinatal Outcomes following IVF or ICSI in Humans with Donated Oocytes. | Aging and rejuvenation | 2023 | Aging and rejuvenation; Male Fertility |
|
Advances of xenogeneic ovarian extracellular matrix hydrogels for in vitro follicle development and oocyte maturation | Other | 2023 | Other |
|
Antimüllerian hormone (AMH) and age as predictors of preimplantation genetic testing for aneuploidies (PGT-A) cycle outcomes and blastocyst quality on day 5 in women undergoing in vitro fertilization (IVF). | Pre-Implantation genetics | 2023 | Pre-Implantation genetics;Female Fertility |
|
Antioxidant Supplementation Alleviates Mercury-Induced Cytotoxicity and Restores the Implantation-Related Functions of Primary Human Endometrial Cells. | Endometrial receptivity | 2023 | Endometrial receptivity;Other |
|
Artificial Intelligence in Andrology: From Semen Analysis to Image Diagnostics. | Technology development | 2023 | Technology development;Male Fertility |
|
Association between oocyte donors' or recipients' BMI with clinical outcomes after first single blastocyst transfers. The uterus is the mostly affected. | Female fertility | 2023 | Female fertility |
|
Association between sequence variants in Follicle Stimulating Hormone Receptor gene and reproductive outcomes following in vitro fertilization in predicted normoreponders. A multicenter multinational prospective cohort study | Female fertility | 2023 | Female fertility |
|
Association of blood cadmium and lead levels with self-reported reproductive lifespan and pregnancy loss: The national health and nutrition examination survey 1999-2018. | Other | 2023 | Other |
|
Better late than never: the clinical value of Day 7 blastocysts. | IVF Laboratory | 2023 | IVF Laboratory |
|
Bioaccumulation of Non-Essential Trace Elements Detected in Women's Follicular Fluid, Urine, and Plasma Is Associated with Poor Reproductive Outcomes following Single Euploid Embryo Transfer: A Pilot Study. | Other | 2023 | Other;Female Fertility |
|
BOLOGNA VS POSEIDON CRITERIA AS PREDICTORS OF THE LIKELIHOOD OF OBTAINING AT LEAST ONE EUPLOID EMBRYO IN POOR OVARIAN RESPONSE: AN ANALYSIS OF 6,889 CYCLES | Pre-Implantation genetics | 2023 | Pre-Implantation genetics |
|
Cell-cell interactions during the formation of primordial follicles in humans. | Female fertility | 2023 | Female fertility |
|
Clinical pregnancy rate for frozen embryo transfer with HRT: a randomized controlled pilot study comparing 1 week versus 2 weeks of oestradiol priming. | IVF Clinical | 2023 | IVF Clinical |
|
Clinical validation of an automatic classification algorithm applied on cleavage stage embryos: analysis for blastulation, euploidy, implantation, and live-birth potential. | Technology development | 2023 | Technology development |
|
Controlled Ovarian Stimulation Initiated at Different Phases of the Menstrual Cycle for Fertility Preservation in Oncological Patients: a Retrospective Study. | Female fertility | 2023 | Female fertility; Other |
|
Controversy and Consensus on Indications for Sperm DNA Fragmentation Testing in Male Infertility: A Global Survey, Current Guidelines, and Expert Recommendations. | Male Fertility | 2023 | Male Fertility |
|
Deciphering a shared transcriptomic regulation and the relative contribution of each regulator type through endometrial gene expression signatures. | Endometrial receptivity | 2023 | Endometrial receptivity |
|
Deep learning system for classification of ploidy status using time-lapse videos. | Technology development | 2023 | Technology development;Pre-Implantation genetics |
|
Delta and kappa opioid receptors in human endometrium during the menstrual cycle: expression and localization | Endometrial receptivity | 2023 | Endometrial receptivity |
|
Development and Validation of an Endometriosis Diagnostic Method Based on Serum Biomarkers and Clinical Variables. | Reproductive disorders | 2023 | Reproductive disorders |
|
Discard or not discard, that is the question: an international survey across 117 embryologists on the clinical management of borderline quality blastocysts. | Technology development | 2023 | Technology development;Pre-Implantation genetics |
|
Does Varicocele Repair Improve Conventional Semen Parameters? A Meta-Analytic Study of Before-After Data. | Male Fertility | 2023 | Male Fertility;Surgery |
|
DuoStim reduces time to pregnancy, minimizes treatment discontinuation, and is potentially cost-effective. | IVF Clinical | 2023 | IVF Clinical;Female Fertility |
|
Duration of oestrogen exposure does not affect reproductive outcome in artificial cycles: a retrospective analysis of more than 7000 hormonal replacement therapy cycles for an embryo transfer. | IVF Clinical | 2023 | IVF Clinical;Female fertility |
|
Editorial: GnRH agonist triggering of final oocyte maturation: Improving safety without compromising success. | Female fertility | 2023 | Female fertility;IVF clinical |
|
Efectos del IMC sobre la cantidad y madurez ovacitaria en un programa de donación de ovulos | Female Fertility | 2023 | Female Fertility |
|
Effect of a Multi-Ingredient Coriolus-versicolor-Based Vaginal Gel in Women with HPV-Dependent Cervical Lesions: The Papilobs Real-Life Prospective Study. | Other | 2023 | Other |
|
Effect of incubation and analysis temperatures on sperm kinematics and morphometrics during human semen analysis | IVF Laboratory | 2023 | IVF Laboratory;Male Fertility |
|
Elevated anti-Müllerian hormone levels are not associated with preterm delivery after in vitro fertilization or ovulation induction | Female fertility | 2023 | Female fertility |
|
Embryonic arrest: causes and implications. | Female Fertility | 2023 | Female Fertility;IVF laboratory |
|
Endometrial receptivity tests in reproduction. A swot analysis | Endometrial receptivity | 2023 | Endometrial receptivity |
|
ESHRE PGT Consortium data collection XXI: PGT analyses in 2018. | Pre-Implantation genetics | 2023 | Pre-Implantation genetics |
|
Evaluation of costs associated with fertility treatment leading to a live birth after one fresh transfer: A global perspective | IVF Clinical | 2023 | IVF Clinical |
|
Evidence-based guideline: unexplained infertility†. | IVF Clinical | 2023 | IVF Clinical |
|
Fertility preservation in women with benign gynaecological conditions. | Cryobiology | 2023 | Cryobiology ;Reproductive disorders |
|
First pilot study of maternal spindle transfer for the treatment of repeated in vitro fertilization failures in couples with idiopathic infertility | Female fertility | 2023 | Female fertility; Other |
|
Getting closer to the truth. | Other | 2023 | Other;IVF Clinical |
|
H3K4me3 mediates uterine leiomyoma pathogenesis via neuronal processes, synapsis components, proliferation, and Wnt/β-catenin and TGF-β pathways. | Epigenetics | 2023 | Epigenetics |
|
Healthy live birth following embryo transfer of a blastocyst of tetrapronuclear (4PN) origin: a case report. | Pre-Implantation genetics | 2023 | Pre-Implantation genetics |
|
Hiding in plain sight. | IVF Clinical | 2023 | IVF Clinical;Female Fertility |
|
How to deal with confounders in an infertility study? | Other | 2023 | Other |
|
How to select healthy sperm for intracytoplasmic sperm injection in samples with high sperm DNA fragmentation? | Male Fertility | 2023 | Male Fertility |
|
Human blastocysts uptake extracellular vesicles secreted by endometrial cells containing miRNAs related to implantation. | Endometrial receptivity | 2023 | Endometrial receptivity |
|
Impaired telomere pathway and fertility in Senescence-Accelerated Mice Prone 8 females with reproductive senescence. | Aging and rejuvenation | 2023 | Aging and rejuvenation;Other |
|
Implementing preconception expanded carrier screening in a universal healthcare system: a model-based cost-effectiveness analysis. | Other | 2023 | Other |
|
Improving success rates by applying interventions in clinical practice and measuring their impact: a multicenter retrospective analysis of more than 240,000 cycles | IVF Clinical | 2023 | IVF Clinical;Other |
|
Incidence and severity of ovarian hyperstimulation syndrome (OHSS) in high responders after gonadotropin-releasing hormone (GnRH) agonist trigger in "freeze-all" approach. | Reproductive disorders | 2023 | Reproductive disorders;Female Fertility |
|
Increased cytotoxic natural killer cells in the endometrium alone cannot be considered the immunological cause of recurrent miscarriage | Endometrial receptivity | 2023 | Endometrial receptivity; Immunology |
|
Influence of telomerase activity and initial distribution on human follicular aging: Moving from a discrete to a continuum model | Female fertility | 2023 | Female fertility; Other |
|
Investigating the significance of segmental aneuploidy findings in preimplantation embryos | Pre-Implantation genetics | 2023 | Pre-Implantation genetics |
|
Is Medroxiprogesterone acetate an adequate alternative to GnRH-antagonist in oocyte vitrification for social fertility preservation and preimplantation genetic testing for aneuploidy cycles? | IVF Clinical | 2023 | IVF Clinical;Female Fertility |
|
Lesbian shared IVF: the ROPA method: a systematic review. | IVF Clinical | 2023 | IVF Clinical;Other |
|
Live birth rates following individualized dosing algorithm of follitropin delta in a long GnRH agonist protocol | IVF Clinical | 2023 | IVF Clinical |
|
Living donor uterus transplant in the UK: A case report. | Surgery | 2023 | Surgery;Reproductive disorders |
|
Local intra-endometrial estrogen biosynthesis leading to progesterone resistance impacts implantation in adenomyosis and endometriosis. | Reproductive disorders | 2023 | Reproductive disorders;Female Fertility |
|
Long-term effect of chemotherapy after ovarian decortication on the ovarian function in women surviving cancer. | Female fertility | 2023 | Female fertility;other |
|
Metaphase-II oocyte competence is unlinked to the gonadotrophins used for ovarian stimulation: a matched case-control study in women of advanced maternal age. | 2023 | ||
|
Mini donacion. Qué podemos esperar con menos de 8 ovocitos | Female fertility | 2023 | Female fertility |
|
Mosaic results after preimplantation genetic testing for aneuploidy may be accompanied by changes in global gene expression. | Pre-Implantation genetics | 2023 | Pre-Implantation genetics |
|
Myo-inositol, probiotics and micronutrient supplement: A double-edged sword for the elevated BMI population attempting conception | Other | 2023 | Other;Female Fertility |
|
Natural killer cell subsets in endometrial fluid: a pilot study of their association with the endometrial cycle and reproductive parameters. | Endometrial receptivity | 2023 | Endometrial receptivity |
|
Nature (almost) always prevails - challenging the status quo of artificial frozen embryo transfers | Cryobiology | 2023 | Cryobiology |
|
New insights into the non-equivalence of the maternal and paternal genomes during the first few days of life | Epigenetics | 2023 | Epigenetics |
|
Obstetrical and Perinatal Outcomes Are Not Associated with Advanced Paternal Age in IVF or ICSI Pregnancies with Autologous Oocytes. | Male Fertility | 2023 | Male Fertility |
|
Oocyte in vitro maturation does not adversely affect chromosome segregation during the first meiotic division: a prospective study assessing culture in the presence or absence of autologous cumulus cells | IVF Laboratory | 2023 | IVF Laboratory |
|
Optimization of human semen analysis using CASA-Mot technology. | Technology development | 2023 | Technology development |
|
Ovarian rescue in women with premature ovarian insufficiency: facts and fiction | Aging and rejuvenation | 2023 | Aging and rejuvenation; Female Fertility |
|
Perinatal outcomes in lesbian couples employing shared motherhood IVF compared with those performing artificial insemination with donor sperm. | Female fertility | 2023 | Female fertility;IVF clinical |
|
PGT-HLA programmes for the cure of a sick sibling: clinical strategies for this challenging search | Pre-Implantation genetics | 2023 | Pre-Implantation genetics |
|
Phytoestrogens Present in Follicular Fluid and Urine Are Positively Associated with IVF Outcomes following Single Euploid Embryo Transfer. | Other | 2023 | Other |
|
Predicting the likelihood of live birth: an objective and user-friendly blastocyst grading system | IVF Laboratory | 2023 | IVF Laboratory |
|
Preimplantation genetic testing for aneuploidy is not related to adverse obstetric and neonatal outcomes in singleton pregnancies. | Pre-Implantation genetics | 2023 | Pre-Implantation genetics |
|
Progesterone in HRT-FET cycles: a game of hide and seek. | IVF clinical | 2023 | IVF clinical;Female Fertility |
|
RECURRENT IMPLANTATION FAILURE (RIF): REALITY OR A STATISTICAL MIRAGE? Consensus statement from the July 1, 2022 Lugano Workshop on repeated implantation failures (RIF) | Endometrial receptivity | 2023 | Endometrial receptivity; Other |
|
Reply of the Authors: Recurrent implantation failure: reality or a statistical mirage? | Other | 2023 | Other;Pre-Implantation genetics |
|
Reproductive outcomes of oocyte donation in patients with uterine Müllerian anomalies. | Reproductive disorders | 2023 | Reproductive disorders |
|
Safety of assisted reproductive techniques in gynecological cancer patients. | IVF Clinical | 2023 | IVF Clinical;Other |
|
Screening for diminished ovarian reserve in Portugal: a cost-saving answer to shorten the fertility journey. | IVF Clinical | 2023 | IVF Clinical |
|
Semen processing using MACS before ICSI deemed safe towards obstetric and perinatal outcomes of cycles using either donated or autologous oocytes: a retrospective multicentre study. | IVF Laboratory | 2023 | IVF Laboratory; Male Fertility |
|
Shared in vitro fertilization among female couples: clinical outcomes of the Reception of Oocytes from the Partner (ROPA) method | IVF Clinical | 2023 | IVF Clinical;Female Fertility |
|
Should embryo rebiopsy be considered a regular strategy to increase the number of embryos available for transfer? | Pre-Implantation genetics | 2023 | Pre-Implantation genetics |
|
Single intraovarian dose of stem cell- and platelet-secreted factors mitigates age-related ovarian infertility in a murine model. | Stem cells | 2023 | Stem cells; Aging and rejuvenation |
|
Single-cell multi-omic analysis profiles defective genome activation and epigenetic reprogramming associated with human pre-implantation embryo arrest | Epigenetics | 2023 | Epigenetics |
|
Sperm epigenetics landscape: correlation with embryo quality, reproductive outcomes and offspring's health. | Epigenetics | 2023 | Epigenetics |
|
Technical Aspects and Clinical Limitations of Sperm DNA Fragmentation Testing in Male Infertility: A Global Survey, Current Guidelines, and Expert Recommendations. | Male Fertility | 2023 | Male Fertility |
|
The destinies of human embryos reaching blastocyst stage between Day 4 and Day 7 diverge as early as fertilization. | IVF Laboratory | 2023 | IVF Laboratory |
|
The Distribution of High and Low-Level Mosaicism and Maternal Age: Lessons and Hesitations | Pre-Implantation genetics | 2023 | Pre-Implantation genetics |
|
The effect of dietary habits on oocyte/sperm quality. | Female fertility | 2023 | Female fertility;Male Fertility |
|
The first mitotic division: a perilous bridge connecting the zygote and the early embryo | Pre-Implantation genetics | 2023 | Pre-Implantation genetics |
|
The HERA (Hyper-response Risk Assessment) Delphi consensus definition of hyper-responders for in-vitro fertilization. | Female fertility | 2023 | Female fertility;IVF clinical |
|
The HERA (Hyper-response Risk Assessment) Delphi consensus for the management of hyper-responders in in vitro fertilization. | Female fertility | 2023 | Female fertility |
|
The human periconceptional maternal-embryonic space in health and disease. | Endometrial receptivity | 2023 | Endometrial receptivity;Female Fertility |
|
The Impact of Essential Trace Elements on Ovarian Response and Reproductive Outcomes following Single Euploid Embryo Transfer. | Other | 2023 | Other;Female Fertility |
|
The international transportation of frozen embryos does not affect IVF outcomes. | Cryobiology | 2023 | Cryobiology |
|
The NR2F2-HAND2 signaling axis regulates progesterone actions in the uterus at early pregnancy. | Endometrial receptivity | 2023 | Endometrial receptivity;Other |
|
The patient or the blastocyst; which leads the perfect outcome prediction? | IVF Clinical | 2023 | IVF Clinical |
|
The Prevalence of Sporadic and Recurrent Pregnancy Loss | Female fertility | 2023 | Female fertility |
|
The Ratio of Serum Progesterone (P4) to the Number of Follicles (P4/follicle) is a More Objective Parameter for Euploidy Rate as Compared to Systemic Progesterone Levels. | Pre-Implantation genetics | 2023 | Pre-Implantation genetics;Female Fertility |
|
The role of genetic testing in suspected fulminant myocarditis: A case report | Other | 2023 | Other |
|
The role of thrombophilias in reproduction: A swot analysis. | 2023 | ||
|
Time-Lapse Imaging. Morphokinetic analysis of In Vitro Fertilization outcomes. | IVF Laboratory | 2023 | IVF Laboratory |
|
Treatment options for endometrial hypoproliferation. | Reproductive disorders | 2023 | Reproductive disorders |
|
Usability, accuracy, and cost-effectiveness of a medical software for early pregnancies: a retrospective study. | Technology development | 2023 | Technology development |
|
Use of gonadotropins in ovarian stimulation in Spain: Delphi consensus. | Female fertility | 2023 | Female fertility |
|
Using Unlabeled Information of Embryo Siblings from the Same Cohort Cycle to Enhance In Vitro Fertilization Implantation Prediction. | Technology development | 2023 | Technology development;IVF laboratory |
|
Vaginal progesterone for preventing preterm birth and adverse perinatal outcomes in twin gestations: a systematic review and meta-analysis | Female fertility | 2023 | Female fertility |
|
Avoid mixing apples and oranges: blastocysts diagnosed with uniform whole chromosome aneuploidies are reproductively incompetent and their transfer is harmful. | 2022 | ||
|
ESHRE survey results and good practice recommendations on managing chromosomal mosaicism. | 2022 | ||
|
Evidence of Paraoxonases 1, 2, and 3 Expression in Human Ovarian Granulosa Cells. | Other | 2022 | Other |
|
Neither rationale nor scientific evidence exist to support that double stimulation is potentially unsafe. | 2022 | ||
|
Response to: Is mild stimulation the way forward? | 2022 | ||
|
The Addition of Dydrogesterone after Frozen Embryo Transfer in Hormonal Substituted Cycles with Low Progesterone Levels. | 2022 | ||
|
#ESHREjc report: Discrete choice experiments and patient decision-making in ART. | 2022 | ||
|
#ESHREjc report: seeing is believing! How time lapse imaging can improve IVF practice and take it to the future clinic. | IVF laboratory | 2022 | IVF laboratory |
|
A critical appraisal of safety data of dydrogesterone for the support of early pregnancy: a scoping review and meta-analysis | IVF clinical | 2022 | IVF clinical;Other |
|
A double-blind randomized controlled trial investigating a time-lapse algorithm for selecting Day 5 blastocysts for transfer. | 2022 | ||
|
A non-invasive artificial intelligence approach for the prediction of human blastocyst ploidy: a retrospective model development and validation study. | IVF laboratory | 2022 | IVF laboratory |
|
A propensity score-based, comparative study assessing humid and dry time-lapse incubation, with single-step medium, on embryo development and clinical outcomes. | IVF laboratory | 2022 | IVF laboratory |
|
A randomized, non-inferiority trial on the DuoStim strategy in PGT-A cycles | Female fertility | 2022 | Female fertility;Pre-Implantation genetics |
|
A randomized, controlled, first-in-patient trial of choriogonadotropin beta added to follitropin delta in women undergoing ovarian stimulation in a long GnRH agonist protocol. | Female fertility | 2022 | Female fertility |
|
Adenomyosis decreases the live birth rate but may not affect perinatal outcomes in assisted reproductive cycles. | Reproductive disorders | 2022 | Reproductive disorders |
|
Adjustment of progesterone administration after endometrial transcriptomic analysis does not improve reproductive outcomes in women with adenomyosis | Reproductive disorders | 2022 | Reproductive disorders;Endometrial receptivity |
|
Age-related fertility decline: is there a role for elective ovarian tissue cryopreservation? | Female fertility | 2022 | Female fertility;Aging and rejuvenation |
|
AKAP13 Enhances CREB1 Activation by FSH in Granulosa Cells. | Female fertility | 2022 | Female fertility;Other |
|
Antisperm Antibody Testing: A Comprehensive Review of Its Role in the Management of Immunological Male Infertility and Results of a Global Survey of Clinical Practices. | Male fertility | 2022 | Male fertility |
|
Are commercial warming kits interchangeable for vitrified human blastocysts? Further evidence for the adoption of a Universal Warming protocol. | 2022 | ||
|
Association between number of oocytes and cumulative live birth rate: a systematic review | IVF clinical | 2022 | IVF clinical |
|
Association of hysterectomy and invasive epithelial ovarian and tubal cancer: a cohort study within UKCTOCS. | Surgery | 2022 | Surgery |
|
Automatic characterization of human embryos at day 4 post-insemination from time-lapse imaging using supervised contrastive learning and inductive transfer learning techniques | IVF laboratory | 2022 | IVF laboratory;Technology development |
|
Bioengineering trends in female reproduction: a systematic review. | Other | 2022 | Other;Female fertility |
|
BMI and miscarriage after IVF. | Female fertility | 2022 | Female fertility |
|
Breaking the ageing paradigm in endometrium: endometrial gene expression related to cilia and ageing hallmarks in women over 35 years. | Endometrial receptivity | 2022 | Endometrial receptivity |
|
Calcifediol (25OHD) Deficiency and Its Treatment in Women's Health and Fertility. | Other | 2022 | Other;Reproductive disorders |
|
Calcium Ionophore A23187 treatment to rescue unfertilized oocytes: a prospective randomized analysis of sibling oocytes | Female fertility | 2022 | Female fertility |
|
Clinical Opinion: The diagnosis and management of suspected fetal growth restriction: an evidence-based approach. | Other | 2022 | Other |
|
Clinical, obstetric and perinatal outcomes after vitrified-warmed euploid blastocyst transfer are independent of cryo-storage duration. | 2022 | ||
|
Commercial Surrogacy: An Overview. | IVF clinical | 2022 | IVF clinical |
|
Common genetic variation in KATNAL1 non-coding regions is involved in the susceptibility to severe phenotypes of male infertility. | Male fertility | 2022 | Male fertility |
|
Common Variation in the PIN1 Locus Increases the Genetic Risk to Suffer from Sertoli Cell-Only Syndrome | Reproductive disorders | 2022 | Reproductive disorders;Male Fertility |
|
Comparative single-cell transcriptomic profiles of human androgenotes and parthenogenotes during early development. | IVF laboratory | 2022 | IVF laboratory |
|
Considerations on the use of carrier screening testing in human reproduction: comparison between recommendations from the Italian Society of Human Genetics and other international societies. | Other | 2022 | Other;IVF clinical |
|
Correction to: Therapy with probiotics and synbiotics for polycystic ovarian syndrome: a systematic review and meta‑analysis. | Reproductive disorders | 2022 | Reproductive disorders;Female fertility |
|
Correction: Embryos of Robertsonian Translocation Carriers Exhibit a Mitotic Interchromosomal Effect That Enhances Genetic Instability during Early Development. | Pre-Implantation genetics | 2022 | Pre-Implantation genetics |
|
COVID-19 mRNA vaccines have no impact on endometrial receptivity after euploid embryo transfer | Endometrial receptivity | 2022 | Endometrial receptivity;Other |
|
Deciphering the Role of Histone Modifications in Uterine Leiomyoma: Acetylation of H3K27 Regulates the Expression of Genes Involved in Proliferation, Cell Signaling, Cell Transport, Angiogenesis and Extracellular Matrix Formation. | Epigenetics | 2022 | Epigenetics |
|
Decreased Expression of Sam68 Is Associated with Insulin Resistance in Granulosa Cells from PCOS Patients. | 2022 | ||
|
Distress response in granulosa cells of women affected by PCOS with or without insulin resistance. | Reproductive disorders | 2022 | Reproductive disorders;Female fertility |
|
Does morphological assessment predict oocyte developmental competence? A systematic review and proposed score. | 2022 | ||
|
Effect of A23187 ionophore treatment on human blastocyst development-a sibling oocyte study. | IVF laboratory | 2022 | IVF laboratory;IVF clinical |
|
Effect of male sexual abstinence on reproductive outcomes | Male fertility | 2022 | Male fertility |
|
Effect of rLH Supplementation during Controlled Ovarian Stimulation for IVF: Evidence from a Retrospective Analysis of 1470 Poor/Suboptimal/Normal Responders Receiving Either rFSH plus rLH or rFSH Alone. | 2022 | ||
|
Effect of Sperm Selection by Magnetic-Activated Cell Sorting in D-IUI: A Randomized Control Trial | Male fertility | 2022 | Male fertility |
|
Effects of age and oligoasthenozoospermia on telomeres of sperm and blood cells. | Male fertility | 2022 | Male fertility;Other |
|
Embolic Microspheres Observed during Metroplasty | Surgery | 2022 | Surgery;Reproductive disorders |
|
Endocrine-Disrupting Chemicals, Gut Microbiota, and Human (In)Fertility-It Is Time to Consider the Triad. | 2022 | ||
|
Endometrial Cells Acutely Exposed to Phthalates In Vitro Do Not Phenocopy Endometriosis. | Reproductive disorders | 2022 | Reproductive disorders |
|
Endometrial gene expression differences in women with COVID-19. | Endometrial receptivity | 2022 | Endometrial receptivity |
|
Endometriosis Increases the Risk of Placenta Previa in Both IVF Pregnancies and the General Obstetric Population. | Reproductive disorders | 2022 | Reproductive disorders |
|
Erectile dysfunction as a marker of endocrine and glycemic disorders. | 2022 | ||
|
Establishment of Adenomyosis Organoids as a Preclinical Model to Study Infertility. | Reproductive disorders | 2022 | Reproductive disorders;Female fertility |
|
European policies on same-sex relationships, adoption and assisted reproduction | Other | 2022 | Other |
|
Extended embryo culture up to 14 days | IVF laboratory | 2022 | IVF laboratory |
|
Extracellular vesicles secreted by adenomyosis endometrial organoids contain miRNAs involved in adenomyosis progression, embryo implantation failure, and pregnancy complications | Reproductive disorders | 2022 | Reproductive disorders;IVF Clinical |
|
Female Infertility Is Associated with an Altered Expression Profile of Different Members of the Tachykinin Family in Human Granulosa Cells. | Female fertility | 2022 | Female fertility;Other |
|
Fertility counseling in women with hereditary cancer syndromes. | 2022 | ||
|
Fertility sparing treatment in patients with endometrial cancer (FERT-ENC): a multicentric retrospective study from the Spanish Investigational Network Gynecologic Oncology Group (SPAIN-GOG). | Female fertility | 2022 | Female fertility;Other |
|
Fertilization signatures as biomarkers of embryo quality. | 2022 | ||
|
Fine-tuning IVF laboratory key performance indicators of the Vienna consensus according to female age. | 2022 | ||
|
Follicular activation in women previously diagnosed with poor ovarian response: a randomized, controlled trial | Aging and rejuvenation | 2022 | Aging and rejuvenation;Female fertility |
|
Future Challenges and Opportunities of Extracellular Matrix Hydrogels in Female Reproductive Medicine | Other | 2022 | Other |
|
Gonadotropin receptor polymorphisms (FSHR N680S and LHCGR N312S) are not predictive of clinical outcome and live birth in assisted reproductive technology | Female fertility | 2022 | Female fertility |
|
GPX3 Overexpression in Cumulus Cells Entails a Poor Prognosis for Uterine Implantation of Morphotype A Embryos. | 2022 | ||
|
Have we been a little overly receptive? | Endometrial receptivity | 2022 | Endometrial receptivity |
|
How slow is too slow? A comprehensive portrait of Day 7 blastocysts and their clinical value standardized through artificial intelligence. | 2022 | ||
|
Human 1PN and 3PN zygotes recapitulate all morphokinetic events of normal fertilization but reveal novel developmental errors. | 2022 | ||
|
Human blastocyst spontaneous collapse is associated with worse morphological quality and higher degeneration and aneuploidy rates: a comprehensive analysis standardized through artificial intelligence. | 2022 | ||
|
Human kinematic and morphometric sperm subpopulation analysis using CASA technology: A new approach to spermatozoa classification | Male fertility | 2022 | Male fertility |
|
Human umbilical cord platelet-rich plasma to treat endometrial pathologies: methodology, composition and pre-clinical models. | Endometrial receptivity | 2022 | Endometrial receptivity;Reproductive disorders |
|
Hysterosalpingography (HSG) is obsolete: Hysterosalpingo-contrast foam sonography (HyFoSy) should be the alternative | Other | 2022 | Other;Female fertility |
|
Immune and spermatogenesis-related loci are involved in the development of extreme patterns of male infertility. | Male fertility | 2022 | Male fertility |
|
Impact of administration route on serum progesterone levels in women undergoing artificial endometrial preparation | Female fertility | 2022 | Female fertility |
|
Impact of COVID-19 on Infertility Treatments: Not Even a Global Pandemic Was Strong Enough to Hamper Successful Pregnancies | IVF clinical | 2022 | IVF clinical |
|
Impact of parental chromosomal polymorphisms on the incidence of congenital anomalies and perinatal complications in a cohort of newborns conceived after ICSI + PGT-A. | Pre-Implantation genetics | 2022 | Pre-Implantation genetics |
|
Impact of Varicocele Repair on Semen Parameters in Infertile Men: A Systematic Review and Meta-Analysis. | Male fertility | 2022 | Male fertility;Surgery |
|
Integrative analysis of the DNA methylome and transcriptome in uterine leiomyoma shows altered regulation of genes involved in metabolism, proliferation, extracellular matrix and vesicles. | Epigenetics | 2022 | Epigenetics;Reproductive disorders |
|
Inter-centre reliability in embryo grading across several IVF clinics is limited: implications for embryo selection. | 2022 | ||
|
Intracytoplasmic sperm injection for all or for a few? | IVF clinical | 2022 | IVF clinical |
|
IVF/ICSI cumulative live birth rates per consumed oocyte remain comparable regardless of sperm DNA fragmentation by TUNEL | Male fertility | 2022 | Male fertility |
|
Lights and shadows of preimplantation genetic testing for aneuploidy: better focusing on the accurate report of nonmosaic aneuploidies. | 2022 | ||
|
Limits imposed by the experimental design of a large prospective non-inferiority study on PGT-A invalidate many of the conclusions. | Pre-Implantation genetics | 2022 | Pre-Implantation genetics |
|
Maternal effect factors that contribute to oocytes developmental competence: an update. | 2022 | ||
|
Mercury impairs human primary endometrial stromal cell function. | Endometrial receptivity | 2022 | Endometrial receptivity |
|
microRNA-based signatures obtained from endometrial fluid identify implantative endometrium. | Endometrial receptivity | 2022 | Endometrial receptivity |
|
Mitochondrial dysfunction caused by targeted deletion of Mfn1 does not result in telomere shortening in oocytes. | Female fertility | 2022 | Female fertility;other |
|
Monozygotic twin rate among ART centers: a multicenter analysis of data from 18 Italian units. | 2022 | ||
|
Mosaic Embryo Transfer: A cautionary tale | Pre-Implantation genetics | 2022 | Pre-Implantation genetics |
|
Multi- and Transgenerational Effects of Environmental Toxicants on Mammalian Reproduction. | 2022 | ||
|
Multiyear outcomes using sibling oocytes demonstrates safety and efficacy of a simplified culture system consistent with use in a low-cost IVF setting. | IVF laboratory | 2022 | IVF laboratory |
|
No evidence for age-related differences in mtRNA quality in the female germline. | Other | 2022 | Other |
|
Not in the same patient population but on the same topic. The ERA test has not proven clinically useful to improve implantation yet, and our data support this fact. | Endometrial receptivity | 2022 | Endometrial receptivity;IVF Clinical |
|
Obese women exhibit reduced serum progesterone levels on the day of embryo transfer in artificially prepared cycles involving administration of vaginal progesterone | Female fertility | 2022 | Female fertility |
|
On the reproductive capabilities of aneuploid human preimplantation embryos. | Pre-Implantation genetics | 2022 | Pre-Implantation genetics |
|
Oocyte aging: looking beyond chromosome segregation errors. | 2022 | ||
|
Oocyte vitrification for elective fertility preservation: a SWOT analysis | Cryobiology | 2022 | Cryobiology;Female fertility |
|
Originator recombinant human follitropin alfa versus recombinant human follitropin alfa biosimilars in Spain: a cost-effectiveness analysis of assisted reproductive technology related to fresh embryo transfers | Female fertility | 2022 | Female fertility;IVF clinical |
|
Ovarian reserve parameters and IVF outcomes in 510 women with poor ovarian response (POR) treated with intraovarian injection of autologous platelet rich plasma (PRP). | Aging and rejuvenation | 2022 | Aging and rejuvenation;Female fertility |
|
Ovarian rescue in women with premature ovarian insufficiency (POI): facts and fiction | Aging and rejuvenation | 2022 | Aging and rejuvenation |
|
Patient tailored infertility care is the way forward | Other | 2022 | Other;IVF Clinical |
|
Perinatal outcome of babies born after using a simplified IVF culture system versus ICSI with sibling oocytes: a prospective cohort study. | IVF laboratory | 2022 | IVF laboratory |
|
Perinatal outcomes in children born after fresh or frozen embryo transfer using donated oocytes. | Cryobiology | 2022 | Cryobiology |
|
Personalized Nutrition in the Management of Female Infertility: New Insights on Chronic Low-Grade Inflammation. | 2022 | ||
|
Physical activity and sperm quality: influence in sperm donors. | Male fertility | 2022 | Male fertility |
|
Pituitary suppression with GnRH agonists (GnRHa) before ART may be insufficient to treat women with severe adenomyosis: Evidence from a case series | Reproductive disorders | 2022 | Reproductive disorders;Female fertility |
|
Polycystic ovarian syndrome and miscarriage in IVF: systematic revision of the literature and meta-analysis. | Reproductive disorders | 2022 | Reproductive disorders;Female fertility |
|
Post-Vasectomy Semen Analysis: Optimizing Laboratory Procedures and Test Interpretation through a Clinical Audit and Global Survey of Practices. | Male fertility | 2022 | Male fertility |
|
Predicted COVID-19 molecular effects on endometrium reveal key dysregulated genes and functions. | Endometrial receptivity | 2022 | Endometrial receptivity |
|
Predicting embryonic aneuploidy rate in IVF patients using whole-exome sequencing. | Pre-Implantation genetics | 2022 | Pre-Implantation genetics |
|
Prediction of ovarian response using the automated Elecsys AMH assay in gonadotropin-releasing hormone antagonist cycles | Female fertility | 2022 | Female fertility |
|
Predictive value of seminal oxidation-reduction potential (ORP) analysis for reproductive outcomes of intracytoplasmic sperm injection (ICSI) cycles | Male fertility | 2022 | Male fertility |
|
Prevention of multiple pregnancies in gonadotropin-insemination cycles. | IVF clinical | 2022 | IVF clinical;Female fertility |
|
Probability of Pregnancy With Mono vs Multiple Folliculogenesis in Women With Unexplained Infertility. | Female fertility | 2022 | Female fertility |
|
Relationship between air bubble location at embryo transfer and implantation and ongoing pregnancy rates | Other | 2022 | Other;Female fertility |
|
Reply of the Authors: B-cell Lymphoma 6 (BCL6) Testing Before In Vitro Fertilization as a Predictor of Failure | Other | 2022 | Other |
|
Role of Mitochondria Transfer in Infertility: A Commentary. | Female fertility | 2022 | Female fertility |
|
ROPA – Lesbian Shared in vitro fertilization – Ethical aspects | Female fertility | 2022 | Female fertility;Other |
|
Seasonal variation in semen quality is not associated with fecundity in the Utah Population Database. | Male fertility | 2022 | Male fertility |
|
Second stimulation in the same ovarian cycle: an option to fully-personalize the treatment in poor prognosis patients undergoing PGT-A. | 2022 | ||
|
Serum progesterone concentrations are reduced in obese women on the day of embryo transfer | Female fertility | 2022 | Female fertility |
|
Should patients be screened for chronic endometritis before assisted reproductive technology? | Reproductive disorders | 2022 | Reproductive disorders |
|
Should You Trust Intuition or An Online Algorithm to Aid in the Diagnosis Of Ectopic Pregnancy? | Other | 2022 | Other |
|
Similar reproductive outcomes between lesbian-shared IVF (ROPA) and IVF with autologous oocytes | Female fertility | 2022 | Female fertility |
|
Spatiotemporal perturbations of pronuclear breakdown preceding syngamy affect early human embryo development: a retrospective observational study. | 2022 | ||
|
Sperm aminopeptidase N identifies the potential for high-quality blastocysts and viable embryos in oocyte-donation cycles. | Male fertility | 2022 | Male fertility |
|
Sperm DNA fragmentation and microfluidics: A new era in human sperm selection | Male fertility | 2022 | Male fertility |
|
Sperm deoxyribonucleic acid fragmentation (by terminal deoxynucleotidyl transferase biotin dUTP nick end labeling assay) does not impair reproductive success measured as cumulative live birth rates per donor metaphase II oocyte used | Male fertility | 2022 | Male fertility |
|
Standards in semen examination: publishing reproducible and reliable data based on high-quality methodology. | Male fertility | 2022 | Male fertility |
|
Switching to testicular sperm after a previous ICSI failure with ejaculated sperm significantly improves blastocyst quality without increasing aneuploidy risk. | Male fertility | 2022 | Male fertility;Pre-Implantation genetics |
|
Targeted Deletion of Mitofusin 1 and Mitofusin 2 Causes Female Infertility and Loss of Follicular Reserve. | Female fertility | 2022 | Female fertility |
|
Telomeres and oocyte maturation rate are not reduced by COVID-19 except in severe cases. | Male fertility | 2022 | Male fertility;Aging and rejuvenation |
|
Telomeres, aging and reproduction. | Aging and rejuvenation | 2022 | Aging and rejuvenation |
|
The actual impact of SARS-CoV-2/COVID-19 pandemic on IVF activity: a survey across Italian ART centers. | 2022 | ||
|
The case for mild stimulation for IVF: recommendations from The International Society for Mild Approaches in Assisted Reproduction. | IVF clinical | 2022 | IVF clinical;Female fertility |
|
The chances of obtaining a euploid embryo and subsequent live birth remain consistent with national age-based rates after an in vitro fertilization cycle that produced only aneuploid embryos. | Pre-Implantation genetics | 2022 | Pre-Implantation genetics |
|
The effect of extended cryo-storage following vitrification on embryo competence: a systematic review and meta-analysis. | 2022 | ||
|
The effect of polymorphisms in FSHR gene on late follicular phase progesterone and estradiol serum levels in predicted normoresponders. | Female fertility | 2022 | Female fertility |
|
The Effect of Uterine Adenomyosis on IVF Outcomes: a Systematic Review and Meta-analysis. | Reproductive disorders | 2022 | Reproductive disorders;Female fertility |
|
The higher the score, the better the clinical outcome: retrospective evaluation of automatic embryo grading as a support tool for embryo selection in IVF laboratories. | IVF laboratory | 2022 | IVF laboratory |
|
The journey from oogenesis to implantation and beyond: a special issue of JARG by the Italian Society of Embryology, Reproduction and Research (SIERR). | 2022 | ||
|
The Pathway of Female Couples in a Fertility Clinic | Female fertility | 2022 | Female fertility |
|
The Role of Antihyperglycemic Drugs and Diet on Erectile Function: Results from a Perspective Study on a Population with Prediabetes and Diabetes. | 2022 | ||
|
The role of endometrial staining for CD138 as a marker of chronic endometritis in predicting live birth. | Endometrial receptivity | 2022 | Endometrial receptivity;IVF clinical |
|
The role of thrombophilias in reproduction: a SWOT analysis | Other | 2022 | Other;Reproductive disorders |
|
The role of thyroid function in female and male infertility: a narrative review. | 2022 | ||
|
The type of SARS-CoV-2 vaccine does not affect ovarian function in assisted reproduction cycle. | IVF clinical | 2022 | IVF clinical;Female fertility |
|
The use of intraovarian injection of autologous platelet rich plasma (PRP) in patients with poor ovarian response and premature ovarian insufficiency. | Aging and rejuvenation | 2022 | Aging and rejuvenation;Reproductive disorders |
|
Time-Lapse Systems: A Comprehensive Analysis on Effectiveness. | IVF laboratory | 2022 | IVF laboratory |
|
Timing of Delivery for Twins With Growth Discordance and Growth Restriction: An Individual Participant Data Meta-analysis. | Other | 2022 | Other |
|
To freeze or not to freeze for elective fertility preservation | Cryobiology | 2022 | Cryobiology |
|
Transcriptomic landscape of granulosa cells and peripheral blood mononuclear cells in women with PCOS compared to young poor responders and women with normal response. | Reproductive disorders | 2022 | Reproductive disorders;Female fertility |
|
Transient non-cyclical activity of external myometrium: consider this to avoid errors in diagnosis of adenomyosis and uterine anomalies. | Other | 2022 | Other |
|
Ulipristal Acetate in Adenomyosis | Reproductive disorders | 2022 | Reproductive disorders |
|
Update on preimplantation genetic testing for aneuploidy and outcomes of embryos with mosaic results. | Pre-Implantation genetics | 2022 | Pre-Implantation genetics |
|
Use of mineral oil in IVF culture systems: physico-chemical aspects, management, and safety. | 2022 | ||
|
Use of the endometrial receptivity array to guide personalized embryo transfer after a failed transfer attempt was associated with a lower cumulative and per transfer live birth rate during donor and autologous cycles. | Endometrial receptivity | 2022 | Endometrial receptivity |
|
Uterine Transplantation in 2021: Recent Developments and the Future. | Surgery | 2022 | Surgery |
|
Vaginal progesterone for the prevention of preterm birth and adverse perinatal outcomes in twin gestations with a short cervix: an updated individual patient data meta-analysis. | Female fertility | 2022 | Female fertility |
|
We know to err (meiotically) is human, but do paternal factors impact paternal aneuploidy? | Male fertility | 2022 | Male fertility;Pre-Implantation genetics |
| Clinical application of sequencing-based methods for parallel preimplantation genetic testing for mitochondrial DNA disease and aneuploidy | Pre-Implantation genetics | 2021 | Pre-Implantation genetics | |
|
Corpus luteum score, a simple Doppler examination to prognose early pregnancies | IVF clinical | 2021 | IVF clinical |
|
Effects of Hydrosalpinx on Endometrial Implantation Failures: Evaluating Salpingectomy in Women Undergoing in vitro fertilization | IVF clinical | 2021 | IVF clinical;Endometrial receptivity;Surgery |
|
Eurycoma longifolia (Jack) Improves Serum Total Testosterone in Men: A Systematic Review and Meta-Analysis of Clinical Trials. | 2021 | ||
|
Fertility technologies and how to optimize laboratory performance to support the shortening of time to birth of a healthy singleton: a Delphi consensus. | 2021 | ||
|
Immunologic causes and thrombophilia in recurrent pregnancy loss | Immunology | 2021 | Immunology;Reproductive disorders |
|
Impact of chronic endometritis in infertility: A SWOT analysis | Endometrial receptivity | 2021 | Endometrial receptivity;Reproductive disorders |
|
In vitro fertilization and andrology laboratories in 2030. | 2021 | ||
|
Maximizing live birth rates cannot be the only key performance indicator of IVF. | 2021 | ||
|
Noninvasive preimplantation genetic testing for aneuploidy exhibits high rates of deoxyribonucleic acid amplification failure and poor correlation with results obtained using trophectoderm biopsy | Pre-Implantation genetics | 2021 | Pre-Implantation genetics |
|
Noninvasive preimplantation genetic testing for aneuploidy in spent culture medium as a substitute for trophectoderm biopsy | Pre-Implantation genetics | 2021 | Pre-Implantation genetics |
| Number needed to freeze: cumulative live birth rate after fertility preservation in women with endometriosis | Cryobiology | 2021 | Cryobiology ;Reproductive disorders | |
|
Preimplantation genetic testing to evaluate for mitochondrial deoxyribonucleic acid disease and aneuploidy: a two-birds-with-one-stone approach | Pre-Implantation genetics | 2021 | Pre-Implantation genetics |
|
Recurrent implantation failure: how common is it? | IVF clinical | 2021 | IVF clinical;Reproductive disorders |
|
Reproductive Endocrinology and Infertility fellowship programs: Does one size fit all? | Other | 2021 | Other |
|
Role of the sperm, oocyte, and embryo in recurrent pregnancy loss | IVF laboratory | 2021 | IVF laboratory;Reproductive disorders |
|
Selection of fertilization strategies for different sperm parameters in vitro fertilization. | 2021 | ||
|
Stem Cell Paracrine Signaling for Treatment of Premature Ovarian Insufficiency | Aging and rejuvenation | 2021 | Aging and rejuvenation |
|
The efficacy of Zingiber officinale on dyslipidaemia, blood pressure, and inflammation as cardiovascular risk factors: A systematic review. | 2021 | ||
|
The journey toward personalized embryo selection algorithms | IVF laboratory | 2021 | IVF laboratory |
|
Vitamin D in human reproduction: some answers and many more questions | IVF clinical | 2021 | IVF clinical |
| "Quality is not an act, it is a habit." Reflection on the role of the fertilization rate in the quality control strategies of assisted reproduction treatments. | IVF laboratory | 2021 | IVF laboratory | |
|
"The back-up vasectomy reversal." Simultaneous sperm retrieval and vasectomy reversal in the couple with advanced maternal age: a cost-effectiveness analysis. | Male fertility | 2021 | Male fertility |
| (Pro)renin Receptor Is Present in Human Sperm and It Adversely Affects Sperm Fertility Ability | Male fertility | 2021 | Male fertility | |
|
[Risk of mayor and minor birth defects in children conceived by assisted reproductive technology (IVF/ICSI): A prospective controlled cohort study]. | Male fertility | 2021 | Male fertility |
| 5-aza-2'-deoxycitidine inhibits cell proliferation, extracellular matrix formation and Wnt/β-catenin pathway in human uterine leiomyomas. | 2021 | |||
|
A 300 IR sublingual tablet is an effective, safe treatment for house dust mite-induced allergic rhinitis: An international, double-blind, placebo-controlled, randomized phase III clinical trial | 2021 | ||
|
A Comparative Study to Assess the Efficacy of Two Different Estradiol Formulations during In Vitro Fertilization. | IVF clinical | 2021 | IVF clinical |
|
A global approach to addressing the policy, research and social challenges of male reproductive health | Other | 2021 | Other |
|
A multicenter, prospective, blinded, nonselection study evaluating the predictive value of an aneuploid diagnosis using a targeted next-generation sequencing-based preimplantation genetic testing for aneuploidy assay and impact of biopsy | 2021 | ||
|
A multi-centre international study of salivary hormone oestradiol and progesterone measurements in ART monitoring | 2021 | ||
|
A Natural Xenogeneic Endometrial Extracellular Matrix Hydrogel Toward Improving Current Human in vitro Models and Future in vivo Applications | IVF clinical | 2021 | IVF clinical;Pre-Implantation genetics;IVF laboratory |
|
A Natural Xenogeneic Endometrial Extracellular Matrix Hydrogel Toward Improving Current Human in vitro Models and Future in vivo Applications. | Endometrial receptivity | 2021 | Endometrial receptivity |
|
A review of the pathophysiology of recurrent implantation failure | IVF clinical | 2021 | IVF clinical |
|
A View from the past into our collective future: the oncofertility consortium vision statement | Endometrial receptivity | 2021 | Endometrial receptivity |
|
A View from the past into our collective future: the oncofertility consortium vision statement. | Cryobiology | 2021 | Cryobiology ;Female fertility |
|
A global approach to addressing the policy, research and social challenges of male reproductive health | Male fertility | 2021 | Male fertility |
|
An artificial intelligence model based on the proteomic profile of euploid embryos and blastocyst morphology: a preliminary study | 2021 | ||
|
Analysis of DNA variants in miRNAs and miRNA 3'UTR binding sites in female infertility patients | 2021 | ||
|
Analysis of female demographics in the United States: life expectancy, education, employment, family building decisions, and fertility service utilization | Endometrial receptivity | 2021 | Endometrial receptivity;Reproductive disorders |
|
Analysis of female demographics in the United States: life expectancy, education, employment, family building decisions, and fertility service utilization. | IVF clinical | 2021 | IVF clinical |
|
Analysis of serum and endometrial progesterone in determining endometrial receptivity. | Endometrial receptivity | 2021 | Endometrial receptivity;Reproductive disorders |
|
Antibacterial and Antifungal Activity of the Human Endometrial Fluid during the Natural Cycle. | 2021 | ||
|
Are we approaching automated assisted reproductive technology? Sperm analysis, oocyte manipulation and insemination | IVF clinical | 2021 | IVF clinical |
| Are we approaching automated assisted reproductive technology? Sperm analysis, Oocyte manipulation and insemination. | IVF laboratory | 2021 | IVF laboratory | |
|
Assessing efficacy of intravenous acetaminophen for perioperative pain control for oocyte retrieval: a randomized, double-blind, placebo-controlled trial | IVF clinical | 2021 | IVF clinical |
| Assessment of embryo implantation potential with a cloud-based automatic software | 2021 | |||
|
Association between clinical and IVF laboratory parameters and miscarriage after single euploid embryo transfers. | Pre-Implantation genetics | 2021 | Pre-Implantation genetics |
|
Avoiding Asherman’s syndrome: refining our approach to uterine evacuation | Pre-Implantation genetics | 2021 | Pre-Implantation genetics;IVF laboratory |
|
Bacterial vaginosis and its association with infertility, endometritis, and pelvic inflammatory disease | 2021 | ||
|
B-cell lymphoma 6 expression is not associated with live birth in a normal responder in vitro fertilization population | IVF clinical | 2021 | IVF clinical |
|
Bioengineered Endometrial Hydrogels with Growth Factors Promote Tissue Regeneration and Restore Fertility in Murine Models. | IVF clinical | 2021 | IVF clinical |
|
Blastocyst formation is similar in obese and normal weight women: a morphokinetic study. | IVF laboratory | 2021 | IVF laboratory;Reproductive disorders |
|
Blastulation rates of sibling oocytes in two IVF culture media: an evidence-based workflow to implement newly commercialized products. | 2021 | ||
|
Can measuring the luteal phase progesterone level bridge the divide between the Atlantic? | IVF clinical | 2021 | IVF clinical;Endometrial receptivity |
|
Cesarean Section Scar Nodule, Ovarian Cyst, and Dysmenorrhea. | Other | 2021 | Other |
|
Chemotherapy Can Interfere in Implantation in In-vitro Fertilization. | IVF clinical | 2021 | IVF clinical;Endometrial receptivity |
|
Circulating cytokines during the blastocyst peri-implantation period | Immunology | 2021 | Immunology;Endometrial receptivity |
|
Circulating cytokines during the blastocyst peri-implantation period. | Immunology | 2021 | Immunology;IVF laboratory |
|
Clinical validity and utility of preconception expanded carrier screening for the management of reproductive genetic risk in IVF and general population. | 2021 | ||
|
Comparison of different sources of platelet-rich plasma as treatment option for infertility-causing endometrial pathologies | 2021 | ||
|
Consistency in rates of diagnosis of embryonic mosaicism, segmental abnormalities, and "no call" results among experienced embryologists performing preimplantation genetic testing for aneuploidy. | Pre-Implantation genetics | 2021 | Pre-Implantation genetics;IVF laboratory |
|
Correction to: Diminished Ovarian Reserve Chemotherapy-Induced Mouse Model: A Tool for the Preclinical Assessment of New Therapies for Ovarian Damage | 2021 | ||
|
Correction to: Minimal ovarian stimulation is an alternative to conventional protocols for older women according to Poseidon's stratification: a retrospective multicenter cohort study. | IVF clinical | 2021 | IVF clinical |
|
Cryopreserved Gamete and Embryo Transport: Proposed Protocol and Form Templates-SIERR (Italian Society of Embryology, Reproduction, and Research). | 2021 | ||
|
Cumulative live birth rates in ICSI cycles with donated oocytes are not improved by magnetic-activated cell sorting: A retrospective study in unselected males | Male fertility | 2021 | Male fertility |
| Cytokines in embryonic secretome as potential markers for embryo selection | 2021 | |||
| Deciphering the role of PGRMC1 during human decidualization using an in vitro approach. | IVF clinical | 2021 | IVF clinical;Endometrial receptivity;Female fertility | |
| Development of Decellularized Oviductal Hydrogels as a Support for Rabbit Embryo Culture | IVF clinical | 2021 | IVF clinical | |
| Development of Decellularized Oviductal Hydrogels as a Support for Rabbit Embryo Culture. | Female fertility | 2021 | Female fertility | |
|
Diagnostic Accuracy Study Comparing Hysterosalpingo-Foam Sonography and Hysterosalpingography for Fallopian Tube Patency Assessment | Surgery | 2021 | Surgery;Other |
|
Diet and environmental factors affecting reproduction | Female fertility | 2021 | Female fertility;Reproductive disorders;Male fertility |
|
Different CO(2) settings (6.0% vs 7.0%) do have an impact on extracellular pH of culture medium (pHe) and euploidy rates rather than on blastocyst development: a sibling oocyte study. | IVF clinical | 2021 | IVF clinical;Endometrial receptivity |
| Differential effects of the immunosuppressive calcineurin inhibitors cyclosporine-A and tacrolimus on ovulation in a murine model | Other | 2021 | Other | |
| Differential sperm proteomic profiles according to pregnancy achievement in intracytoplasmic sperm injection cycles: a pilot study | Female fertility | 2021 | Female fertility | |
| Differential sperm proteomic profiles according to pregnancy achievement in intracytoplasmic sperm injection cycles: a pilot study. | Male fertility | 2021 | Male fertility | |
| Disease-inducing potential of two leukemic cell lines in a xenografting model | Other | 2021 | Other | |
| Disease-inducing potential of two leukemic cell lines in a xenografting model. | Aging and rejuvenation | 2021 | Aging and rejuvenation | |
|
DNase activity in human seminal plasma and follicular fluid and its inhibition by follicular fluid chelating agents. | 2021 | ||
| Do donor spermatozoa improve reproductive outcomes after oocyte donation failure? A retrospective analysis of cumulative live birth rates per donor oocyte consumed | IVF laboratory | 2021 | IVF laboratory | |
| Do donor spermatozoa improve reproductive outcomes after oocyte donation failure? A retrospective analysis of cumulative live birth rates per donor oocyte consumed. | Male fertility | 2021 | Male fertility;IVF laboratory | |
|
Do Pregnancy-Induced Brain Changes Reverse? The Brain of a Mother Six Years after Parturition | IVF clinical | 2021 | IVF clinical |
|
Do Pregnancy-Induced Brain Changes Reverse? The Brain of a Mother Six Years after Parturition. | Immunology | 2021 | Immunology;Endometrial receptivity |
|
Does Coenzyme Q10 Supplementation Improve Human Oocyte Quality? | IVF laboratory | 2021 | IVF laboratory;IVF clinical |
|
Dynamic assessment of human sperm DNA damage III: the effect of sperm freezing techniques | 2021 | ||
|
Early detection of pregnancy after in vitro fertilization and embryo transfer with hyperglycosylated hCG versus Elecsys HCG+β assay: the hyperPOC study | IVF clinical | 2021 | IVF clinical |
|
Early Pregnancy Outcomes in Fresh Versus Deferred Embryo Transfer Cycles for Endometriosis-Associated Infertility: A Retrospective Cohort Study | Pre-Implantation genetics | 2021 | Pre-Implantation genetics |
|
Early Pregnancy Outcomes in Fresh Versus Deferred Embryo Transfer Cycles for Endometriosis-Associated Infertility: A Retrospective Cohort Study. | Reproductive disorders | 2021 | Reproductive disorders;IVF clinical;Cryobiology |
|
Editorial: Assisted reproductive technology (ART) in a changing world | Reproductive disorders | 2021 | Reproductive disorders;IVF clinical;Cryobiology |
|
Editorial: Assisted reproductive technology (ART) in a changing world. | IVF clinical | 2021 | IVF clinical |
|
Editors' farewell. | Other | 2021 | Other |
| Educational needs of fertility health care professionals using assisted reproductive technologies: A multi-country mixed-methods study | 2021 | |||
|
Educational needs of fertility healthcare professionals using ART: a multi-country mixed-methods study. | 2021 | ||
|
Effect and in silico characterization of genetic variants associated with severe spermatogenic disorders in a large Iberian cohort | Other | 2021 | Other |
|
Effect and in silico characterization of genetic variants associated with severe spermatogenic disorders in a large Iberian cohort. | Male fertility | 2021 | Male fertility |
|
Effect of Dexamethasone Co-Treatment During Ovarian Stimulation in Women of Different Reproductive Age With Elevated Early Follicular Phase Progesterone Level: a Prospective Longitudinal Study. | IVF clinical | 2021 | IVF clinical |
|
Effects of age and oligosthenozoospermia on telomeres of sperm and blood cells | Male fertility | 2021 | Male fertility |
|
Effects of Hydrosalpinx on Endometrial Implantation Failures: Evaluating Salpingectomy in Women Undergoing in vitro fertilization. | 2021 | ||
| Elevated serum progesterone does not impact euploidy rates in PGT-A patients. | Pre-Implantation genetics | 2021 | Pre-Implantation genetics;IVF laboratory | |
|
Embryo morphokinetic score is associated with biomarkers of developmental competence and implantation. | 2021 | ||
|
Embryology outcomes after oocyte vitrification with super-cooled slush nitrogen are similar to outcomes with conventional liquid nitrogen: a randomized controlled trial | IVF laboratory | 2021 | IVF laboratory |
|
Embryos with mosaic results: busting the myth! | Pre-Implantation genetics | 2021 | Pre-Implantation genetics |
| Emerging follicular activation strategies to treat women with poor ovarian response and primary ovarian insufficiency | Other | 2021 | Other | |
| Emerging follicular activation strategies to treat women with poor ovarian response and primary ovarian insufficiency. | IVF clinical | 2021 | IVF clinical | |
|
Endometrial receptivity screening in the general assisted reproductive technology population | Other | 2021 | Other |
|
Endometrial receptivity screening in the general assisted reproductive technology population. | Endometrial receptivity | 2021 | Endometrial receptivity |
|
Endometrial scratching can be offered outside clinical research setting: let us show you why | Pre-Implantation genetics | 2021 | Pre-Implantation genetics |
|
Endometrial scratching can be offered outside clinical research setting: let us show you why. | Endometrial receptivity | 2021 | Endometrial receptivity;IVF clinical |
|
Endometriosis shows no impact on the euploid blastocyst rate per cohort of inseminated metaphase-II oocytes: A case-control study. | 2021 | ||
|
ESHRE guideline: medically assisted reproduction in patients with a viral infection/disease | IVF clinical | 2021 | IVF clinical |
|
Estrogen Replacement Therapy Induces Antioxidant and Longevity-Related Genes in Women after Medically Induced Menopause. | Other | 2021 | Other |
|
Euploidy prediction: possible or impossible? Closer or further away? | 2021 | ||
|
Euploidy rates are not affected when embryos are cultured in a continuous (CCM) or sequential culture medium (SCM): a sibling oocyte study | IVF laboratory | 2021 | IVF laboratory |
|
Euploidy rates are not affected when embryos are cultured in a continuous (CCM) or sequential culture medium (SCM): a sibling oocyte study. | IVF laboratory | 2021 | IVF laboratory |
| Evaluation of genome-wide DNA methylation profile of human embryos with different developmental competences | IVF clinical | 2021 | IVF clinical | |
| Evaluation of genome-wide DNA methylation profile of human embryos with different developmental competences. | Epigenetics | 2021 | Epigenetics;Pre-Implantation genetics | |
| EVALUATION OF THE TRANSCRIPTOMIC PROFILES OF CUMULUS CELLS ASSOCIATED WITH EUPLOID VERSUS WHOLE CHROMOSOME 21 ANEUPLOID EMBRYOS REVEALS DIFFERENTIALLY EXPRESSED GENES | 2021 | |||
|
Expanding the time interval between ovulation triggering and oocyte injection: does it affect the embryological and clinical outcome? | 2021 | ||
|
Extensive analysis of mitochondrial DNA quantity and sequence variation in human cumulus cells and assisted reproduction outcomes. | Reproductive disorders | 2021 | Reproductive disorders;IVF laboratory |
|
Female underweight and risk of ectopic pregnancy | 2021 | ||
|
Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives. | 2021 | ||
|
Fertility technologies and how to optimize laboratory performance to support the shortening of time to birth of a healthy singleton: a Delphi consensus | IVF clinical | 2021 | IVF clinical;IVF laboratory |
|
Fertilization rate as a novel indicator for cumulative live birth rate: a multicenter retrospective cohort study of 9,394 complete in vitro fertilization cycles. | 2021 | ||
|
Fetal nondiabetic-macrosomia: risk factors for pregnancy adverse outcome and comparison of two growth curves in the prediction of cesarean section | Pre-Implantation genetics | 2021 | Pre-Implantation genetics |
|
Fetal nondiabetic-macrosomia: risk factors for pregnancy adverse outcome and comparison of two growth curves in the prediction of cesarean section. | Other | 2021 | Other |
|
Fitz-Hugh-Curtis Syndrome: A Case Report | Other | 2021 | Other |
|
Focus on time-lapse analysis: blastocyst collapse and morphometric assessment as new features of embryo viability | IVF laboratory | 2021 | IVF laboratory |
| Frequent loss of heterozygosity in CRISPR-Cas9-edited early human embryos. | Pre-Implantation genetics | 2021 | Pre-Implantation genetics | |
|
Fresh embryo transfer results in altered placental epigenetic regulation: a rationale for frozen embryo transfer. | Epigenetics | 2021 | Epigenetics;IVF clinical;Cryobiology |
|
Fungi Sensitization in Spain: Importance of the Alternaria alternata Species and Its Major Allergen Alt a 1 in the Allergenicity. | Other | 2021 | Other |
|
Future challenges for clinical embryologists. | 2021 | ||
|
Genetic causes of preimplantation embryo developmental failure. | 2021 | ||
|
Global Methylome Scores Correlate with Histological Subtypes of Colorectal Carcinoma and Show Different Associations with Common Clinical and Molecular Features. | Other | 2021 | Other |
|
Growth hormone supplementation in women who are not poor responders | Cryobiology | 2021 | Cryobiology |
|
Growth hormone supplementation in women who are not poor responders. | IVF clinical | 2021 | IVF clinical |
|
Guidelines for biomarker discovery in endometrium: correcting for menstrual cycle bias reveals new genes associated with uterine disorders | Male fertility | 2021 | Male fertility |
|
Guidelines for biomarker discovery in endometrium: Correcting for menstrual cycle bias reveals new genes associated with uterine disorders. | Endometrial receptivity | 2021 | Endometrial receptivity;Reproductive disorders |
|
Histologic Analysis of Testes from Prepubertal Patients Treated with Chemotherapy Associates Impaired Germ Cell Counts with Cumulative Doses of Cyclophosphamide, Ifosfamide, Cytarabine, and Asparaginase | 2021 | ||
|
Histone deacetylase inhibition by suberoylanilide hydroxamic acid: a therapeutic approach to treat human uterine leiomyoma | Reproductive disorders | 2021 | Reproductive disorders |
|
How bilastine is used to treat allergic rhinitis and urticaria in children. | Other | 2021 | Other |
|
How fixed versus variable gonadotropin dose during controlled ovarian stimulation could influence the management of infertility patients undergoing IVF treatment: a national Delphi consensus. | 2021 | ||
|
How often should ring pessaries be removed or changed in women with advanced POP? A prospective observational study | IVF clinical | 2021 | IVF clinical;IVF laboratory |
|
How often should ring pessaries be removed or changed in women with advanced POP? A prospective observational study. | Other | 2021 | Other |
|
How to provide fertility treatment during COVID-19 pandemic | IVF laboratory | 2021 | IVF laboratory;Reproductive disorders |
|
How to provide fertility treatment during COVID-19 pandemic. | IVF clinical | 2021 | IVF clinical;IVF laboratory |
|
Human embryo polarization requires PLC signaling to mediate trophectoderm specification. | IVF laboratory | 2021 | IVF laboratory |
|
Identifying and optimizing human endometrial gene expression signatures for endometrial dating. | Endometrial receptivity | 2021 | Endometrial receptivity |
|
Impact of low serum progesterone levels on the day of embryo transfer on pregnancy outcome: a prospective cohort study in artificial cycles with vaginal progesterone | 2021 | ||
|
Impact of Plasmatic Progesterone on the Day of Frozen Embryo Transfer in Hormone-induced Cycles. | IVF clinical | 2021 | IVF clinical;Reproductive disorders |
| Improved Models of Human Endometrial Organoids Based on Hydrogels from Decellularized Endometrium. | Endometrial receptivity | 2021 | Endometrial receptivity | |
|
Improving Reporting of Clinical Studies Using the POSEIDON Criteria: POSORT Guidelines. | 2021 | ||
|
In vitro fertilization and andrology laboratory in 2030: expert visions | IVF laboratory | 2021 | IVF laboratory |
|
In vitro fertilization and andrology laboratory in 2030: expert visions. | 2021 | ||
|
Individual culture leads to decreased blastocyst formation but does not affect pregnancy outcomes in the setting of a single, vitrified-warmed euploid blastocyst transfer. | IVF laboratory | 2021 | IVF laboratory |
|
Individualized luteal phase support normalizes live birth rate in women with low progesterone levels on the day of embryo transfer in artificial endometrial preparation cycles | IVF clinical | 2021 | IVF clinical |
|
Influence of social determinants on fertility: a critical review | 2021 | ||
|
International Committee for Monitoring Assisted Reproductive Technologies world report: assisted reproductive technology, 2014†. | IVF clinical | 2021 | IVF clinical;IVF laboratory |
|
Is a freeze-all policy the optimal solution to circumvent the effect of late follicular elevated progesterone? A multicentric matched-control retrospective study analysing cumulative live birth rate in 942 non-elective freeze-all cycles. | 2021 | ||
|
Is a randomized controlled design sufficient for a trial to be valuable? | 2021 | ||
|
Is it in our patients' blood? On a quest for predictors of blastocysts' aneuploidy rate. | 2021 | ||
|
Leave the past behind: women's reproductive history shows no association with blastocysts' euploidy and limited association with live birth rates after euploid embryo transfers. | 2021 | ||
|
Lending clarity via specificity to the diagnosis of chronic endometritis | Endometrial receptivity | 2021 | Endometrial receptivity |
|
Machine Learning-Based Approach Highlights the Use of a Genomic Variant Profile for Precision Medicine in Ovarian Failure. | Reproductive disorders | 2021 | Reproductive disorders |
|
Maternal body mass index associates with blastocyst euploidy and live birth rates: the tip of an iceberg? | 2021 | ||
|
McDonald versus Shirodkar cervical cerclage for prevention of preterm birth: a systematic review and meta-analysis of pregnancy outcomes. | Other | 2021 | Other |
|
Measuring success in IVF is a complex multidisciplinary task: time for a consensus? | 2021 | ||
| Medroxyprogesterone acetate is a useful alternative to a gonadotropin-releasing hormone antagonist in oocyte donation: a randomized, controlled trial | Aging and rejuvenation | 2021 | Aging and rejuvenation | |
| Medroxyprogesterone acetate is a useful alternative to a gonadotropin-releasing hormone antagonist in oocyte donation: a randomized, controlled trial. | IVF clinical | 2021 | IVF clinical | |
| Meta-analysis of the embryo freezing transfer interval | Male fertility | 2021 | Male fertility;IVF laboratory | |
| Meta-analysis of the embryo freezing transfer interval. | Cryobiology | 2021 | Cryobiology ;IVF laboratory | |
|
Metabolic imaging of human cumulus cells reveals associations among metabolic profiles of cumulus cells, patient clinical factors, and oocyte maturity. | IVF laboratory | 2021 | IVF laboratory |
|
Mild versus conventional ovarian stimulation for IVF in poor, normal and hyper-responders: a systematic review and meta-analysis. | 2021 | ||
|
Minimal ovarian stimulation is an alternative to conventional protocols for older women according to Poseidon's stratification: a retrospective multicenter cohort study | Cryobiology | 2021 | Cryobiology ;Reproductive disorders |
|
Minimal ovarian stimulation is an alternative to conventional protocols for older women according to Poseidon's stratification: a retrospective multicenter cohort study. | IVF clinical | 2021 | IVF clinical |
|
Missing an important finding: why overly generalizable studies are a double-edged sword. | Other | 2021 | Other |
|
Mitochondrial enrichment in infertile patients: a review of different mitochondrial replacement therapies. | IVF clinical | 2021 | IVF clinical |
|
Mosaic embryos: hiding in plain sight. | Pre-Implantation genetics | 2021 | Pre-Implantation genetics |
|
Mosaic human preimplantation embryos and their developmental potential in a prospective, non-selection clinical trial. | 2021 | ||
|
Multidisciplinary consensus on the criteria for fertility preservation in cancer patients. | Reproductive disorders | 2021 | Reproductive disorders;IVF clinical |
|
Natural Cycle Results in Lower Implantation Failure than Ovarian Stimulation in Advanced-Age Poor Responders Undergoing IVF: Fertility Outcomes from 585 Patients. | 2021 | ||
|
NEO-OVOGÉNESIS Y CÉLULAS MADRE GERMINALES, ¿DESAFIANDO AL DOGMA? | 2021 | ||
|
New concepts and difficulties with progesterone supplementation in the luteal phase | Cryobiology | 2021 | Cryobiology ;Female fertility |
|
New concepts and difficulties with progesterone supplementation in the luteal phase. | IVF clinical | 2021 | IVF clinical |
|
Nitric oxide-targeted protein phosphorylation during human sperm capacitation. | Male fertility | 2021 | Male fertility |
|
Nitrite and Nitrate Levels in Follicular Fluid From Human Oocyte Donors Are Related to Ovarian Response and Embryo Quality | IVF clinical | 2021 | IVF clinical;IVF laboratory |
|
Non-invasive PGT | Pre-Implantation genetics | 2021 | Pre-Implantation genetics |
|
Noninvasive prenatal testing in women undergoing in vitro fertilization with preimplantation genetic testing | IVF clinical | 2021 | IVF clinical;Psychology |
|
Noninvasive prenatal testing in women undergoing in vitro fertilization with preimplantation genetic testing. | Pre-Implantation genetics | 2021 | Pre-Implantation genetics |
|
Novel therapeutic targets to improve IVF outcomes in endometriosis patients: a review and future prospects. | Reproductive disorders | 2021 | Reproductive disorders;IVF clinical |
| Obesity Affects Endometrial Receptivity by Displacing the Window of Implantation. | Endometrial receptivity | 2021 | Endometrial receptivity;Female fertility;Reproductive disorders | |
|
Oocyte competence is independent of the ovulation trigger adopted: a large observational study in a setting that entails vitrified-warmed single euploid blastocyst transfer. | 2021 | ||
|
Oocyte or embryo number needed to optimize live birth and cumulative live birth rates in mild stimulation IVF cycles. | 2021 | ||
| Oocyte vitrification for fertility preservation for both medical and nonmedical reasons. | Cryobiology | 2021 | Cryobiology ;IVF laboratory;Reproductive disorders | |
|
Oscillations of estradiol and gonadotropins are a missing link to solving the mystery of mono-ovulation in humans | 2021 | ||
|
Parameters of poor prognosis in preimplantation genetic testing for monogenic disorders. | Pre-Implantation genetics | 2021 | Pre-Implantation genetics |
| Pathways and factors regulated by bone marrow-derived stem cells in human ovarian tissue. | Stem cells | 2021 | Stem cells;Female fertility | |
|
Pathways to fatherhood: evaluating the priorities of self-identified gay and bisexual men pursuing family building options | IVF clinical | 2021 | IVF clinical |
|
Peering into the window of receptivity: extracellular vesicles containing small noncoding RNAs as potential biomarkers. | Endometrial receptivity | 2021 | Endometrial receptivity |
|
Perceptions and Motivations for Uterus Transplant in Transgender Women | IVF clinical | 2021 | IVF clinical |
|
Perinatal and obstetric outcomes in singleton pregnancies following fresh versus cryopreserved blastocyst transfer: a meta-analysis. | 2021 | ||
|
Personalized medicine for allergy treatment: Allergen immunotherapy still a unique and unmatched model | 2021 | ||
|
Perturbations of morphogenesis at the compaction stage affect blastocyst implantation and live birth rates. | 2021 | ||
|
PGT-A for recurrent pregnancy loss: evidence is growing but the issue is not resolved. | Pre-Implantation genetics | 2021 | Pre-Implantation genetics;Reproductive disorders |
|
Physicochemical and Functional Characterization of Female Reproductive Fluids: A Report of the First Two | Female fertility | 2021 | Female fertility;Reproductive disorders |
|
Plasticity of the human preimplantation embryo: developmental dogmas, variations on themes and self-correction. | 2021 | ||
|
Possible therapeutic effect of royal jelly on endometriotic lesion size, pain sensitivity, and neurotrophic factors in a rat model of endometriosis. | Reproductive disorders | 2021 | Reproductive disorders |
|
Potential long-term risks associated with maternal aging (the role of the mitochondria). | 2021 | ||
|
Practical Clinical and Diagnostic Pathway for the Investigation of the Infertile Couple. | 2021 | ||
| Prediction of embryo survival and live birth rates after cryotransfers of vitrified blastocysts | Aging and rejuvenation | 2021 | Aging and rejuvenation | |
|
Prediction of embryo survival and live birth rates after cryo-transfers of vitrified blastocysts according to morphology and day of blastulation: a retrospective study including 11936 blastocysts | Cryobiology | 2021 | Cryobiology |
|
Proteomic analysis of extracellular vesicles secreted by primary human epithelial endometrial cells reveals key proteins related to embryo implantation. | Endometrial receptivity | 2021 | Endometrial receptivity |
| Proteomics based drug repositioning applied to improve in vitro fertilization implantation: an artificial intelligence model. | IVF clinical | 2021 | IVF clinical | |
| Rate of true recurrent implantation failure is low: results of three successive frozen euploid single embryo transfers | 2021 | |||
|
Recombinant human luteinizing hormone co-treatment in ovarian stimulation for assisted reproductive technology in women of advanced reproductive age: a systematic review and meta-analysis of randomized controlled trials. | 2021 | ||
| Reduced FSH and LH action: implications for medically assisted reproduction | Immunology | 2021 | Immunology;Reproductive disorders | |
| Reduced FSH and LH action: implications for medically assisted reproduction. | IVF clinical | 2021 | IVF clinical | |
|
Reply: 'Second stimulation in the same ovarian cycle', probably a terminology more appropriate than 'luteal phase stimulation' in the DuoStim protocol. | 2021 | ||
| Reproductive aging and telomeres: Are women and men equally affected | 2021 | |||
|
Reproductive aging and telomeres: are women and men equally affected? | 2021 | ||
|
Reproductive senescence impairs the energy metabolism of human luteinized granulosa cells. | IVF laboratory | 2021 | IVF laboratory;Reproductive disorders |
| Rescuing monopronucleated-derived human blastocysts: a model to study chromosomal topography and fingerprinting. | IVF laboratory | 2021 | IVF laboratory;Pre-Implantation genetics | |
|
Round spermatid injection into human oocytes: a systematic review and meta-analysis | Immunology | 2021 | Immunology;IVF laboratory |
|
Round spermatid injection into human oocytes: a systematic review and meta-analysis. | Male fertility | 2021 | Male fertility |
|
SARS-CoV-2 infection negatively affects ovarian function in ART patients. | Reproductive disorders | 2021 | Reproductive disorders;Other |
|
SARS-CoV-2 pandemic and repercussions for male infertility patients: A proposal for the individualized provision of andrological services | 2021 | ||
|
SARS-CoV-2 persistence at subzero temperatures. | 2021 | ||
|
Self-Monitoring of Urinary Hormones in Combination with Telemedicine - a Timely Review and Opinion Piece in Medically Assisted Reproduction. | IVF clinical | 2021 | IVF clinical |
|
Seminal and testicular microbiome and male fertility: A systematic review | Male fertility | 2021 | Male fertility |
|
Serum anti-Mullerian hormone levels are not associated with aneuploidy rates in human blastocysts | IVF clinical | 2021 | IVF clinical |
| Serum anti-Müllerian hormone levels are not associated with aneuploidy rates in human blastocysts. | IVF clinical | 2021 | IVF clinical;Pre-Implantation genetics;IVF laboratory | |
|
Serum luteal phase progesterone in women undergoing frozen embryo transfer in assisted conception: a systematic review and meta-analysis. | IVF clinical | 2021 | IVF clinical |
|
Serum Progesterone Profile Across the Mid and Late Luteal Phase in Artificial Cycles Is Associated With Pregnancy Outcome. | IVF clinical | 2021 | IVF clinical |
|
Severe male factor in in vitro fertilization: definition, prevalence, and treatment. An update. | 2021 | ||
|
Sexual Dysfunction in Men Who Have Sex With Men. | Male fertility | 2021 | Male fertility |
| Shorter telomere length of white blood cells is associated with higher rates of aneuploidy among infertile women undergoing in vitro fertilization | 2021 | |||
|
Sperm DNA fragmentation index and cumulative live birth rate in a cohort of 2,713 couples undergoing assisted reproduction treatment. | 2021 | ||
| Sperm DNA methylation epimutation biomarker for paternal offspring autism susceptibility | 2021 | |||
|
Sperm Selection by Magnetic-Activated Cell Sorting before Microinjection of Autologous Oocytes Increases Cumulative Live Birth Rates with Limited Clinical Impact: A Retrospective Study in Unselected Males | Male fertility | 2021 | Male fertility;IVF laboratory |
|
Spontaneous pregnancy versus assisted reproductive technologies: implications on maternal mental health | Other | 2021 | Other |
|
Spontaneous pregnancy versus assisted reproductive technologies: implications on maternal mental health. | IVF clinical | 2021 | IVF clinical;Psychology |
| Stem cell secreted factor therapy regenerates the ovarian niche and rescues follicles | Male fertility | 2021 | Male fertility | |
| Stem Cells and the Endometrium: From the Discovery of Adult Stem Cells to Pre-Clinical Models | Endometrial receptivity | 2021 | Endometrial receptivity;Reproductive disorders | |
| Stem cell-secreted factor therapy regenerates the ovarian niche and rescues follicles | Male fertility | 2021 | Male fertility | |
| Stem Cells and the Endometrium: From the Discovery of Adult Stem Cells to Pre-Clinical Models. | Endometrial receptivity | 2021 | Endometrial receptivity | |
|
Strategies for managing asherman's syndrome and endometrial atrophy: Since the classical experimental models to the new bioengineering approach. | 2021 | ||
|
Supply and Demand of Energy in the Oocyte and the Role of Mitochondria. | 2021 | ||
|
Taking a second look at obstetrical outcomes after assisted reproductive technologies | IVF clinical | 2021 | IVF clinical |
|
TESE-ICSI outcomes per couple in vasectomized males are negatively affected by time since the intervention, but not other comorbidities | Male fertility | 2021 | Male fertility;IVF laboratory |
|
Testosterone priming (short or long course) before IVF does not improve the number of oocytes retrieved in poor ovarian responders: a randomized controlled trial (TESTOPRIM) | IVF clinical | 2021 | IVF clinical |
| Testosterone does not improve ovarian response in Bologna poor responders: a randomized controlled trial (TESTOPRIM) | 2021 | |||
|
The Appraisal of Body Content (ABC) trial: increased male or female adiposity does not significantly impact in vitro fertilization laboratory or clinical outcomes | Other | 2021 | Other |
|
The Appraisal of Body Content (ABC) trial: increased male or female adiposity does not significantly impact in vitro fertilization laboratory or clinical outcomes | IVF clinical | 2021 | IVF clinical;IVF laboratory |
|
The back-up vasectomy reversal. Simultaneous sperm retrieval and vasectomy reversal in the couple with advanced maternal age: a cost-effectiveness analysis | Male fertility | 2021 | Male fertility |
|
The BD Odon Device: an update of its current state | IVF laboratory | 2021 | IVF laboratory |
|
The concordance rates of an initial trophectoderm biopsy with the rest of the embryo using PGTseq, a targeted next-generation sequencing platform for preimplantation genetic testing-aneuploidy | Pre-Implantation genetics | 2021 | Pre-Implantation genetics |
|
The cyto-protective effects of LH on ovarian reserve and female fertility during exposure to gonadotoxic alkylating agents in an adult mouse model. | IVF clinical | 2021 | IVF clinical;Pre-Implantation genetics;IVF laboratory |
|
The effect of late-follicular phase progesterone rise on embryo ploidy, blastocyst formation rate and cumulative live birth rates following a freeze-only strategy | IVF clinical | 2021 | IVF clinical |
|
The effect of phosphodiesterase-5 inhibitors on uteroplacental and fetal cerebral perfusion in pregnancies with fetal growth restriction: A systematic review and meta-analysis | Other | 2021 | Other |
|
The ghost in the machine (learning). | IVF clinical | 2021 | IVF clinical;IVF laboratory |
|
The impact of the female genital tract microbiome in women health and reproduction: a review. | IVF clinical | 2021 | IVF clinical;Female fertility |
|
The Impact of Unbalanced Maternal Nutritional Intakes on Oocyte Mitochondrial Activity: Implications for Reproductive Function. | 2021 | ||
| The morphokinetic signature of mosaic embryos: evidence in support of their own genetic identity | IVF laboratory | 2021 | IVF laboratory | |
|
The paternal toolbox for embryo development and health. | 2021 | ||
|
The position of the euploid blastocyst in the uterine cavity influences implantation. | IVF laboratory | 2021 | IVF laboratory |
| The RNA content of human sperm reflects prior events in spermatogenesis and potential post-fertilization effects. | Male fertility | 2021 | Male fertility | |
|
The slippery slope antedating syngamy: pronuclear activity in preparation for the first cleavage. | 2021 | ||
|
The subcortical maternal complex: emerging roles and novel perspectives. | 2021 | ||
|
The Use of Vaginal Lubricants and Ultrasound Gels Can have Deleterious Effects on Sperm Function. | Endometrial receptivity | 2021 | Endometrial receptivity;IVF clinical |
| The morphokinetic signature of mosaic embryos: evidence in support of their own genetic identity | IVF laboratory | 2021 | IVF laboratory | |
| Timing of spermatogonial stem cell transplantation affects the spermatogenic recovery outcome in mice | Cryobiology | 2021 | Cryobiology ;IVF laboratory | |
| Timing of spermatogonial stem cell transplantation affects the spermatogenic recovery outcome in mice. | Other | 2021 | Other | |
|
Transcriptional changes through menstrual cycle reveal a global transcriptional derepression underlying the molecular mechanism involved in the window of implantation | Male fertility | 2021 | Male fertility |
|
Transcriptional changes through menstrual cycle reveal a global transcriptional derepression underlying the molecular mechanism involved in the window of implantation. | Endometrial receptivity | 2021 | Endometrial receptivity |
|
Transcriptional progression during meiotic prophase I reveals sex-specific features and X chromosome dynamics in human fetal female germline. | Female fertility | 2021 | Female fertility |
|
Transplantation of cryopreserved ovarian tissue in a series of 285 women: a review of five leading European centers. | Surgery | 2021 | Surgery;Cryobiology |
|
Treatment with Calcium Ionophore Improves The Results in Patients with Previous Unsuccessful Attempts at The Fertilization: A Cohort Study. | IVF laboratory | 2021 | IVF laboratory |
|
Undetectable viral RNA from SARS-CoV-2 in endometrial biopsies from women with COVID-19: a preliminary study | Other | 2021 | Other;Endometrial receptivity |
|
Use of dopamine agonists to target angiogenesis in women with endometriosis | 2021 | ||
|
Uterine natural killer cells: from foe to friend in reproduction | Epigenetics | 2021 | Epigenetics;Pre-Implantation genetics |
|
Uterine natural killer cells: from foe to friend in reproduction. | IVF laboratory | 2021 | IVF laboratory |
|
Uterine Transplantation: Review of Livebirths and Reproductive Implications. | Surgery | 2021 | Surgery |
|
Vaginal progesterone in twin gestation and a short cervix: revisiting an individual patient data systematic review and meta-analysis. | Other | 2021 | Other |
|
Variant haplophasing by long-read sequencing: proof of concept in preimplantation genetic workup and an opportunity to distinguish balanced and normal embryos | Endometrial receptivity | 2021 | Endometrial receptivity;IVF clinical |
|
Variants Ala307Ala and Ser680Ser of 307 and 680 FSHr polymorphisms negatively influence on assisted reproductive techniques outcome and determine high probability of non-pregnancy in Caucasian patients. | Reproductive disorders | 2021 | Reproductive disorders |
| Vitamin D as an effective treatment in human uterine leiomyomas independent of mediator complex subunit 12 mutation | 2021 | |||
|
Vitamin D in Follicular Fluid Correlates With the Euploid Status of Blastocysts in a Vitamin D Deficient Population. | Aging and rejuvenation | 2021 | Aging and rejuvenation |
|
vNOTES for adnexal procedures | IVF laboratory | 2021 | IVF laboratory;Technology development |
|
vNOTES for adnexal procedures | Other | 2021 | Other |
|
We are starting a new stage | Other | 2021 | Other |
|
What are the advantages of the DuoStim strategy? | Aging and rejuvenation | 2021 | Aging and rejuvenation |
|
What Do We Know about Classical and Non-Classical Progesterone Receptors in the Human Female Reproductive Tract? A Review. | Endometrial receptivity | 2021 | Endometrial receptivity |
|
When embryology meets genetics: the definition of developmentally incompetent preimplantation embryos (DIPE)-the consensus of two Italian scientific societies. | 2021 | ||
|
Will the introduction of automated ART laboratory systems render the majority of embryologists redundant? | IVF laboratory | 2021 | IVF laboratory |
|
Perceptions and Motivations for Uterus Transplant in Transgender Women. | Surgery | 2021 | Surgery;Psychology |
|
The BD Odon Device: an update of its current state. | Other | 2021 | Other |
|
A 5-year multicentre randomized controlled trial comparing personalized, frozen and fresh blastocyst transfer in IVF | 2020 | ||
|
A comparison of the relative efficiency of ICSI and extended culture with epididymal sperm versus testicular sperm in patients with obstructive azoospermia | 2020 | ||
| A follow-up survey on the reproductive intentions and experiences of women undergoing planned oocyte cryopreservation | 2020 | |||
| A picture of the covid-19 impact on IVIRMA fertility treatment clinics in Spain and Italy | 2020 | |||
|
Academic pursuits in board-certified reproductive endocrinologists | 2020 | ||
|
Ai in the treatment of fertility: Key considerations | 2020 | ||
| ALWAYS ICSI A SWOT analysis. | 2020 | |||
| ALWAYS ICSI? A SWOT analysis | 2020 | |||
| Analysis of accessible chromatin landscape in the inner cell mass and trophectoderm of human blastocysts | 2020 | |||
|
Aneuploidy and recombination in the human preimplantation embryo. Copy number variation analysis and genome-wide polymorphism genotyping | 2020 | ||
| Anti-Mullerian hormone is an independent marker for oocyte survival after vitrification | 2020 | |||
|
Aromatase Inhibitors for Ovarian Stimulation in Patients with Breast Cancer | 2020 | ||
|
Assessment and management of the risk of SARS-CoV-2 infection in an IVF laboratory. | 2020 | ||
|
Assisted reproduction and thromboembolic risk in the COVID-19 pandemic | 2020 | ||
|
Becoming a mother entails anatomical changes in the ventral striatum of the human brain that facilitate its responsiveness to offspring cues | 2020 | ||
|
Birthweight of singletons born after blastocyst-stage or cleavage-stage transfer: analysis of a data set from three randomized controlled trials | 2020 | ||
| Blastocyst collapse as an embryo marker of low implantation potential: a time-lapse multicentre study | 2020 | |||
| Blastocyst mitochondrial DNA (mtDNA) is not affected by oocyte vitrification: a sibling oocyte study | 2020 | |||
| Cervical pregnancy in assisted reproduction: an analysis of risk factors in 91,067 ongoing pregnancies | 2020 | |||
|
Cesarean Section Scar Nodule, Ovarian Cyst, and Dysmenorrhea | Surgery | 2020 | Surgery |
|
Clinical Application of Antioxidants to Improve Human Oocyte Mitochondrial Function: A Review | 2020 | ||
| Clinical error rates of next generation sequencing and array comparative genomic hybridization with single thawed euploid embryo transfer | 2020 | |||
| Clinical outcomes after the transfer of blastocysts characterized as mosaic by high resolution Next Generation Sequencing- further insights | 2020 | |||
|
Commentary on regulation of leiomyoma stem cell proliferation by WNT4 via AKT-dependent beta-Catenin activation | 2020 | ||
| Comparison of controlled ovary stimulation protocols for in vitro fertilisation: A meta-analysis | 2020 | |||
|
Comparison of pregnancy outcomes following intrauterine insemination in young women with decreased versus normal ovarian reserve | 2020 | ||
|
Comprehensive analysis of soluble RNAs in human embryo culture media and blastocoel fluid. | 2020 | ||
|
Congenital Uterine Malformation by Experts (CUME): diagnostic criteria for T-shaped uterus | 2020 | ||
|
Consistency in rates of diagnosis of embryonic mosaicism, segmental abnormalities, and “no call” results among experienced embryologists performing preimplantation genetic testing for aneuploidy | 2020 | ||
| Copper and lead exposures disturb reproductive features of primary endometrial stromal and epithelial cells | 2020 | |||
|
Coronavirus disease-19 and fertility: viral host entry protein expression in male and female reproductive tissues | 2020 | ||
|
Correction to: EStradiol and PRogesterone in In vitro ferTilization (ESPRIT): a multicenter study evaluating third versus secondgeneration estradiol and progesterone immunoassays | 2020 | ||
|
Corrigendum. Definition of a clinical strategy to enhance the efficacy, efficiency and safety of egg donation cycles with imported vitrified oocytes. | 2020 | ||
|
Corrigendum. Do we need to measure progesterone in oocyte donation cycles? A retrospective analysis evaluating cumulative live birth rates and embryo quality | 2020 | ||
|
COVID-19 and ART: the view of the Italian Society of Fertility and Sterility and Reproductive Medicine. | 2020 | ||
|
COVID-19 and assisted reproductive technology services: repercussions for patients and proposal for individualized clinical management | 2020 | ||
|
COVID-19 and assisted reproductive technology services: repercussions for patients and proposal for individualized clinical management. | 2020 | ||
|
COVID-19 infection in first trimester of pregnancy marked by a liver cytolysis in a woman previously treated by hydroxychloroquine for repeated implantation failure: a case report | 2020 | ||
|
COVID-19 pandemic and maternal mental health: a systematic review and meta-analysis | 2020 | ||
| COVID-19 should be a novel indication for fertility preservation | 2020 | |||
|
COVID-19: lessons from the Italian reproductive medical experience | 2020 | ||
| Cumulus cells have longer telomeres than leukocytes in reproductive-age women | 2020 | |||
|
Deep inside the pandemic, from inactivity to action: let's be ready | 2020 | ||
|
Definition of a clinical strategy to enhance the efficacy, efficiency and safety of egg donation cycles with imported vitrified oocytes. | 2020 | ||
|
Delayed start gonadotropin-releasing hormone antagonist protocol in Bologna poor-responders: A systematic review and meta-analysis of randomized controlled trials | 2020 | ||
|
Development and Psychometric Validation of a Screening Questionnaire to Detect Excessive Menstrual Blood Loss That Interferes in Quality of Life: The SAMANTA Questionnaire | 2020 | ||
| Developmental potential of aneuploid human embryos cultured beyond implantation | 2020 | |||
|
DNA Fragmentation in Viable and Non-Viable Spermatozoa Discriminates Fertile and Subfertile Subjects with Similar Accuracy. | 2020 | ||
|
Do we need to measure progesterone in oocyte donation cycles? A retrospective analysis evaluating cumulative live birth rates and embryo quality | 2020 | ||
|
DuoStim - a reproducible strategy to obtain more oocytes and competent embryos in a short time-frame aimed at fertility preservation and IVF purposes. A systematic review. | 2020 | ||
|
DuoStim cycles potentially boost reproductive outcomes in poor prognosis patients | 2020 | ||
|
DuoStim: a new strategy proposed for women with poor ovarian response | 2020 | ||
|
Early pregnancy loss in patients with polycystic ovary syndrome after IVM versus standard ovarian stimulation for IVF/ICSI | 2020 | ||
|
Effect of GnRH agonist before IVF on outcomes in infertile endometriosis patients: a randomized controlled trial | 2020 | ||
|
Effect of Group Embryo Culture under Low-Oxygen Tension in Benchtop Incubators on Human Embryo Culture: Prospective, Randomized, Controlled Trial | 2020 | ||
|
Effects of intraovarian injection of autologous platelet rich plasma on ovarian reserve and IVF outcome parameters in women with primary ovarian insufficiency | 2020 | ||
|
Embryo morphokinetics analysis and reproductive outcomes with assisted oocyte activation by a calcium ionophore after prior fertilization failure. A multicentric retrospective study | 2020 | ||
|
Embryo's Natural Motion (enMotion): a paired randomized controlled trial evaluating a dynamic embryo culture system | 2020 | ||
| Empathetic application of machine learning may address appropriate utilization of ART | 2020 | |||
| Endometrial Liquid Biopsy Provides a miRNA Roadmap of the Secretory Phase of the Human Endometrium | 2020 | |||
|
Endometrioma and reproductive issues: a well-informed patient may be the driver for change | 2020 | ||
|
Endometriosis and Reproduction: What We Have Learned | 2020 | ||
|
Erratum: ESHRE guideline: ovarian stimulation for IVF/ICSI | 2020 | ||
|
ESHRE guideline: ovarian stimulation for IVF/ICSI(dagger) | 2020 | ||
|
ESHRE PGT Consortium and SIG Embryology good practice recommendations for polar body and embryo biopsy for PGT | 2020 | ||
|
ESHRE PGT Consortium and SIG Embryology good practice recommendations for polar body and embryo biopsy for PGT. | 2020 | ||
|
Establishing the follitropin delta dose that provides a comparable ovarian response to 150 IU/day follitropin alfa | 2020 | ||
|
EStradiol and PRogesterone in In vitro ferTilization (ESPRIT): a multicenter study evaluating third- versus second-generation estradiol and progesterone immunoassays | 2020 | ||
|
Estrategias de mejora de la fertilidad: Preservación, rejuvenecimiento y células madre | 2020 | ||
|
Evaluation of fertilization, usable blastocyst development and sustained implantation rates according to intracytoplasmic sperm injection operator experience | 2020 | ||
|
Evaluation of Male Fertility-Associated Loci in a European Population of Patients with Severe Spermatogenic Impairment | 2020 | ||
|
Evaluation of the endometrial receptivity assay and the preimplantation genetic test for aneuploidy in overcoming recurrent implantation failure | 2020 | ||
| Exome sequencing links CEP120 mutation to maternally derived aneuploid conception risk | 2020 | |||
| Exploring undiagnosed celiac disease in women with recurrent reproductive failure: The gluten-free diet could improve reproductive outcomes | 2020 | |||
|
External validation of putative biomarkers in eutopic endometrium of women with endometriosis using NanoString technology | 2020 | ||
|
Fallopian tube endometriosis: clinical implications | 2020 | ||
|
Female infertility is associated with an altered expression of the neurokinin B/neurokinin B receptor and kisspeptin/kisspeptin receptor systems in ovarian granulosa and cumulus cells | 2020 | ||
|
Female obesity increases the risk of miscarriage of euploid embryos | 2020 | ||
|
Finding a retained embryo after attempted embryo transfer: How does it impact outcomes? | 2020 | ||
|
Follicle-stimulating hormone dosage negatively associated with live birth in donor/recipient model: a case for milder donor stimulation? | 2020 | ||
| Follicular-phase endometrial scratching: a truncated randomized controlled trial | 2020 | |||
|
For the Supreme Court: choose another | 2020 | ||
|
Freeze-all, for whom, when, and how | 2020 | ||
| Frozen embryo transfer after pgt-a cycles: To wait or not to wait? | 2020 | |||
|
Frozen embryo transfer and preeclampsia: where is the link? | 2020 | ||
|
Frozen-warmed blastocyst transfer after 6 or 7 days of progesterone administration: impact on live birth rate in hormone replacement therapy cycles | 2020 | ||
|
Gonadotropin-releasing hormone antagonist linzagolix: possible treatment for assisted reproduction patients presenting with adenomyosis and endometriosis? | 2020 | ||
|
Good practice recommendations for the use of time-lapse technology(dagger) | 2020 | ||
|
Good practice recommendations for the use of time-lapse technology†. | 2020 | ||
|
Growth hormone cotreatment for poor responders undergoing in vitro fertilization cycles: a systematic review and meta-analysis | 2020 | ||
|
Hair Cortisol Concentrations as a Biomarker to Predict a Clinical Pregnancy Outcome after an IVF Cycle: A Pilot Feasibility Study | 2020 | ||
|
Healthy baby born after icsi with ejaculated immotile spermatozoa from a male kartagener syndrome using magnetic-activated cell sorting (macs) as a compliment of sperm preparation technique: A case report | 2020 | ||
|
Heterogeneity Among Poor Ovarian Responders According to Bologna Criteria Results in Diverging Cumulative Live Birth Rates | 2020 | ||
|
Heterogeneity Among Poor Ovarian Responders According to Bologna Criteria Results in Diverging Cumulative Live Birth Rates. | 2020 | ||
|
High satisfaction among women undergoing oocyte retrieval without anesthesia in a well-selected patient population | 2020 | ||
|
HMGA2 involvement in uterine leiomyomas development through angiogenesis activation | 2020 | ||
| How vitamin D level influences in vitro fertilization outcomes: results of a systematic review and meta-analysis | 2020 | |||
|
Human female meiosis checkpoints: how much DNA damage is allowed? | 2020 | ||
|
Identifying biomarkers for predicting successful embryo implantation: applying single to multi-OMICs to improve reproductive outcomes | 2020 | ||
| Impact of ABVD chemotherapy on ovarian reserve after fertility preservation in reproductive-aged women with Hodgkin lymphoma | 2020 | |||
| Impact of endometrial polyps detected during the follicular phase of intrauterine insemination treatments | 2020 | |||
|
Impact of Genetic Variations and Epigenetic Mechanisms on the Risk of Obesity | 2020 | ||
| Impact of Ovarian Aging in Reproduction: From Telomeres and Mice Models to Ovarian Rejuvenation | 2020 | |||
|
Impact of paternal age on embryology and pregnancy outcomes in the setting of a euploid single-embryo transfer with ejaculated sperm: Retrospective cohort study | 2020 | ||
|
Impact of Serum Estradiol Levels Prior to Progesterone Administration in Artificially Prepared Frozen Embryo Transfer Cycles | 2020 | ||
|
Impact of underlying stress in infertility | 2020 | ||
|
Importance of early and precise ascertainment of mosaic Turner syndrome for fertility preservation and assisted reproduction counseling. | 2020 | ||
|
In vitro fertilization in underweight women: focus on obstetric outcome | 2020 | ||
|
Incidence, Origin, and Predictive Model for the Detection and Clinical Management of Segmental Aneuploidies in Human Embryos. | 2020 | ||
|
Infertility and reproductive rights after the COVID-19 pandemic | 2020 | ||
|
Inhibin A-A Promising Predictive Parameter for Determination of Final Oocyte Maturation in Ovarian Stimulation for IVF/ICSI | 2020 | ||
|
Interpretation of noninvasive prenatal testing results following in vitro fertilization and preimplantation genetic testing for aneuploidy | 2020 | ||
|
Intracytoplasmic sperm injection is not superior to conventional IVF in couples with non-male factor infertility and preimplantation genetic testing for aneuploidies (PGT-A) | 2020 | ||
|
Introduction: Key performance indicators in assisted reproductive technologies | 2020 | ||
|
Introduction: Sea changes in reproductive physiology | 2020 | ||
|
Intronic variation of the SOHLH2 gene confers risk to male reproductive impairment | 2020 | ||
|
Is a naturally reduced antimullerian hormone at a young age linked to an increased risk of cancer development? | 2020 | ||
|
Is it safe and effective to maintain the vaginal pessary without removing it for 2 consecutive years? | 2020 | ||
|
Is ovarian response associated with adverse perinatal outcomes in GnRH antagonist IVF/ICSI cycles? | 2020 | ||
|
Is there a link between focal adenomyosis and infertility? | 2020 | ||
|
Is there a role for human leukocyte antigen-G typing in infertility treatment? | 2020 | ||
| Isthmocele and ovarian stimulation for IVF: considerations for a reproductive medicine specialist | 2020 | |||
|
IUI and uterine lavage of in vivo-produced blastocysts for PGT purposes: is it a technically and ethically reasonable perspective? Is it actually needed? | 2020 | ||
|
Key metrics and processes for validating embryo diagnostics | 2020 | ||
|
Levothyroxine and thyroid peroxidase antibodies in women with recurrent pregnancy loss | 2020 | ||
| Long-term vitamin D treatment decreases human uterine leiomyoma size in a xenograft animal model | 2020 | |||
|
Luteal phase after conventional stimulation in the same ovarian cycle might improve the management of poor responder patients fulfilling the Bologna criteria: a case series. | 2020 | ||
| Magnetic-Activated Cell Sorting (MACS): A Useful Sperm-Selection Technique in Cases of High Levels of Sperm DNA Fragmentation | 2020 | |||
|
Male Infertility and the Future of In Vitro Fertilization | 2020 | ||
| Managing the IVF laboratory during a pandemic: international perspectives from laboratory managers | 2020 | |||
|
Maternal spindle transfer overcomes embryo developmental arrest caused by ooplasmic defects in mice | 2020 | ||
| Microphysiological Modeling of the Human Endometrium | 2020 | |||
|
Microribonucleic acids in sperm and spent culture media: a new direction in predictive diagnostics or another disappointment? | 2020 | ||
|
Mild versus conventional ovarian stimulation for IVF in poor responders: a systematic review and meta-analysis. | 2020 | ||
|
Mitochondrial DNA content decreases during in vitro human embryo development: Insights into mitochondrial DNA variation in preimplantation embryos donated for research | 2020 | ||
| Mitochondrial DNA content is not predictive of reproductive competence in euploid blastocysts | 2020 | |||
|
Mitochondrial Dynamics and Microglia as New Targets in Metabolism Regulation | 2020 | ||
|
Mitochondrial Dysfunction and Ovarian Aging | 2020 | ||
|
Mitochondrial function in women with polycystic ovary syndrome | 2020 | ||
|
Multicenter prospective study of concordance between embryonic cell-free DNA and trophectoderm biopsies from 1301 human blastocysts. | 2020 | ||
|
Natural fluids collected from the reproductive tract of women can be used as additives for human in vitro embryo culture media | IVF laboratory | 2020 | IVF laboratory |
|
New insights for fertility preservation by ovarian tissue cryopreservation and transplantation in pediatric cancer patients | 2020 | ||
| New Insights into the Anterior Complex | 2020 | |||
|
Non-invasive preimplantation genetic testing (niPGT): the next revolution in reproductive genetics? | 2020 | ||
|
Novel and conventional embryo parameters as input data for artificial neural networks: an artificial intelligence model applied for prediction of the implantation potential | 2020 | ||
|
Novel nonclassic progesterone receptor PGRMC1 pulldown-precipitated proteins reveal a key role during human decidualization | 2020 | ||
|
Oocyte activation, oolemma piercing, and real-time viability confirmation in human oocytes using electrophysiological techniques | 2020 | ||
| Oocyte vitrification for fertility preservation in women with endometriosis: an observational study | 2020 | |||
|
Oocytes of women who are obese or overweight have lower levels of n-3 polyunsaturated fatty acids compared with oocytes of women with normal weight | 2020 | ||
|
Optimizing ovarian tissue quality before cryopreservation: comparing outcomes of three decortication methods on stromal and follicular viability | 2020 | ||
| Outcome of in-vitro oocyte maturation in patients with PCOS: does phenotype have an impact? | 2020 | |||
| Ovarian stimulation does not influence the uterine immune environment in healthy infertile women | 2020 | |||
|
Ovarian tissue cryopreservation is standard of care in prepubertal patients, but does it have to be? | 2020 | ||
|
Parental human leukocyte antigen-C allotypes are predictive of live birth rate and risk of poor placentation in assisted reproductive treatment | 2020 | ||
|
Personalized Medicine in Infertile Men | 2020 | ||
|
Personalized medicine through three-dimensional cell-based culture systems in assisted reproductive technologies: How close are we? | 2020 | ||
|
Phthalates and Bisphenol A: Presence in Blood Serum and Follicular Fluid of Italian Women Undergoing Assisted Reproduction Techniques. | 2020 | ||
| Preeclampsia: a defect in decidualization is associated with deficiency of Annexin A2 | 2020 | |||
| Preimplantation genetic testing for aneuploidy in patients with partial X monosomy using their own oocytes: is this a suitable indication? | 2020 | |||
|
Preimplantation genetic testing for aneuploidy: the conundrum with aneuploid embryo transfers | 2020 | ||
|
Premature progesterone rise as a trigger of polycystic ovarian syndrome | 2020 | ||
|
Primary syphilis – an atypical presentation | Reproductive disorders | 2020 | Reproductive disorders |
|
Progesterone is a physiological trigger of ovulatory gonadotropins | 2020 | ||
|
Progesterone use in assisted reproductive technology | 2020 | ||
|
Prognostic Value of Blastocyst Grade after Frozen Euploid Embryo Transfer in Patients with Recurrent Pregnancy Loss | 2020 | ||
|
Recurrent implantation failure might be overestimated without PGT-A | 2020 | ||
|
Registro nacional de actividad-registro de la sociedad española de fertilidad de fecundación in vitro e inyección espermática intracitoplasmática. Años 2016 y 2017 | 2020 | ||
|
Relationship between serum progesterone (P) levels and pregnancy outcome: lessons from artificial cycles when using vaginal natural micronized progesterone | 2020 | ||
|
Reproductive senescence and energetic metabolism of human luteinized granulosa cells: is it all about ATP? A prospective cohort and critical view | 2020 | ||
| Role of Angiotensin-(1-7) via MAS receptor in human sperm motility and acrosome reaction | 2020 | |||
|
Role of the patient's social features in the destiny of cryopreserved surplus embryos | 2020 | ||
|
Round Spermatid Injection | 2020 | ||
| Sam68 mediates leptin signaling and action in human granulosa cells: possible role in leptin resistance in PCOS | 2020 | |||
| SARS-CoV-2 infection risk assessment in the endometrium: viral infection-related gene expression across the menstrual cycle | 2020 | |||
|
Self-Detection of the LH Surge in Urine After GnRH Agonist Trigger in IVF-How to Minimize Failure to Retrieve Oocytes | 2020 | ||
|
Septate uterus and reproductive outcomes: let's get serious about this | 2020 | ||
|
Septate uterus and reproductive outcomes: let's get serious about this. | 2020 | ||
| Serum progesterone levels could predict diagnosis, completion and complications of miscarriage | 2020 | |||
|
Serum progesterone levels on day of embryo transfer in frozen embryo transfer cycles-the truth lies in the detail | 2020 | ||
| Should vanishing twin pregnancies be systematically excluded from cell-free fetal DNA testing? | 2020 | |||
|
Similar miRNomic signatures characterize the follicular fluids collected after follicular and luteal phase stimulations in the same ovarian cycle. | 2020 | ||
| Single and double embryo transfer provide similar live birth rates in frozen cycles | 2020 | |||
| Single-cell transcriptomic atlas of the human endometrium during the menstrual cycle | 2020 | |||
|
Sperm count affects cumulative birth rate of assisted reproduction cycles in relation to ovarian response. | 2020 | ||
|
Sperm DNA fragmentation on the day of fertilization is not associated with embryologic or clinical outcomes after IVF/ICSI | 2020 | ||
| Sperm Mitochondrial DNA Copy Number Is Not a Predictor of Intracytoplasmic Sperm Injection (ICSI) Cycle Outcomes | 2020 | |||
|
Stem cell paracrine actions in tissue regeneration and potential therapeutic effect in human endometrium: a retrospective study | 2020 | ||
|
Tacrolimus Improves the Implantation Rate in Patients with Elevated Th1/2 Helper Cell Ratio and Repeated Implantation Failure (RIF) | 2020 | ||
|
Taking the "art" out of "ART" | 2020 | ||
|
Term oocyte maturation and term ovarian stimulation: impact on oocyte competence | 2020 | ||
| The appraisal of body content (ABC) trial: obesity does not significantly impact gamete production in infertile men and women | Other | 2020 | Other | |
|
The ART of frozen embryo transfer: back to nature! | 2020 | ||
|
The BCL-2 pathway preserves mammalian genome integrity by eliminating recombination-defective oocytes | 2020 | ||
| The continuum of ovarian response leading to BIRTH, a real world study of ART in Spain | 2020 | |||
|
The dawn of the future: 30 years from the first biopsy of a human embryo. The detailed history of an ongoing revolution. | 2020 | ||
|
The effect of ICSI-related procedural timings and operators on the outcome. | 2020 | ||
|
The euploid blastocysts obtained after luteal phase stimulation show the same clinical, obstetric and perinatal outcomes as follicular phase stimulation-derived ones: a multicenter study. | 2020 | ||
|
The excessive presence (percentage or number) of endometrial immune cells in patients with chronic endometritis cannot be associated with reduced endometrial receptivity or recurrent pregnancy failure | 2020 | ||
|
The first choice of the preimplantation embryo: How compaction and polarity build cell identity | 2020 | ||
| The first glimpse of the endometrial microbiota in early pregnancy | 2020 | |||
|
The freeze-all strategy versus agonist triggering with low-dose hCG for luteal phase support in IVF/ICSI for high responders: a randomized controlled trial | 2020 | ||
|
The Future of Cryopreservation in Assisted Reproductive Technologies | 2020 | ||
|
The impact of age beyond ploidy: outcome data from 8175 euploid single embryo transfers | 2020 | ||
| The impact of endometrioma size on ovarian responsiveness | 2020 | |||
|
The Impact of Female Genital Microbiota on Fertility and Assisted Reproductive Treatments | 2020 | ||
|
The influence of oxygen concentration during embryo culture on obstetric and neonatal outcomes: a secondary analysis of a randomized controlled trial | 2020 | ||
|
The lipidome of endometrial fluid differs between implantative and non-implantative IVF cycles | 2020 | ||
|
The performance of the Elecsys(R) anti-Mullerian hormone assay in predicting extremes of ovarian response to corifollitropin alfa | 2020 | ||
| The Portuguese obstetricians’ preconception counselling during COVID19 pandemic | Reproductive disorders | 2020 | Reproductive disorders | |
|
The proliferative phase endometrium in IVF/ICSI: an in-cycle molecular analysis predictive of the outcome following fresh embryo transfer | 2020 | ||
|
The reproductive microbiome - clinical practice recommendations for fertility specialists | 2020 | ||
|
The Role of the Urologist in a Reproductive Endocrinology and Infertility Practice | 2020 | ||
|
The search must go on-for patients with recurrent pregnancy loss | 2020 | ||
| The vaginal microbiome in uterine transplantation | 2020 | |||
| Therapy with probiotics and synbiotics for polycystic ovarian syndrome: a systematic review and meta-analysis | 2020 | |||
|
Three simple metrics to define in vitro fertilization success rates | 2020 | ||
|
Three-dimensional ultrasound diagnosis of adenomyosis is not associated with adverse pregnancy outcome following single thawed euploid blastocyst transfer: prospective cohort study | 2020 | ||
|
Timing of frozen-thawed embryo transfers-does it really matter? | 2020 | ||
| To delay or not frozen embryo transfer in freeze-all cycles? | 2020 | |||
|
To trigger or not to trigger ovulation in a natural cycle for frozen embryo transfer: a randomized controlled trial | 2020 | ||
| Uterine disorders affecting female fertility: what are the molecular functions altered in endometrium? | 2020 | |||
|
Uterine Transplantation; Review of Livebirths and Reproductive Implications | 2020 | ||
|
Validation of ART Calculator for Predicting the Number of Metaphase II Oocytes Required for Obtaining at Least One Euploid Blastocyst for Transfer in Couples Undergoing in vitro Fertilization/Intracytoplasmic Sperm Injection. | 2020 | ||
| Varying levels of serum estradiol do not alter the timing of the early endometrial secretory transformation | 2020 | |||
|
When Regenerative Medicine Faces the Challenges of Reproductive Medicine: A Review Study on Recent Advances in the Strategies for Derivation of Gametes from Stem Cells | Technology development | 2020 | Technology development;Psychology |
|
Which key performance indicators are most effective in evaluating and managing an in vitro fertilization laboratory? | 2020 | ||
|
Women's vitamin D levels and IVF results: a systematic review of the literature and meta-analysis, considering three categories of vitamin status (replete, insufficient and deficient) | 2020 | ||
| Young women with poor ovarian response exhibit epigenetic age acceleration based on evaluation of white blood cells using a DNA methylation-derived age prediction model | 2020 | |||
|
Should we still perform fresh embryo transfers in ART? | 2019 | ||
|
25 historic papers: an ASRM 75th birthday gift from Fertility and Sterility | 2019 | ||
|
A brief history of oocyte cryopreservation: Arguments and facts. | 2019 | ||
|
A comparison of morphokinetic markers predicting blastocyst formation and implantation potential from two large clinical data sets | 2019 | ||
|
A Multicenter, Randomized, Equivalence Trial of a New Recombinant Human Chorionic Gonadotropin Preparation versus Ovitrelle((R)) for Ovulation in Women Undergoing Intrauterine Insemination Following Ovarian Stimulation | 2019 | ||
| A new system of sperm cryopreservation: evaluation of survival, motility, DNA oxidation, and mitochondrial activity | 2019 | |||
|
A Strength, Weaknesses, Opportunities and Threats analysis on time lapse | 2019 | ||
|
Adjusting for age: is it enough to just say you did it? | 2019 | ||
|
Advanced Maternal Age in IVF: Still a Challenge? The Present and the Future of Its Treatment. | 2019 | ||
|
Altered expression of the kisspeptin/KISS1R and neurokinin B/NK3R systems in mural granulosa and cumulus cells of patients with polycystic ovarian syndrome | 2019 | ||
|
Alternative patterns of partial embryo compaction: prevalence, morphokinetic history and possible implications. | 2019 | ||
|
An integrated investigation of oocyte developmental competence: expression of key genes in human cumulus cells, morphokinetics of early divisions, blastulation, and euploidy. | 2019 | ||
|
Another step forward toward the identification of sperm function biomarkers with a novel approach evaluating microRNA related pairs | 2019 | ||
|
Anti-müllerian hormone variability during ovarian stimulation for IVF: A novel approach to predict fertility treatment outcomes | IVF clinical | 2019 | IVF clinical |
| Anxiety and Stress at Different Stages of Treatment in Women Undergoing In vitro Fertilization-Intracytoplasmic Sperm Injection | 2019 | |||
|
Author Reply | 2019 | ||
|
Autologous mitochondrial transfer as a complementary technique to intracytoplasmic sperm injection to improve embryo quality in patients undergoing in vitro fertilization-a randomized pilot study | 2019 | ||
|
Bed rest after an embryo transfer: a systematic review and meta-analysis | 2019 | ||
|
Bioengineering strategies of the uterus towards improving current investigative models and female reproductive health | 2019 | ||
|
Breakthroughs and challenges of modern developmental biology and reproductive medicine. | 2019 | ||
|
Chromosome errors in human eggs shape natural fertility over reproductive life span. | 2019 | ||
|
Chronic endometritis is associated with an altered microbiome, but what about treatment and clinical outcomes? | 2019 | ||
| Cleavage stage mitochondrial DNA is correlated with preimplantation human embryo development and ploidy status | 2019 | |||
|
Co-incubation of spermatozoa with human follicular fluid reduces sperm DNA fragmentation by mitigating DNase activity in the seminal plasma. | 2019 | ||
|
Combining pessary, cerclage and vaginal progesterone to prevent preterm birth: Why not? | 2019 | ||
|
Cómo conseguir la revista que queremos: Relevante e indexada | 2019 | ||
|
Contribution of cryopreservation to the cumulative live birth rate: a large multicentric cycle-based data analysis from the Italian National Registry. | 2019 | ||
|
Corifollitropin alfa for ovarian stimulation in in vitro fertilization: a systematic review and meta-analysis of randomized controlled trials | 2019 | ||
|
Correction to: Contribution of cryopreservation to the cumulative live birth rate: a large multicentric cycle-based data analysis from the Italian National Registry. | 2019 | ||
|
Correction to: ICSI does not offer any benefit over conventional IVF across different ovarian response categories in non-male factor infertility: a European multicenter analysis | 2019 | ||
|
Corrigendum to "Evaluation of sexual function in women with deep infiltrating endometriosis" [Sex. Reprod. Healthcare 16 (2018) 6-9] | 2019 | ||
|
Cumulative live birth rates in in-vitro fertilization. | 2019 | ||
|
Current Controversies in Prenatal Diagnosis 3: Gene editing should replace embryo selection following PGD | Pre-implantation genetics | 2019 | Pre-implantation genetics;Technology development |
|
Decision-making for pediatric allergy immunotherapy for aeroallergens: a narrative review | 2019 | ||
|
Deep learning enables robust assessment and selection of human blastocysts after in vitro fertilization | 2019 | ||
|
Definition and validation of a custom protocol to detect miRNAs in the spent media after blastocyst culture: searching for biomarkers of implantation. | 2019 | ||
|
Deregulation of miR-324/KISS1/kisspeptin in early ectopic pregnancy: mechanistic findings with clinical and diagnostic implications | 2019 | ||
|
Dexamethasone does not prevent malignant cell reintroduction in leukemia patients undergoing ovarian transplant: risk assessment of leukemic cell transmission by a xenograft model | 2019 | ||
|
Diminished Ovarian Reserve Chemotherapy-Induced Mouse Model: A Tool for the Preclinical Assessment of New Therapies for Ovarian Damage | 2019 | ||
|
Diminished ovarian reserve versus ovarian aging: overlaps and differences | 2019 | ||
|
Divining the genetic status of embryos: consult the medium? | 2019 | ||
|
Donor IUI is equally effective for heterosexual couples, single women and lesbians, but autologous IUI does worse | 2019 | ||
|
Double intrauterine insemination (IUI) of no benefit over single IUI among lesbian and single women seeking to conceive | 2019 | ||
|
Double stimulation in the same ovarian cycle (DuoStim) is an intriguing strategy to improve oocyte yield and the number of competent embryos in a short timeframe. | 2019 | ||
|
Efectos del estilo de vida y determinados compuestos tóxicos sobre la fertilidad masculina | 2019 | ||
| Effect of oocyte morphology on post-warming survival and embryo development in vitrified autologous oocytes | 2019 | |||
|
Effect on Sperm DNA Quality Following Sperm Selection for ART: New Insights. | 2019 | ||
|
Effects of adenomyosis on obstetric outcomes | 2019 | ||
|
Embryonic Aneuploidy after Preimplantation Genetic Screening: Age- and Indication-Matched Comparative Study between Indian and Spanish Population | 2019 | ||
|
Embryonic aneuploidy rates are equivalent in natural cycles and gonadotropin-stimulated cycles | 2019 | ||
|
Embryonic cell-free DNA versus trophectoderm biopsy for aneuploidy testing: concordance rate and clinical implications. | 2019 | ||
|
Endometrial receptivity and implantation in women with previous failed embryo transfers: to scratch or not to scratch? | 2019 | ||
|
Endometrial Stromal Cells Circulate in the Bloodstream of Women with Endometriosis: A Pilot Study | 2019 | ||
|
Environment air pollution related to art facilities and its potential involvement in ivf outcomes | 2019 | ||
|
Erratum. Worth the wait? Day 7 blastocysts have lower euploidy rates but similar sustained implantation rates as Day 5 and Day 6 blastocysts | 2019 | ||
|
Ethnical and sociocultural differences causing infertility are poorly understood-insights from the Arabian perspective | 2019 | ||
|
EUropean REcommendations for female FERtility preservation (EU-REFER): A joint collaboration between oncologists and fertility specialists. | 2019 | ||
|
Exploring the association between physical activity and gut microbiota composition: a review of current evidence. | 2019 | ||
|
Follitropin delta in repeated ovarian stimulation for IVF: a controlled, assessor-blind Phase 3 safety trial | 2019 | ||
| Gonadotropin-releasing hormone analogs for gonadal protection during gonadotoxic chemotherapy: A systematic review and meta-analysis | 2019 | |||
|
Growth disparities in uterine leiomyomas associated with MED12 mutation | 2019 | ||
|
Happy Birthday to ASRM from Fertility and Sterility | 2019 | ||
|
How time to healthy singleton delivery could affect decision-making during infertility treatment: a Delphi consensus | 2019 | ||
|
How time to healthy singleton delivery could affect decision-making during infertility treatment: a Delphi consensus. | 2019 | ||
|
Human Blastocyst Biopsy and Vitrification. | 2019 | ||
| Human Endometrial Reconstitution From Somatic Stem Cells: The Importance of Niche-Like Cells | 2019 | |||
|
Human oocytes and zygotes are ready for ultra-fast vitrification after 2 minutes of exposure to standard CPA solutions. | 2019 | ||
| Human uterine transplantation: a review of outcomes from the first 45 cases | 2019 | |||
|
ICSI does not offer any benefit over conventional IVF across different ovarian response categories in non-male factor infertility: a European multicenter analysis | 2019 | ||
|
Impact of hypogonadotropic hypogonadism on ovarian reserve and response | 2019 | ||
|
Impact of parental over- and underweight on the health of offspring | 2019 | ||
|
In vitro fertilization and infertility do not cause a significant alteration in placental gene expression at the end of the first trimester | 2019 | ||
|
Individualization of the starting dose of follitropin delta reduces the overall OHSS risk and/or the need for additional preventive interventions: cumulative data over three stimulation cycles | 2019 | ||
|
Individualized luteal phase support | 2019 | ||
| Influence of Caesarean section-pregnancy interval on uterine rupture risk and IVF pregnancy rates: systematic review and mathematical modelling | 2019 | |||
| Inhibition of KIF20A by BKS0349 reduces endometriotic lesions in a xenograft mouse model | 2019 | |||
| Inhibition of tumor cell proliferation in human uterine leiomyomas by vitamin D via Wnt/beta-catenin pathway | 2019 | |||
|
Interchromosomal effect in carriers of translocations and inversions assessed by preimplantation genetic testing for structural rearrangements (PGT-SR) | 2019 | ||
|
Introduction: Infertility etiology and offspring health | 2019 | ||
| Is empirical use of the antibiotic combination of cefuroxime and clavulanic acid rational? | 2019 | |||
|
Is it realistic to consider vitamin D as a follicular and serum marker of human oocyte quality? | 2019 | ||
|
Is the transport of frozen embryos a good option to improve results in a transnational oocyte donation program? | 2019 | ||
| iTRAQ comparison of proteomic profiles of endometrial receptivity | 2019 | |||
|
Kiss/Kiss1r system in reproductive axis, interaction with NKB | Female fertility | 2019 | Female fertility; IVF laboratory;Female fertility |
|
Long-term GnRH agonist therapy before in vitro fertilisation (IVF) for improving fertility outcomes in women with endometriosis | 2019 | ||
|
Looking past the appearance: a comprehensive description of the clinical contribution of poor-quality blastocysts to increase live birth rates during cycles with aneuploidy testing. | 2019 | ||
|
Lower follicular n-3 polyunsaturated fatty acid levels are associated with a better response to ovarian stimulation | 2019 | ||
|
Macrophages display proinflammatory phenotypes in the eutopic endometrium of women with endometriosis with relevance to an infectious etiology of the disease | 2019 | ||
|
Male factor infertility impacts the rate of mosaic blastocysts in cycles of preimplantation genetic testing for aneuploidy. | 2019 | ||
|
Male Oxidative Stress Infertility (MOSI): Proposed Terminology and Clinical Practice Guidelines for Management of Idiopathic Male Infertility | 2019 | ||
|
Management of Women With an Unexpected Low Ovarian Response to Gonadotropin. | 2019 | ||
|
Maternal telomere length is shorter in intrauterine growth restriction versus uncomplicated pregnancies, but not in the offspring or in IVF-conceived newborns | 2019 | ||
|
Mathematical model to study the aging of the human follicle according to the telomerase activity | 2019 | ||
|
Minimizing mosaicism: assessing the impact of fertilization method on rate of mosaicism after next-generation sequencing (NGS) preimplantation genetic testing for aneuploidy (PGT-A) | 2019 | ||
|
Mitochondria as a biomarker for IVF outcome | 2019 | ||
|
Mitochondria as a tool for oocyte rejuvenation | 2019 | ||
|
Mitochondrial DNA copy number as a predictor of embryo viability | 2019 | ||
|
Modelos predictivos en reproducción asistida: Revisión sistemática y análisis crítico | 2019 | ||
| Modified natural cycle IVF versus conventional stimulation in advanced-age Bologna poor responders | 2019 | |||
|
Mosaic embryos present a challenging clinical decision | 2019 | ||
| mtDNA dynamics between cleavage-stage embryos and blastocysts | 2019 | |||
|
New Frontiers in IVF: mtDNA and autologous germline mitochondrial energy transfer | 2019 | ||
| NGS Analysis of Human Embryo Culture Media Reveals miRNAs of Extra Embryonic Origin | 2019 | |||
|
Noninvasive embryo assessment: how close are we? | 2019 | ||
|
Non-invasive mitochondrial DNA quantification on Day 3 predicts blastocyst development: a prospective, blinded, multi-centric study. | 2019 | ||
| Novel noninvasive embryo selection algorithm combining time-lapse morphokinetics and oxidative status of the spent embryo culture medium | 2019 | |||
|
Observational Study of the Social Determinants of Health in Subfertile versus Nonsubfertile Women | 2019 | ||
|
Obstetrical complications of thin endometrium in assisted reproductive technologies: a systematic review | 2019 | ||
| Ongoing pregnancies in patients with unexplained recurrent pregnancy loss: adverse obstetric outcomes | 2019 | |||
| Oocyte donation in donors with levonorgestrel intrauterine device: a good match? | 2019 | |||
|
Oocyte quantity and quality are crucial for a perspective of fertility preservation in women with Turner syndrome. | 2019 | ||
|
Oocyte quantity, as well as oocyte quality, plays a significant role for the cumulative live birth rate of a POSEIDON criteria patient. | 2019 | ||
|
Ovarian stimulated cycles reduce protection of follicular fluid against free radicals | 2019 | ||
|
Ovarian stimulation for oocyte vitrification does not modify disease-free survival and overall survival rates in patients with early breast cancer | 2019 | ||
|
Personalized Embryo Transfer Helps in Improving In vitro Fertilization/ICSI Outcomes in Patients with Recurrent Implantation Failure | 2019 | ||
|
Perspectives in Gamete and Embryo Cryopreservation. | 2019 | ||
|
PGDIS Position Statement on the Transfer of Mosaic Embryos 2019 | 2019 | ||
|
Pharmacogenetics of FSH Action in the Female. | 2019 | ||
|
Phthalates and other endocrine-disrupting chemicals: the 21st century's plague for reproductive health | 2019 | ||
| Phytoestrogen exposure alters endometrial stromal cells and interferes with decidualization signaling | 2019 | |||
|
Predicting suboptimal oocyte yield following GnRH agonist trigger by measuring serum LH at the start of ovarian stimulation | 2019 | ||
|
Pregnancy and adolescence entail similar neuroanatomical adaptations: A comparative analysis of cerebral morphometric changes | 2019 | ||
| Prevalence of structural birth defects in IVF-ICSI pregnancies resulting from autologous and donor oocytes in Indian sub-continent: Results from 2444 births | 2019 | |||
|
Recommendations for good practice in ultrasound: oocyte pick up(dagger) | 2019 | ||
| Recurrent Miscarriage and Implantation Failure of Unknown Cause Studied by a Panel of Thrombophilia Conditions: Increased Frequency of FXIII Val34Leu Polymorphism | 2019 | |||
|
Registered reports: prospective peer review emphasizes science over spin | 2019 | ||
|
Regulation of boar sperm functionality by the nitric oxide synthase/nitric oxide system | 2019 | ||
|
Reply: Bone marrow-derived endometrial cells: What you see is what you get | 2019 | ||
|
Reply: Careful and expert interpretation of PGT-A data can resolve the mosaicism dilemma | 2019 | ||
|
Reply: RE: a cost-effectiveness modeling evaluation comparing a biosimilar follitropin alfa preparation with its reference product for live birth outcome in Germany, Italy, and Spain | 2019 | ||
|
Reprint of: Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome | 2019 | ||
| Reproductive outcomes after hysteroscopic metroplasy for women with ... | IVF clinical | 2019 | IVF clinical; IVF laboratory | |
| Rethinking the time interval to embryo transfer after uterus transplantation - DUETS (Dallas UtErus Transplant Study) | 2019 | |||
|
Second-generation preimplantation genetic testing for aneuploidy in assisted reproduction: a SWOT analysis | 2019 | ||
|
Segmental aneuploidy in human blastocysts: a qualitative and quantitative overview | 2019 | ||
| Serum and follicular fluid Stem Cell Factor assay in IVF poor responder and normal responder patients: a predictive biomarker of oocyte retrieval | 2019 | |||
| Should the reproductive risk of a couple aiming to conceive be tested in the contemporary clinical context? | 2019 | |||
|
Significant Serum Progesterone Variations on the Day of Final Oocyte Maturation in Stimulated IVF Cycles | 2019 | ||
|
Single-cell RNA sequencing of oocytes from ovarian endometriosis patients reveals a differential transcriptomic profile associated with lower quality | 2019 | ||
| Sperm chromosomal abnormalities and their contribution to human embryo aneuploidy | 2019 | |||
|
Sperm DNA fragmentation to predict embryo development, implantation, and miscarriage: still an open question. | 2019 | ||
|
State of the art and emerging drug therapies for female infertility. | 2019 | ||
| Tachykinins and Kisspeptins in the Regulation of Human Male Fertility | 2019 | |||
|
Testosterone therapy for women with poor ovarian response undergoing IVF: a meta-analysis of randomized controlled trials | 2019 | ||
|
Thaw, biopsy and refreeze strategy for PGT-A on previously cryopreserved embryos. | 2019 | ||
|
The association between assisted reproductive technologies and low birth weight | 2019 | ||
| The clinicians dilemma with mosaicism-an insight from inner cell mass biopsies | 2019 | |||
|
The cytogenetic constitution of human blastocysts: insights from comprehensive chromosome screening strategies | 2019 | ||
| The effect of different temperature conditions on human embryosin vitro: two sibling studies | 2019 | |||
|
The endometrial immune environment of women with endometriosis | 2019 | ||
|
The enigmatic morula: mechanisms of development, cell fate determination, self-correction and implications for ART. | 2019 | ||
|
The High Prevalence of Testicular Adrenal Rest Tumors in Adult Men With Congenital Adrenal Hyperplasia Is Correlated With ACTH Levels. | 2019 | ||
|
The main will of the patients of a private Italian IVF clinic for their aneuploid/affected blastocysts would be donation to research: a currently forbidden choice. | 2019 | ||
|
The model of "genetic compartments": a new insight into reproductive genetics | 2019 | ||
|
The POSEIDON Criteria and Its Measure of Success Through the Eyes of Clinicians and Embryologists | 2019 | ||
|
The POSEIDON Criteria and Its Measure of Success Through the Eyes of Clinicians and Embryologists. | 2019 | ||
|
The preimplantation genetic testing debate continues: first the hype, then the tension, now the hypertension? | 2019 | ||
| The role of progesterone elevation in IVF | 2019 | |||
|
The seminal microbiome in health and disease | 2019 | ||
|
Three-dimensional ultrasound diagnosis of T-shaped uterus is associated with adverse pregnancy outcomes after embryo transfer | 2019 | ||
|
Time of morulation and trophectoderm quality are predictors of a live birth after euploid blastocyst transfer: a multicenter study | 2019 | ||
|
Time of morulation and trophectoderm quality are predictors of a live birth after euploid blastocyst transfer: a multicenter study. | 2019 | ||
|
Time-lapse imaging: the state of the artdagger | 2019 | ||
|
Tissue-specific decellularized endometrial substratum mimicking different physiological conditions influences in vitro embryo development in a rabbit model | 2019 | ||
|
Total Motile Sperm Count Trend Over Time: Evaluation of Semen Analyses From 119,972 Men From Subfertile Couples | 2019 | ||
|
Towards complication-free assisted reproduction technology | 2019 | ||
| Transcriptomic behavior of genes associated with chromosome 21 aneuploidies in early embryo development | 2019 | |||
|
Treatment potential of bone marrow-derived stem cells in women with diminished ovarian reserves and premature ovarian failure | 2019 | ||
|
Understanding the role of killer cell immunoglobulin-like receptors in pregnancy complications | 2019 | ||
| Urethrovaginal space during the third trimester of pregnancy is not related to vaginal orgasm | 2019 | |||
|
Use of granulocyte colony-stimulating factor in ART treatment does not increase the risk of adverse perinatal outcomes | 2019 | ||
|
Uterus transplantation from a deceased donor | 2019 | ||
|
Vibrational characterization of granulosa cells from patients affected by unilateral ovarian endometriosis: New insights from infrared and Raman microspectroscopy. | 2019 | ||
|
When next-generation sequencing-based preimplantation genetic testing for aneuploidy (PGT-A) yields an inconclusive report: diagnostic results and clinical outcomes after re biopsy | 2019 | ||
|
Worth the wait? Day 7 blastocysts have lower euploidy rates but similar sustained implantation rates as Day 5 and Day 6 blastocysts | 2019 | ||
|
[Assessment of the erectile function and patients' perception of improvement in Spanish patients with erectile dysfunction] | 2018 | ||
|
3D NIR-II Molecular Imaging Distinguishes Targeted Organs with High-Performance NIR-II Bioconjugates | 2018 | ||
| A cost-effectiveness modeling evaluation comparing a biosimilar follitropin alfa preparation with its reference product for live birth outcome in Germany, Italy and Spain | 2018 | |||
|
A modern approach to the management of candidates for assisted reproductive technology procedures. | 2018 | ||
|
A new predictive parameter for embryo transfer success: a path forward is needed to implement it in technique training | 2018 | ||
|
Activin and inhibin a in predicting outcome of pregnancies of unknown location after art | 2018 | ||
|
An optimized controlled rate slow cooling protocol for bovine ovarian tissue cryopreservation by means of X-ray computed tomography. | 2018 | ||
|
Analysis of Protein Oxidative Modifications in Follicular Fluid from Fertile Women: Natural Versus Stimulated Cycles | 2018 | ||
|
Anti-mullerian Hormone During Natural Cycle Presents Significant Intra and Intercycle Variations When Measured With Fully Automated Assay | 2018 | ||
|
Assisted Reproductive Technology and Origins of Disease: The Clinical Realities and Implications | 2018 | ||
| Association between alcohol intake and cardiac remodeling | 2018 | |||
|
Associations of blastocyst features, trophectoderm biopsy and other laboratory practice with post-warming behavior and implantation. | 2018 | ||
| Asynchronous and pathological windows of implantation: two causes of recurrent implantation failure | 2018 | |||
| Autologous stem cell ovarian transplantation to increase reproductive potential in patients who are poor responders | 2018 | |||
| Basic and Clinical Approaches for Fertility Preservation and Restoration in Cancer Patients | 2018 | |||
|
Better together than alone: the cumulus benefits | 2018 | ||
|
Biochemical pregnancy loss after frozen embryo transfer seems independent of embryo developmental stage and chromosomal status. | 2018 | ||
| Birthweight of singletons born after cleavage-stage or blastocyst transfer in fresh and warming cycles | 2018 | |||
|
Celiac disease is not more prevalent in patients undergoing in vitro fertilization and does not affect reproductive outcomes with or without treatment: a large prospective cohort study | 2018 | ||
|
Characterization of parent-of-origin methylation using the Illumina Infinium MethylationEPIC array platform | 2018 | ||
| Clinical reassessment of human embryo ploidy status between cleavage and blastocyst stage by Next Generation Sequencing | 2018 | |||
|
Clinical trial registry alone is not adequate: on the perception of possible endpoint switching and P-hacking | 2018 | ||
|
Comparative economic study of the use of corifollitropin alfa and daily rFSH for controlled ovarian stimulation in older patients: Cost-minimization analysis based on the PURSUE study | 2018 | ||
|
Comparison of Effectiveness of Different Protocols Used for Controlled Ovarian Hyperstimulation in Intrauterine Insemination Cycle | 2018 | ||
| Comparison of the SwimCount Home Diagnostic Test with Conventional Sperm Analysis | Male fertility | 2018 | Male fertility | |
|
Comparison of two closed carriers for vitrification of human blastocysts in a donor program. | 2018 | ||
|
Complexities and potential pitfalls of clinical study design and data analysis in assisted reproduction | 2018 | ||
|
Congenital Uterine Malformation by Experts (CUME): better criteria for distinguishing between normal/arcuate and septate uterus? | 2018 | ||
|
Contemporary management of high-grade renal trauma: Results from the american association for the surgery of trauma genitourinary trauma study | 2018 | ||
|
Continuous embryo culture elicits higher blastulation but similar cumulative delivery rates than sequential: a large prospective study. | 2018 | ||
|
Conventional versus minimal ovarian stimulation: an intra-patient comparison of ovarian response in poor-responder women according to Bologna Criteria | 2018 | ||
|
Correlation between neonatal outcomes of twins depends on the outcome: secondary analysis of twelve randomised controlled trials | 2018 | ||
|
Corrigendum: Letter to the Editor: Individualized FSH dosing improves safety and reduces iatrogenic poor response while maintaining live-birth rates | 2018 | ||
|
Corrigendum: Low serum progesterone on the day of embryo transfer is associated with a diminished ongoing pregnancy rate in oocyte donation cycles after artificial endometrial preparation: a prospective study | 2018 | ||
|
Crossing the germline: Crispr-cas9 and our responsibility as reproductive endocrinology and infertility physicians | 2018 | ||
|
Cumulative live birth rate in freeze-all cycles is comparable to that of a conventional embryo transfer policy at the cleavage stage but superior at the blastocyst stage. | 2018 | ||
|
Cumulative live birth rates according to the number of oocytes retrieved after the first ovarian stimulation for in vitro fertilization/intracytoplasmic sperm injection: a multicenter multinational analysis including approximately 15,000 women | 2018 | ||
| Cumulative live birth rates after ivf in patients with polycystic ovaries: Phenotype matters | 2018 | |||
|
Cumulus cell transcriptome profiling is not predictive of live birth after in vitro fertilization: a paired analysis of euploid sibling blastocysts | 2018 | ||
|
Current status and future prospects of noninvasive preimplantation genetic testing for aneuploidy | 2018 | ||
|
Data sharing requirements: perspectives from three authors | 2018 | ||
|
Diagnostic efficacy of blastocoel fluid and spent media as sources of DNA for preimplantation genetic testing in standard clinical conditions. | 2018 | ||
|
Different Endometrial Receptivity in Each Hemiuterus of a Woman with Uterus Didelphys and Previous Failed Embryo Transfers | 2018 | ||
| Differential insulin and steroidogenic signaling in insulin resistant and non-insulin resistant human luteinized granulosa cells-A study in PCOS patients | 2018 | |||
|
Differential proteomic analysis of endometrial fluid suggests increased inflammation and impaired glucose metabolism in non-implantative IVF cycles and pinpoints PYGB as a putative implantation marker | 2018 | ||
|
Diminished ovarian reserve and poor response to stimulation in patients <38 years old: a quantitative but not qualitative reduction in performance | 2018 | ||
|
DNA methylation-based age prediction and telomere length in white blood cells and cumulus cells of infertile women with normal or poor response to ovarian stimulation | 2018 | ||
| Do immature and mature sibling oocytes recovered from stimulated cycles have the same reproductive potential? | 2018 | |||
|
Does the molecular and metabolic profile of human granulosa cells correlate with oocyte fate? New insights by Fourier transform infrared microspectroscopy analysis. | 2018 | ||
|
Does the type of gnrh analogue used, affect live birth rates in women with endometriosis undergoing ivf/icsi treatment, according to the rafs stage? | 2018 | ||
|
Double Stimulation in the Same Ovarian Cycle (DuoStim) to Maximize the Number of Oocytes Retrieved From Poor Prognosis Patients: A Multicenter Experience and SWOT Analysis. | 2018 | ||
| Dysregulated genes and their functional pathways in luteinized granulosa cells from PCOS patients after cabergoline treatment | 2018 | |||
|
Effect of dietary supplementation with a highly pure and concentrated docosahexaenoic acid (DHA) supplement on human sperm function | 2018 | ||
|
Efforts to redefine endometriosis prevalence in low-risk patients | 2018 | ||
|
Elective and Onco-fertility preservation: factors related to IVF outcomes | 2018 | ||
|
Embryo morphokinetic characteristics and euploidy. | 2018 | ||
|
Endometrioma, fertility, and assisted reproductive treatments: connecting the dots | 2018 | ||
|
Evaluation of a new freezing protocol containing 20% dimethyl sulphoxide concentration to cryopreserve human ovarian tissue. | 2018 | ||
| Evaluation of a Possible Association between estradiol and progesterone levels and ectopic pregnancy in low risk women undergoing IVF/ICSI | Reproductive disorders | 2018 | Reproductive disorders; IVF clinical;IVF clinical;Female fertility;Reproductive disorders | |
| Evaluation of PAI-1 in endometriosis using a homologous immunocompetent mouse model | 2018 | |||
|
Evaluation of sexual function in women with deep infiltrating endometriosis | 2018 | ||
|
Extracellular vesicles: a promising tool for assessment of embryonic competence | 2018 | ||
| Fertility rescue and ovarian follicle growth promotion by bone marrow stem cell infusion | 2018 | |||
|
Fertility, IVF and reproductive genetics | 2018 | ||
| Fetal sex determination in twin pregnancies using cell free fetal DNA analysis | 2018 | |||
|
Forty years of IVF | 2018 | ||
|
Frequency of the T307A, N680S, and -29G>A single-nucleotide polymorphisms in the follicle-stimulating hormone receptor in Mexican subjects of Hispanic ancestry | 2018 | ||
| GnRH antagonist for endometrial priming in an oocyte donation programme: a prospective, randomized controlled trial | 2018 | |||
|
GnRHa trigger and luteal coasting: a new approach for the ovarian hyperstimulation syndrome high-risk patient? | 2018 | ||
| High sperm DNA fragmentation delays human embryo kinetics when oocytes from young and healthy donors are microinjected | 2018 | |||
|
How new technical knowledge impacts clinical approach to infertile patients | 2018 | ||
|
Human leukocyte antigen DQ2/DQ8 positivity in women with history of stillbirth | 2018 | ||
| Human sperm testicular angiotensin-converting enzyme helps determine human embryo quality | 2018 | |||
| Hysteroscopic septum resection and reproductive medicine: A SWOT analysis | 2018 | |||
|
Impact of late-follicular phase elevated serum progesterone on cumulative live birth rates: Is there a deleterious effect on embryo quality? | 2018 | ||
|
Impact of Maternal Age on Oocyte and Embryo Competence. | 2018 | ||
|
Impact of stimulation duration and gonadotropin type on the incidence of premature progesterone elevation - a retrospective analysis of the Ensure data | 2018 | ||
|
Implantation failure of endometrial origin: what is new? | 2018 | ||
|
Inconclusive chromosomal assessment after blastocyst biopsy: prevalence, causative factors and outcomes after re-biopsy and re-vitrification. A multicenter experience. | 2018 | ||
|
Individualized FSH dosing improves safety and reduces iatrogenic poor response while maintaining live-birth rates | 2018 | ||
| Infertile Couples Prefer Twins: Analysis of Their Reasons and Clinical Characteristics Related to This Preference | 2018 | |||
|
Influence of temperature, serum, and gonadotropin supplementation in short- and long-term organotypic culture of human immature testicular tissue | 2018 | ||
|
Innovations in assisted reproductive technologies: Impact on contemporary donor egg practice and future advances | 2018 | ||
| Inter-assay variation and reproducibility of progesterone measurements during ovarian stimulation for IVF | 2018 | |||
|
International Committee for Monitoring Assisted Reproductive Technology: world report on assisted reproductive technology, 2011 | 2018 | ||
|
Introduction: Cancer biomarkers and fertility | 2018 | ||
|
Introduction: IVF's 40th world birthday | 2018 | ||
|
Is hyaluronic acid really ineffective? | 2018 | ||
| Is the ovarian reserve influenced by vitamin D deficiency and the dress code in an infertile Iranian population? | 2018 | |||
|
Knowledge gaps in male infertility: a reproductive endocrinology and infertility perspective | 2018 | ||
|
Knowledge gaps in male infertility: an REI perspective. | Male fertility | 2018 | Male fertility;IVF clinical;IVF laboratory |
| Leptin action in normal and pathological pregnancies | 2018 | |||
|
Let's rescue oocytes: in vitro maturation 2.0 is coming | 2018 | ||
| Lgr5 Does Not Vary Throughout the Menstrual Cycle in Endometriotic Human Eutopic Endometrium | 2018 | |||
|
Luteal Coasting and Individualization of Human Chorionic Gonadotropin Dose after Gonadotropin-Releasing Hormone Agonist Triggering for Final Oocyte Maturation-A Retrospective Proof-of-Concept Study | 2018 | ||
|
Luteal phase anovulatory follicles result in the production of competent oocytes: intra-patient paired case-control study comparing follicular versus luteal phase stimulations in the same ovarian cycle. | 2018 | ||
|
Luteal phase serum progesterone levels after GnRH-agonist trigger - how low is still high enough for an ongoing pregnancy? | 2018 | ||
|
Magnetic-activated cell sorting is not completely effective at reducing sperm DNA fragmentation. | 2018 | ||
| Metabolic imaging with the use of fluorescence lifetime imaging microscopy (flim) accurately detects mitochondrial dysfunction in mouse oocytes | 2018 | |||
|
Metabolism of the oocyte and the preimplantation embryo: Implications for assisted reproduction | 2018 | ||
|
Mitochondrial unfolded protein response gene clpp is required to maintain ovarian follicular reserve during aging, for oocyte competence, and development of pre-implantation embryos | 2018 | ||
|
Need to define and validate an early pregnancy loss screening strategy | 2018 | ||
|
Next generation sequencing for preimplantation genetic testing for aneuploidy: friend or foe? | 2018 | ||
|
On Reproductive Work in Spain: Transnational Adoption, Egg Donation, Surrogacy | 2018 | ||
|
One Plus One Is Better Than Two: Cumulative Reproductive Outcomes Are Better after Two Elective Single Blastocyst Embryo Transfers Compared to One Double Blastocyst Embryo Transfer | 2018 | ||
|
Oocyte and Embryo Manipulation and Epigenetics | 2018 | ||
|
Oocyte vitrification versus ovarian cortex transplantation in fertility preservation for adult women undergoing gonadotoxic treatments: a prospective cohort study | 2018 | ||
|
Origin and composition of cell-free DNA in spent medium from human embryo culture during preimplantation development | 2018 | ||
| Ovarian endometriosis and infertility: in vitro fertilization (IVF) or surgery as the first approach? | 2018 | |||
|
Ovarian manipulation in ART: going beyond physiological standards to provide best clinical outcomes | 2018 | ||
|
Ovarian stimulation under the effect of isotretinoin | 2018 | ||
|
Ovarian stimulation with corifollitropin alfa followed by hp-hMG compared to hp-hMG in patients at risk of poor ovarian response undergoing ICSI: A randomized controlled trial | 2018 | ||
|
Ovarian tissue cryopreservation by stepped vitrification and monitored by X-ray computed tomography. | 2018 | ||
| Pancreatic autoimmunity: An unknown etiology on patients with assisted reproductive techniques (ART)-recurrent reproductive failure | 2018 | |||
|
Perinatal and Peripartum Outcomes in Vanishing Twin Pregnancies Achieved by In Vitro Fertilization | 2018 | ||
|
Personalized ovarian stimulation for assisted reproductive technology: study design considerations to move from hype to added value for patients | 2018 | ||
|
Polycystic ovary syndrome throughout a woman's life | 2018 | ||
|
Pores for thought: preimplantation genetic testing using a nanopore-based DNA sequencer | 2018 | ||
| Pre-clinical validation of a closed surface system (Cryotop SC) for the vitrification of oocytes and embryos in the mouse model | 2018 | |||
|
Preclinical validation of a targeted next generation sequencing-based comprehensive chromosome screening methodology in human blastocysts | 2018 | ||
| Pregnancy after vasectomy: Surgical reversal or assisted reproduction? | 2018 | |||
|
Preimplantation genetic testing for aneuploidy is cost-effective, shortens treatment time, and reduces the risk of failed embryo transfer and clinical miscarriage | 2018 | ||
|
Premature progesterone elevation: targets and rescue strategies | 2018 | ||
|
Premature progesterone rise in ART-cycles | 2018 | ||
|
Prevalence of XXY karyotypes in human blastocysts: multicentre data from 7549 trophectoderm biopsies obtained during preimplantation genetic testing cycles in IVF. | 2018 | ||
|
Progesterone for preparation of the endometrium for frozen-thawed blastocyst transfer in vitro fertilization cycles: a prospective study on patients' opinions on a new subcutaneous formulation. | 2018 | ||
|
Proteomic pattern of implantative human endometrial fluid in in vitro fertilization cycles | 2018 | ||
|
Proton-pump inhibitor use does not affect semen quality in subfertile men | 2018 | ||
|
Quest for a less invasive approach to preimplantation genetic testing remains ongoing | 2018 | ||
|
Recombinant luteinizing hormone supplementation in assisted reproductive technology: a systematic review | 2018 | ||
|
Reduction in oxygen tension to 2% in extended culture: a more physiologic system may mean more blastocysts available for transfer | 2018 | ||
|
Relevance of assessing the uterine microbiota in infertility | 2018 | ||
|
Reply to Liu et al.: Decidualization defect in severe preeclampsia | 2018 | ||
| Risk of pelvic inflammatory disease after intrauterine insemination: a systematic review | 2018 | |||
|
Search for new molecular biomarkers to diagnose endometriosis continues | 2018 | ||
|
Selection of preimplantation embryos using time-lapse microscopy in in vitro fertilization: State of the technology and future directions | 2018 | ||
|
Should we consider telomere length and telomerase activity in male factor infertility? | 2018 | ||
| Should we continue to measure endometrial thickness in modern-day medicine? | IVF clinical | 2018 | IVF clinical; IVF laboratory;IVF clinical | |
|
Simplifying luteal phase support in stimulated assisted reproduction cycles | 2018 | ||
| Small-sized follicles could contribute to high-order multiple pregnancies: outcomes of 6552 intrauterine insemination cycles | 2018 | |||
|
Social media in the REI clinic: what do patients want? | 2018 | ||
|
Sperm DNA fragmentation in donors and normozoospermic patients attending for a first spermiogram: Static and dynamic assessment. | 2018 | ||
| Sperm lipidic profiles differ significantly between ejaculates resulting in pregnancy or not following intracytoplasmic sperm injection | 2018 | |||
|
The diagnosis of chronic endometritis in infertile asymptomatic women: a comparative study of histology, microbial cultures, hysteroscopy, and molecular microbiology | 2018 | ||
|
The dilemma of aneuploidy screening on low responders | 2018 | ||
|
The Effect of Copper on Endometrial Receptivity and Induction of Apoptosis on Decidualized Human Endometrial Stromal Cells. | 2018 | ||
|
The Effect of Dose Adjustments in a Subsequent Cycle of Women With Suboptimal Response Following Conventional Ovarian Stimulation | 2018 | ||
|
The effect of low-dose ovarian stimulation with HMG plus progesterone on pregnancy outcome in women with history of recurrent pregnancy loss and secondary infertility: a retrospective cohort study | 2018 | ||
|
The impact of contemporary preimplantation genetic screening and diagnosis on the detection of aneuploidy and inherited genetic diseases | 2018 | ||
|
The impact of ejaculatory abstinence on semen analysis parameters: A systematic review | 2018 | ||
|
The implications of male human papilloma virus infection in couples seeking assisted reproduction technologies | 2018 | ||
|
The pros and cons of preimplantation genetic testing for aneuploidy: clinical and laboratory perspectives | 2018 | ||
|
The role of mitochondrial activity in female fertility and assisted reproductive technologies: overview and current insights | 2018 | ||
|
The Status of Genetic Screening in Recurrent Pregnancy Loss | 2018 | ||
| Three-Dimensional Angiogenic Evaluation of the Effect of Mifepristone in early gestation: pilot study | Female fertility | 2018 | Female fertility;Reproductive disorders; IVF clinical;Female fertility;Pre-implantation genetics | |
|
Time-lapse imaging: clearly useful to both laboratory personnel and patient outcomes versus just because we can doesn't mean we should | 2018 | ||
|
To invade, or to observe, that is the question | 2018 | ||
|
Total urokinase-type plasminogen activator (uPA) levels in seminal plasma are associated with positive assisted reproductive technology outcomes | 2018 | ||
|
Translational Regulation of Gene Expression During Oogenesis and Pre-Implantation Embryo Development | Female fertility | 2018 | Female fertility |
|
Ultrasound-guided embryo transfer: summary of the evidence and new perspectives. A systematic review and meta-analysis | 2018 | ||
|
Unexpected repeat immature oocyte response after IVF stimulation: a case report | 2018 | ||
|
Use of testicular sperm for intracytoplasmic sperm injection in men with high sperm DNA fragmentation: a SWOT analysis | 2018 | ||
|
Using Mouse Oocytes to Assess Human Gene Function During Meiosis I | 2018 | ||
| Uterine stem cells: from basic research to advanced cell therapies | 2018 | |||
| Uterus Transplantation: A Rapidly Expanding Field | 2018 | |||
|
Validation of a targeted next generation sequencing-based comprehensive chromosome screening platform for detection of triploidy in human blastocysts | 2018 | ||
| Variables associated with mitochondrial copy number in human blastocysts: what can we learn from trophectoderm biopsies? | 2018 | |||
| Veratridine-sensitive Na(+) channels regulate human sperm fertilization capacity | 2018 | |||
|
Very low anti-mullerian hormone concentrations are not an independent predictor of embryo quality and pregnancy rate | 2018 | ||
|
Vitrification of human oocytes | 2018 | ||
|
What is new in the management of poor ovarian response in IVF? | 2018 | ||
|
What to do when good-quality embryos repeatedly fail to implant | 2018 | ||
|
Analysis of implantation and ongoing pregnancy rates following the transfer of mosaic diploid-aneuploid blastocysts. | 2017 | ||
|
Update on fertility preservation from the barcelona international society for fertility preservation-eshre-asrm 2015 expert meeting: Indications, results and future perspectives | 2017 | ||
|
[Fertility preservation in the oncology patient] | 2017 | ||
|
A call for standardized outcomes in microTESE. | Male fertility | 2017 | Male fertility; IVF clinical;Female fertility |
|
A Glenohumeral joint model for rehabilitation exoskeleton SOFI. Clinical trial and results. | Reproductive disorders | 2017 | Reproductive disorders |
| A Higher Ovarian Response after Stimulation for IVF Is Related to a Higher Number of Euploid Embryos | 2017 | |||
| A novel homologous model for noninvasive monitoring of endometriosis progression | 2017 | |||
|
A pilot randomized controlled trial of day 3 single embryo transfer with adjunctive time-lapse selection versus day 5 single embryo transfer with or without adjunctive time-lapse selection | 2017 | ||
|
Aberrant expression of epithelial leucine-rich repeat containing G protein-coupled receptor 5-positive cells in the eutopic endometrium in endometriosis and implications in deep-infiltrating endometriosis | 2017 | ||
|
Abnormally fertilized oocytes can result in healthy live births: improved genetic technologies for preimplantation genetic testing can be used to rescue viable embryos in in vitro fertilization cycles | 2017 | ||
|
Abnormally fertilized oocytes can result in healthy live births: improved genetic technologies for preimplantation genetic testing can be used to rescue viable embryos in in vitro fertilization cycles. | 2017 | ||
|
ABO blood group incompatibility and infertility: still an open debate | 2017 | ||
|
Advances in preimplantation genetic testing for monogenic disease and aneuploidy | 2017 | ||
|
Amniotic therapeutic biomaterials in urology: Current and future applications | 2017 | ||
| Analysis of the morphological dynamics of blastocysts after vitrification/warming: defining new predictive variables of implantation | 2017 | |||
|
Anti-mullerian hormone dynamics during gnrh-antagonist short protocol for ivf/icsi in women with varying ovarian reserve levels | 2017 | ||
|
Antioxidant system in semen and exogenous supplementation. | Male fertility | 2017 | Male fertility;Reproductive disorders |
|
Assessment of embryo morphology and developmental dynamics by time-lapse microscopy: is there a relation to implantation and ploidy? | 2017 | ||
|
Assisted Reproduction. Yen and Jaffe’s Reproductive Endocrinology: Physiology, Pathophysiology and Clinical Management, 8th edition, 2017. | IVF clinical | 2017 | IVF clinical;Female fertility |
|
Bioengineering the Uterus: An Overview of Recent Advances and Future Perspectives in Reproductive Medicine | 2017 | ;IVF clinical | |
|
Birthweight and the effects of culture media. | 2017 | ||
|
Capítulo 3- Banco de Óvulos. | IVF clinical | 2017 | IVF clinical;Female fertility |
|
Chapter 10 Human Oocyte Vitrification | 2017 | ||
| Characterization of reproductive endocrinology and infertility (REI) fellowship applicants: guiding our mentees toward success | 2017 | |||
| Characterizing the endometrial microbiome: next generation sequencing of the 16s ribosomal gene. | Endometrial receptivity | 2017 | Endometrial receptivity;Immunology | |
|
Childhood cancer risk in the siblings and cousins of men with poor semen quality | 2017 | ||
|
Chromatin and single-cell rna-seq profiling reveal dynamic signaling and metabolic transitions during human spermatogonial stem cell development | 2017 | ||
|
Cigarette smoking significantly alters sperm DNA methylation patterns | Male fertility | 2017 | Male fertility;Epigenetics |
| Clinical implications of mitochondrial DNA quantification on pregnancy outcomes: A blinded prospective non-selection study | 2017 | |||
|
Clinical use of sperm DNA fragmentation analysis results, a practical example of how to deal with too much information from the literature in reproductive medicine | 2017 | ||
|
Combination of uterine natural killer cell immunoglobulin receptor haplotype and trophoblastic HLA-C ligand influences the risk of pregnancy loss: a retrospective cohort analysis of direct embryo genotyping data from euploid transfers | 2017 | ||
|
Comprehensive chromosome screening and gene expression analysis from the same biopsy in human preimplantation embryos | 2017 | ||
|
Continuing to deliver: the evidence base for pre-implantation genetic screening | 2017 | ||
|
Contribution of immunology to implantation failure of euploid embryos | 2017 | ||
| Corrigendum to "A Higher Ovarian Response after Stimulation for IVF Is Related to a Higher Number of Euploid Embryos" | 2017 | |||
| De- and recellularization of the pig uterus: a bioengineering pilot study | 2017 | |||
|
Defective decidualization during and after severe preeclampsia reveals a possible maternal contribution to the etiology | 2017 | ||
|
Detailed investigation into the cytogenetic constitution and pregnancy outcome of replacing mosaic blastocysts detected with the use of high-resolution next-generation sequencing | 2017 | ||
|
Detecting mosaicism in trophectoderm biopsies: current challenges and future possibilities. | 2017 | ||
|
Detection of mosaicism at blastocyst stage with the use of high-resolution next-generation sequencing | 2017 | ||
|
Detection of segmental aneuploidy and mosaicism in the human preimplantation embryo: technical considerations and limitations. | Pre-implantation genetics | 2017 | Pre-implantation genetics;Technology development;IVF laboratory |
|
DHEA supplementation can result in assay changes which may impact clinical decisions in IVF | IVF clinical | 2017 | IVF clinical;Female fertility;IVF laboratory |
|
Diagnosis and clinical management of duplications and deletions. | 2017 | ||
|
Does an increased body mass index affect endometrial gene expression patterns in infertile patients? A functional genomics analysis | 2017 | ||
|
Does cumulative live birth plateau beyond a certain ovarian response? | 2017 | ||
| Does premature elevated progesterone on the day of trigger increase spontaneous abortion rates in fresh and subsequent frozen embryo transfers? | Reproductive disorders | 2017 | Reproductive disorders | |
|
Does supplementation with progestogens in the first trimester of pregnancy prevent miscarriage in women with unexplained recurrent miscarriage? | IVF clinical | 2017 | IVF clinical;Female fertility |
|
Donación de óvulos y esperma: un estudio predictivo de las características de los candidatos compensados económicamente y su evolución en el tiempo. | IVF clinical | 2017 | IVF clinical; IVF laboratory |
|
Dual ovarian stimulation and random start in assisted reproductive technologies: from ovarian biology to clinical application. | 2017 | ||
| Dynamic expression of PGRMC1 and SERBP1 in human endometrium: an implication in the human decidualization process | 2017 | |||
| Economic impact of ovarian stimulation with corifollitropin alfa versus conventional daily gonadotropins in oocyte donors: a randomized study | 2017 | |||
|
Effect of Body Mass Index on the Outcome of In-Vitro Fertilization/Intracytoplasmic Sperm Injection in Women | 2017 | ||
|
Effect of progesterone elevation in follicular phase of IVF-cycles on the endometrial receptivity | 2017 | ||
|
Effect of the male factor on the clinical outcome of intracytoplasmic sperm injection combined with preimplantation aneuploidy testing: observational longitudinal cohort study of 1,219 consecutive cycles. | 2017 | ||
|
Efforts to redefine endometriosis in low-risk patients. | Reproductive disorders | 2017 | Reproductive disorders;Immunology;IVF clinical |
|
Embryo transfer techniques: an American Society for Reproductive Medicine survey of current Society for Assisted Reproductive Technology practices | 2017 | ||
|
Embryonic factors associated with recurrent implantation failure. Recurrent Implantation Failure, 2017. | IVF clinical | 2017 | IVF clinical;Female fertility |
|
Embryonic poly(a)-binding protein is required at the preantral stage of mouse folliculogenesis for oocyte-somatic communication | 2017 | ||
| Embryos with morphokinetic abnormalities may develop into euploid blastocysts | 2017 | |||
|
Endocrine causes of implantation failure. | Female fertility | 2017 | Female fertility; IVF clinical; IVF laboratory;Reproductive disorders |
|
Endometrial microbiome | 2017 | ||
|
Endometrial microbiota-new player in town | 2017 | ||
|
Enhanced techniques to "power" embryonic mitochondria research | 2017 | ||
|
Equivalent seminal characteristics in human and stallion at first and second ejaculated fractions. | 2017 | ||
|
Erratum to: Dehydroepiandrosterone (DHEA) supplementation results in supraphysiologic DHEA-S serum levels and progesterone assay interference that may impact clinical management in IVF | 2017 | ||
| Estimation of preterm labor immediacy by nonlinear methods | 2017 | |||
|
Estimulación ovárica controlada con hormona foliculoestimulante recombinante de acción prolongada frente a hormona foliculoestimulante recombinante diaria: Experiencia en nuestro centro | 2017 | ||
|
Estrategia no Errores en el laboratorio de Fecundación in Vitro. | IVF clinical | 2017 | IVF clinical; IVF laboratory |
| Evaluation of comprehensive chromosome screening platforms for the detection of mosaic segmental aneuploidy | 2017 | |||
|
Ferroportin mrna is down-regulated in granulosa and cervical cells from infertile women | 2017 | ||
|
Fertility treatment for the transgender community: a public opinion study | 2017 | ||
|
Fibroblast growth factor 2 (FGF2) is present in human spermatozoa and is related with sperm motility. The use of recombinant FGF2 to improve motile sperm recovery | 2017 | ||
|
Follicular flushing: time to look elsewhere to improve in vitro fertilisation outcomes? | 2017 | ||
|
Freeze all strategy in assisted reproduction: why it is not warranted? | IVF clinical | 2017 | IVF clinical;Female fertility |
|
Future of egg donation. | IVF clinical | 2017 | IVF clinical;Female fertility |
| Genome editing reveals a role for OCT4 in human embryogenesis. | Technology development | 2017 | Technology development;Female fertility;Female fertility;Endometrial receptivity | |
| Genomic instability during reprogramming by nuclear transfer is DNA replication dependent | 2017 | |||
|
High relative deoxyribonucleic acid content of trophectoderm biopsy adversely affects pregnancy outcomes | 2017 | ||
|
Human female meiosis revised: new insights into the mechanisms of chromosome segregation and aneuploidies from advanced genomics and time-lapse imaging. | 2017 | ||
|
Hydroxypropyl cellulose supplementation in vitrification solutions: a prospective study with donor oocytes. | 2017 | ||
|
Identification and characterization of Aurora kinase B and C variants associated with maternal aneuploidy | 2017 | ||
|
Impact of Endometrial Preparation Protocols for Frozen Embryo Transfer on Live Birth Rates | 2017 | ||
|
Impact of very low anti-Mullerian hormone on pregnancy success | 2017 | ||
| Impact of vitamin D levels on ovarian reserve and ovarian response to ovarian stimulation in oocyte donors | 2017 | |||
|
Impacts of abstinence time on semen parameters in a large population-based cohort of subfertile men | 2017 | ||
|
Improving US databases for male fertility. | Male fertility | 2017 | Male fertility; IVF clinical |
|
In vitro fertilization with preimplantation genetic diagnosis for aneuploidies in advanced maternal age: a randomized, controlled study | 2017 | ||
|
Individual luteolysis pattern after GnRH-agonist trigger for final oocyte maturation | 2017 | ||
|
Individual luteolysis post gnrh-agonist-trigger in gnrh-antagonist protocols | 2017 | ||
|
Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial | IVF clinical | 2017 | IVF clinical;Female fertility |
|
Infertility Stress in Couples Undergoing Intrauterine Insemination and In Vitro Fertilization Treatments | 2017 | ||
| Inter-cycle and inter-observer variability of the antral follicle count in routine clinical practice | 2017 | |||
|
Inter-laboratory agreement on embryo classification and clinical decision: Conventional morphological assessment vs. time lapse | 2017 | ||
|
Interobserver agreement in the study of 2D and 3D sonographic criteria for adenomyosis. | Reproductive disorders | 2017 | Reproductive disorders;Female fertility |
|
Introduction: Immunology and assisted reproductive technology in the 21st century | 2017 | ||
|
Introduction: Subchromosomal abnormalities in preimplantation embryonic aneuploidy screening | 2017 | ||
| Karyomapping: A single centre's experience from application of methodology to ongoing pregnancy and live-birth rates | 2017 | |||
|
Laser acupuncture before and after embryo transfer improves In Vitro fertilization outcomes: A four- armed randomized controlled trial | IVF clinical | 2017 | IVF clinical; IVF laboratory;IVF clinical |
|
Laser acupuncture before and after embryo transfer improves in vitro fertilization outcomes: A four-armed randomized controlled trial | IVF clinical | 2017 | IVF clinical;Female fertility |
| Leucine-rich repeat-containing G-protein-coupled receptor 5-positive cells in the endometrial stem cell niche | 2017 | |||
| Levels of trophectoderm mitochondrial DNA do not predict the reproductive potential of sibling embryos | 2017 | |||
| Lipidomic profiling of endometrial fluid in women with ovarian endometriosisdagger | 2017 | |||
|
Live birth after replacement of an embryo obtained from a spontaneously in vitro matured metaphase-I oocyte. | 2017 | ||
| Live birth derived from oocyte spindle transfer to prevent mitochondrial disease | 2017 | |||
|
Live imaging of follicle stimulating hormone receptors in gonads and bones using near infrared II fluorophore | Female fertility | 2017 | Female fertility;Reproductive disorders |
|
Long-awaited long-term follow-up of reproductive parameters in female offspring conceived with the use of intracytoplasmic sperm injection | 2017 | ||
|
Longitudinal patterns of occurrence and remission of erectile dysfunction in men with type 1 diabetes | 2017 | ||
|
Low serum progesterone on the day of embryo transfer is associated with a diminished ongoing pregnancy rate in oocyte donation cycles after artificial endometrial preparation: a prospective study | 2017 | ||
|
Magnetic cell sorting of semen containing spermatozoa with high DNA fragmentation in ICSI cycles decreases miscarriage rate. | 2017 | ||
|
Male factor and oxidative stress. | Male fertility | 2017 | Male fertility;Reproductive disorders |
|
Management of radiation therapy oncology group grade 4 urinary adverse events after radiotherapy for prostate cancer | 2017 | ||
|
Meta-signature of human endometrial receptivity: a meta-analysis and validation study of transcriptomic biomarkers | 2017 | ||
|
Mild stimulation for in vitro fertilization. | 2017 | ||
| Mitochondrial DNA quantification as a tool for embryo viability assessment: retrospective analysis of data from single euploid blastocyst transfers. | Technology development | 2017 | Technology development;IVF laboratory | |
|
Mitochondrial DNA quantity as a biomarker for blastocyst implantation potential | 2017 | ||
|
Mitochondrial dysfunction and ovarian senescence | Female fertility | 2017 | Female fertility; IVF clinical |
|
Morphology matters: are all euploid blastocysts created equal? | 2017 | ||
|
Mosaicism between trophectoderm and inner cell mass. | 2017 | ||
| Mu opioid receptor in the human endometrium: Dynamics of its expression and localization during the menstrual cycle | 2017 | |||
|
National survey on use of time-lapse imaging systems in ivf laboratories | 2017 | ||
|
Natural killer cells in reproduction: helpful, harmful, or misunderstood? | Endometrial receptivity | 2017 | Endometrial receptivity;Immunology;IVF clinical |
|
Novel approach to recurrent implantation failure: short-term copper intrauterine device placement | 2017 | ||
|
Obesity, male infertility, and the sperm epigenome | 2017 | ||
| Obstetric and perinatal outcome of babies born from sperm selected by MACS from a randomized controlled trial | Male fertility | 2017 | Male fertility;IVF laboratory | |
|
Obstetric and perinatal outcomes of pregnancies conceived with embryos cultured in a time-lapse monitoring system | 2017 | ||
|
On developing a thesis for Reproductive Endocrinology and Infertility fellowship: a case study of ultra-low (2%) oxygen tension for extended culture of human embryos | 2017 | ||
|
One for all or all for one? The evolution of embryo morphokinetics | 2017 | ||
|
Oocyte and sperm donation: A predictive study of financially compensated candidates’ characteristics and their change over time | 2017 | ||
|
Oocyte, embryo and blastocyst cryopreservation in art: Systematic review and meta-analysis comparing slow-freezing versus vitrification to produce evidence for the development of global guidance | 2017 | ||
|
Oocyte, embryo and blastocyst cryopreservation in ART: systematic review and meta-analysis comparing slow-freezing versus vitrification to produce evidence for the development of global guidance. | 2017 | ||
|
Outcomes and Recommendations of an Indian Expert Panel for Improved Practice in Controlled Ovarian Stimulation for Assisted Reproductive Technology | 2017 | ||
|
Ovarian transposition: A surgical option for fertility preservation | 2017 | ||
|
Oxygen tension in embryo culture: does a shift to 2% O2 in extended culture represent the most physiologic system? | 2017 | ||
|
Patients with endometriosis have aneuploidy rates equivalent to their age-matched peers in the in vitro fertilization population | Reproductive disorders | 2017 | Reproductive disorders;Pre-implantation genetics |
|
Paving the way for a gold standard of care for infertility treatment: improving outcomes through standardization of laboratory procedures | 2017 | ||
|
PGS for recurrent pregnancy loss: still an open question. | 2017 | ||
| Pregnancy leads to long-lasting changes in human brain structure | 2017 | |||
| Pregnancy, Hormonal Treatments for Infertility, Contraception, and Menopause in Women After Ischemic Stroke: A Consensus Document | 2017 | |||
|
Preimplantation embryonic mosaicism: origin, consequences and the reliability of comprehensive chromosome screening | 2017 | ||
|
Preimplantation genetic diagnosis for aneuploidy testing in women older than 44 years: a multicenter experience. | 2017 | ||
|
Prospective study of automated versus manual annotation of early time-lapse markers in the human preimplantation embryo | 2017 | ||
|
Protocolo de ciclo natural para tratamientos de fiv: Resultados clínicos | IVF clinical | 2017 | IVF clinical;IVF laboratory;IVF laboratory |
| Reply: Detecting mosaicism in trophectoderm biopsies | 2017 | |||
|
Reply: Detecting mosaicism in trophectoderm biopsies. | 2017 | ||
| Reply: Mitochondrial DNA quantification-the devil in the detail | 2017 | |||
|
Reproductive outcomes of testicular versus ejaculated sperm for intracytoplasmic sperm injection among men with high levels of DNA fragmentation in semen: systematic review and meta-analysis | 2017 | ||
|
Review the 'peer review' | 2017 | ||
|
Revisiting the progesterone to oocyte ratio | 2017 | ||
|
Risk of childhood mortality in family members of men with poor semen quality | 2017 | ||
| Role of Stro1+/CD44+ stem cells in myometrial physiology and uterine remodeling during pregnancy | 2017 | |||
|
Serum biomarkers of erectile dysfunction in diabetes mellitus: A systematic review of current literature | 2017 | ||
| Severe pre-eclampsia is associated with alterations in cytotrophoblasts of the smooth chorion | 2017 | |||
|
Should we forget about embryos till day 5? | 2017 | ||
|
Sigue habiendo indicaciones para el ciclo natural? | IVF clinical | 2017 | IVF clinical; IVF laboratory;Aging and rejuvenation |
|
Sperm DNA fragmentation testing in male infertility work-up: are we ready? | 2017 | ||
|
Sperm DNA fragmentation: from promising to estandarization | Male fertility | 2017 | Male fertility;IVF clinical |
|
Sperm DNA integrity: from 'promising' to standardization | 2017 | ||
| Spermatozoa with numerical chromosomal abnormalities are more prone to be retained by Annexin V-MACS columns | 2017 | |||
|
Supplementation with progestogens in the first trimester of pregnancy to prevent miscarriage in women with unexplained recurrent miscarriage: a systematic review and meta-analysis of randomized, controlled trials. | Reproductive disorders | 2017 | Reproductive disorders;Female fertility;Surgery |
|
Survey of Fertility Preservation Options Available to Patients With Cancer Around the Globe. J Glob Oncol. 4, pp. 1 - 16. 28/06/2017. | 2017 | ;IVF clinical;Pre-implantation genetics | |
|
Telomeres in aging and reproduction. | Aging and rejuvenation | 2017 | Aging and rejuvenation;Female fertility |
|
The history behind successful uterine transplantation in humans | 2017 | ||
| The impact of elevated progesterone at the initiation of an artificially prepared frozen embryo transfer cycle: a case series. | IVF clinical | 2017 | IVF clinical;Female fertility | |
|
The impact of vitrification in artificial reproductive technology programmes | Cryobiology | 2017 | Cryobiology; IVF laboratory |
| The incidence and origin of segmental aneuploidy in human oocytes and preimplantation embryos | 2017 | |||
|
The International Glossary on Infertility and Fertility Care, 2017. | 2017 | ||
|
The most well kept secret, embryo culture media: a smart reveal from an expert | 2017 | ||
|
The slow growing embryo and premature progesterone elevation: Compounding factors for embryo-endometrial asynchrony | 2017 | ||
|
The Use of Laparoscopy Simulation to Explore Gender Differences in Resident Surgical Confidence. | Surgery | 2017 | Surgery;Reproductive disorders;IVF laboratory |
|
The use of morphokinetic as a predictor of implantation | 2017 | ||
|
The Vienna consensus: report of an expert meeting on the development of ART laboratory performance indicators | 2017 | ||
| Three-dimensional NIR-II molecular imaging distinguishes targeting organs with high-performance NIR-II bioconjugates. | 2017 | |||
|
Totipotencia y fertilidad. | 2017 | ||
|
Translocations, inversions and other chromosome rearrangements | 2017 | ||
| Type of chromosome abnormality affects embryo morphology dynamics | 2017 | |||
|
Type of gonadotropin used during controlled ovarian stimulation induces differential gene expression in human cumulus cells: A randomized study | 2017 | ||
|
Urethral strictures and artificial urinary sphincter placement | 2017 | ||
|
Use of gonadotropins in infertile patients | 2017 | ||
|
Uterine fibroids and reproduction. | Reproductive disorders | 2017 | Reproductive disorders;Female fertility |
|
Uterus transplantation: an open door to the possibility of having children | 2017 | ||
|
Vaginal progesterone decreases preterm birth and neonatal morbidity and mortality in women with a twin gestation and a short cervix: an updated meta-analysis of individual patient data | 2017 | ||
|
Versatility of the suprapubic port in robotic assisted laparoscopic myomectomy | 2017 | ||
|
Vitamin D binding protein is lower in infertile patients compared to fertile controls: a case control study | 2017 | ||
|
Vitamin D Deficiency Does Not Influence Reproductive Outcomes of IVF-ICSI: A Study of Oocyte Donors and Recipients | 2017 | ||
|
Vitamin D in human reproduction | 2017 | ||
|
Vitrified-warmed blastocyst transfer on the 5th or 7th day of progesterone supplementation in an artificial cycle: a randomised controlled trial | IVF clinical | 2017 | IVF clinical;Female fertility |
| What Drives Embryo Development? Chromosomal Normality or Mitochondria? | 2017 | |||
|
What else can we do? The latest attempt to improve the sperm's path | 2017 | ||
| What the human sperm methylome tells us | 2017 | |||
|
Why natural killer cells are not enough: a further understanding of killer immunoglobulin-like receptor and human leukocyte antigen | 2017 | ||
| Window of implantation transcriptomic stratification reveals different endometrial subsignatures associated with live birth and biochemical pregnancy | 2017 | |||
|
45,X product of conception after preimplantation genetic diagnosis and euploid embryo transfer: evidence of a spontaneous conception confirmed by DNA fingerprinting. | 2016 | ||
|
5,X product of conception after preimplantation genetic diagnosis and euploid embryo transfer: evidence of a spontaneous conception confirmed by DNA fingerprinting. | 2016 | ||
| A combination of hydroxypropyl cellulose and trehalose as supplementation for vitrification of human oocytes: a retrospective cohort study | Female fertility | 2016 | Female fertility;IVF laboratory;Female fertility | |
|
A cost-effectiveness evaluation comparing originator follitropin alfa to the biosimilar for the treatment of infertility. | IVF clinical | 2016 | IVF clinical;Female fertility;Female fertility |
|
A fresh look at the freeze-all protocol: a SWOT analysis | IVF laboratory | 2016 | IVF laboratory;IVF clinical;IVF clinical |
|
A new more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept | IVF clinical | 2016 | IVF clinical;Female fertility;IVF clinical;IVF laboratory |
|
A new more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept. | 2016 | ||
| A randomized and blinded comparison of qpcr and NGS based detection of aneuploidy in a cell line mixture model of blastocyst biopsy mosaicism. | Technology development | 2016 | Technology development;Pre-implantation genetics;Female fertility | |
| Adenomyosis in infertile women: prevalence and the role of 3D ultrasound as a marker of severity of the disease | Reproductive disorders | 2016 | Reproductive disorders;Surgery | |
|
Aging and the environment affect gamete and embryo potential: can we intervene? | 2016 | ||
| Aging is associated with changes in mitochondrial dynamics, function and mtDNA quantity. | Female fertility | 2016 | Female fertility;Aging and rejuvenation | |
|
Analysis of MYO-Inositol effect on spermatozoa motility, in hyper viscous ejaculates and in patients with grades II and III varicocele | 2016 | ||
| Aneuploidy screening by array comparative genomic hybridization improves success rates of in vitro fertilization: A multicenter Indian study. | Pre-implantation genetics | 2016 | Pre-implantation genetics;IVF laboratory | |
| Angiotensin II type 2 receptor is expressed in human sperm cells and is involved in sperm motility | Male fertility | 2016 | Male fertility;IVF laboratory;IVF laboratory;Reproductive disorders | |
| ART complications (II). Ovarian hyperstimulation syndrome: diagnosis. Infertility and Assisted Reproduction. Algorithms for taking decisions. | IVF clinical | 2016 | IVF clinical;Female fertility;IVF laboratory;IVF clinical | |
|
Artificial oocyte activation with calcium ionophore does not cause a widespread increase in chromosome segregation errors in the second meiotic division of the oocyte. | 2016 | ||
|
Assisted reproductive techniques after fertility-sparing treatments in gynaecological cancers | Reproductive disorders | 2016 | Reproductive disorders;IVF laboratory;Immunology |
|
Autologous cell therapy with CD133+ bone marrow-derived stem cells for refractory Asherman's syndrome and endometrial atrophy: a pilot cohort study | 2016 | ||
| Automatic time-lapse instrument is superior to single-point morphology observation for selecting viable embryos: retrospective study in oocyte donation | IVF laboratory | 2016 | IVF laboratory;IVF clinical;Female fertility;Pre-implantation genetics | |
| Bacterial and fungal contamination risks in human oocyte and embryo cryopreservation: open versus closed vitrification systems | 2016 | |||
|
Basic procedures in an ART laboratory. | IVF laboratory | 2016 | IVF laboratory;IVF clinical;IVF laboratory;IVF clinical |
|
Bibliometrics: tracking research impact by selecting the appropriate metrics | 2016 | ||
| Biological effects of plasma rich in growth factors (PRGF) on human endometrial fibroblasts. | Endometrial receptivity | 2016 | Endometrial receptivity;Female fertility;IVF laboratory | |
|
Blastocyst culture using single versus sequential media in clinical IVF: a systematic review and meta-analysis of randomized controlled trials. | 2016 | ||
| Blastocyst development in single medium with or without renewal on day 3: a prospective cohort study on sibling donor oocytes in a time-lapse incubator | IVF laboratory | 2016 | IVF laboratory;IVF clinical | |
|
Both slowly developing embryos and a variable pace of luteal endometrial progression may conspire to prevent normal birth in spite of a capable embryo | IVF clinical | 2016 | IVF clinical;Female fertility |
|
Building a model to increase live birth rate through patient-specific optimization of embryo transfer day | IVF laboratory | 2016 | IVF laboratory;IVF clinical |
|
Cancer and fertility preservation: international recommendations from an expert meeting. | 2016 | ||
| Cancer risk in first- and second-degree relatives of men with poor semen quality. | Male fertility | 2016 | Male fertility;Reproductive disorders | |
|
Cáncer, esterilidad y técnicas de reproducción asistida | Reproductive disorders | 2016 | Reproductive disorders;Female fertility |
|
Capítulo 1 -Fisiología e impacto clínico de las diferentes formas de hormona foliculoestimulante. | IVF clinical | 2016 | IVF clinical;Female fertility |
|
Cardiovascular Autonomic Neuropathy, Sexual Dysfunction, and Urinary Incontinence in Women With Type 1 Diabetes. | Reproductive disorders | 2016 | Reproductive disorders;Surgery;Female fertility;Male fertility |
|
Cardiovascular Safety of Isobaric of Isobaric Levobupivacaine versus Hyperbaric Bupivacaine for Spinal Anesthesia in Patients 65 Years or Older Undergoing | Reproductive disorders | 2016 | Reproductive disorders;Reproductive disorders |
| Causes and estimated incidences of sex-chromosome misdiagnosis in preimplantation genetic diagnosis of aneuploidy. | Pre-implantation genetics | 2016 | Pre-implantation genetics;Technology development | |
|
Challenges facing contemporary preimplantation genetic screening. | Pre-implantation genetics | 2016 | Pre-implantation genetics;Female fertility;Pre-implantation genetics;IVF laboratory |
|
Characterizing the safety of clomiphene citrate in male patients through prostate-specific antigen, hematocrit, and testosterone levels. | Male fertility | 2016 | Male fertility |
|
Claims-based analysis of male infertility: a cautious step in the right direction. | Male fertility | 2016 | Male fertility;IVF laboratory |
| Clinical utility of sperm DNA fragmentation testing: practice recommendations based on clinical scenarios. | Technology development | 2016 | Technology development;Male fertility;IVF laboratory | |
|
Combination of metabolism measurement and a time-lapse system provides an embryo selection method based on oxygen uptake and chronology of cytokinesis timing | IVF laboratory | 2016 | IVF laboratory;IVF clinical |
|
Comparative study of highly purified HMG versus recombinant FSH + recombinant LH in ovulation induction for intrauterine insemination: A randomized controlled trial. | IVF clinical | 2016 | IVF clinical;Female fertility;IVF clinical;Male fertility |
|
Confirmation rates of array-CGH in day-3 embryo and blastocyst biopsies for preimplantation genetic screening | 2016 | ||
|
Conservation of ovarian reserve across ethnicities: evidence of the evolutionary importance of maintenance of ovarian reserve. | Female fertility | 2016 | Female fertility;IVF laboratory |
|
Consistent and reproducible outcomes of blastocyst biopsy and aneuploidy screening across different biopsy practitioners: a multicentre study involving 2586 embryo biopsies. | 2016 | ||
| Cross-talk between FSH and endoplasmic reticulum stress: a mutually suppressive relationship. | Female fertility | 2016 | Female fertility | |
| Cumulative live birth rates after fresh and vitrified cleavage-stage versus blastocyst-stage embryo transfer in the first treatment cycle. | IVF laboratory | 2016 | IVF laboratory;IVF clinical;IVF laboratory;IVF clinical | |
|
Curbside consults in the era of social media connectivity and the creation of the SREI Forum. | IVF clinical | 2016 | IVF clinical;Female fertility |
|
Current controversies in prenatal diagnosis 4: preimplantation genetic screening should be routinely offered to all preimplantation genetic diagnosis cases. | Pre-implantation genetics | 2016 | Pre-implantation genetics;Technology development |
|
CYP1A1 3801T>C polymorphism implicated in altered xenobiotic metabolism is not associated with variations in sperm production and function as measured by total motile sperm and fertilization rates with intracytoplasmic sperm injection. | Male fertility | 2016 | Male fertility;IVF clinical |
|
CYP1A1 3801T>C Polymorphism implicated in altered xenobiotic metabolism is not Associated with Variations in Total Motile Sperm or Fertilization Rates with ICSI. | Reproductive disorders | 2016 | Reproductive disorders;IVF clinical |
|
CYP1A1 3801T>C Polymorphism is not Associated with Variations in Total Motile Sperm or Fertilization Rates with ICSI. | Male fertility | 2016 | Male fertility;IVF laboratory |
|
Decreased fecundity and sperm DNA methylation patterns. | Technology development | 2016 | Technology development;Male fertility |
| Dehydroepiandrosterone (DHEA) supplementation results in supraphysiologic DHEA- S serum levels and progesterone assay interference that may impact clinical management in IVF | 2016 | ;Female fertility;Male fertility | ||
| Delayed blastulation, multinucleation and expansion grade are independently associated with live birth rates in frozen blastocyst transfer cycles. | IVF laboratory | 2016 | IVF laboratory;IVF clinical | |
|
Detection of Missing Proteins Using the PRIDE Database as a Source of Mass Spectrometry Evidence | Technology development | 2016 | Technology development;IVF laboratory;Reproductive disorders |
|
Development and validation of concurrent preimplantation genetic diagnosis for single gene disorders and comprehensive chromosomal aneuploidy screening without whole-genome amplification. | Technology development | 2016 | Technology development;Pre-implantation genetics |
|
Diagnosis of Endometrial-Factor Infertility: Current Approaches and New Avenues for Research | 2016 | ||
|
Dietary supplementation with docosahexaenoic acid (DHA) improves seminal antioxidant status and decreases sperm DNA fragmentation | 2016 | ||
|
Disclosure in scientific meetings: should we take any steps further? | 2016 | ||
|
Distribution patterns of segmental aneuploidies in human blastocysts identified by next-generation sequencing | 2016 | ||
| Do ARTs affect the incidence of monozygotic twinning? | IVF laboratory | 2016 | IVF laboratory;IVF clinical;IVF laboratory;IVF clinical | |
|
Does a frozen embryo transfer ameliorate the effect of elevated progesterone seen in fresh transfer cycles? | IVF clinical | 2016 | IVF clinical;Cryobiology;Female fertility |
| Does the addition of time-lapse morphokinetics in the selection of embryos for transfer improve pregnancy rates? A randomized controlled trial. | IVF laboratory | 2016 | IVF laboratory;IVF clinical | |
| Drug gastrointestinal absorption in rat: Strain and gender differences. | Technology development | 2016 | Technology development;Female fertility | |
| Dual Triggering with Gonadotropin-Releasing Hormone Agonist and Standard Dose Human Chorionic Gonadotropin in Patients with a high Immature Oocyte Rate. | IVF clinical | 2016 | IVF clinical;Female fertility | |
| Dynamic of expression and localization of cannabinoid-degrading enzymes FAAH and MGLL in relation to CB1 during the meiotic maturation of human oocytes. | Female fertility | 2016 | Female fertility;Reproductive disorders;IVF clinical | |
|
Early protein profile of human embryonic secretome. | 2016 | ||
|
Editorial Comment. | Reproductive disorders | 2016 | Reproductive disorders;Male fertility;IVF laboratory |
| Effect of surgery on ovarian reserve in women with endometriomas, endometriosis and controls. | Reproductive disorders | 2016 | Reproductive disorders;Surgery;IVF clinical;Technology development | |
|
Electronic witness system in IVF-patients perspective. | 2016 | ||
|
Embryonic aneuploidy does not differ among genetic ancestry according to continental origin as determined by ancestry informative markers. | Pre-implantation genetics | 2016 | Pre-implantation genetics;IVF laboratory |
|
Embryonic aneuploidy does not differ amongst major ethnicities as determined by genotyping. | Pre-implantation genetics | 2016 | Pre-implantation genetics;Female fertility;IVF clinical;IVF laboratory |
|
Endometrial microbiome at the time of embryo transfer: next generation sequencing of 16S ribosomal subunit. | Endometrial receptivity | 2016 | Endometrial receptivity;IVF laboratory |
|
Endometrial 'scratching': what the data show | 2016 | ||
|
Estudio del impacto bibliométrico de la Revista Iberoamericana de Fertilidad. | Female fertility | 2016 | Female fertility;Reproductive disorders;IVF laboratory;IVF clinical |
|
Ethnicity is an independent predictor of IVF-ICSI outcome: a study of 5,549 cycles in Spain and India | Reproductive disorders | 2016 | Reproductive disorders;IVF clinical |
| Evaluation of dual trigger with gonadotropin-releasing hormone agonist and human chorionic gonadotropin in improving oocyte maturity rates: A prospective randomized study | 2016 | |||
|
Evaluation of the antiproliferative, proapoptotic, and antiangiogenic effects of a double-stranded RNA mimic complexed with polycations in an experimental mouse model of leiomyoma | Technology development | 2016 | Technology development;Female fertility;IVF clinical;Female fertility |
|
Evidence that the endometrial microbiota has an effect on implantation success or failure | 2016 | ||
| Examining potential reasons why euploid blastocysts do not always implant. Part 1. Optimizing the culture environment and embryo manipulation to maintain viability. | Female fertility | 2016 | Female fertility;IVF laboratory;Female fertility;IVF clinical | |
|
Exccesive age-related decline in functional ovarian reserve in infertile women: prospective cohort of 15500 women. | Aging and rejuvenation | 2016 | Aging and rejuvenation;Female fertility;IVF clinical |
|
Excessive Age-Related Decline in Functional Ovarian Reserve in Infertile Women: Prospective Cohort of 15,500 Women. | Female fertility | 2016 | Female fertility;Aging and rejuvenation;IVF clinical;Male fertility |
|
Expanded carrier screening in an infertile population: how often is clinical decision making affected? | IVF clinical | 2016 | IVF clinical;Male fertility;Female fertility;Technology development |
|
Expression of Tachykinins and Tachykinin Receptors and Interaction with Kisspeptin in Human Granulosa and Cumulus Cells | Female fertility | 2016 | Female fertility;Reproductive disorders |
|
Failure mode and effects analysis of witnessing protocols for ensuring traceability during PGD/PGS cycles. | 2016 | ||
|
Fertility treatment in spinal cord injury and other neurologic disease. Review. | Reproductive disorders | 2016 | Reproductive disorders;Male fertility;Female fertility |
|
First validated clinical test selects best embryos for IVF and viable pregnancies. | Technology development | 2016 | Technology development;IVF laboratory |
|
FMR1 Gene CGG repeat number variation within the normal range is not predictive of ovarian response in IVF cycles. | Reproductive disorders | 2016 | Reproductive disorders;IVF clinical |
|
FMR1 gene CGG repeat variation within the normal range is not predictive of ovarian response in IVF cycles. | IVF clinical | 2016 | IVF clinical;Female fertility |
|
Follicular versus luteal phase ovarian stimulation during the same menstrual cycle (DuoStim) in a reduced ovarian reserve population results in a similar euploid blastocyst formation rate: new insight in ovarian reserve exploitation. | 2016 | ||
|
Following declining human chorionic gonadotropin values in pregnancies of unknown location: when is it safe to stop? | Female fertility | 2016 | Female fertility;Reproductive disorders;IVF laboratory;IVF clinical |
|
Free vitamin D does not vary through the follicular phase of the menstrual cycle. | Female fertility | 2016 | Female fertility;Reproductive disorders |
| Free vitamin D does not vary through the proliferative phase of the menstrual cycle. | Reproductive disorders | 2016 | Reproductive disorders;IVF laboratory | |
| Frozen-thawed embryo transfers in natural cycles with spontaneous or induced ovulation: the search for the best protocol continues | IVF clinical | 2016 | IVF clinical;Cryobiology;Female fertility;Technology development | |
|
Generation of meiomaps of genome-wide recombination and chromosome segregation in human oocytes. | 2016 | ||
| Generation of mice with longer and better preserved telomeres in the absence of genetic manipulations | Reproductive disorders | 2016 | Reproductive disorders;Technology development;Psychology | |
| Genetic mutation that may contribute to failure of prolapse surgery in Caucasian women: A case-control study. | Surgery | 2016 | Surgery;Reproductive disorders;IVF laboratory;Female fertility | |
|
Genotypically determined ancestry across an infertile population: ovarian reserve and response parameters are not influenced by continental origin. | IVF clinical | 2016 | IVF clinical;Female fertility |
|
Glycemic control and urinary tract infections in women with Type-1 Diabetes: Results from the DCCT/EDIC. | Reproductive disorders | 2016 | Reproductive disorders;Female fertility |
|
High responder: optimizing your stimulation without complications. | IVF clinical | 2016 | IVF clinical;Female fertility;IVF laboratory;IVF clinical |
|
Hormone-Based Treatments in Subfertile Males. Review. | Technology development | 2016 | Technology development;Male fertility |
| How much have we learned from time-lapse in clinical IVF? | 2016 | |||
|
How to draw up a management plan when an IVF cycle has failed. Practical Problems in Assisted Reproduction | IVF clinical | 2016 | IVF clinical;Female fertility |
|
Human Embryos Created by Embryo Splitting Secrete Significantly Lower Levels of miRNA-30c. | 2016 | ||
|
Human Oocyte-Derived Methylation Differences Persist in the Placenta Revealing Widespread Transient Imprinting | 2016 | ||
|
Human somatic cells subjected to genetic induction with six germ line-related factors display meiotic germ cell-like features | Reproductive disorders | 2016 | Reproductive disorders;Reproductive disorders |
|
Human spermatogonial stem cells display limited proliferation in vitro under mouse spermatogonial stem cell culture conditions | Male fertility | 2016 | Male fertility;IVF laboratory |
|
Human uterus transplantation in focus. British Medical Bulletin | 2016 | ;IVF clinical | |
|
Hysteroscopy before IVF: can it improve outcomes? | 2016 | ||
|
Impact of gonadotropin type on progesterone elevation during ovarian stimulation in GnRH antagonist cycles | IVF clinical | 2016 | IVF clinical;Female fertility;IVF clinical;Male fertility |
| Impact of vitrification on the mitochondrial activity and redox homeostasis of human oocyte | Cryobiology | 2016 | Cryobiology;Female fertility;IVF laboratory;IVF clinical | |
|
Implementing PGD/PGD-A in IVF clinics: considerations for the best laboratory approach and management. | 2016 | ||
| Increased Expression of Aquaporin 9 in Trophoblast From Gestational Diabetic Patients. | Reproductive disorders | 2016 | Reproductive disorders | |
| Infertilidad masculina asociada a las microdeleciones del cromosoma Y. Opciones reproductivas y riesgos de la descendencia. | Male fertility | 2016 | Male fertility;IVF clinical;IVF clinical;Male fertility | |
| Insulin and Leptin Signaling in Placenta from Gestational Diabetic Subjects | Reproductive disorders | 2016 | Reproductive disorders;IVF clinical;IVF laboratory | |
|
International Committee for Monitoring Assisted Reproductive Technologies world report: Assisted Reproductive Technology 2008, 2009 and 2010 | 2016 | ||
|
Intrauterine human chorionic gonadotropin infusion in oocyte donors promotes endometrial synchrony and induction of early decidual markers for stromal survival: a randomized clinical trial | Endometrial receptivity | 2016 | Endometrial receptivity;Female fertility |
| Investigation of sperm telomere length as a potential marker of paternal genome integrity and semen quality. | Male fertility | 2016 | Male fertility;Technology development | |
|
Is FMR1 CGG repeat length a predictor of in vitro fertilization stimulation response or outcome? | IVF clinical | 2016 | IVF clinical;Female fertility;IVF clinical |
|
Is luteal phase support successfully performed using 25 mg/day of subcutaneous progesterone in controlled ovarian stimulation cycles with GnRH agonist triggering? | IVF clinical | 2016 | IVF clinical;Female fertility;IVF clinical;Male fertility |
| Is the effect of premature elevated progesterone augmented by human chorionic gonadotropin versus gonadotropin-releasing hormone agonist trigger? | Reproductive disorders | 2016 | Reproductive disorders;IVF clinical | |
| Is the effect of premature elevated progesterone augmented by human chorionic gonadotropin versus gonadotropin-releasing hormone agonist trigger? | IVF clinical | 2016 | IVF clinical;Female fertility;IVF laboratory;IVF clinical | |
|
IVF: progress through Technology development . | IVF clinical | 2016 | IVF clinical;Female fertility;Technology development |
| Kinetics of the early development of uniparental human haploid embryos | Pre-implantation genetics | 2016 | Pre-implantation genetics;IVF laboratory | |
|
Laparoscopic Vaginal-Assisted Hysterectomy with Complete Vaginectomy for Female-To-Male Genital Reassignment Surgery. | Surgery | 2016 | Surgery;IVF clinical |
| Láser assisted hatching afinamiento (LAHA) en ciclos de fecundación in vitro en 2 grupos de edades. | IVF laboratory | 2016 | IVF laboratory;IVF clinical;IVF clinical;Male fertility | |
|
Local and systemic factors and implantation: what is the evidence? | Female fertility | 2016 | Female fertility;IVF laboratory |
|
Microfluidics: The future of microdissection TESE? | Technology development | 2016 | Technology development;Male fertility;IVF clinical |
|
MicroRNAs in spent blastocyst culture medium are derived from trophectoderm cells and can be explored for human embryo reproductive competence assessment. | 2016 | ||
|
Minimal Stimulation In Vitro Fertilization: A Better Outcome. | 2016 | ||
|
Mitochondrial DNA as a biomarker for in vitro fertilization (IVF) outcome | Technology development | 2016 | Technology development;IVF laboratory |
| Modulating mitochondrial quality in disease transmission: towards enabling mitochondrial DNA disease carriers to have healthy children | IVF laboratory | 2016 | IVF laboratory;IVF clinical;Reproductive disorders | |
|
Monitoring Stemness in Long-Term hESC Cultures by Real-Time PCR | 2016 | ||
|
Morphokinetic analysis and embryonic prediction for blastocyst formation through an integrated time-lapse system | IVF laboratory | 2016 | IVF laboratory;IVF clinical |
|
Morphokinetic behavior of euploid and aneuploid embryos analyzed by time-lapse in embryoscope | IVF laboratory | 2016 | IVF laboratory;IVF clinical |
|
Mosaicism: “survival of the fittest” versus “no embryo left behind”. | Pre-implantation genetics | 2016 | Pre-implantation genetics;Technology development |
| Multiple thrombophilic single nucleotide polymorphisms lack a significant effect on outcomes in fresh IVF cycles: an analysis of 1717 patients. | Technology development | 2016 | Technology development;Female fertility | |
|
New approaches for multifactor preimplantation genetic diagnosis of monogenic diseases and aneuploidies from a single biopsy. | 2016 | ||
| Next Generation Sequencing Based Comprehensive Chromosome Screening in Mouse Polar Bodies, Oocytes, and Embryos. | Technology development | 2016 | Technology development;Pre-implantation genetics;Female fertility;Male fertility | |
|
Non-steroidal anti-inflammatory drug (NSAID) use is not associated with erectile dysfunction risk: results from the Prostate Cancer Prevention Trial. | Male fertility | 2016 | Male fertility;Reproductive disorders |
| ONCO-TESE: Obtaining spermatozoa after radical orchiectomy for testicular tumour and azoospermia | 2016 | |||
|
One uterus bridging three generations: first live birth after mother-to-daughter uterus transplantation. | 2016 | ||
|
Oocyte cryopreservation for fertility preservation in women with cancer | Cryobiology | 2016 | Cryobiology;Female fertility |
| Oocyte vitrification as an efficient option for elective fertility preservation | Cryobiology | 2016 | Cryobiology;Female fertility;Reproductive disorders | |
| Oocytes vitrification as an efficient option for elective fertility preservation (EFP). | Cryobiology | 2016 | Cryobiology;Female fertility;Female fertility | |
| Open versus closed oocyte vitrification in an oocyte donation programme: a prospective randomized sibling oocyte study. | IVF clinical | 2016 | IVF clinical;Female fertility;Female fertility;IVF laboratory;IVF clinical | |
| Optimal uterine anatomy and physiology necessary for normal implantation and placentation | Female fertility | 2016 | Female fertility;IVF clinical;IVF clinical;Female fertility | |
|
Optimization of microelectrophoresis to select highly negatively charged sperm. | Technology development | 2016 | Technology development;Male fertility;IVF clinical;Technology development |
|
Optimizing the culture environment and embryo manipulation to help maintain embryo developmental potential | 2016 | ||
| Osmotic-shock produced by vitrification solutions improves immature human oocytes in vitro maturation | 2016 | |||
|
Ovarian hyperstimulation syndrome: review and new classification criteria for reporting in clinical trials | 2016 | ||
|
Ovarian Stimulation in Cancer Patients. | IVF clinical | 2016 | IVF clinical;Female fertility;IVF laboratory;IVF clinical |
| Ovarian Stimulation in Cancer Patients. Fertility Preservation Basic Principles. | IVF clinical | 2016 | IVF clinical;Female fertility;IVF clinical | |
|
Ovarian stimulation, insemination, and contraception | IVF clinical | 2016 | IVF clinical;Female fertility;IVF clinical;Technology development |
|
Ovarian Tissue Cryopreservation: Slow Freezing | IVF laboratory | 2016 | IVF laboratory;IVF clinical;IVF clinical |
| Pathophysiologic processes have an impact on the plasma metabolomic signature of endometriosis patients | Reproductive disorders | 2016 | Reproductive disorders;Technology development;Pre-implantation genetics;Male fertility;Female fertility | |
|
Patient reported outcomes measures in neurogenic bladder and bowel: A systematic review of the current literature. | Reproductive disorders | 2016 | Reproductive disorders |
| Pilot initiative in India to explore the gonadal function and fertility outcomes of a cohort of childhood cancer survivors | 2016 | |||
| Polymorphisms in the MTHFR gene influence embryo viability and the incidence of aneuploidy | Female fertility | 2016 | Female fertility;IVF laboratory;IVF clinical | |
|
Predictors of sperm recovery after cryopreservation in testicular cancer. | Technology development | 2016 | Technology development;Male fertility;Female fertility |
|
Preimplantation genetic diagnosis for infertility. | Pre-implantation genetics | 2016 | Pre-implantation genetics;Technology development;IVF laboratory;Endometrial receptivity |
| Preimplantation genetic diagnosis: an overview and recent advances. | Pre-implantation genetics | 2016 | Pre-implantation genetics;Technology development;IVF clinical;Technology development | |
|
Preimplantation genetic diagnosis: why are obstetric and neonatal risks increased? The need for more data. | 2016 | ||
|
Preimplantation genetic screening - what a wonderful world it would be! | 2016 | ||
|
Pre-implantation genetic testing in ART: who will benefit and what is the evidence? | 2016 | ||
|
Promoting the use of elective single embryo transfer in clinical practice. | IVF clinical | 2016 | IVF clinical;Female fertility;IVF clinical;Female fertility |
|
Pros and cons of implementing a carrier genetic test in an infertility practice | IVF clinical | 2016 | IVF clinical;Female fertility;Reproductive disorders |
|
Prospective risk of stillbirth and neonatal complications in twin pregnancies: systematic review and meta-analysis | 2016 | ||
|
Protocols to induce ovulation and "progesterone block" experiments | 2016 | ||
|
Protocols to induce ovulation and “progesterone block” experiments | IVF clinical | 2016 | IVF clinical;Female fertility;IVF clinical |
| Regimen of ovarian stimulation affects oocyte and therefore embryo quality | IVF clinical | 2016 | IVF clinical;Female fertility | |
|
Response: in reference to 'Strategies to manage refractory endometrium: state of the art 2016' | Endometrial receptivity | 2016 | Endometrial receptivity;Female fertility;IVF laboratory;IVF clinical |
|
Revised guidelines for good practice in IVF laboratories (2015) | IVF laboratory | 2016 | IVF laboratory;IVF clinical |
|
Revised guidelines for good practice in IVF laboratories (2015). | 2016 | ||
|
Same-sex reproduction: Medical treatment options and psychosocial considerations | 2016 | ||
|
Same-sex reproduction:Medical treatment options and psychosocial considerations. | Reproductive disorders | 2016 | Reproductive disorders;IVF clinical;Technology development |
|
Sequential versus Monophasic Media Impact Trial (SuMMIT): a paired randomized controlled trial comparing a sequential media system to a monophasic medium. | IVF laboratory | 2016 | IVF laboratory;IVF clinical;Female fertility;Cryobiology |
|
SNP array-based analyses of unbalanced embryos as a reference to distinguish between balanced translocation carrier and normal blastocysts. | Technology development | 2016 | Technology development;Pre-implantation genetics;IVF laboratory;Female fertility |
|
Sociocultural influences on fertility in the Middle East: the role of parental consanguinity, obesity and vitamin D deficiency | 2016 | ||
|
Spermatozoa from infertile patients exhibit differences of DNA methylation associated with spermatogenesis-related processes: an array-based analysis | Technology development | 2016 | Technology development;Male fertility;IVF laboratory;Reproductive disorders |
| Spermatozoa from normozoospermic fertile and infertile individuals convey a distinct miRNA cargo | Male fertility | 2016 | Male fertility;IVF laboratory | |
| Strategies to manage refractory endometrium: state of the art in 2016 | IVF clinical | 2016 | IVF clinical;Female fertility;IVF laboratory;IVF clinical | |
| Study of nucleation status in the second cell cycle of human embryo and its impact on implantation rate | IVF laboratory | 2016 | IVF laboratory;IVF clinical | |
|
Subfertility increases risk of testicular cancer: evidence from population-based semen samples. | Male fertility | 2016 | Male fertility;Reproductive disorders;IVF laboratory |
|
Surgical Management of Ureteral Strictures Arising From Radiotherapy for Prostate Cancer. | Surgery | 2016 | Surgery;Male fertility;IVF laboratory |
| Técnicas invasivas y no invasivas en el diagnóstico de embriones humanos. | Technology development | 2016 | Technology development;Pre-implantation genetics;Female fertility | |
|
Teratozoospermia and asthenozoospermia are associated with specific epigenetic signatures. | Technology development | 2016 | Technology development;Male fertility;Female fertility;IVF clinical |
|
The challenge of embryonic mosaicism in preimplantation genetic screening | Pre-implantation genetics | 2016 | Pre-implantation genetics;IVF laboratory;IVF clinical;IVF laboratory |
| The effect of an immediate frozen embryo transfer following a freeze-all protocol: a retrospective analysis from two centres. | IVF laboratory | 2016 | IVF laboratory;IVF clinical;IVF laboratory;IVF clinical | |
|
The effect of gestational age and cervical length measurements in the prediction of spontaneous preterm birth in twin pregnancies: an individual patient level meta-analysis | 2016 | ||
|
The endometrium in assisted reproductive technology: How thin is thin? | 2016 | ||
|
The future of reproductive medicine centers | IVF laboratory | 2016 | IVF laboratory;IVF clinical;IVF clinical;IVF laboratory |
|
The impact of a prior Cesarean delivery on embryo transfer: a prospective study. | IVF clinical | 2016 | IVF clinical;Female fertility;IVF clinical |
|
The Impact of Biopsy on Human Embryo Developmental Potential during Preimplantation Genetic Diagnosis. | 2016 | ||
|
The influence of placental perfusion on birthweight in women with gestational diabetes. | 2016 | ||
| The opioid peptide beta-endorphin stimulates acrosome reaction in human spermatozoa. | Male fertility | 2016 | Male fertility;IVF clinical;IVF clinical | |
| The role of Indian gynecologists in oncofertility care and counselling | 2016 | |||
|
The state of "freeze-for-all" in human ARTs | IVF laboratory | 2016 | IVF laboratory;IVF clinical;IVF laboratory;IVF clinical |
|
The use of ovarian reserve markers in IVF clinical practice: a national consensus. | 2016 | ||
|
The why, the how and the when of PGS 2.0: current practices and expert opinions of fertility specialists, molecular biologists, and embryologists | Pre-implantation genetics | 2016 | Pre-implantation genetics;Technology development |
|
The why, the how and the when of PGS 2.0: current practices and expert opinions of fertility specialists, molecular biologists, and embryologists. | 2016 | ||
|
Thermal and clinical performance of a closed device designed for human oocyte vitrification based on the optimization of the warming rate. | 2016 | ||
|
Time-lapse: the remaining questions to be answered | IVF laboratory | 2016 | IVF laboratory;IVF clinical;Female fertility;IVF clinical |
| To delay or not to delay a frozen embryo transfer after a failed fresh embryo transfer attempt? | IVF laboratory | 2016 | IVF laboratory;IVF clinical | |
|
Towards clinical application of pronuclear transfer to prevent mitochondrial DNA disease. | Technology development | 2016 | Technology development;IVF laboratory |
| Translating Regenerative Medicine to the Clinic. Advances in Translational Medicine. Regenerative Medicine and Tissue Engineering in Reproductive Medicine: Future Clinical Applications in Human Infertility. | Stem cells | 2016 | Stem cells;Female fertility;Female fertility | |
|
Trends in ectopic pregnancy rates following assisted reproductive technologies in the UK: a 12-year nationwide analysis including 160 000 pregnancies. | IVF clinical | 2016 | IVF clinical;Female fertility |
|
Type of gonadotropin during controlled ovarian stimulation affects the endocrine profile in follicular fluid and apoptosis rate in cumulus cells | IVF clinical | 2016 | IVF clinical;Female fertility;IVF laboratory;IVF clinical |
|
Type of gonadotropin during controlled ovarian stimulation affects the endocrine profile in follicular fluid and apoptosis rate in cumulus cells. | IVF clinical | 2016 | IVF clinical;Female fertility;IVF laboratory;IVF clinical |
|
Using donor gametes, embryos. | IVF clinical | 2016 | IVF clinical;Female fertility |
| Vitamin D deficiency and pregnancy rates following frozen-thawed embryo transfer: a prospective cohort study. | IVF laboratory | 2016 | IVF laboratory;IVF clinical;IVF clinical | |
|
Vitamin D in human reproduction-an evolving landscape | Reproductive disorders | 2016 | Reproductive disorders;Female fertility;IVF clinical;IVF laboratory |
|
Why abandoning sustained implantation rate may be throwing the baby out with the bathwater | IVF clinical | 2016 | IVF clinical;Female fertility |
|
Why all women should freeze their eggs | 2016 | ||
|
Why all women should freeze their eggs. | Cryobiology | 2016 | Cryobiology;Female fertility;IVF laboratory |
|
Why do euploid embryos miscarry? A case-control study comparing the rate of aneuploidy within presumed euploid embryos that resulted in miscarriage or live birth using next-generation sequencing. | Pre-implantation genetics | 2016 | Pre-implantation genetics;Technology development;IVF clinical;Technology development |
|
Comparison of array comparative genomic hybridization and quantitative real-time PCR-based aneuploidy screening of blastocyst biopsies. | 2015 | ||
| Fertility preservation for age-related fertility decline | 2015 | |||
|
[Nurses as a support to improve the quality of life during assisted reproduction]. | 2015 | ||
|
24-chromosome PCR for aneuploidy screening. | Technology development | 2015 | Technology development;Pre-implantation genetics;IVF clinical;IVF laboratory |
|
A multi-centre phase 3 study comparing efficacy and safety of Bemfola((R)) versus Gonal-f((R)) in women undergoing ovarian stimulation for IVF | IVF clinical | 2015 | IVF clinical;Female fertility |
| A novel method to determine perineal artery occlusion among male bicyclists. | Male fertility | 2015 | Male fertility | |
|
Absence of luteal phase defect and spontaneous pregnancy in IVF patients despite GnRH-agonist trigger and "freeze all policy" without luteal phase support: a report of four cases. | Reproductive disorders | 2015 | Reproductive disorders;Female fertility |
| Altered Levels of Mitochondrial DNA Are Associated with Female Age, Aneuploidy, and Provide an Independent Measure of Embryonic Implantation Potential. | Aging and rejuvenation | 2015 | Aging and rejuvenation;Female fertility | |
|
Antral Follicle Priming Before Intracytoplasmic Sperm Injection in Previously Diagnosed Low Responders: A Randomized Controlled Trial (FOLLPRIM) | 2015 | ;Reproductive disorders | |
|
ART & PCOS. | Female fertility | 2015 | Female fertility;IVF clinical |
| ART and uterine pathology: how relevant is the maternal side for implantation? | 2015 | |||
|
Artificial gametes from stem cells | 2015 | ||
|
Avoiding ovarian hyperstimulation syndrome with the use of gonadotropin-releasing hormone agonist trigger | IVF clinical | 2015 | IVF clinical;Reproductive disorders;IVF clinical;Female fertility |
|
Baja respondedora (I): tipos de gonadotropinas. | Female fertility | 2015 | Female fertility;IVF clinical;IVF clinical |
|
Biomarkers in reproductive medicine: the quest for new answers | 2015 | ||
|
Blastocyst transfer is not associated with increased rates of monozygotic twins when controlling for embryo cohort quality. | IVF laboratory | 2015 | IVF laboratory;IVF clinical;Male fertility;Female fertility |
|
Cancer risk in first and second degree relatives of men with poor semen quality. | Male fertility | 2015 | Male fertility;IVF laboratory |
| Cardiovascular autonomic neuropathy, erectile dysfunction and lower urinary tract symptoms in men with type 1 diabetes: findings from the DCCT/EDIC. | Reproductive disorders | 2015 | Reproductive disorders;Male fertility | |
|
Case studies in Assisted Reproduction. | 2015 | ;IVF clinical;Cryobiology | |
| Cell Therapy and Tissue Engineering from and toward the Uterus | 2015 | |||
| Characterization and quantification of proteins secreted by single human embryos prior to implantation. | IVF laboratory | 2015 | IVF laboratory;Female fertility | |
|
Circulating miR-200-family micro-RNAs have altered plasma levels in patients with endometriosis and vary with blood collection time | 2015 | ||
| Collapse of blastocysts is strongly related to lower implantation success: a time-lapse study | Female fertility | 2015 | Female fertility;IVF clinical;Female fertility | |
|
Comparison of reproductive outcome in oligozoospermic men with high sperm DNA fragmentation undergoing intracytoplasmic sperm injection with ejaculated and testicular sperm. | 2015 | ||
|
Comprehensive carrier genetic test using next-generation deoxyribonucleic acid sequencing in infertile couples wishing to conceive through assisted reproductive technology | IVF clinical | 2015 | IVF clinical;IVF laboratory;Immunology |
|
Comprehensive chromosome screening improves embryo selection: a meta-analysis. | Pre-implantation genetics | 2015 | Pre-implantation genetics;Female fertility;Female fertility;IVF clinical |
|
Congenital malformations, chromosomal abnormalities and perinatal results in IVF/ICSI newborns resulting from very poor quality embryos: a case-control study | IVF laboratory | 2015 | IVF laboratory;IVF clinical |
| Contribution of different bone marrow-derived cell types in endometrial regeneration using an irradiated murine model | Aging and rejuvenation | 2015 | Aging and rejuvenation;Immunology | |
|
Converting a Problem into an Opportunity: mtDNA Heteroplasmy Shift | 2015 | ||
| Cryopreserved embryo transfer is an independent risk factor for placenta accreta in the IVF/ICSI population. | Cryobiology | 2015 | Cryobiology;IVF laboratory | |
|
Cyclin E1 plays a key role in balancing between totipotency and differentiation in human embryonic cells. | Stem cells | 2015 | Stem cells;Female fertility |
|
Day-3 embryo metabolomics in the spent culture media is altered in obese women undergoing in vitro fertilization | Female fertility | 2015 | Female fertility;IVF laboratory |
|
Deep impact: sequencing embryo biopsy specimens at increasing depth. | Female fertility | 2015 | Female fertility;Pre-implantation genetics |
| Deliveries from trophectoderm biopsied, fresh and vitrified blastocysts derived from polar body biopsied, vitrified oocytes. | Cryobiology | 2015 | Cryobiology;IVF laboratory;IVF laboratory;IVF clinical | |
|
Demographic and socio-economic differences between men seeking infertility evaluation and those seeking surgical sterilization: from the National Survey of Family Growth. | Male fertility | 2015 | Male fertility;Female fertility |
|
Developmental clock compromises human twin model created by embryo splitting. | 2015 | ||
|
Diagnosis of human preimplantation embryo viability | 2015 | ||
|
Difference in birth weight of consecutive sibling singletons is not found in oocyte donation when comparing fresh versus frozen embryo replacements | Female fertility | 2015 | Female fertility;Cryobiology |
|
Discordant embryonic aneuploidy testing and prenatal ultrasonography prompting androgen insensitivity syndrome diagnosis. | Pre-implantation genetics | 2015 | Pre-implantation genetics;Reproductive disorders |
| Dopamine agonist inhibits vascular endothelial growth factor protein production and secretion in granulosa cells | Female fertility | 2015 | Female fertility;IVF clinical | |
|
Doubtful association between progesterone therapy and fetal nuchal translucency | IVF clinical | 2015 | IVF clinical;Female fertility |
|
Effect of male and female body mass index on pregnancy and live birth success after in vitro fertilization. | Male fertility | 2015 | Male fertility;Female fertility;IVF clinical |
|
Effects of adipocyte-secreted factors on decidualized endometrial cells: modulation of endometrial receptivity in vitro | Endometrial receptivity | 2015 | Endometrial receptivity;Female fertility |
| Elective single versus double embryo transfer: live birth outcome and patient acceptance in a prospective randomised trial | IVF laboratory | 2015 | IVF laboratory;IVF clinical | |
| Elective single versus double embryo transfer: live birth outcome and patient acceptance in a prospective randomised trial. | IVF laboratory | 2015 | IVF laboratory;IVF clinical | |
|
Elevated Progesterone levels in women on DHEA supplementation likely represents assay interference. | IVF clinical | 2015 | IVF clinical;Female fertility |
|
Embryonic poly(A)-binding protein (EPAB) is required for EGF signaling and cumulus expansion in female mice. | Female fertility | 2015 | Female fertility;IVF clinical |
|
Endometrial disruption does not improve implantation in patients who have failed the transfer of euploid blastocysts. | Endometrial receptivity | 2015 | Endometrial receptivity;IVF laboratory |
|
Endometriosis and ART. | Female fertility | 2015 | Female fertility;IVF clinical;IVF clinical |
|
Endometriosis and ascites, a strategy to achieve pregnancy. | Female fertility | 2015 | Female fertility;IVF clinical;Female fertility;Technology development |
|
Ergonomic Strain in Minimally Invasive Surgery: Addressing the Strain Epidemic. | Surgery | 2015 | Surgery;Female fertility;IVF clinical |
|
Evaluation of the potential therapeutic effects of a double-stranded RNA mimic complexed with polycations in an experimental mouse model of endometriosis | Female fertility | 2015 | Female fertility;Reproductive disorders |
|
Expression and characterization of three Aurora kinase C splice variants found in human oocytes. | Female fertility | 2015 | Female fertility;Reproductive disorders;IVF clinical |
|
Failure mode and effects analysis of witnessing protocols for ensuring traceability during IVF. | 2015 | ||
|
Fertility preservation for age-related fertility decline - authors' reply | 2015 | ||
|
Follicular and endocrine dose responses according to anti-Mullerian hormone levels in IVF patients treated with a novel human recombinant FSH (FE 999049) | IVF clinical | 2015 | IVF clinical;Female fertility;IVF clinical |
|
Follicular fluid and mural granulosa cells microRNA profiles vary in in vitro fertilization patients depending on their age and oocyte maturation stage | 2015 | ||
| Gene polymorphisms and HLA-G expression in spontaneous abortions. | Female fertility | 2015 | Female fertility;IVF clinical | |
|
Genome-wide maps of recombination and chromosome segregation in human oocytes and embryos show selection for maternal recombination rates. | 2015 | ||
|
Global deoxyribonucleic acid methylation: a window into the spermatogonial stem cell's reproductive potential. | Epigenetics | 2015 | Epigenetics;Stem cells |
|
Grupo de interés de calidad de ASEBIR: Actualización de las especificaciones para los indicadores de calidad de la Asociación para el Estudio de la Biología de la Reproducción (ASEBIR). | IVF clinical | 2015 | IVF clinical;IVF laboratory |
|
High responders and patients with a good prognosis are not immune to the negative impact on live birth rate of elevated P on the day of triggering | 2015 | ||
| High-grade renal injuries are often isolated in sports-related trauma. | Reproductive disorders | 2015 | Reproductive disorders | |
| How to Perform the Best Intrauterine Insemination? A Review. Andrology-Open Access. | IVF clinical | 2015 | IVF clinical;IVF laboratory | |
| Hsa-miR-30d, secreted by the human endometrium, is taken up by the pre-implantation embryo and might modify its transcriptome | 2015 | |||
| Human CD133(+) bone marrow-derived stem cells promote endometrial proliferation in a murine model of Asherman syndrome | Stem cells | 2015 | Stem cells;Immunology | |
|
Human Endometrial Transcriptomics: Implications for Embryonic Implantation | 2015 | ||
|
Human stem cells from single blastomeres reveal pathways of embryonic or trophoblast fate specification | 2015 | ||
|
Immune testing and treatment: still an open debate | 2015 | ||
|
Immunology and human reproduction | 2015 | ||
|
Immunology and human reproduction. | Immunology | 2015 | Immunology;IVF clinical;IVF laboratory;IVF clinical;Female fertility |
|
Impact of blastocyst biopsy and comprehensive chromosome screening technology on preimplantation genetic screening: a systematic review of randomized controlled trials | 2015 | ||
|
Inherent difficulties of meta-analysis for surgical techniques in male infertility: an argument for standardizing reporting and outcomes. | Surgery | 2015 | Surgery;Male fertility;IVF clinical;IVF laboratory |
|
Intra-sample heterogeneity of sperm DNA methylation. | Epigenetics | 2015 | Epigenetics;Male fertility;Aging and rejuvenation |
|
Introducing Larger Equipment: A Novel Method in Laparoscopic Surgery with Smaller Port Sites. | Technology development | 2015 | Technology development;Surgery;Reproductive disorders;Male fertility |
|
Introduction: Microbiome in human reproduction. | IVF clinical | 2015 | IVF clinical;Female fertility;IVF clinical |
|
Investigating the optimal preconception TSH range for patients undergoing IVF when controlling for embryo quality. | Reproductive disorders | 2015 | Reproductive disorders;Female fertility;IVF laboratory;IVF clinical |
|
Investigating the subfertile male: which tests are practically relevant? Infertility Management Series 2: Practical Management of Male Infertility. | Male fertility | 2015 | Male fertility;IVF clinical |
| Is endometrial receptivity transcriptomics affected in women with endometriosis? A pilot study | 2015 | |||
| Is parental consanguinity associated with reduced ovarian reserve? | Female fertility | 2015 | Female fertility;IVF clinical;Female fertility | |
| Is there a relationship between time-lapse parameters and embryo sex? | 2015 | |||
|
IVF: a short but exciting story | 2015 | ||
|
IVF: a short but exciting story. | IVF clinical | 2015 | IVF clinical;IVF laboratory |
|
Karyomapping - a comprehensive means of simultaneous monogenic and cytogenetic PGD: comparison with standard approaches in real time for Marfan syndrome. | Pre-implantation genetics | 2015 | Pre-implantation genetics;IVF laboratory;IVF clinical |
| Karyomapping allows preimplantation genetic diagnosis of a de-novo deletion undetectable using conventional PGD technology. | Technology development | 2015 | Technology development;Pre-implantation genetics | |
| Karyomapping identifies second polar body DNA persisting to the blastocyst stage: implications for embryo biopsy. | IVF laboratory | 2015 | IVF laboratory;IVF clinical | |
|
La greffe d'utérus : résumé de l'expérience du programme suédois. Médecine de la Reproduction Gynécologie Endocrinologie. | 2015 | ;IVF clinical;IVF laboratory | |
|
La tecnología del Time-lapse y su aplicación en las clínicas de reproducción asistida. | Technology development | 2015 | Technology development;IVF laboratory |
|
Large bilateral endometrioma in IVF. | Female fertility | 2015 | Female fertility;IVF clinical;IVF clinical;Female fertility |
|
Lights and Shadows about the Effectiveness of IVF in HIV Infected Women: A Systematic Review. | Female fertility | 2015 | Female fertility;IVF clinical |
| Live births following Karyomapping of human blastocysts: experience from clinical application of the method. | Female fertility | 2015 | Female fertility;Pre-implantation genetics | |
| Livebirth after uterus transplantation | 2015 | ;IVF clinical | ||
| Livebirth after uterus transplantation. | 2015 | ;Female fertility | ||
|
Loop electrosurgical excision procedure: a risk for spontaneous abortion? | 2015 | ||
|
Management of a Case of Severe Pelvic Fracture Related Bladder Trauma. | Reproductive disorders | 2015 | Reproductive disorders;Female fertility |
|
Maternal and fetal outcomes in pregnant women with acute promyelocytic leukemia | 2015 | ||
|
Meet our new editor | 2015 | ||
|
Micro-electrophoresis: a noninvasive method of sperm selection based on membrane charge. | Technology development | 2015 | Technology development;Male fertility;Reproductive disorders;Female fertility |
|
MicroRNA: a step beyond bulk seminal parameters? | Male fertility | 2015 | Male fertility |
|
Mitochondrial DNA Assessment to Determine Oocyte and Embryo Viability. | Female fertility | 2015 | Female fertility;IVF laboratory;IVF clinical;IVF laboratory |
| Mitochondrial DNA content as a viability score in human euploid embryos: less is better | 2015 | |||
| Molecular analysis of products of conception obtained by hysteroembryoscopy from infertile couples | 2015 | |||
|
Monozygotic twinning after assisted reproductive technologies: a case report of asymmetric development and incidence during 19 years in an international group of in vitro fertilization clinics | IVF laboratory | 2015 | IVF laboratory;IVF clinical |
| Morphokinetics as a predictor of self-correction to diploidy in tripronucleated intracytoplasmic sperm injection-derived human embryos | Female fertility | 2015 | Female fertility;IVF laboratory | |
| New methods to improve the safety assessment of cryopreserved ovarian tissue for fertility preservation in breast cancer patients | 2015 | |||
| New strategy for diagnosing embryo implantation potential by combining proteomics and time-lapse technologies | Technology development | 2015 | Technology development;IVF clinical;Female fertility | |
|
No evidence of association between blastocyst aneuploidy and morphokinetic assessment in a selected population of poor-prognosis patients: a longitudinal cohort study. | 2015 | ||
|
Non-motile sperm cell separation using a spiral channe | Male fertility | 2015 | Male fertility;IVF laboratory |
|
Nuclear magnetic resonance metabolomic profiling of urine provides a noninvasive alternative to the identification of biomarkers associated with endometriosis | 2015 | ||
| Obstetric and neonatal outcome of pregnancies fathered by males on immunosuppression after solid organ transplantation | 2015 | ;Aging and rejuvenation | ||
|
Ongoing pregnancy rates in intrauterine insemination are affected by late follicular-phase progesterone levels | Female fertility | 2015 | Female fertility;IVF clinical;IVF clinical;Technology development |
|
Oocyte cryopreservation as a preventive measure for age-related fertility loss. | Cryobiology | 2015 | Cryobiology;Aging and rejuvenation;Male fertility;IVF clinical |
| Oocyte donation outcome after oncological treatment in cancer survivors | Female fertility | 2015 | Female fertility;IVF clinical | |
|
Oocyte mitochondrial function and reproduction. | Female fertility | 2015 | Female fertility;Aging and rejuvenation |
|
Oocyte versus embryo cryopreservation for fertility preservation in cancer patients: guaranteeing a women's autonomy. | 2015 | ||
|
Open versus closed systems for vitrification of human oocytes and embryos. | 2015 | ||
|
Ovarian actions of resveratrol. | Female fertility | 2015 | Female fertility;IVF clinical;Female fertility |
|
Ovarian ageing | Female fertility | 2015 | Female fertility;Aging and rejuvenation;IVF clinical;Technology development |
|
Ovarian cortex transplantation: time to move on from experimental studies to open clinical application | 2015 | ||
| Ovarian hyperstimulation syndrome after gonadotropin-releasing hormone agonist triggering and "freeze-all": in-depth analysis of genetic predisposition. | Female fertility | 2015 | Female fertility;IVF laboratory | |
|
Ovarian stimulation in patients with breast cancer | Female fertility | 2015 | Female fertility;IVF clinical;IVF laboratory |
| Ovarian transplantation: to activate or not to activate. | Immunology | 2015 | Immunology;Female fertility;IVF laboratory;IVF clinical | |
| Ovary transplantation: to activate or not to activate | 2015 | |||
| Overexpression of the truncated form of High Mobility Group A proteins (HMGA2) in human myometrial cells induces leiomyoma-like tissue formation | 2015 | |||
|
Patologías Endocrinas de baja Prevalencia; Somatostatinoma. Manual para el manejo en reproducción. | Female fertility | 2015 | Female fertility;IVF clinical;IVF laboratory;IVF clinical |
| Poor glycemic control is associated with reduced prostate specific antigen concentrations in men with type 1 diabetes. | Male fertility | 2015 | Male fertility | |
| Poor ovarian response in women undergoing in vitro fertilization (IVF) is associated with altered micro RNA expression in cumulus cells. | Female fertility | 2015 | Female fertility;IVF clinical | |
|
Potential use of kisspeptin in ovarian stimulation. | Female fertility | 2015 | Female fertility;IVF clinical;Male fertility |
|
Prediction model for aneuploidy in early human embryo development revealed by single-cell analysis | 2015 | ||
|
Preimplantation genetic screening using comprehensive chromosome screening: evidence and remaining challenges | Pre-implantation genetics | 2015 | Pre-implantation genetics;IVF clinical;IVF laboratory;Female fertility |
|
Progesterone supplementation in the frozen embryo transfer cycle | Female fertility | 2015 | Female fertility;IVF clinical;IVF laboratory |
|
Prospective study into the value of the automated Elecsys antimullerian hormone assay for the assessment of the ovarian growing follicle pool | 2015 | ||
| Reduced blastocyst formation in reduced culture volume. | IVF laboratory | 2015 | IVF laboratory;IVF clinical;IVF clinical | |
|
Reduction of multiple pregnancies in the advanced maternal age population after implementation of an elective single embryo transfer policy coupled with enhanced embryo selection: pre- and post-intervention study. | 2015 | ||
|
Reproductive tract microbiome in assisted reproductive technologies. | IVF laboratory | 2015 | IVF laboratory;IVF clinical;Female fertility |
|
Revisiting ovarian hyper stimulation syndrome: Towards OHSS free clinic | Female fertility | 2015 | Female fertility;IVF clinical |
|
Robotic single-site myomectomy: a step-by-step tutorial. | Surgery | 2015 | Surgery;Female fertility;IVF clinical;IVF laboratory |
|
Role of oocyte vitrification for fertility preservation programs. | Cryobiology | 2015 | Cryobiology;Aging and rejuvenation;IVF clinical;Reproductive disorders |
| Routine use of next-generation sequencing for preimplantation genetic diagnosis of blastomeres obtained from embryos on day 3 in fresh in~vitro fertilization cycles. | Technology development | 2015 | Technology development;Pre-implantation genetics | |
| s endometrial receptivity transcriptomics affected in women with endometriosis? A pilot study. | Endometrial receptivity | 2015 | Endometrial receptivity;Female fertility;Technology development | |
|
Seminal quality in the first fraction of ejaculate. | 2015 | ||
|
Short-Term PTEN Inhibition Improves In Vitro Activation of Primordial Follicles, Preserves Follicular Viability, and Restores AMH Levels in Cryopreserved Ovarian Tissue From Cancer Patients | 2015 | ||
|
Significance of premature progesterone rise in IVF | IVF laboratory | 2015 | IVF laboratory;IVF clinical;IVF clinical |
| Single site laparoscopy for fertility preservation: a cohort study | 2015 | |||
|
Six years' experience in ovum donation using vitrified oocytes: report of cumulative outcomes, impact of storage time, and development of a predictive model for oocyte survival rate | Female fertility | 2015 | Female fertility;Cryobiology;IVF laboratory;IVF clinical |
|
Soluble ligands and their receptors in human embryo development and implantation | 2015 | ||
| Spanish consensus on premature menopause | 2015 | |||
| Sperm concentration is poorly associated with hypoandrogenism in infertile men. | Reproductive disorders | 2015 | Reproductive disorders;Male fertility;IVF clinical | |
|
Sperm selection in natural conception: what can we learn from Mother Nature to improve assisted reproduction outcomes? | 2015 | ||
| Spermatozoa from patients with seminal alterations exhibit a differential micro-ribonucleic acid profile | Male fertility | 2015 | Male fertility;IVF clinical | |
| Stem cells in reproductive medicine: ready for the patient? | 2015 | |||
|
Strategies for controlled ovarian stimulation in the setting of ovarian ageing. | Aging and rejuvenation | 2015 | Aging and rejuvenation;IVF clinical;IVF clinical |
| Stro-1/CD44 as putative human myometrial and fibroid stem cell markers | 2015 | |||
|
Successful ICSI in an azoospermic and kidney transplant man with type 1 primary hyperoxaluria and first histopathological testicular findings described in the literature | IVF laboratory | 2015 | IVF laboratory;IVF clinical;IVF laboratory;Female fertility |
| Supraumbilical primary trocar insertion for laparoscopic access: the relationship between points of entry and retroperitoneal vital vasculature by imaging. | Surgery | 2015 | Surgery;Reproductive disorders | |
|
Systematic review on clinical outcomes following selection of human preimplantation embryos with time-lapse monitoring | IVF clinical | 2015 | IVF clinical;Female fertility;IVF laboratory;Pre-implantation genetics;IVF clinical |
| Targeted Germline Modifications in Rats Using CRISPR/Cas9 and Spermatogonial Stem Cells. | Technology development | 2015 | Technology development;Male fertility;Reproductive disorders | |
|
Techniques for enclosed morcellation in gynecologic surgery. | Surgery | 2015 | Surgery;Female fertility;IVF clinical |
|
The Dilution Effect and Information Integration in Perceptual Decision Making. | Reproductive disorders | 2015 | Reproductive disorders;IVF clinical |
|
The educational and professional status of clinical embryology and clinical embryologists in Europe | IVF laboratory | 2015 | IVF laboratory;IVF clinical |
|
The Maternal Cytokine and Chemokine Profile of Naturally Conceived Gestations Is Mainly Preserved during In Vitro Fertilization and Egg Donation Pregnancies | IVF laboratory | 2015 | IVF laboratory;IVF clinical |
| The Metabolomic Profile of Spent Culture Media from Day-3 Human Embryos Cultured under Low Oxygen Tension | 2015 | |||
|
The microbiome in assisted reproductive technologies. | IVF clinical | 2015 | IVF clinical;IVF laboratory |
|
The microbiome in human reproduction. | IVF clinical | 2015 | IVF clinical;IVF laboratory;IVF laboratory;IVF clinical;Female fertility |
|
The necessity to define the sub-optimal responders | Female fertility | 2015 | Female fertility;IVF clinical |
| The safety and efficacy of clomiphene citrate in hypoandrogenic and subfertile men. | Male fertility | 2015 | Male fertility;Reproductive disorders | |
|
The Separation of Sexual Activity and Reproduction in Human Social Evolution. | Female fertility | 2015 | Female fertility;Male fertility;IVF laboratory;IVF clinical |
|
The time to prevent mendelian genetic diseases from donated or own gametes has come | Pre-implantation genetics | 2015 | Pre-implantation genetics |
|
The time to prevent mendelian genetic diseases from donated or own gametes has come. | Pre-implantation genetics | 2015 | Pre-implantation genetics |
| The updated Cochrane review 2014 on GnRH agonist trigger: repeating the same errors | IVF clinical | 2015 | IVF clinical;Female fertility;IVF laboratory | |
| The updated Cochrane review 2014 on GnRH agonist trigger: repeating the same errors. | IVF clinical | 2015 | IVF clinical;Female fertility;IVF laboratory | |
| The use of morphokinetics as a predictor of implantation: a multicentric study to define and validate an algorithm for embryo selection | Technology development | 2015 | Technology development;IVF clinical;Pre-implantation genetics | |
| The use of morphokinetics as a predictor of implantation: a multicentric study to define and validate an algorithm for embryo selection. | Technology development | 2015 | Technology development;IVF clinical | |
|
Thirty-five years later, the first assisted reproductive technology program opens in Cambodia | 2015 | ||
|
Time-lapse in the IVF lab: how should we assess potential benefit? | 2015 | ||
|
Time-Lapse in the IVL lab: how should we assess potential benefit | Technology development | 2015 | Technology development;IVF laboratory;Female fertility;IVF laboratory;IVF clinical |
|
To pill or not to pill in GnRH antagonist cycles: that is the question! | 2015 | ||
|
To pill or not to pill in GnRH-antagonist cycles: still an open debate | 2015 | ||
|
To pill or not to pill in GnRH-antagonist cycles: still an open debate. | 2015 | ||
|
Treatment of infertility associated with deep endometriosis: definition of therapeutic balances | IVF clinical | 2015 | IVF clinical;Reproductive disorders |
|
Trends in clinical reproductive medicine research: 10 years of growth | 2015 | ||
|
Trends Over Time and Surgical Outcomes of Abdominal, Mini-Laparotomy, and Traditional and Robotic-Assisted Laparoscopy With and Without Tandem Mini-Laparotomy: A Comparison of Myomectomy Techniques | Surgery | 2015 | Surgery;Reproductive disorders |
|
Ulipristal acetate in uterine fibroids | 2015 | ||
|
Understanding and improving endometrial receptivity | 2015 | ||
|
Understanding Mammalian Germ Line Development with In Vitro Models | 2015 | ||
| Understanding mammlian germ line development with in Vitro Models. | Female fertility | 2015 | Female fertility;Male fertility;IVF clinical | |
|
Understanding the new WHO semen parameters. Infertility Management Series 2: Practical Management of Male Infertility. | IVF laboratory | 2015 | IVF laboratory;Male fertility |
| Uterine transplantation is not a good use of limited resources: AGAINST: It is a highly effective infertility treatment | 2015 | |||
| Uterus transplantation trial: 1-year outcome | 2015 | |||
|
Validation of next-generation sequencing for comprehensive chromosome screening of embryos. | Technology development | 2015 | Technology development;Female fertility;IVF laboratory |
|
Valoración Embrionaria por Mofocinética. Criterios de Nomenclatura y Anotaciones. | IVF clinical | 2015 | IVF clinical;IVF laboratory;IVF clinical |
|
Variability of permeability estimation from different protocols of subculture and transport experiments in cell monolayers. | Technology development | 2015 | Technology development;Female fertility |
|
Vitamin D and in vitro fertilization outcome | Female fertility | 2015 | Female fertility;IVF laboratory;IVF laboratory |
|
Vitamin D and in vitro fertilization outcome. | Female fertility | 2015 | Female fertility;IVF laboratory;IVF laboratory |
|
Vitamin D levels do not affect IVF outcomes following the transfer of euploid blastocysts. | Reproductive disorders | 2015 | Reproductive disorders;Female fertility |
|
Vitamin D levels do not impact IVF outcomes following the transfer of a euploid blastocyst. Reply to Letter. | Female fertility | 2015 | Female fertility;IVF clinical;IVF clinical |
|
What does morphokinetics add to embryo selection and in-vitro fertilization outcomes? | Technology development | 2015 | Technology development;IVF clinical;Female fertility;IVF laboratory;IVF clinical |
|
Reply of the authors | 2014 | ||
|
A cautionary note against embryo aneuploidy risk assessment using time-lapse imaging. | 2014 | ||
| A greater number of euploid blastocysts in a given cohort predicts excellent outcomes in single embryo transfer cycles. | Female fertility | 2014 | Female fertility;IVF clinical;IVF laboratory | |
| A minimally invasive methodology based on morphometric parameters for day 2 embryo quality assessment | 2014 | |||
|
A multicenter prospective study to assess the effect of early cleavage on embryo quality, implantation, and live-birth rate | 2014 | ||
|
Allogeneic uterus transplantation in baboons: surgical technique and challenges to long-term graft survival | 2014 | ;Female fertility | |
|
An engaging example of translational medicine: the Wnt/beta-catenin cellular pathway and pharmacological research in fibroid treatment | Reproductive disorders | 2014 | Reproductive disorders;Female fertility;IVF laboratory |
| Analysis of embryo morphokinetics, multinucleation and cleavage anomalies using continuous time-lapse monitoring in blastocyst transfer cycles. | Technology development | 2014 | Technology development;Female fertility;IVF laboratory | |
|
Aneuploidy across individual chromosomes at the embryonic level in trophectoderm biopsies: changes with patient age and chromosome structure. | Aging and rejuvenation | 2014 | Aging and rejuvenation;Female fertility |
|
Artículo de revisión "marcadores de gestación no intrauterina” | Female fertility | 2014 | Female fertility |
|
Assessment of the implantation of day-2 human embryos by morphometric nonsubjective parameters | 2014 | ||
| BACs-on-Beads technology: a reliable test for rapid detection of aneuploidies and microdeletions in prenatal diagnosis | 2014 | |||
|
Clinical genetic testing for male factor infertility: current applications and future directions. | Pre-implantation genetics | 2014 | Pre-implantation genetics;Technology development;Female fertility;IVF clinical;IVF laboratory |
|
Clinical management of endometrial receptivity | 2014 | ||
|
Clinical outcomes following time-lapse monitoring for selection of preimplantation embryos: A systematic review. | Female fertility | 2014 | Female fertility;IVF clinical |
| Clinical utilization of a rapid low-pass whole genome sequencing technique for the diagnosis of aneuploidy in human embryos prior to implantation. | Technology development | 2014 | Technology development;Pre-implantation genetics | |
| Clinical validation of embryo culture and selection by morphokinetic analysis: a randomized, controlled trial of the EmbryoScope | 2014 | |||
|
Clinically recognizable error rate after the transfer of comprehensive chromosomal screened euploid embryos is low. | IVF clinical | 2014 | IVF clinical;Female fertility |
|
Comparative analysis of three sperm DNA damage assays and sperm nuclear protein content in couples undergoing assisted reproduction treatment. | Male fertility | 2014 | Male fertility;IVF clinical;IVF clinical;IVF laboratory |
|
Comparison of effects of different statins on growth and steroidogenesis of rat ovarian theca-interstitial cells. | Female fertility | 2014 | Female fertility |
|
Comprehensive chromosome screening (CCS) with synchronous blastocyst transfer: Time for a paradigm shift. | Technology development | 2014 | Technology development;IVF clinical |
|
Correlation between standard blastocyst morphology, euploidy and implantation: an observational study in two centers involving 956 screened blastocysts. | 2014 | ||
|
Current understanding of somatic stem cells in leiomyoma formation | 2014 | ||
| Deciphering the proteomic signature of human endometrial receptivity | Endometrial receptivity | 2014 | Endometrial receptivity;Female fertility | |
|
Defining the “sweet spot” for administered luteinizing hormone-to-follicle-stimulating hormone gonadotropin ratios during ovarian stimulation to protect against a clinically significant late follicular increase in progesterone: an analysis of 10,280 first in vitro fertilization cycles. | Female fertility | 2014 | Female fertility;IVF clinical |
|
Demographics of pediatric renal trauma. | Surgery | 2014 | Surgery;IVF clinical;IVF laboratory |
|
Diminished Effect of Maternal Age on Implantation After Preimplantation Genetic Diagnosis With Array Comparative Genomic Hybridization. | Aging and rejuvenation | 2014 | Aging and rejuvenation;Female fertility |
|
Does Lower Uterine Segment Involvement in Grade 3 Endometrial Cancer Impact Recurrence Patterns and Patient Outcomes? | IVF clinical | 2014 | IVF clinical;Reproductive disorders |
|
Dopamine receptor 2 activation inhibits ovarian vascular endothelial growth factor secretion in an ovarian hyperstimulation syndrome (OHSS) animal model: implications for treatment of OHSS with dopamine receptor 2 agonists | Female fertility | 2014 | Female fertility;IVF clinical;IVF clinical;IVF laboratory |
|
Dopamine receptor 2 activation inhibits ovarian vascular endothelial growth factor secretion in vitro: implications for treatment of ovarian hyperstimulation syndrome with dopamine receptor 2 agonists | IVF clinical | 2014 | IVF clinical;Female fertility |
|
Effect of serum progesterone concentration on day of embryo transfer in donor oocyte cycles. | Female fertility | 2014 | Female fertility;IVF clinical |
|
Ehtnicity as a determinant of the ovarian reserve: differences in ovarian aging between Spanish and Indian women. | Female fertility | 2014 | Female fertility;IVF clinical |
|
Ejaculatory sperm production in non-obstructive azoospermic patients with a history of negative testicular biopsy after the administration of an aromatase inhibitor: report of two cases. | Male fertility | 2014 | Male fertility;IVF laboratory |
| Embryo aneuploidy screening with CGH arrays in the absence of implantation. | Pre-implantation genetics | 2014 | Pre-implantation genetics;Female fertility | |
|
Embryo biopsy for aneuploidy detection in the general infertility population. | Female fertility | 2014 | Female fertility;Pre-implantation genetics;IVF laboratory;IVF clinical |
|
Embryology Training for Reproductive Endocrine Fellows in the Clinical Human Embryology Laboratory | IVF clinical | 2014 | IVF clinical;IVF laboratory;Reproductive disorders |
|
Embryonic aneuploidy: overcoming molecular genetics challenges improves outcomes and changes practice patterns. | Pre-implantation genetics | 2014 | Pre-implantation genetics;Female fertility |
| Embryonic miRNA profiles of normal and ectopic pregnancies | 2014 | |||
|
Endocrine profile following stimulation with recombinant follicle stimulating hormone and luteinizing hormone versus highly purified human menopausal gonadotropin | Female fertility | 2014 | Female fertility;IVF clinical;IVF laboratory |
| Endometrial CXCL13 expression is cycle regulated in humans and aberrantly expressed in humans and macaques with endometriosis | Reproductive disorders | 2014 | Reproductive disorders;Female fertility;IVF clinical;IVF laboratory | |
|
Endometrial infusion of human chorionic gonadotropin at the time of blastocyst embryo transfer does not impact clinical outcomes: a randomized double-blind, placebo controlled trial. | IVF clinical | 2014 | IVF clinical;Female fertility;IVF laboratory |
|
Endometrial infusion of human chorionic gonadotropin at the time of blastocyst embryo transfer does not impact clinical outcomes: a randomized, double-blind, placebo-controlled trial. | Female fertility | 2014 | Female fertility;IVF clinical |
| Epab is dispensable for Spermatogenesis and Male Fertility in Mice. | Male fertility | 2014 | Male fertility;IVF clinical;IVF laboratory | |
| Ethics of uterus transplantation with live donors. Fertility and Sterility | 2014 | ;Female fertility | ||
| Ethnicity as a determinant of ovarian reserve: differences in ovarian aging between Spanish and Indian women | Female fertility | 2014 | Female fertility;IVF laboratory | |
|
Examining the temperature of embryo culture in IVF: a randomized controlled trial comparing traditional core temperature (37°C) to a more physiologic, cooler temperature (36°C). | IVF laboratory | 2014 | IVF laboratory;Female fertility;IVF laboratory;IVF clinical |
|
Experience in IVIg Therapy for Selected Women with Recurrent Reproductive Failure and NK Cell Expansion. | Reproductive disorders | 2014 | Reproductive disorders;Female fertility;IVF laboratory |
| Expression of neurokinin B/NK3 receptor and kisspeptin/KISS1 receptor in human granulosa cells | IVF clinical | 2014 | IVF clinical;Female fertility | |
| Expression of neurokinin B/NK3 receptor and kisspeptin/KISS1 receptor in human granulosa cells. | IVF clinical | 2014 | IVF clinical;Female fertility | |
| Factors affecting the outcome of “Endometrial Scratch” in women with recurrent implantation failure. | Female fertility | 2014 | Female fertility;IVF clinical;IVF clinical | |
|
Feasibility, acceptance, and efectiveness of an ergonomics training program. | Reproductive disorders | 2014 | Reproductive disorders;Aging and rejuvenation;IVF laboratory |
|
Fertility preservation: moving ahead faster than expected! | 2014 | ||
|
First clinical uterus transplantation trial: a six-month report | 2014 | ||
|
Follicle stimulating hormone receptor (FSHR) alternative skipping of exon 2 or 3 affects ovarian response to FSH. | Female fertility | 2014 | Female fertility;IVF clinical;IVF laboratory |
|
Genetic associations with diminished ovarian reserve: a systematic review of the literature. | Aging and rejuvenation | 2014 | Aging and rejuvenation;Female fertility |
|
Genetics of male infertility. Review. | Male fertility | 2014 | Male fertility;IVF laboratory;Female fertility |
|
Genetics of primary ovarian insufficiency: a review | Female fertility | 2014 | Female fertility;IVF clinical |
|
Genome-wide karyomapping accurately identifies the inheritance of single-gene defects in human preimplantation embryos in vitro. | Technology development | 2014 | Technology development;Female fertility |
|
Genome-wide parent-of-origin DNA methylation analysis reveals the intricacies of human imprinting and suggests a germline methylation-independent mechanism of establishment | 2014 | ||
| Germ cell transplantation into mouse testes procedure | 2014 | |||
|
Germ line development: lessons learned from pluripotent stem cells | Stem cells | 2014 | Stem cells;Female fertility;IVF laboratory |
| Health outcomes of children born after IVF/ICSI: a review of current expert opinion and literature. | IVF laboratory | 2014 | IVF laboratory;IVF clinical | |
|
High progesterone levels in women with high ovarian response do not affect clinical outcomes: a retrospective cohort study | IVF clinical | 2014 | IVF clinical;Female fertility |
|
High progesterone levels in women with high ovarian response do not affect clinical outcomes: a retrospective cohort study. | IVF clinical | 2014 | IVF clinical;Female fertility |
|
Human embryonic aneuploidy. | Pre-implantation genetics | 2014 | Pre-implantation genetics;Female fertility |
| Human embryonic poly(A) binding protein (EPAB) alternative splicing is differentially regulated in human oocytes and embryos. | Female fertility | 2014 | Female fertility;IVF clinical | |
|
Human germ cell differentiation from pluripotent embryonic stem cells and induced pluripotent stem cells | 2014 | ||
|
Impact of circulating levels of total and bioavailable serum vitamin D on pregnancy rate in egg donation recipients | IVF clinical | 2014 | IVF clinical;Female fertility |
|
Impact of fresh versus cryopreserved testicular sperm upon intracytoplasmic sperm injection pregnancy outcomes in men with azoospermia due to spermatogenic dysfunction: a meta-analysis. | Cryobiology | 2014 | Cryobiology;Male fertility;Male fertility;IVF clinical;IVF laboratory |
|
Impact of ovarian stimulation with gonadotrophins on embryo aneuploidy | Female fertility | 2014 | Female fertility;IVF clinical;Female fertility;IVF clinical |
| Improved sensitivity to detect recombination using qPCR for Dyskeratosis Congenita PGD. | Pre-implantation genetics | 2014 | Pre-implantation genetics;IVF clinical | |
| Improving ovarian tissue cryopreservation for oncologic patients: slow freezing versus vitrification, effect of different procedures and devices | 2014 | |||
|
Improving the Reporting of Clinical Trial of Infertility Treatments (IMPRINT): modifying the CONSORT statement. | Female fertility | 2014 | Female fertility;IVF clinical;IVF clinical |
|
Improving the Reporting of Clinical Trials of Infertility Treatments (IMPRINT): modifying the CONSORT statement | 2014 | ||
| Increasing the probability of selecting chromosomally normal embryos by time-lapse morphokinetic analysis. | Pre-implantation genetics | 2014 | Pre-implantation genetics;Female fertility;Female fertility | |
| Increasing the probability of selecting chromosomally normal embryos by time-lapse morphokinetics analysis | Pre-implantation genetics | 2014 | Pre-implantation genetics;Female fertility;Female fertility | |
| Influence of follicle rupture and uterine contractions on intrauterine insemination outcome: a new predictive model | IVF clinical | 2014 | IVF clinical;IVF laboratory | |
|
Inhibition of Delta-like 4 mediated signaling induces abortion in mice due to deregulation of decidual angiogenesis | Female fertility | 2014 | Female fertility;IVF clinical |
|
Intrauterine Insemination. | Female fertility | 2014 | Female fertility;Male fertility;Female fertility;IVF clinical;IVF laboratory |
|
Intrauterine Insemination. Chapter 12: Design, Equipment and Personnel Management for Intrauterine Insemination Laboratory. | IVF clinical | 2014 | IVF clinical;IVF laboratory |
|
Introduction: Are we advancing in our scientific understanding and therapeutic improvement of uterine fibroids... or not? | 2014 | ||
|
Introduction: MicroRNAs in human reproduction: small molecules with crucial regulatory roles | 2014 | ||
|
Is ovarian reserve related to blood type? | 2014 | ||
|
Is there still a role for primary realignment for stricture due to pelvic fracture? | Surgery | 2014 | Surgery |
|
ISGE statement on oral emergency contraception | 2014 | ||
|
Lack of association of KATNAL1 gene sequence variants and azoospermia in humans. | Male fertility | 2014 | Male fertility |
|
Live birth after embryo transfer in an unresponsive thin endometrium | Reproductive disorders | 2014 | Reproductive disorders;Female fertility;Pre-implantation genetics |
| Live birth after PGD with confirmation by a comprehensive approach (karyomapping) for simultaneous detection of monogenic and chromosomal disorders. | Pre-implantation genetics | 2014 | Pre-implantation genetics;Technology development | |
| Live birth rates after IVF are reduced by both low and high progesterone levels on the day of human chorionic gonadotrophin administration. | IVF laboratory | 2014 | IVF laboratory;IVF clinical | |
|
Local endometrial trauma: a Treatment Strategy to Improve Implantation Rates | Reproductive disorders | 2014 | Reproductive disorders;IVF clinical |
|
Male endocrine dysfunction. Review. | Male fertility | 2014 | Male fertility;Reproductive disorders |
|
Management of adults with prior failed hypospadias surgery. Review. | Surgery | 2014 | Surgery;Male fertility |
|
Management of poor responders in IVF: is there anything new? | 2014 | ||
| Maternal KIR haplotype influence life birth rate after embryo transfer in vitro fertilization (IVF) cycles. | IVF clinical | 2014 | IVF clinical;IVF laboratory | |
|
Maternal KIR haplotype influences live birth rate after double embryo transfer in IVF cycles in patients with recurrent miscarriages and implantation failure | IVF clinical | 2014 | IVF clinical;IVF laboratory;IVF clinical |
|
Men with diabetes may require more aggressive treatment for erectile dysfunction. | Male fertility | 2014 | Male fertility;Reproductive disorders;IVF clinical |
|
Metabolism of female reproduction: Regulatory mechanisms and clinical implications. | Female fertility | 2014 | Female fertility;IVF clinical;Male fertility |
|
Metabolomic assessment of embryo viability. | Female fertility | 2014 | Female fertility;IVF clinical |
|
Metabolomic prediction of pregnancy viability in superovulated cattle embryos and recipients with fourier transform infrared spectroscopy | Technology development | 2014 | Technology development;IVF laboratory |
| Metformin is associated with improved survival in endometrial cancer. | Reproductive disorders | 2014 | Reproductive disorders;Female fertility;IVF clinical | |
|
MicroRNA and implantation | 2014 | ||
|
Mild ovarian stimulation using clomiphene citrate and menotropins versus clomiphene citrate and recombinant follicle-stimulating hormone/luteinizing hormone combination in low responder patients | IVF clinical | 2014 | IVF clinical;Female fertility |
| New insights into the expression profile and function of micro-ribonucleic acid in human spermatozoa | Male fertility | 2014 | Male fertility | |
|
New tools for embryo selection: comprehensive chromosome screening by array comparative genomic hybridization | 2014 | ||
|
Next-generation sequencing: challenges in reproductive genetics | 2014 | ||
|
Next-generation sequencing: the dawn of a new era for preimplantation genetic diagnostics. | Technology development | 2014 | Technology development;Pre-implantation genetics;Female fertility;IVF clinical |
| Non-invasive prediction of embryonic sex in cattle by metabolomic analysis of in vitro culture medium with Fourier transfrom infrared spectroscopy. | IVF laboratory | 2014 | IVF laboratory;Technology development;IVF clinical | |
| Non-invasive techniques: Embryo selection by transcriptomics, proteomics and metabolomics. | Technology development | 2014 | Technology development;IVF clinical | |
| Obstetric and perinatal outcome of babies born from vitrified oocytes | Female fertility | 2014 | Female fertility;IVF clinical;Female fertility | |
| Obstetric outcome after oocyte freezing for fertility preservation in women with cancer. | Cryobiology | 2014 | Cryobiology;Female fertility | |
| Obstetric outcome after oocyte vitrification and warming for fertility preservation in women with cancer | Cryobiology | 2014 | Cryobiology;Female fertility;IVF laboratory;IVF clinical | |
|
Obstetrical and neonatal outcomes from the BEST Trial: Single embryo transfer with aneuploidy screening improves outcomes after in vitro fertilization without compromising delivery rates. | Pre-implantation genetics | 2014 | Pre-implantation genetics;Female fertility |
|
OMICS- current and future perspectives in reproductive medicine and technology. | Technology development | 2014 | Technology development;IVF clinical;IVF laboratory;Female fertility |
|
OMICS: Current and future perspectives in reproductive medicine and technology | 2014 | ||
| Oocyte versus embryo vitrification for delayed embryo transfer: an observational study | 2014 | |||
|
Ovarian response to recombinant human follicle-stimulating hormone: a randomized, antimullerian hormone-stratified, dose-response trial in women undergoing in vitro fertilization/intracytoplasmic sperm injection | Female fertility | 2014 | Female fertility;IVF laboratory;IVF clinical |
|
Paciente con riesgo de embarazo múltiple. Casos Clínicos de Reproducción Asistida e Infertilidad. | Female fertility | 2014 | Female fertility;IVF clinical |
|
Paternal influence of sperm DNA integrity on early embryonic development. | Male fertility | 2014 | Male fertility;IVF clinical;IVF clinical;IVF laboratory |
| Persistence of urothelial carcinoma of the bladder risk among former smokers: results from a contemporary, prospective cohort study. | Male fertility | 2014 | Male fertility;Reproductive disorders;IVF clinical;IVF laboratory | |
| Polar body based aneuploidy screening is poorly predictive of embryo ploidy and reproductive potential. | Pre-implantation genetics | 2014 | Pre-implantation genetics;Female fertility | |
|
Poor responders and androgen adjuvant treatment: "Still haven't found what I'm looking for...". | Female fertility | 2014 | Female fertility;IVF clinical |
|
Prediction of pregnancy viability in bovine in vitro-produced embryos and recipient plasma with Fourier transform infrared spectroscopy. | Female fertility | 2014 | Female fertility;IVF clinical |
| Pregnancy after allogeneic uterus transplantation in the rat: perinatal outcome and growth trajectory | 2014 | |||
|
Pregnancy success after hysteroscopic sterilization reversal. | Surgery | 2014 | Surgery;Female fertility;Aging and rejuvenation;IVF laboratory |
|
Presente y futuro de la evaluación del semen con finalidad reproductiva en un centro de reproducción asistida | Male fertility | 2014 | Male fertility;IVF clinical |
|
Prevalence of Androgen Deficiency and Predisposing Risk Factors in Men with Type I Diabetes Mellitus: Findings from the DCCT/EDIC. | Male fertility | 2014 | Male fertility;IVF clinical |
|
Prevalence of low testosterone and predisposing risk factors in men with type 1 diabetes mellitus: findings from the DCCT/EDIC. | Male fertility | 2014 | Male fertility |
| Proposed guidelines on the nomenclature and annotation of dynamic human embryo monitoring by a time-lapse user group | 2014 | |||
|
Prospective assessment of mid-secretory endometrial LIF in women with unexplained infertility and suspected endometriosis. | Female fertility | 2014 | Female fertility;IVF clinical |
|
Psychological Stress and Reproductive Failure. | Psychology | 2014 | Psychology;Female fertility;IVF clinical;IVF laboratory;Male fertility |
| Quality of additional embryos transferred on pregnancy outcomes in IVF: predictions using a mathematical approach | 2014 | |||
| Recurrent Implantation Failure: Definition and Management. | Female fertility | 2014 | Female fertility;IVF clinical;Female fertility | |
|
Refined phenotyping, large cohorts, and collaborative research are vital for realizing the potential of genomics to transform care for male infertility. | Male fertility | 2014 | Male fertility;IVF clinical;Female fertility |
|
Relationship between maternal immunological response during pregnancy and onset of preeclampsia | 2014 | ||
|
Removal of annexin V-positive sperm cells for intracytoplasmic sperm injection in ovum donation cycles does not improve reproductive outcome: a controlled and randomized trial in unselected males | IVF laboratory | 2014 | IVF laboratory;Male fertility |
| Removal of annexin V–positive sperm cells for intracytoplasmic sperm injection in ovum donation cycles does not improve reproductive outcome: a controlled and randomized trial in unselected males. | Male fertility | 2014 | Male fertility;IVF laboratory;IVF clinical | |
|
Reply: Endometrial scratching for women with repeated implantation failure | Female fertility | 2014 | Female fertility;IVF clinical;IVF clinical;Female fertility |
|
Response: poor responders and androgen adjuvant treatment: "still haven't found what I'm looking for…". | Female fertility | 2014 | Female fertility;IVF clinical;IVF clinical |
|
Resveratrol potentiates the inhibition of simvastatin on rat ovarian theca-intertitial cell steroidogenesis. | Female fertility | 2014 | Female fertility;IVF laboratory;IVF clinical |
|
Review of “Neonatal insulin action impairs hypothalamic neurocircuit formation in response to maternal high-fat feeding.” | Female fertility | 2014 | Female fertility;IVF clinical |
|
Role of statins in PCOS management | Reproductive disorders | 2014 | Reproductive disorders;Female fertility;Pre-implantation genetics;IVF clinical;IVF laboratory |
|
Scheduling cycles with gonadotropin-releasing hormone antagonist protocol in in vitro fertilization: Is there a scope in batch in vitro fertilization? | 2014 | ||
|
Scratching beneath 'The Scratching Case': systematic reviews and meta-analyses, the back door for evidence-based medicine | 2014 | ||
|
Severe ovarian hyperstimulation syndrome after gonadotropin-releasing hormone (GnRH) agonist trigger and "freeze-all" approach in GnRH antagonist protocol | Reproductive disorders | 2014 | Reproductive disorders;Female fertility |
|
Simple circumcision device: proof of concept for a single-visit, adjustable device to facilitate safe adult male circumcision. | Technology development | 2014 | Technology development;Male fertility;IVF clinical;IVF laboratory |
| Simultaneous assessment of aneuploidy, polymorphisms, and mitochondrial DNA content in human polar bodies and embryos with the use of a novel microarray platform. | Pre-implantation genetics | 2014 | Pre-implantation genetics;Technology development;Surgery | |
| Sperm DNA Fragmentation, Recurrent Implantation Failure and Recurrent Miscarriage | Male fertility | 2014 | Male fertility;Female fertility;IVF clinical | |
| Spontaneous recovery from reproductive failure in a hand reared male western lowland gorilla (Gorilla gorilla gorilla). | Male fertility | 2014 | Male fertility;Reproductive disorders | |
|
Succesful twin delivery following transmyometrial embryo transfer in a patient with a false uterine cavity. | IVF clinical | 2014 | IVF clinical;IVF laboratory;IVF laboratory;Reproductive disorders |
|
Successful pregnancy after treatment with ulipristal acetate for uterine fibroids | 2014 | ||
|
Successful twin delivery following transmyometrial embryo transfer in a patient with a false uterine cavity. | Female fertility | 2014 | Female fertility;IVF clinical;Cryobiology;Female fertility |
|
Telomere length and aneuploidy: clinical and biological insights into human preimplantation embryos. | Pre-implantation genetics | 2014 | Pre-implantation genetics;Female fertility |
|
The ethical implications of preimplantation genetic diagnosis. | Pre-implantation genetics | 2014 | Pre-implantation genetics;IVF clinical;IVF clinical |
| The expression of mRNA-binding protein TIA-1 is down-regulated in ectopic endometrium. | Female fertility | 2014 | Female fertility;Reproductive disorders;IVF laboratory | |
|
The future of reproductive medical education | 2014 | ||
| The human first cell cycle: impact on implantation | Female fertility | 2014 | Female fertility;IVF laboratory;IVF laboratory | |
|
The impact of assisted reproductive technologies on genomic imprinting and imprinting disorders. | IVF clinical | 2014 | IVF clinical;Female fertility;IVF clinical |
| The impact of using the combined oral contraceptive pill for cycle scheduling on gene expression related to endometrial receptivity | Endometrial receptivity | 2014 | Endometrial receptivity;Female fertility;IVF clinical | |
| The impact of using the combined oralcontraceptive pill for cycle scheduling ongene expression related to endometrial receptivity. | Female fertility | 2014 | Female fertility;Endometrial receptivity | |
|
The nature of aneuploidy with increasing age of the female partner: a review of 15,169 consecutive trophectoderm biopsies evaluated with comprehensive chromosomal screening. | Aging and rejuvenation | 2014 | Aging and rejuvenation;Pre-implantation genetics;Male fertility;IVF clinical |
|
The transcriptomic and proteomic effects of ectopic overexpression of miR-30d in human endometrial epithelial cells | 2014 | ||
|
Timing the window of implantation by nucleolar channel system prevalence matches the accuracy of the endometrial receptivity array | 2014 | ||
|
Transcriptomics of the human endometrium | 2014 | ||
|
Tuberculosis. In Casos Clinicos de Reproducción Asistida e Infertilidad | IVF clinical | 2014 | IVF clinical;IVF laboratory |
|
Uniparental disomy in the human blastocyst is exceedingly rare. | Pre-implantation genetics | 2014 | Pre-implantation genetics;IVF clinical |
|
Variable maternal methylation overlapping the nc886/vtRNA2-1 locus is locked between hypermethylated repeats and is frequently altered in cancer | 2014 | ||
|
Variants in DPF3 and DSCAML1 are associated with sperm morphology. | Male fertility | 2014 | Male fertility |
|
What a difference two days make: "personalized" embryo transfer (pET) paradigm: a case report and pilot study | 2014 | ||
|
What a difference two days make: “personalized” embryo transfer (pET) paradigm: A case report and pilot study. | Female fertility | 2014 | Female fertility;IVF clinical;Reproductive disorders |
|
When is clomiphene or gonadotropin IUI futile? Results of the Fast Track and Standard Treatment Trial and the Forty and Over Treatment Trial, two prospective randomized controlled trials. | Female fertility | 2014 | Female fertility;IVF clinical |
| 5-years experience employing oocyte vitrification to preserve fertility for medical and non-medical indications. | Cryobiology | 2013 | Cryobiology;Female fertility | |
| A time to look back: analysis of morphokinetic characteristics of human embryo development. | Female fertility | 2013 | Female fertility;IVF clinical | |
|
Additive effect of factors related to assisted conception on the reduction of maternal serum pregnancy-associated plasma protein A concentrations and the increased false-positive rates in first-trimester Down syndrome screening. | Pre-implantation genetics | 2013 | Pre-implantation genetics;IVF clinical;IVF clinical;Surgery |
|
Alterations in the gene expression of aneuploid oocytes and associated cumulus cells. | Pre-implantation genetics | 2013 | Pre-implantation genetics;Female fertility;Female fertility |
|
Assessment of sperm using mRNA microarray technology. | Technology development | 2013 | Technology development;Male fertility;IVF clinical |
|
Assisted reproduction in same sex couples. | IVF clinical | 2013 | IVF clinical;IVF laboratory;Cryobiology |
| Bed rest after embryo transfer negatively affects in vitro fertilization: a randomized controlled clinical trial. | IVF clinical | 2013 | IVF clinical;Female fertility;Immunology | |
|
Blastocyst biopsy with comprehensive chromosome screening and fresh embryo transfer significantly increases IVF implantation and delivery rates: a randomized controlled trial. | Technology development | 2013 | Technology development;Female fertility;IVF laboratory |
| Characterization of the Gonadotropin Releasing Hormone Receptor (GnRHR) expression and activity in the Female Mouse Ovary. | Female fertility | 2013 | Female fertility;IVF clinical;Reproductive disorders | |
|
Cleavage stage biopsy significantly impairs human embryonic implantation potential while blastocyst biopsy does not: a randomized and paired clinical trial. | Technology development | 2013 | Technology development;Female fertility;IVF laboratory |
| Clinical Characteristics of Women with Recurrent Implantation Failure. | Reproductive disorders | 2013 | Reproductive disorders;Female fertility | |
|
Comprehensive chromosome screening alters traditional morphology-based embryo selection: a prospective study of 100 consecutive cycles of planned fresh euploid blastocyst transfer. | Technology development | 2013 | Technology development;Female fertility |
|
Contemporary trends in the immediate surgical management of renal trauma using a national database. | Surgery | 2013 | Surgery;IVF clinical |
|
Cost-effectiveness of hysteroscopy screening for infertile women. | Female fertility | 2013 | Female fertility;IVF clinical;IVF laboratory |
|
Could Safety Boards provide a valuable took to enhance the safety of reproductive medicine? | Female fertility | 2013 | Female fertility;IVF clinical;IVF laboratory;IVF clinical |
|
Cumulus and granulosa cell markers of oocyte and embryo quality. | Female fertility | 2013 | Female fertility;IVF clinical |
| Current practices and regulations for embryo transfer worldwide: implications on ART outcome. | IVF laboratory | 2013 | IVF laboratory;IVF clinical;IVF clinical;IVF laboratory | |
|
Current trends and progress in clinical applications of oocyte cryopreservation. | IVF clinical | 2013 | IVF clinical;IVF laboratory |
| Cycle scheduling for in vitro fertilization with oral contraceptive pills versus oral estradiol valerate: a randomized, controlled trial. | IVF clinical | 2013 | IVF clinical;Female fertility;IVF clinical;IVF laboratory | |
| Differentially regulated expression of neurokinin B (NKB)/NK3 receptor system in uterine leiomyomata. | Female fertility | 2013 | Female fertility | |
| Discordant chromosome placental mosaicism in a dichorionic twin pregnancy | Female fertility | 2013 | Female fertility;IVF clinical;Female fertility;Male fertility | |
|
Early luteal phase endocrine profile is affected by the mode of triggering final oocyte maturation and the luteal phase support used in recombinant follicle-stimulating hormone–gonadotropin-releasing hormone antagonist in vitro fertilization cycles | IVF clinical | 2013 | IVF clinical;IVF laboratory;Female fertility;Male fertility |
| Effect of vitrification on human oocytes: a metabolic profiling study | Cryobiology | 2013 | Cryobiology;Female fertility;Female fertility;IVF clinical | |
|
Effects of simvastatin on retinoic acid system in primary human endometrial stromal cells and in a chimeric model of human endometriosis. | Reproductive disorders | 2013 | Reproductive disorders;Female fertility;Pre-implantation genetics;IVF clinical;IVF laboratory |
|
Embryos whose polar bodies contain isolated reciprocal chromosome aneuploidy are almost always euploid. | Female fertility | 2013 | Female fertility;Pre-implantation genetics |
|
Endometrial integrin expression in women with recurrent implantation failure after IVF; relationship to pregnancy outcome | IVF clinical | 2013 | IVF clinical;Reproductive disorders |
|
Ergonomic deficits in robotic gynecologic oncology surgery: A need for intervention. | Technology development | 2013 | Technology development;Surgery |
|
Evaluation of targeted next-generation sequencing based preimplantation genetic diagnosis of monogenic disease. | Technology development | 2013 | Technology development;Pre-implantation genetics;IVF laboratory |
| Evaluation of the degree of satisfaction in oocyte donors using sustained-release FSH corifollitropin ?. | Female fertility | 2013 | Female fertility;IVF laboratory | |
|
Extended culture and the risk of preterm delivery in singletons: confounding by indication? | Female fertility | 2013 | Female fertility;IVF clinical |
|
Failures (with some successes) of assisted reproduction and gamete donation programs. | IVF laboratory | 2013 | IVF laboratory;IVF clinical |
|
False positive rate of an arrayCGH platform for single-cell preimplantation genetic screening and subsequent clinical application on day-3 | Pre-implantation genetics | 2013 | Pre-implantation genetics;Technology development |
|
Female obesity: short- and long-term consequences on the offspring. | Female fertility | 2013 | Female fertility;IVF clinical |
|
Fever without a source in the pregnant patient: A case report and review of the literature. | Female fertility | 2013 | Female fertility;IVF clinical |
|
Filling the void about sperm function knowledge and how the -omics approach can close the circle. | Male fertility | 2013 | Male fertility;IVF laboratory;IVF clinical |
|
Finasteride and male infertility: a case for prospective collaborative research databases? | Male fertility | 2013 | Male fertility |
|
FISH reanalysis of inner cell mass and trophectoderm samples of previously array-CGH screened blastocysts shows high accuracy of diagnosis and no major diagnostic impact of mosaicism at the blastocyst stage. | 2013 | ||
| Five years' experience using oocyte vitrification to preserve fertility for medical and nonmedical indications. | Cryobiology | 2013 | Cryobiology;Female fertility | |
|
Four-hour quantitative real-time polymerase chain reaction– based comprehensive chromosome screening and accumulating evidence of accuracy, safety predictive values and clinical efficacy. | Technology development | 2013 | Technology development;Pre-implantation genetics |
| Gamete and embryo assessment in assisted reproduction: emerging technologies | Technology development | 2013 | Technology development;Female fertility;IVF laboratory;Female fertility | |
|
Genetic polymorphisms of serotonin transporter and receptor 1A could influence success during embryo implantation and maintenance of pregnancy. | IVF clinical | 2013 | IVF clinical;IVF laboratory |
|
Genetics of the germ line formation. | Female fertility | 2013 | Female fertility;Male fertility |
| Genomic DNA in human blastocoele fluid. | Female fertility | 2013 | Female fertility;IVF laboratory;IVF clinical;IVF laboratory | |
|
GnRH analogies in the prevention of Ovarian Hyperstimulation Syndrome. | Female fertility | 2013 | Female fertility;IVF clinical;IVF laboratory |
|
GnRH analogues in the prevention of ovarian hyperstimulation syndrome. | Female fertility | 2013 | Female fertility;IVF clinical;IVF laboratory;IVF clinical |
|
GnRH-agonist triggering to avoid ovarian hyperstimulation syndrome: a review of the evidence. | IVF clinical | 2013 | IVF clinical;Female fertility |
|
High-density SNP arrays and next generation sequencing for pre-implantation genetic diagnosis. | Technology development | 2013 | Technology development;Pre-implantation genetics;IVF laboratory;Female fertility |
|
How curved is too curved? The severity of penile deformity may predict sexual disability among men with Peyronie's disease. | Male fertility | 2013 | Male fertility;Reproductive disorders;IVF laboratory |
| Impact of final oocyte maturation using gonadotropin-releasing hormone agonist triggering and different luteal support protocols on endometrial gene expression | Female fertility | 2013 | Female fertility;IVF clinical;IVF clinical;IVF laboratory | |
|
Implantation in assisted reproduction: a look at endometrial receptivity | Female fertility | 2013 | Female fertility;IVF clinical;IVF laboratory |
| In vitro fertilization outcome in women with unoperated bilateral endometriomas | IVF clinical | 2013 | IVF clinical;Reproductive disorders;IVF clinical;IVF laboratory | |
|
In vitro fertilization with single euploid blastocyst transfer: a randomized controlled trial. | IVF laboratory | 2013 | IVF laboratory;Female fertility |
|
Incidental identification of balanced translocation carrier patients through comprehensive chromosome screening of IVF-derived blastocysts. | Pre-implantation genetics | 2013 | Pre-implantation genetics;Female fertility;Technology development |
|
Increased doses of vaginal progesterone for the prevention of preterm birth in twin pregnancies: a randomised controlled double-blind multicentre trial | IVF clinical | 2013 | IVF clinical;Female fertility;IVF clinical |
|
Increased numbers of DNA-damaged spermatozoa in samples presenting an elevated rate of numerical chromosome abnormalities. | Male fertility | 2013 | Male fertility;Aging and rejuvenation;IVF clinical |
|
Increased pregnancy after reduced male abstinence. | 2013 | ||
|
Is morphokinetic analysis the answer? | IVF laboratory | 2013 | IVF laboratory;IVF clinical;Psychology |
|
Is vitrification of oocytes useful for fertility preservation for age-related fertility decline and in cancer patients? | Cryobiology | 2013 | Cryobiology;Female fertility |
| Lack of association of MTHFR rs1801133 polymorphism and CTCFL mutations with sperm methylation errors in infertile patients | Male fertility | 2013 | Male fertility;Epigenetics;IVF laboratory;IVF clinical | |
|
Levels and associations among self-esteem, fertility distress, coping and reaction to potentially being a genetic carrier in women with Diminished Ovarian | Psychology | 2013 | Psychology;Female fertility;Female fertility |
| Metabolomic profiling of oocytes and embryos using spectroscopy: potential clinical use and pitfalls. | Technology development | 2013 | Technology development;IVF clinical;Pre-implantation genetics;IVF clinical;IVF laboratory | |
|
Morphological and cytogenetic assessment of cleavage and blastocyst stage embryos. | Female fertility | 2013 | Female fertility;IVF laboratory;IVF clinical;IVF laboratory |
| mRNA-binding protein ZFP36 is expressed in atherosclerotic lesions and reduces inflammation in human aortic endothelial cells. | Reproductive disorders | 2013 | Reproductive disorders;Technology development | |
|
Natural Birth-induced UCP2 in Brain Development. | Female fertility | 2013 | Female fertility;IVF clinical;IVF clinical;IVF laboratory |
| Natural lh surge vs hCG triggered vs hormone replace treatment (HRT): do pregnancy rates differ? | IVF clinical | 2013 | IVF clinical;Female fertility | |
|
Next-generation sequencing for preimplantation genetic diagnosis. Letter to the Editor. | Technology development | 2013 | Technology development;Pre-implantation genetics |
|
Obesity and poor reproductive outcome: female and male body weight matter | Female fertility | 2013 | Female fertility;Male fertility |
| Obesity reduces uterine receptivity: clinical experience from 9,587 first cycles of ovum donation with normal weight donors. | Reproductive disorders | 2013 | Reproductive disorders;Female fertility;Female fertility | |
|
Obstetric and neonatal outcomes from the BEST Trial: Single embryo transfer with aneuploidy screening improves outcomes after IVF without compromising delivery rates. | Pre-implantation genetics | 2013 | Pre-implantation genetics;IVF clinical |
|
Oocyte donation and endometriosis: What are the lessons? | Reproductive disorders | 2013 | Reproductive disorders;Female fertility |
| Oocyte insemination techniques are related to alterations of embryo developmental timing in an oocyte donation model. | Female fertility | 2013 | Female fertility;IVF laboratory;Female fertility;IVF clinical | |
| Outcome of cryotransfer of embryos developed from vitrified oocytes: double vitrification has no impact on delivery rates. | Cryobiology | 2013 | Cryobiology;Female fertility | |
|
Outcomes of splenectomy in patients with Common Variable Immunodeficiency (CVID): a survey of 45 patients | Immunology | 2013 | Immunology;Surgery;IVF clinical;IVF laboratory |
| PGE2and PGF2? Concentrations in Human Endometrial Fluid as Biomarkers for Embryonic Implantation. | IVF clinical | 2013 | IVF clinical;Female fertility;IVF laboratory | |
|
Predictors of twins following cryopreserved double embryo transfer on day 3. | Cryobiology | 2013 | Cryobiology;IVF laboratory |
|
Preimplantation genetic diagnosis. | Pre-implantation genetics | 2013 | Pre-implantation genetics;Female fertility;IVF clinical |
|
Preimplantation genetic screening using fluorescence in situ hybridization in patients with repetitive implantation failure and advanced maternal age: two randomized trials | Pre-implantation genetics | 2013 | Pre-implantation genetics;Female fertility |
|
Preimplantation genetic screening. | Pre-implantation genetics | 2013 | Pre-implantation genetics;Female fertility;Female fertility |
|
Protocols for tracking and witnessing samples and patients in assisted reproductive technology. | IVF laboratory | 2013 | IVF laboratory;IVF clinical;Female fertility |
|
Publication misrepresentation among urology residency applicants. | Surgery | 2013 | Surgery;Male fertility |
|
Questions about the accuracy of polar body analysis for preimplantation genetic screening. | Pre-implantation genetics | 2013 | Pre-implantation genetics;Female fertility |
|
Raw and test-thaw semen parameters after cryopreservation among men with newly diagnosed cancer. | Cryobiology | 2013 | Cryobiology;Male fertility;Female fertility |
| Reduced oxygen tension improves embryo quality but not clinical pregnancy rates: a randomized clinical study into ovum donation cycles. | Female fertility | 2013 | Female fertility;IVF clinical | |
| Regulation of gene expression in the oocyte and early embryo: implications for transcriptomic and proteomic embryo assessment. | Female fertility | 2013 | Female fertility;Technology development;IVF laboratory | |
|
Reply of the authors. | Female fertility | 2013 | Female fertility;IVF clinical |
|
Reply: Questions about the accuracy of polar body analysis for preimplantation genetic screening. | 2013 | ||
| Risk factors for renal cell carcinoma in the VITAL study. | Reproductive disorders | 2013 | Reproductive disorders | |
|
Selecting the optimal time to perform biopsy for preimplantation genetics | Pre-implantation genetics | 2013 | Pre-implantation genetics;IVF laboratory;IVF clinical |
|
Selection of high potential embryos using time-lapse imaging: the era of morphokinetics. | Technology development | 2013 | Technology development;Female fertility |
|
Sequential comprehensive chromosome analysis on polar bodies, blastomeres and trophoblast: insights into female meiotic errors and chromosomal segregation in the preimplantation window of embryo development. | 2013 | ||
| Short-term storage of tripronucleated human embryos. | Female fertility | 2013 | Female fertility;IVF laboratory | |
| Similar morphokinetic patterns in embryos derived from obese and normoweight infertile women: a time-lapse study. | IVF clinical | 2013 | IVF clinical;IVF laboratory;techonology development | |
|
Spermatozoa and seminal plasma fatty acids as predictors of cryopreservation success | Cryobiology | 2013 | Cryobiology;Male fertility;Psychology |
|
The accuracy and reproducibility of the endometrial receptivity array is superior to histology as a diagnostic method for endometrial receptivity | 2013 | ||
|
The complex triad of obesity, race and diabetes in Type I and Type II endometrial cancers: examining their distribution and associations with outcomes. | Reproductive disorders | 2013 | Reproductive disorders;Female fertility |
| The follicular hormonal profile in low-responder patients undergoing unstimulated cycles: Is it hypoandrogenic? | 2013 | |||
| The international agreement study on the diagnosis of the septate uterus at office hysteroscopy in infertile patients | Reproductive disorders | 2013 | Reproductive disorders;Male fertility | |
| The origin and impact of embryonic aneuploidy. | Pre-implantation genetics | 2013 | Pre-implantation genetics;Female fertility;IVF clinical;IVF laboratory | |
|
The Paradigm of Clinical IVF is shifting: The Time to Incorporate Validated Technologies and an Enhanced Understanding of Physiology is now. | Technology development | 2013 | Technology development;IVF clinical |
|
The Textbook of Clinical Embryology | IVF clinical | 2013 | IVF clinical;IVF laboratory;IVF clinical;Technology development |
|
The transcriptome of follicular cells: biological insights and clinical implications for the treatment of infertility. | Female fertility | 2013 | Female fertility;Male fertility;IVF clinical;IVF laboratory |
| The type of GnRH analogue used during controlled ovarian stimulation influences early embryo developmental kinetics: a time-lapse study. | Female fertility | 2013 | Female fertility;IVF clinical;IVF clinical | |
| The voltage-gated sodium channel Nav1.8 is expressed in human sperm. | Male fertility | 2013 | Male fertility | |
|
To preserve or not to preserve: How difficult is the decision about fertility preservation? | 2013 | ||
|
Transcriptomic analysis of cumulus and granulosa cells as a marker of embryo viability. | Female fertility | 2013 | Female fertility;Technology development |
| Treatment of Luteal Phase Defects in Assisted Reproduction. | Reproductive disorders | 2013 | Reproductive disorders;Female fertility;IVF clinical;IVF laboratory;Pre-implantation genetics | |
| Triggering with different doses of gonadotropin releasing hormone (GnRH) agonist in oocyte donor cycles: a randomized clinical trial (RCT). | Female fertility | 2013 | Female fertility;IVF clinical | |
|
Type of culture media does not affect embryo kinetics: a time-lapse analysis of sibling oocytes. | IVF laboratory | 2013 | IVF laboratory;Female fertility;IVF clinical;IVF laboratory |
|
Undifferentiated round cell sarcoma of the broad ligament. | Surgery | 2013 | Surgery;Female fertility;IVF clinical;IVF laboratory |
|
Validity and reliability of a smartphone application for the assessment of penile deformity in Peyronie's disease. | Male fertility | 2013 | Male fertility;Technology development;Female fertility;IVF clinical;IVF laboratory |
|
White E. Long-term NSAID use and incident urothelial cell carcinoma in the VITamins and Lifestyle (VITAL) study | Male fertility | 2013 | Male fertility;Reproductive disorders;IVF clinical |
|
A comparison of live birth rates and cumulative ongoing pregnancy rates between Europe and North America after ovarian stimulation with corifollitropin alfa or recombinant follicle-stimulating hormone | 2012 | ||
|
A decrease in serum estradiol levels after human chorionic gonadotrophin administration predicts significantly lower clinical pregnancy and live birth rates in in vitro fertilization cycles. | Female fertility | 2012 | Female fertility;IVF clinical;IVF clinical;IVF laboratory |
| A national study of trauma level designation and renal trauma outcomes. | Surgery | 2012 | Surgery;Male fertility | |
|
A novel model of human implantation: 3D endometrium-like culture system to study attachment of human trophoblast (Jar) cell spheroids | 2012 | ||
|
A randomized assessor-blind trial comparing highly purified hMG and recombinant FSH in a GnRH antagonist cycle with compulsory single-blastocyst transfer | 2012 | ||
|
A review of recent trials selecting viable embryos for transfer: comprehensive time-lapse imaging analysis. | IVF clinical | 2012 | IVF clinical;IVF laboratory |
| Accumulation of oocytes: a new strategy for managing low-responder patients | Female fertility | 2012 | Female fertility;IVF clinical | |
| Advances in ovarian hyperstimulation in cancer patients. | IVF clinical | 2012 | IVF clinical;Technology development;IVF clinical | |
|
Agonist trigger: what is the best approach? Agonist trigger with vitrification of oocytes or embryos | Cryobiology | 2012 | Cryobiology;Female fertility;IVF laboratory;IVF clinical |
|
Alteration of gene expression in human cumulus cells as a potential indicator of oocyte aneuploidy. | Pre-implantation genetics | 2012 | Pre-implantation genetics;Female fertility;IVF laboratory;IVF clinical |
| Analysis of follicular fluid and serum markers of oxidative stress in women with infertility related to endometriosis | Reproductive disorders | 2012 | Reproductive disorders;Female fertility;IVF laboratory;IVF clinical | |
| Analysis of the expression of neurokinin B, kisspeptin, and their cognate receptors NK3R and KISS1R in the human female genital tract. | Female fertility | 2012 | Female fertility;Female fertility | |
|
Aneuploidy Screening for Embryo Selection. | Pre-implantation genetics | 2012 | Pre-implantation genetics;Female fertility;Female fertility;IVF clinical;IVF laboratory |
| Annexin A2 is critical for embryo adhesiveness to the human endometrium by RhoA activation through F-actin regulation | 2012 | |||
| Autocrine regulation of human sperm motility by the met-enkephalin opioid peptide. | Stem cells | 2012 | Stem cells;Endometrial receptivity;IVF clinical;Female fertility | |
|
Biomolecules of Human Female fertility - Potential Therapeutic Targets for Pharmaceutical Design. | Female fertility | 2012 | Female fertility;IVF clinical;Female fertility;IVF clinical;IVF laboratory |
|
Blastocyst preimplantation genetic diagnosis of a mitochondrial DNA disorder. | Female fertility | 2012 | Female fertility;Pre-implantation genetics |
| Bone marrow-derived cells from male donors do not contribute to the endometrial side population of the recipient | 2012 | |||
|
Can we skip weekends in GnRH antagonist cycles without compromising the final outcome? | 2012 | ||
|
Characteristics of chromosomal abnormalities diagnosed after spontaneous abortions in an infertile population. | Female fertility | 2012 | Female fertility;Pre-implantation genetics;IVF laboratory |
| Characterization of the kisspeptin system in human spermatozoa | 2012 | |||
|
Characterization of two heterozygous mutations of the oocyte activation factor phospholipase C zeta (PLC?) from an infertile man by use of minisequencing of individual sperm and expression in somatic cells. | Male fertility | 2012 | Male fertility;Female fertility;IVF laboratory;IVF clinical;Pre-implantation genetics |
| Chromosomal abnormalities in embryos from couples with a previous aneuploid miscarriage | Female fertility | 2012 | Female fertility;Pre-implantation genetics | |
|
Cleavage of endometrial alpha-integrins into their functional forms is mediated by proprotein convertase 5/6 | 2012 | ||
| Comparison of Cryotip vs. Cryotop for mouse and human blastomere vitrification | 2012 | |||
|
Comprehensive chromosome screening and embryo selection: moving toward single euploid blastocyst transfer. | Female fertility | 2012 | Female fertility;Pre-implantation genetics |
|
Comprehensive chromosome screening is highly predictive of the reproductive potential of human embryos: a prospective, blinded, nonselection study. | Technology development | 2012 | Technology development;Pre-implantation genetics |
|
Conservative management vs early surgery for high grade pediatric renal trauma--do nephrectomy rates differ? | Surgery | 2012 | Surgery;IVF laboratory;Female fertility |
| Consistent and predictable delivery rates after oocyte vitrification: an observational longitudinal cohort multicentric study | Cryobiology | 2012 | Cryobiology;Female fertility | |
|
Consistent and predictable delivery rates after oocyte vitrification: an observational longitudinal cohort multicentric study. | 2012 | ||
| Cumulative newborn rates increase with the total number of transferred embryos according to an analysis of 15,792 ovum donation cycles | Female fertility | 2012 | Female fertility;IVF clinical | |
|
Cumulus cell gene expression in assessment of oocyte quality. | Female fertility | 2012 | Female fertility |
|
Delivery of a chromosomally normal child from an oocyte with reciprocal aneuploid polar bodies. | Female fertility | 2012 | Female fertility;Pre-implantation genetics |
|
Development and validation of an accurate quantitative real-time polymerase chain reaction – based assay for human blastocyst comprehensive chromosomal aneuploidy screening. Seminal Contribution. | Technology development | 2012 | Technology development;Pre-implantation genetics |
|
Development of a novel synthetic oligopeptide for the detection of DNA damage in human spermatozoa. | Male fertility | 2012 | Male fertility;Technology development;IVF laboratory;IVF clinical |
|
Development of pelvic abscess during pregnancy following transvaginal oocyte retrieval and in vitro fertilization | Female fertility | 2012 | Female fertility;IVF clinical;IVF laboratory |
|
Developmental potential of embryos from intracytoplasmic sperm injection cycles containing fragmented oocytes. | Female fertility | 2012 | Female fertility;IVF laboratory;IVF laboratory |
| Differential metabolic profiling of non-pure trisomy 21 human preimplantation embryos | 2012 | |||
|
Divergent RNA-binding proteins, DAZL and VASA, induce meiotic progression in human germ cells derived in vitro | 2012 | ||
|
Do inclusive trauma systems improve outcomes after renal trauma? | Surgery | 2012 | Surgery |
| Dose of recombinant FSH and estradiol concentration on day of HCG affect embryo development kinetics. | Female fertility | 2012 | Female fertility;IVF clinical;IVF laboratory | |
| Dose of recombinant FSH and oestradiol concentration on day of HCG affect embryo development kinetics | 2012 | |||
|
Dynamic phosphorylation of embryonic poly(A)-binding protein (ePAB) is required for Xenopus oocyte maturation. | Female fertility | 2012 | Female fertility |
| Early progesterone cessation after in vitro fertilization/intracytoplasmic sperm injection: a randomized, controlled trial | IVF laboratory | 2012 | IVF laboratory;IVF clinical;IVF laboratory;IVF clinical | |
|
Effect of adenomyosis on implantation | 2012 | ||
| Effect of antiangiogenic treatment on peritoneal endometriosis-associated nerve fibers | 2012 | |||
|
Efficacy and safety of human chorionic gonadotropin for follicular phase stimulation in assisted reproduction: a systematic review and meta-analysis | 2012 | ||
| Efficiency and purity provided by the existing methods for the isolation of luteinized granulosa cells: a comparative study | IVF clinical | 2012 | IVF clinical;Female fertility;IVF laboratory | |
|
Efficient Use of Early Obstetric Sonography in the Emergency Department Setting. | Technology development | 2012 | Technology development;Female fertility |
|
El futuro de la reproducción son los incubadores con un sistema de time-lapse? | Technology development | 2012 | Technology development;IVF laboratory;IVF clinical |
| Elevated progesterone during ovarian stimulation for IVF. | IVF clinical | 2012 | IVF clinical;IVF laboratory | |
|
Embryo assessment strategies and their validation for clinical use: a critical analysis of methodology. | Female fertility | 2012 | Female fertility;IVF clinical;IVF clinical;Female fertility |
| Embryo incubation and selection in a time-lapse monitoring system improves pregnancy outcome compared with a standard incubator: a retrospective cohort study | IVF laboratory | 2012 | IVF laboratory;Female fertility | |
| Embryonic poly(A) binding protein (EPAB) is required for oocyte maturation and Female fertility in mouse. | Female fertility | 2012 | Female fertility;IVF laboratory | |
|
Embryos of Robertsonian Translocation Carriers Exhibit a Mitotic Interchromosomal Effect That Enhances Genetic Instability during Early Development. | Female fertility | 2012 | Female fertility;IVF clinical;Female fertility;IVF clinical;IVF laboratory |
|
Empty follicle syndrome after GnRHa triggering versus hCG triggering in COS | Female fertility | 2012 | Female fertility;IVF clinical;Pre-implantation genetics |
|
Empty follicle syndrome after GnRHa triggering versus hCG triggering in COS. | Female fertility | 2012 | Female fertility;IVF clinical;Pre-implantation genetics |
|
Endometrial gene expression in the early luteal phase is impacted by mode of triggering final oocyte maturation in recFSH stimulated and GnRH antagonist co-treated IVF cycles | Female fertility | 2012 | Female fertility;IVF clinical |
| Epab and Pabpc1 are differentially expressed during male germ cell development. | Male fertility | 2012 | Male fertility | |
|
Epidemiology of fertility preservation. | Female fertility | 2012 | Female fertility;IVF clinical;IVF clinical |
|
Erectile dysfunction is not independently associated with cardiovascular death: data from the vitamins and lifestyle (VITAL) study. | Male fertility | 2012 | Male fertility;IVF clinical |
|
Estados Intersexuales y Disgenesias. Síndrome de Morris (pseudohermafroditismos masculinos) | Reproductive disorders | 2012 | Reproductive disorders;Male fertility |
|
Etiology of OHSS and use of dopamine agonists | Female fertility | 2012 | Female fertility;IVF clinical |
|
Evaluation of embryo quality: Time-lapse imaging to assess embryo morphokinesis. | IVF clinical | 2012 | IVF clinical;IVF laboratory |
| Exam of fresh semen. Manual práctico de esterilidad y Reproducción Humana. | Male fertility | 2012 | Male fertility;IVF laboratory | |
|
Factor cervical y esterilidad. | Female fertility | 2012 | Female fertility;Reproductive disorders |
|
Factores moleculares de infertilidad en el espermatozoide más allá del Manual de la Organización Mundial de la Salud de 2010. | Male fertility | 2012 | Male fertility;IVF clinical;IVF clinical |
|
Fertility considerations in young women with hematological malignancies | 2012 | ||
|
Fertility preservation in young women with breast cancer | 2012 | ||
| Follicular and endocrine profiles associated with different GnRH-antagonist regimens: a randomized controlled trial | Female fertility | 2012 | Female fertility;IVF clinical;IVF laboratory;IVF clinical | |
| FSH receptor in vitro modulation by testosterone and hCG in human luteinized granulosa cells | IVF clinical | 2012 | IVF clinical;IVF laboratory | |
|
Full in vitro fertilization laboratory mechanization: toward robotic assisted reproduction? | 2012 | ||
|
Gene and protein expression signature of endometrial glandular and stromal compartments during the window of implantation | 2012 | ||
|
Hepatitis B virus in human oocytes and embryos | Female fertility | 2012 | Female fertility;IVF clinical;Cryobiology;Technology development |
|
Hepatitis B virus in human oocytes and embryos. | Female fertility | 2012 | Female fertility;IVF clinical;Cryobiology;Technology development |
|
High ovarian response does not jeopardize ongoing pregnancy rates and increases cumulative pregnancy rates in a GnRH-antagonist protocol. | Female fertility | 2012 | Female fertility |
|
Hormonal and molecular characterization of follicular fluid, cumulus cells and oocytes from pre-ovulatory follicles in stimulated and unstimulated cycles | Female fertility | 2012 | Female fertility;IVF clinical;IVF laboratory |
|
Human pre-implantation embryo development | 2012 | ||
| Identification and characterization of the human leiomyoma side population as putative tumor-initiating cells | 2012 | |||
| In vitro production of haploid cells after coculture of CD49f+ with Sertoli cells from testicular sperm extraction in nonobstructive azoospermic patients | 2012 | |||
|
Increasing the success of assisted reproduction by defining sperm fertility markers and selecting sperm with the best molecular profile. | Male fertility | 2012 | Male fertility;IVF clinical;IVF clinical |
| Inhibition of histone deacetylase activity in human endometrial stromal cells promotes extracellular matrix remodelling and limits embryo invasion | 2012 | |||
| Intra-age, intercenter, and intercycle differences in chromosome abnormalities in oocytes. | Pre-implantation genetics | 2012 | Pre-implantation genetics;Female fertility | |
|
Intramuscular progesterone versus Crinone 8% gel for luteal phase support in day 3 cryopreserved embryo transfer. | Cryobiology | 2012 | Cryobiology;IVF laboratory;Reproductive disorders |
|
Intravenous immunoglobulin treatment increases live birth rate in a Spanish cohort of women with recurrent reproductive failure and expanded CD56+ cells. | Female fertility | 2012 | Female fertility;Immunology |
|
Is there a benefit for surgery in endometrioma-associated infertility? | 2012 | ||
|
Isoinmunización grave anti-D en una gestación gemelar. | Female fertility | 2012 | Female fertility;IVF clinical |
|
Lavado de semen de varones seropositivos al VIH. ¿Está todo resuelto? | Male fertility | 2012 | Male fertility;IVF clinical |
|
Lavado Seminal en varones seropositivos para el VIH ¿está todo resuelto? | Male fertility | 2012 | Male fertility;IVF clinical |
| Limited implantation success of direct-cleaved human zygotes: a time-lapse study | IVF clinical | 2012 | IVF clinical;IVF laboratory | |
|
Longitudinal anti-müllerian hormone in women with polycystic ovary syndrome: An acupuncture randomized clinical trial, evidence-based complementary and alternative medicine. | Reproductive disorders | 2012 | Reproductive disorders;Female fertility;IVF clinical |
|
Manejo expectante de las gestaciones de localización desconocida después de una técnica de reproducción asistida: Manejo clínico, pronóstico y complicaciones asociadas. | Female fertility | 2012 | Female fertility;IVF clinical |
|
Manual práctico de esterilidad y Reproducción Humana | Male fertility | 2012 | Male fertility;IVF laboratory;Female fertility |
|
Men who seek infertility care may not represent the general U.S. population: data from the National Survey of Family Growth. | Male fertility | 2012 | Male fertility;IVF clinical;IVF laboratory |
|
Methods for comprehensive chromosome screening of oocytes and embryos: capabilities, limitations, and evidence of validity. | Technology development | 2012 | Technology development;Pre-implantation genetics |
|
Microarray-CGH for the Assessment of Aneuploidy in Human Polar Bodies and Oocytes. | Technology development | 2012 | Technology development;Female fertility;IVF laboratory;IVF clinical |
|
Mid-term neurodevelopmental outcome in isolated mild ventriculomegaly diagnosed in fetal life. | Reproductive disorders | 2012 | Reproductive disorders |
| miRNA signature and Dicer requirement during human endometrial stromal decidualization in vitro | 2012 | |||
| Moderate ovarian stimulation does not increase the incidence of human embryo chromosomal abnormalities in in vitro fertilization cycles | 2012 | |||
|
Modified Vecchietti's vaginoplasty with Remeex system in patient with chronic graft-versus-host disease. | Immunology | 2012 | Immunology;Female fertility |
| Oocyte in vitro maturation. | Female fertility | 2012 | Female fertility;IVF laboratory | |
|
Oocyte vitrification does not increase the risk of embryonic aneuploidy or diminish the implantation potential of blastocysts created after ICSI: a novel paired randomized controlled trial using DNA fingerprinting | Cryobiology | 2012 | Cryobiology;Female fertility |
|
Oocyte vitrification: a watershed in ART | 2012 | ||
| Outcomes of vitrified early cleavage-stage and blastocyst-stage embryos in a cryopreservation program: evaluation of 3,150 warming cycles | Cryobiology | 2012 | Cryobiology;Female fertility;IVF clinical;IVF laboratory | |
| Ovarian response to controlled ovarian hyperstimulation in cancer patients is diminished even before oncological treatment | Female fertility | 2012 | Female fertility;IVF clinical;IVF clinical | |
| Ovarian respoonse to controlled ovarian hyperstimulation in cáncer patients is diminished even before oncological treatment. | Female fertility | 2012 | Female fertility;IVF clinical | |
|
Ovarian Stimulation: Today and Tomorrow. | Female fertility | 2012 | Female fertility;IVF clinical;Female fertility |
|
Overcoming challenges of ovarian cancer stem cells: novel therapeutic approaches | 2012 | ||
|
Patients from across Europe have similar views on patient-centred care: an international multilingual qualitative study in infertility care | IVF clinical | 2012 | IVF clinical;IVF laboratory;IVF clinical |
|
Performance of total testosterone measurement to predict free testosterone for the biochemical evaluation of male hypogonadism. | Male fertility | 2012 | Male fertility;Reproductive disorders;IVF laboratory;Female fertility |
|
PGD and aneuploidy screening for 24 chromosomes by genome-wide SNP analysis: a responsible path towards greater utility. | Technology development | 2012 | Technology development;IVF clinical |
|
Pharmacologic therapies in endometriosis: a systematic review | 2012 | ||
|
Pharmacology therapies in endometriosis: a systematic review | Reproductive disorders | 2012 | Reproductive disorders;Female fertility |
| Physical Strain and Urgent Need for Ergonomic Training Among Gynecologic Oncologists who Perform Minimally Invasive Surgery. | Female fertility | 2012 | Female fertility;Surgery | |
| Pilot genome-wide association search identifies potential loci for risk of erectile dysfunction in type 1 diabetes using the DCCT/EDIC study cohor | Male fertility | 2012 | Male fertility;IVF clinical | |
|
Polar body morphology is not predictive of its cell division origin | Female fertility | 2012 | Female fertility;IVF laboratory |
| Pregnancy outcome in women with endometriomas achieving pregnancy through IVF | Female fertility | 2012 | Female fertility;Reproductive disorders;IVF laboratory | |
|
Preimplantation genetic diagnosis (PGD), preimplantation genetic screening (PGS) and the transfer of in vitro fertilized embryos. | Pre-implantation genetics | 2012 | Pre-implantation genetics;IVF clinical |
|
Prenatal BACs-on-Beads: the prospective experience of five prenatal diagnosis laboratories | 2012 | ||
|
Preservación de la fertilidad en la mujer y en el varon. | Female fertility | 2012 | Female fertility;Cryobiology |
|
Recommendations for fertility preservation in patients with lymphoma, leukemia, and breast cancer | 2012 | ||
|
Reply of the authors, Etiology of OHSS and use of dopamine agonists. | Female fertility | 2012 | Female fertility;IVF clinical |
| Semen samples showing an increased rate of spermatozoa with imprinting errors have a negligible effect in the outcome of assisted reproduction techniques | 2012 | |||
| Sildenafil citrate improves perinatal outcome in fetuses from pre-eclamptic rats | Female fertility | 2012 | Female fertility;IVF clinical;Aging and rejuvenation;IVF clinical | |
|
Single embryo transfer with comprehensive chromosome screening results in improved ongoing pregnancy rates and decreased miscarriage rates. | Female fertility | 2012 | Female fertility;Pre-implantation genetics |
|
Somatic stem cells and tissue engineering shed light on unsolved clinical issues in reproductive medicine: in stem cells we trust | 2012 | ||
|
Sperm DNA fragmentation index does not correlate with the sperm or embryo aneuploidy rate in recurrent miscarriage or implantation failure patients | Male fertility | 2012 | Male fertility;Pre-implantation genetics;Female fertility |
|
Spontaneous in vitro maturation of oocytes prior to ovarian tissue cryopreservation in natural cycles of oncologic patients | Cryobiology | 2012 | Cryobiology;IVF laboratory |
|
Spontaneous triggering of ovulation versus HCG administration in patients undergoing IUI: a prospective randomized study. | 2012 | ||
| Successful Live Birth following Preimplantation Genetic Diagnosis for Phenylketonuria in Day 3 Embryos by Specific Mutation Analysis and Elective Single Embryo Transfer. | Female fertility | 2012 | Female fertility;Pre-implantation genetics;IVF laboratory | |
|
Testing the water before swimming: satisfying the need for clinical trials of devices, media, and instruments before their use in assisted reproduction laboratories | IVF laboratory | 2012 | IVF laboratory;IVF clinical;IVF laboratory |
|
The association between fertility clinic performance and patient volume: implications for patients’ response to physician performance. | IVF clinical | 2012 | IVF clinical;IVF laboratory |
|
The dynamics of in vitro maturation of germinal vesicle oocytes | Female fertility | 2012 | Female fertility;IVF laboratory |
|
The genomics of the human endometrium | 2012 | ||
|
The impact of cigarette smoking on the health of descendants. | Female fertility | 2012 | Female fertility;Male fertility |
|
The luteal phase after GnRH-agonist triggering of ovulation: present and future perspectives | Female fertility | 2012 | Female fertility |
|
The mRNA-binding protein Zfp36 is up-regulated by b-adrenergic stimulation and represses IL-6 production in 3T3-L1 adipocytes. | Reproductive disorders | 2012 | Reproductive disorders;Technology development |
|
The oocyte. | 2012 | ||
| The relationship of premature progesterone rise with serum estradiol levels and number of follicles in GnRH antagonist/recombinant FSH-stimulated cycles. | Female fertility | 2012 | Female fertility | |
| The role of LH in ovarian stimulation | 2012 | |||
| The role of LH in Ovarian Stimulation. | Female fertility | 2012 | Female fertility;IVF clinical | |
|
The use of aromatase inhibitors in in vitro fertilization | Female fertility | 2012 | Female fertility;IVF clinical;IVF laboratory;IVF clinical |
|
The use of aromatase inhibitors in in vitro fertilization. | Female fertility | 2012 | Female fertility;IVF clinical;IVF laboratory;IVF clinical |
| Time-dependent O2 consumption patterns determined optimal time ranges for selecting viable human embryos | Female fertility | 2012 | Female fertility;IVF laboratory | |
|
Time-lapse technology: evaluation of embryo quality and new markers for embryo selection. | Technology development | 2012 | Technology development;IVF laboratory;IVF laboratory;IVF clinical |
| Timing of cell division in human cleavage-stage embryos is linked with blastocyst formation and quality | Female fertility | 2012 | Female fertility;IVF clinical | |
| Timing of cell divisions in human cleavage stage embryos correlate with blastocyst formation and quality. | Female fertility | 2012 | Female fertility;IVF clinical;IVF clinical | |
|
Transcriptomic analysis of follicular cells provides information on the chromosomal status and competence of unfertilized oocytes. | Pre-implantation genetics | 2012 | Pre-implantation genetics;Female fertility;IVF clinical;IVF laboratory |
|
Trends of Socioeconomic Disparities in Referral Patterns for Fertility Preservation Consultation. | Female fertility | 2012 | Female fertility;IVF clinical;IVF laboratory |
|
Ulipristal acetate versus leuprolide acetate for uterine fibroids | 2012 | ||
| Understanding the perceptions of and emotional barriers to infertility treatment: a survey in four European countries | Psychology | 2012 | Psychology;IVF clinical | |
| Understanding the perceptions of and emotional barriers to infertility treatment: a survey in four European countries. | Psychology | 2012 | Psychology;IVF clinical | |
|
Use of gonadotropin releasing hormone agonists in fertility preservation. | Female fertility | 2012 | Female fertility;IVF clinical |
|
Viral screening of spent culture media and liquid nitrogen samples of oocytes and embryos from hepatitis B, hepatitis C, and human immunodeficiency virus chronically infected women undergoing in vitro fertilization cycles | Female fertility | 2012 | Female fertility;IVF laboratory;IVF laboratory;IVF clinical |
|
Viral screening of spent culture media and liquid nitrogen samples of oocytes and embryos from hepatitis B, hepatitis C, and human immunodeficiency virus chronically infected women undergoing in vitro fertilization cycles. | Female fertility | 2012 | Female fertility;IVF laboratory;IVF laboratory;IVF clinical |
|
High-dose recombinant LH add-back strategy using high-dose GnRH antagonist is an innovative protocol compared with standard GnRH antagonist | IVF clinical | 2011 | IVF clinical;Female fertility |
|
A maternally inherited autosomal point mutation in human phospholipase C zeta (PLC?) leads to male infertility. | Male fertility | 2011 | Male fertility;Pre-implantation genetics;IVF clinical;IVF laboratory |
|
A novel method of luteal supplementation with recombinant luteinizing hormone when a gonadotropin-releasing hormone agonist is used instead of human chorionic gonadotropin for ovulation triggering: a randomized prospective proof of concept study | 2011 | ;IVF clinical;Female fertility | |
|
A skewed sex ratio following blastocyst culture is a consequence of embryo grading systems that prioritise male embryos for transfer. | IVF clinical | 2011 | IVF clinical;IVF laboratory;IVF clinical |
| Adenomyosis does not affect implantation, but is associated with miscarriage in patients undergoing oocyte donation | Female fertility | 2011 | Female fertility;IVF clinical | |
|
Analysis of diagnostic angiography and angioembolization in the acute management of renal trauma using a national data set. | Surgery | 2011 | Surgery;Aging and rejuvenation |
|
Aneuploidy in the Human Blastocyst | Female fertility | 2011 | Female fertility;Pre-implantation genetics |
|
Antibiotic prophylaxis for hysteroscopy evaluation of the uterine cavity. | Female fertility | 2011 | Female fertility |
|
Aplicación de la tecnología del embryoscope para la cuentificación de la calidad ovocitaria mediante el análisis de los patrones de respiración. | Technology development | 2011 | Technology development;IVF laboratory |
|
Aromatase inhibitors in post-menopausal endometriosis | Female fertility | 2011 | Female fertility;IVF laboratory |
|
Assessment of two thawing processes of cryopreserved human sperm in pellets | Cryobiology | 2011 | Cryobiology;Male fertility;IVF laboratory;IVF clinical |
|
Assisted reproduction in a patient with Klippel-Trenaunay Syndrome: Management of thrombophilia and consumptive coagulopathy. | Female fertility | 2011 | Female fertility;IVF clinical;IVF laboratory;IVF clinical |
|
Assisted Reproduction Techniques-Challenges & Management Options. Vaginal bleeding in the luteal phase after IVF. | IVF clinical | 2011 | IVF clinical;IVF laboratory |
|
Atención a los deseos reproductivos en Europa. | Reproductive disorders | 2011 | Reproductive disorders;IVF laboratory |
| Avoiding the use of human chorionic gonadotropin combined with oocyte vitrification and GnRH agonist triggering versus coasting: a new strategy to avoid ovarian hyperstimulation syndrome. | Female fertility | 2011 | Female fertility;Cryobiology | |
| Children born after autotransplantation of cryopreserved ovarian tissue. a review of 13 live births | 2011 | |||
|
Chromosome Abnormalities in the Human Oocyte. | Female fertility | 2011 | Female fertility;Pre-implantation genetics |
|
Cinematografía para el estudio de la calidad embrionaria. Embryoscope | Technology development | 2011 | Technology development;IVF laboratory;IVF laboratory |
|
Clinical application of oocyte vitrification: a systematic review and meta-analysis of randomized controlled trials | 2011 | ||
| Contemporary genetic technologies and female reproduction | 2011 | |||
|
Cumulative live-birth rates per total number of embryos needed to reach newborn in consecutive in vitro fertilization (IVF) cycles: a new approach to measuring the likelihood of IVF success | Female fertility | 2011 | Female fertility;IVF laboratory;IVF laboratory;Female fertility;Pre-implantation genetics |
|
Current status of human oocyte and embryo cryopreservation | Female fertility | 2011 | Female fertility;IVF clinical;IVF clinical |
| Cycle scheduling with oral contraceptive pills in the GnRH antagonist protocol vs the long protocol: a randomized, controlled trial | IVF clinical | 2011 | IVF clinical;Female fertility | |
| Cyclooxygenase-2 network as predictive molecular marker for clinical pregnancy in in vitro fertilization. | IVF clinical | 2011 | IVF clinical | |
|
Different telomere-length dynamics at the Inner Cell Mass versus Established Embryonic Stem (ES) cells. | Stem cells | 2011 | Stem cells;Aging and rejuvenation;IVF laboratory;IVF clinical |
| Differential transcriptomic profile in spermatozoa achieving pregnancy or not via ICSI. | Male fertility | 2011 | Male fertility;IVF clinical;IVF laboratory | |
|
Does cessation of progesterone supplementation during early pregnancy in patients treated with recFSH/GnRH antagonist affect ongoing pregnancy rates? A randomized controlled trial. | Reproductive disorders | 2011 | Reproductive disorders |
|
Donor Sperm Insemination Cycles: Are Two Inseminations Better Than One? | Male fertility | 2011 | Male fertility;IVF clinical;IVF laboratory;IVF clinical |
|
Effect of GnRH agonist and hCG treatment on VEGF, angiopoietin-2, and VE-cadherin: trying to explain the link to ovarian hyperstimulation syndrome | IVF clinical | 2011 | IVF clinical;Female fertility;IVF laboratory |
| Effect of sperm DNA fragmentation on pregnancy outcome depends on oocyte quality | Male fertility | 2011 | Male fertility;Female fertility;Pre-implantation genetics;Female fertility | |
| Embryo quality, blastocyst and ongoing pregnancy rates in oocyte donation patients whose embryos were monitored by time-lapse imaging | Female fertility | 2011 | Female fertility;IVF clinical;IVF clinical | |
|
Endometrial gene expression in the window of implantation is altered in obese women especially in association with polycystic ovary syndrome | 2011 | ||
| Endometrial gene expressions in the window of implantation is altered in obese women especially in association with polycystic ovary syndrome | Reproductive disorders | 2011 | Reproductive disorders;Female fertility | |
| Endometrial receptivity is affected in women with high circulating progesterone levels at the end of the follicular phase: a functional genomics analysis | 2011 | |||
|
Evidences for the existence of a low dopaminergic tone in polycystic ovarian syndrome: implications for OHSS development and treatment | 2011 | ||
| Ex-vivo oocyte retrieval for fertility preservation. | Reproductive disorders | 2011 | Reproductive disorders | |
| Female overweight is not associated with a higher embryo euploidy rate in first trimester miscarriages karyotyped by hysteroembryoscopy | Female fertility | 2011 | Female fertility;Technology development | |
|
Fertility after age 45: From natural conception to assisted reproductive technology and beyond. | Female fertility | 2011 | Female fertility;Male fertility;Pre-implantation genetics |
|
First births after preimplantation genetic diagnosis of structural chromosome abnormalities using comparative genomic hybridization and microarray analysis. | Female fertility | 2011 | Female fertility;Pre-implantation genetics;Female fertility |
|
Gay men choosing parenthood through assisted reproduction: medical and psychological considerations | Psychology | 2011 | Psychology;Male fertility;IVF laboratory |
|
GnRH agonist for triggering of final oocyte maturation: time for a change of practice? | IVF clinical | 2011 | IVF clinical;Female fertility |
| Haemodynamic effects of long-term administration of sildenafil in normotensive pregnant and non-pregnant rats | 2011 | |||
|
Hermetical goblets for cryostorage of human vitrified specimens. | 2011 | ||
|
High exposure to progesterone between the end of menstruation and the day of triggering final oocyte maturation is associated with a decreased probability of pregnancy in patients treated by in vitro fertilization and intracytoplasmic sperm injection. | Female fertility | 2011 | Female fertility |
|
High-dose recombinant LH add-back strategy using high-dose GnRH antagonist is an innovative protocol compared with standard GnRH antagonist. | IVF clinical | 2011 | IVF clinical;Female fertility |
|
How endometrial secretomics can help in predicting implantation | 2011 | ||
|
How to improve IVF success rates and increase access to treatment: back to basics or more technology? | Technology development | 2011 | Technology development;IVF laboratory;Immunology |
| Impact of luteinizing hormone administration on gonadotropina-releasing hormons antagonist cycles: ana ge-adjusted analysis. | Female fertility | 2011 | Female fertility;IVF clinical;IVF laboratory;IVF clinical | |
| Impact of sperm DNA fragmentation on the outcome of IVF with own or donated oocytes | Male fertility | 2011 | Male fertility;IVF clinical;Female fertility | |
|
Increased live birth rates with GnRH agonist addition for luteal support in ICSI/IVF cycles: a systematic review and meta-analysis. | IVF laboratory | 2011 | IVF laboratory |
|
Individualised controlled ovarian stimulation (iCOS): maximising success rates for assisted reproductive technology patients | 2011 | ||
|
In-vitro Fertilisation | IVF clinical | 2011 | IVF clinical;IVF laboratory |
|
Is earlier administration of human chorionic gonadotropin (hCG) associated with the probability of pregnancy in cycles stimulated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone (GnRH) antagonists? A prospective randomized trial. | Reproductive disorders | 2011 | Reproductive disorders |
|
Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting | 2011 | ||
|
Live birth outcome with trophectoderm biopsy, blastocyst vitrification and SNP microarray based comprehensive chromosome screening in infertile patients. | Female fertility | 2011 | Female fertility;IVF laboratory;IVF clinical;IVF laboratory |
|
Long-term use of supplemental vitamins and minerals does not reduce the risk of urothelial cell carcinoma of the bladder in the VITamins And Lifestyle study. | Reproductive disorders | 2011 | Reproductive disorders;Female fertility |
| Modeling human endometrial decidualization from the interaction between proteome and secretome | 2011 | |||
|
Molecular aspects of follicular development. | Female fertility | 2011 | Female fertility;IVF clinical |
|
Multiple pregnancy vanishing twin syndrome | Reproductive disorders | 2011 | Reproductive disorders;IVF laboratory |
|
New culture devices in ART. | 2011 | ||
|
Observer agreement in the evaluation of the uterine cavity by hysteroscopy prior to in vitro fertilization | IVF laboratory | 2011 | IVF laboratory |
|
Oocyte cryopreservation for donor egg banking | Female fertility | 2011 | Female fertility;Cryobiology |
|
Ovarian stimulation and low birth weight in newborns conceived through in vitro fertilization. | IVF clinical | 2011 | IVF clinical;Female fertility;IVF laboratory;IVF clinical |
|
Ovarian stimulation for PCO patients. Ovarian Stimulation. | Female fertility | 2011 | Female fertility |
| Oxygen consumption is a quality marker for human oocyte competence conditioned by ovarian stimulation regimens | Female fertility | 2011 | Female fertility;IVF clinical;IVF clinical | |
|
Polar bodies: their biological mystery and clinical meaning. | IVF clinical | 2011 | IVF clinical;Female fertility;IVF clinical;Female fertility |
|
Polycystic Ovarian Syndrome. Clinical Infertility and Assisted Reproduction. | Female fertility | 2011 | Female fertility;Reproductive disorders |
|
Predictive value of oocyte morphology in human IVF: a systematic review of the literature. | 2011 | ||
|
Premature progesterone rise and gene expression. | 2011 | ||
|
Prenatal brain damage in preeclamptic animal model induced by gestational nitric oxide synthase inhibition | 2011 | ||
| Progesterone rise on HCG day in GnRH antagonist/rFSH stimulated cycles affects endometrial gene expression | 2011 | |||
|
Proprotein convertase 5/6 is critical for embryo implantation in women: regulating receptivity by cleaving EBP50, modulating ezrin binding, and membrane-cytoskeletal interactions | 2011 | ||
|
Receiver Operating Characteristic (ROC) analysis of Day 5 morphology grading and metabolomic Viability Scores on predicting implantation outcome. | IVF laboratory | 2011 | IVF laboratory;IVF clinical;IVF laboratory |
| Reconstruction of endometrium from human endometrial side population cell lines | 2011 | |||
| Report of results obtained in 2,934 women using donor sperm: donor insemination versus in vitro fertilization according to indication | Female fertility | 2011 | Female fertility;IVF clinical;IVF laboratory | |
|
Reproductive medicine and beyond. | Female fertility | 2011 | Female fertility;Male fertility |
|
Reproductive medicine and inheritance of infertility by offspring: the role of fetal programming | 2011 | ||
| Retroperitoneal ectopic pregnancy after intrauterine insemination | 2011 | |||
| Self-correction in tripronucleated human embryos | 2011 | |||
|
Síndrome microcefalia-coriorretinopatía-linfedema. | Reproductive disorders | 2011 | Reproductive disorders |
|
SNP Microarray Based Concurrent Screening of 24 Chromosome Aneuploidy and Unbalanced Translocations in Preimplantation Human Embryos. | Female fertility | 2011 | Female fertility;Pre-implantation genetics;IVF clinical |
| Specific unsaturated fatty acids enforce the transdifferentiation of human cancer cells toward adipocyte-like cells | 2011 | |||
| Spontaneous in vitro maturation and artificial activation of human germinal vesicle oocytes recovered from stimulated cycles | IVF clinical | 2011 | IVF clinical;IVF laboratory;IVF laboratory | |
| Stem cells in human endometrium and endometrial carcinoma | 2011 | |||
|
Sublingual therapeutic immunization with a polyvalent bacterial preparation in patients with recurrent respiratory infections: immunomodulatory effect on the proliferating capacity of specific CD4+ T cells and impact on clinical outcome. | Immunology | 2011 | Immunology;Female fertility;IVF laboratory |
|
Telomere DNA deficiency is associated with development of human embryonic aneuploidy. | Female fertility | 2011 | Female fertility;Pre-implantation genetics;IVF clinical;IVF laboratory |
| The cytogenetics of polar bodies: insights into female meiosis and the diagnosis of aneuploidy. | Female fertility | 2011 | Female fertility;Pre-implantation genetics;IVF clinical;IVF laboratory | |
| The effects of ergot and non-ergot-derived dopamine agonists in an experimental mouse model of endometriosis | 2011 | |||
|
The impact of chronic endometritis on reproductive outcome | Female fertility | 2011 | Female fertility;IVF clinical;IVF laboratory |
|
The Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting | 2011 | ||
| The mRNA-binding protein HuR is regulated in the menstrual cycle and repressed in ectopic endometrium. | Reproductive disorders | 2011 | Reproductive disorders;Female fertility;IVF laboratory | |
| The relationship between blastocyst morphology, chromosomal abnormality, and embryo gender. | IVF laboratory | 2011 | IVF laboratory;IVF clinical;IVF clinical | |
|
The relationship between isolated teratozoospermia and clinical pregnancy after in vitro fertilization with or without intracytoplasmic sperm injection: a systematic review and meta-analysis. Review. | Male fertility | 2011 | Male fertility;IVF clinical;IVF laboratory;IVF clinical |
|
The reliability of the histological diagnosis of endometritis in asymptomatic IVF cases: a multicenter observer study | IVF clinical | 2011 | IVF clinical;Immunology |
|
The use of morphokinetics as a predictor of embryo implantation | Female fertility | 2011 | Female fertility;IVF clinical;IVF clinical |
| The Use of morphokinetics as predictor of embryo implantation. | Female fertility | 2011 | Female fertility;IVF clinical;Female fertility;IVF laboratory;IVF clinical | |
|
The worldwide frozen embryo reservoir: methodologies to achieve optimal results. | 2011 | ||
|
Therapeutic treatments of mtDNA diseases at the earliest stages of human development. | Technology development | 2011 | Technology development;Pre-implantation genetics |
| Tracking embryo implantation using cell-free fetal DNA enriched from maternal circulation at 9 weeks gestation. | Female fertility | 2011 | Female fertility;IVF clinical;IVF clinical;IVF laboratory | |
|
Transcriptomic signature of trophoblast differentiation in a human embryonic stem cell model | 2011 | ||
|
Use of single nucleotide polymorphism microarrays to distinguish between balanced and normal chromosomes in embryos from a translocation carrier. | Female fertility | 2011 | Female fertility;IVF laboratory;IVF clinical;IVF laboratory |
| Validation of microarray comparative genomic hybridization for comprehensive chromosome analysis of embryos. | Technology development | 2011 | Technology development;Pre-implantation genetics | |
| Vitrification versus slow freezing of oocytes: effects on morphologic appearance, meiotic spindle configuration, and DNA damage. | Cryobiology | 2011 | Cryobiology;Female fertility;IVF laboratory;IVF clinical | |
|
2009 nobel prize in physiology or medicine: Telomeres and telomerase | 2010 | ||
|
A novel single-cell DNA fingerprinting method successfully distinguishes sibling human embryos. | Female fertility | 2010 | Female fertility;IVF laboratory;IVF laboratory |
| A prospective, randomized, controlled trial comparing three different gonadotropin regimens in oocyte donors: ovarian response, in vitro fertilization outcome, and analysis of cost minimization. | Female fertility | 2010 | Female fertility;IVF clinical | |
|
A Review on Automatic Analysis of Human Embryo Microscope Images. | Female fertility | 2010 | Female fertility;IVF clinical |
|
Accurate single cell 24 chromosome aneuploidy screening using whole genome amplification and single nucleotide polymorphism microarrays. | Technology development | 2010 | Technology development;Pre-implantation genetics;Pre-implantation genetics;IVF laboratory |
| Aneploidies in embryos and spermatozoa from patients with Y chromosome microdelections. | Male fertility | 2010 | Male fertility;Pre-implantation genetics;IVF clinical | |
|
Antral follicle count (AFC) can be used in the prediction of ovarian response but cannot predict the oocyte/embryo quality or the in vitro fertilization outcome in an egg donation program. | Female fertility | 2010 | Female fertility;IVF laboratory |
|
Assessing the reproductive competence of individual embryos: a proposal for the validation of new "-omics" technologies. | Technology development | 2010 | Technology development;Pre-implantation genetics;IVF laboratory |
| Autocrine regulation of human sperm motility by tachykinins | Male fertility | 2010 | Male fertility;IVF laboratory | |
|
Blood group and ovarian hyperstimulation syndrome | Female fertility | 2010 | Female fertility;IVF clinical |
| Cigarette smoking affects specific sperm oxidative defenses but does not cause oxidative DNA damage in infertile men. | Male fertility | 2010 | Male fertility;Reproductive disorders | |
| Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for análisis of over 4000 cycles- | Female fertility | 2010 | Female fertility;IVF clinical | |
|
Clinical application of comprehensive chromosomal screening at the blastocyst stage. | Female fertility | 2010 | Female fertility;IVF clinical |
|
Comparative analysis of the germ cell markers c-KIT, SSEA-1 and VASA in testicular biopsies from secretory and obstructive azoospermias. | Male fertility | 2010 | Male fertility;Reproductive disorders |
|
Comprehensive chromosome screening of polar bodies and blastocysts from couples experiencing repeated implantation failure. | Reproductive disorders | 2010 | Reproductive disorders;Female fertility |
|
Corifollitropin alfa in a long GnRH agonist protocol: proof of concept trial. | 2010 | ;IVF clinical | |
| Cryopreserved-thawed human embryo transfer: spontaneous natural cycle is superior to human chorionic gonadotropin–induced natural cycle. | 2010 | ;IVF clinical | ||
|
Cumulative ongoing pregnancy rate achieved with oocyte vitrification and cleavage stage transfer without embryo selection in a standard infertility program. | 2010 | ||
| Cytogenetic analysis of human blastocysts with the use of FISH, CGH and aCGH: scientific data and technical evaluation. | Female fertility | 2010 | Female fertility;Pre-implantation genetics;Female fertility | |
| Does a prediction model for pregnancy of unknown location developed in the UK validate on a US population? | Female fertility | 2010 | Female fertility;IVF clinical;IVF laboratory | |
|
Economics of assisted reproductive technologies. | IVF clinical | 2010 | IVF clinical;IVF clinical |
|
Effect of genistein supplementation of thawing medium on characteristics of frozen spermatozoa. | Male fertility | 2010 | Male fertility;Cryobiology |
|
Embryo aneuploidy and the role of morphological and genetic screening. | Female fertility | 2010 | Female fertility;Pre-implantation genetics;IVF clinical;IVF laboratory |
|
Embryo development of fresh 'versus' vitrified metaphase II oocytes after ICSI: a prospective randomized sibling-oocyte study. | 2010 | ||
| Endometrial advancement after triggering with recombinant or urinary HCG: a randomized controlled pilot study. | 2010 | |||
|
Estudio comparativo de los ciclos FIV-ICSI sometidos a coasting en el Hospital Universitario materno Infantil de Canarias. | 2010 | ;Female fertility | |
| Female Obesity impairs in vitro fertilization outcome without affecting embryo quality. | Female fertility | 2010 | Female fertility;IVF clinical | |
| Gene expression profile in the endometrium on the day of oocyte retrieval after ovarian stimulation with low-dose hCG in the follicular phase. | 2010 | |||
| GnRH agonist administration at the time of implantation does not improve pregnancy outcome in intrauterine insemination cycles: a randomized controlled tria | Female fertility | 2010 | Female fertility;IVF clinical;IVF laboratory;Pre-implantation genetics | |
|
Higher birth rate after recombinant hCG triggering compared with urinary-derived hCG in single-blastocyst IVF antagonist cycles: a randomized controlled trial. | 2010 | ||
|
Human follicular fluid from superovulated women inhibits progesterone receptor-dependent gonadotropin-releasing hormone self-priming in an estrous cycle-dependent manner in the rat. | Female fertility | 2010 | Female fertility;IVF clinical |
| Identification and quantification of dopamine receptor 2 in human eutopic and ectopic endometrium: a novel molecular target for endometriosis therapy. | Reproductive disorders | 2010 | Reproductive disorders;Female fertility;IVF clinical | |
|
Impacto de un complejo de antioxidantes sobre la fragmentación del ADN espermático en varones infértiles | Male fertility | 2010 | Male fertility;IVF clinical;Pre-implantation genetics |
|
Improved detection of aneuploid blastocysts using a new 12-chromosome FISH test. | Technology development | 2010 | Technology development;Pre-implantation genetics |
| Improving FISH diagnosis for preimplantation genetic aneploidy screening | Technology development | 2010 | Technology development;Pre-implantation genetics | |
|
Intramyometrial ectopic pregnancy in an ICSI patient following uterine artery embolization | 2010 | ||
|
Is the use of donor sperm associated with a higher incidence of preeclampsia in women who achieve pregnancy after intrauterine insemination? | 2010 | ||
| La obesidad en las mujeres afecta los resultados de fertilización in vitro pero no la calidad embrionaria. | Female fertility | 2010 | Female fertility;IVF clinical | |
|
Laboratory evaluation in oocyte cryopreservation suggests retrieved oocytes are comparable whether frozen for medical indications, deferred reproduction, or oocyte donation. | Cryobiology | 2010 | Cryobiology;IVF laboratory |
| Las muestras de semen de pacientes infértiles que se someten a una ICSI o IAH difieren considerablemente en sus perfiles de expresión génica | Male fertility | 2010 | Male fertility;IVF laboratory;Female fertility | |
|
Low-dose human chorionic gonadotropin versus estradiol/progesterone luteal phase support in gonadotropin-releasing hormone agonist-triggered assisted reproductive technique cycles: understanding a new approach | Female fertility | 2010 | Female fertility;IVF clinical;Female fertility |
|
Luteal phase support in normo-ovulatory women stimulated with clomiphene citrate for intrauterine insemination: need or habit? | 2010 | ||
| Metabolomic profiling as an adjunct to morphology for non-invasive embryo assessment in women undergoing single embryo transfer. | Female fertility | 2010 | Female fertility;IVF laboratory | |
|
Microarrays and CGH for PGD of chromosome abnormalities and gene defects. | Female fertility | 2010 | Female fertility;Pre-implantation genetics;IVF laboratory |
| Mitotic expression of Spo13 alters M-phase progression and nucleolar localization of Cdc14 in budding yeast. | Technology development | 2010 | Technology development;Female fertility | |
| Monozygotic twinning is not increased after single blastocyst transfer compared with single cleavage-stage embryo transfer. | 2010 | |||
|
Morphologic indicators predict the stage of chromatin condensation of human germinal vesicle oocytes recovered from stimulated cycles. | Female fertility | 2010 | Female fertility;IVF clinical |
|
Non-Traumatic Metatarsal Fracture in Primary Antiphospholipid Syndrome. | Immunology | 2010 | Immunology |
|
Offering excess oocyte aspiration and vitrification to patients undergoing stimulated artificial insemination cycles can reduce the multiple pregnancy risk and accumulate oocytes for later use. | 2010 | ||
|
OMICS in assisted reproduction: possibilities and pitfalls. | Technology development | 2010 | Technology development;IVF clinical |
| Ontological evaluation of transcriptional differences between sperm of infertile males and fertile donors using microarray analysis. | Male fertility | 2010 | Male fertility;IVF clinical | |
| Ovulation Induction with clomiphene citrate. | Female fertility | 2010 | Female fertility;IVF clinical;IVF laboratory | |
| Perfiles de expresión génica en hombres infértiles que se someten a reproducción asistida. | Male fertility | 2010 | Male fertility;IVF clinical;Female fertility;Male fertility | |
|
Perspectives on emerging biomarkers for non-invasive assessment of embryo viability in assisted reproduction. | IVF clinical | 2010 | IVF clinical;IVF laboratory;IVF laboratory |
| Physiology and pathology of ovarian hyperstimulation syndrome. | IVF clinical | 2010 | IVF clinical;IVF laboratory;IVF clinical | |
|
Pregnancy of unknown location: a consensus statement of nomenclature, definitions, and outcome | Female fertility | 2010 | Female fertility;IVF clinical |
|
Pregnancy rates alter incubation in new time-lapse incubator (embryoscope) providing detailed information about embryo development compared to incubation in a standard incubator | Technology development | 2010 | Technology development;IVF laboratory |
|
Prevalence of unsuspected uterine cavity abnormalities diagnosed by office hysteroscopy prior to in vitro fertilization | 2010 | ||
|
Problem based learning: The subfertile couple. | 2010 | ;IVF laboratory | |
|
Profound Transcriptomic Differences Found between Sperm Samples from Sperm Donors vs. Patients Undergoing Assisted Reproduction Techniques Tends to Disappear after Swim-up Sperm Preparation Technique. | Male fertility | 2010 | Male fertility;IVF clinical |
|
Prognostic factors for delivery in patients undergoing repeated preimplantation genetic aneuploidy screening | 2010 | ;IVF clinical | |
| Redefining advanced maternal age as an indication for implantation genetic screening. | Aging and rejuvenation | 2010 | Aging and rejuvenation;Female fertility;IVF clinical | |
| Relevance of testicular sperm DNA oxidation for the outcome of ovum donation cycles. | Male fertility | 2010 | Male fertility;Female fertility | |
| Revisión sobre el efecto de la estimulación ovárica controlada sobre la incidencia de aneuploidias. | IVF laboratory | 2010 | IVF laboratory;IVF clinical;Female fertility;IVF laboratory;IVF clinical | |
|
Robust embryo identification using polar body single nucleotide polymorphism microarray based DNA fingerprinting. | Technology development | 2010 | Technology development;Pre-implantation genetics;IVF laboratory |
|
Severe Refractory Hidradenitis Suppurativa in HIV-Positive Patient Successfully Treated with Infliximab. | Immunology | 2010 | Immunology;Pre-implantation genetics |
| Simultaneous determination in situ of DNA fragmentation and 8-oxoguanine in human sperm. | Male fertility | 2010 | Male fertility;IVF laboratory;Female fertility | |
|
Single Cell Whole Genome Amplification Technique Impacts the Accuracy of SNP Microarray Based Genotyping and Copy Number Analyses. | Technology development | 2010 | Technology development;Pre-implantation genetics;IVF clinical |
|
SNP microarray based 24 chromosome aneuploidy screening demonstrates that cleavage stage FISH poorly predicts aneuploidy in embryos that develop to morphologically normal blastocysts. | Technology development | 2010 | Technology development;Pre-implantation genetics;Female fertility |
|
SNP microarray based 24 chromosome aneuploidy screening is significantly more consistent than FISH. | Technology development | 2010 | Technology development;Pre-implantation genetics |
|
Surgical management of tubal disease and infertility | Reproductive disorders | 2010 | Reproductive disorders;Pre-implantation genetics;Technology development |
| Swim-up procedure selects spermatozoa with longer telomere length. | Male fertility | 2010 | Male fertility;Aging and rejuvenation | |
|
Technology requirements for preimplantation genetic diagnosis to improve assisted reproduction outcomes. | Technology development | 2010 | Technology development;Pre-implantation genetics |
|
The human oocyte and cumulus cells relationship: new insights from the cumulus cell transcriptome. | Female fertility | 2010 | Female fertility;IVF clinical |
|
The impact of ovarian stimulation on the luteal phase ovarian stimulation | 2010 | ;IVF clinical;IVF laboratory | |
|
The non-ergot derived dopamine agonist quinagolide in prevention of early ovarian hyperstimulation syndrome in IVF patients: a randomized, double-blind, placebo-controlled trial. | IVF clinical | 2010 | IVF clinical;Female fertility |
|
The safety of clomifene citrate in the absence of ultrasound monitoring facilities. | Reproductive disorders | 2010 | Reproductive disorders;IVF laboratory |
| The transcriptome of spermatozoa used in homologous intrauterine insemination varies considerably between samples that achieve pregnancy and those that do not. | Male fertility | 2010 | Male fertility;IVF clinical | |
| The use of prediction models of spontaneous pregnancy in in vitro fertilization units reveals differences between the expected results of public and private clinics in Spain. | Female fertility | 2010 | Female fertility;IVF clinical | |
|
Third party reproduction and the aging couple. | Female fertility | 2010 | Female fertility;Male fertility |
|
Toward a method for automatic grading of microscope human embryo images. | Female fertility | 2010 | Female fertility;IVF clinical |
|
Towards a non-invasive assessment of oocyte competence: gene expression approaches | Female fertility | 2010 | Female fertility;IVF clinical;IVF laboratory |
| Transcriptomic profiling of human oocytes: association of meiotic aneuploidy and altered oocyte gene expression. | Female fertility | 2010 | Female fertility;Pre-implantation genetics;IVF clinical;IVF laboratory | |
| Transfer of cryopreserved - thawed embryos in hCG induced natural or clomiphene citrate cycles yields similar live birth rates in normo-ovulatory women. | 2010 | |||
|
Transmission of Mitochondrial DNA Diseases and Ways to Prevent Them. | Female fertility | 2010 | Female fertility;Pre-implantation genetics |
| Twins born after transplantation of ovarian cortical tissue and oocyte vitrification | 2010 | |||
|
Use of cryo-banked oocytes in an ovum donation programme: a prospective, randomized, controlled, clinical trial. | Cryobiology | 2010 | Cryobiology;Female fertility |
|
Vaginal progesterone supplementation has no effect on ongoing pregnancy rate in hCG-induced natural frozen–thawed embryo transfer cycles. | 2010 | ||
|
Visualizing yeast chromosomes and nuclear architecture. | Technology development | 2010 | Technology development |
|
Vitrification of isolated human blastomeres. | Reproductive disorders | 2010 | Reproductive disorders |
| Y chromosome microdelections, sperm DNA fragmentation andsperm oxidative as causes of recurrent of unknown etiology. | Male fertility | 2010 | Male fertility;IVF laboratory;IVF clinical;IVF laboratory | |
| Y chromosome microdeletions, sperm DNA fragmentation and sperm oxidative stress as causes of recurrent spontaneous abortion of unknown etiology. | Male fertility | 2010 | Male fertility;Female fertility;Pre-implantation genetics;IVF laboratory | |
|
14-gauge angiocatheter: the assist port. | Technology development | 2009 | Technology development;Female fertility;IVF clinical |
|
A luteal estradiol for anticipated poor–responder patients may improve delivery rates. | Female fertility | 2009 | Female fertility;IVF clinical;Female fertility |
|
A Strict Infertility Diagnosis Has Poor Agreement with the Clinical Diagnosis Entered Into SART. | IVF clinical | 2009 | IVF clinical |
|
Adjuncts for ovarian stimulation: when do we adopt "orphan indications" for approved drugs? | Female fertility | 2009 | Female fertility;IVF clinical |
|
Apendicitis y gestación Progresos de Obstetricia y Ginecología. | Reproductive disorders | 2009 | Reproductive disorders;IVF laboratory |
|
Assessment of the luteal phase in stimulated and substituted cycles. | 2009 | ||
| Biochemical markers of male infertility: the key role of DNA damage. | Male fertility | 2009 | Male fertility;IVF clinical;IVF laboratory;IVF clinical | |
| Bleeding during transfer is the only parameter of patient anatomy and embryo quality that affects reproductive outcome: a prospective study. | IVF clinical | 2009 | IVF clinical;Female fertility;IVF clinical | |
|
Cardiopatía congénita y rabdomioma cardíaco fetal: una asociación inusual. | Reproductive disorders | 2009 | Reproductive disorders;IVF clinical;IVF laboratory |
|
Circulating estradiol defines the tumor phenotype in menopausal breast cancer patients. | Female fertility | 2009 | Female fertility;IVF clinical |
| Comparative genomic hybridization of oocytes and first polar bodies from young donors. | Female fertility | 2009 | Female fertility;IVF clinical;Pre-implantation genetics;IVF clinical;IVF laboratory | |
| Comprehensive proteomic analysis of human endometrial fluid aspirate. | IVF clinical | 2009 | IVF clinical;Female fertility | |
|
Computerized analysis of normal fetal heart rate pattern throughout gestation. | Reproductive disorders | 2009 | Reproductive disorders;Technology development |
| Differential regulation of VEGF after final oocyte maturation with GnRH agonist versus hCG: a rationale for OHSS reduction. | Female fertility | 2009 | Female fertility;IVF clinical | |
| Dopamine agonist administration causes a reduction in endometrial implants through modulation of angiogenesis in experimentally induced endometriosis. | Female fertility | 2009 | Female fertility;IVF clinical | |
|
Effect of collecting duct histology on renal cell cancer outcome. | Surgery | 2009 | Surgery |
|
Elevated levels of intestinal inflammation in Clostridium difficile infection associated with fluoroquinolone-resistant C. | Immunology | 2009 | Immunology |
| Endometrial fluid is a specific and non-invasive biological sample for protein biomarker identification in endometriosis. | Reproductive disorders | 2009 | Reproductive disorders;Female fertility | |
|
Estudio de coste-efectividad sobre los distintos métodos posibles de cribado poblacional del síndrome de Down. | Reproductive disorders | 2009 | Reproductive disorders;IVF laboratory |
|
Fertility preservation in cancer survivors. | Cryobiology | 2009 | Cryobiology;IVF clinical |
|
First report of the absence of viral load in testicular sperm samples obtained from men with hepatitis C and HIV after washing and their subsequent use. | Male fertility | 2009 | Male fertility;IVF clinical;Male fertility |
| GnRH agonist versus recombinant HCG in an oocyte donation programme: a randomized, prospective, controlled, assessor-blind study. | Male fertility | 2009 | Male fertility;Reproductive disorders | |
| GnRH analogue for the prevention of ovarian hyperstimulation syndrome: a pilot study. | Female fertility | 2009 | Female fertility;IVF clinical | |
|
GnRH antagonist ganirelix prevents premature luteinization in IUI cycles: rationale for its use. | IVF clinical | 2009 | IVF clinical;IVF laboratory |
|
How to avoid ovarian hyperstimulation syndrome: a new indication for dopamine agonists. | Female fertility | 2009 | Female fertility;IVF clinical |
| Improving the patient's experience of IVF/ICSI: a proposal for an ovarian stimulation protocol with GnRH antagonist co-treatment. | IVF clinical | 2009 | IVF clinical;IVF laboratory | |
| In GnRH antagonist/rec-FSH stimulated cycles, advanced endometrial maturation on the day of oocyte retrieval correlates with altered gene expression | 2009 | |||
|
In vitro fertilization pregnancy in a patient with proven chronic endometritis. | 2009 | ;IVF clinical;IVF laboratory | |
| Integridad del ADN y patrón de expresión génica indicadores de calidad espermática y éxito reproductivo | Male fertility | 2009 | Male fertility;IVF clinical;IVF clinical;IVF laboratory | |
|
KiSS-1 in the mammalian ovary: distribution of kisspeptin in human and marmoset and alterations in KiSS-1 mRNA levels in a rat model of ovulatory dysfunction. | Female fertility | 2009 | Female fertility;IVF clinical |
| Letrozole administration during the luteal phase after ovarian stimulation impacts corpus luteum function: a randomized, placebo-controlled trial. | IVF clinical | 2009 | IVF clinical;Female fertility | |
|
Logarithmic curves depicting initial level and rise of serum beta human chorionic gonadotropin and live delivery outcomes with in vitro fertilization: An analysis of 6021 pregnancies. | Female fertility | 2009 | Female fertility;IVF clinical |
|
Long-acting FSH analogue: Corifollitropin-? to sustain multifollicular growth during controlled ovarian stimulation. | 2009 | ||
|
Lte1, Cdc14 and MEN-controlled Cdk inactivation in yeast coordinate rDNA decompaction with late telophase progression. | Technology development | 2009 | Technology development;Reproductive disorders;IVF clinical |
|
Luteal phase oestradiol suppression by letrozole: a pilot study in oocyte donors | 2009 | ||
|
Male infertility: a risk factor for testicular cancer. Review. | Male fertility | 2009 | Male fertility;IVF clinical |
|
Management of endometriomas in women requiring IVF: to touch or not to touch. | Reproductive disorders | 2009 | Reproductive disorders;Female fertility |
|
Mechanism of action of immune globulin. | Immunology | 2009 | Immunology;Female fertility |
| Métodos de selección objetiva de espermatozoides competentes. | Male fertility | 2009 | Male fertility;IVF clinical | |
| Métodos para la selección objetiva de espermatozoides competentes | Male fertility | 2009 | Male fertility;IVF clinical | |
| Microarray analysis in sperm from fertile and infertile men without basic sperm analysis abnormalities reveals a significantly different transcriptome. | Male fertility | 2009 | Male fertility;IVF clinical;IVF clinical | |
| Nuevos métodos de selección embrionaria: una nueva tendencia para transferencias únicas. | Technology development | 2009 | Technology development;Female fertility;ivf laboratory | |
|
Oral contraceptive pretreatment in women undergoing controlled ovarian stimulation in ganirelix acetate cycles may, for a subset of patients, be associated with low serum luteinizing hormone levels, reduced ovarian response to gonadotropins, and early pregnancy loss. | Female fertility | 2009 | Female fertility;IVF clinical |
|
Ovarian stimulation for ovulation induction and in vitro fertilization in patients with systemic lupus erythematosus and antiphospholipid syndrome. | Reproductive disorders | 2009 | Reproductive disorders;Female fertility;IVF clinical |
|
Possible impact of LH-containing gonadotrophins on diploidy rates in preimplantation embryos. | 2009 | ||
| Post-cesarean section morbidity in HIV-positive women. | Female fertility | 2009 | Female fertility;IVF clinical | |
| Prediction of location of a nonviable pregnancy when ultrasound is nondiagnostic. | Female fertility | 2009 | Female fertility;IVF clinical | |
|
Predictors of Upper Tract Urothelial Cell Carcinoma after Primary Bladder Cancer: A Population Based Analysis. | Reproductive disorders | 2009 | Reproductive disorders;Male fertility |
| Preimplantation genetic diagnosis of single-gene disorders: experience with more than 200 cycles conducted by a reference laboratory in the United States. | Female fertility | 2009 | Female fertility;IVF clinical | |
|
Preimplantation genetics. | IVF clinical | 2009 | IVF clinical;IVF laboratory |
|
Preventing transmission of maternally inherited mitochondrial DNA diseases. | Female fertility | 2009 | Female fertility;IVF clinical;IVF laboratory;Male fertility;Female fertility |
|
Reproduction in Couples with Chronic Viral Infections. | Female fertility | 2009 | Female fertility;Male fertility |
|
Should sperm parameters be considered in patient selection for SET? | Male fertility | 2009 | Male fertility;IVF clinical |
| Situación Actual de las técnicas de preservación de la Fertilidad. | Technology development | 2009 | Technology development;IVF clinical;Male fertility | |
| Sperm DNA fragmentation levels in testicular sperm samples from azoospermic males as assessed by the sperm chromatin dispersion (SCD) test. | Male fertility | 2009 | Male fertility;Reproductive disorders | |
|
Symposium: Update on prediction and management of OHSS. Prevention of OHSS--dopamine agonists. | Female fertility | 2009 | Female fertility;IVF clinical |
|
TGF-beta regulates expression of transcription factor KLF6 and its splice variants, and promotes co-operative transactivation of common target genes through a Smad3/Sp1/KLF6 interaction. | Technology development | 2009 | Technology development;Reproductive disorders;Female fertility |
| The impact of in-vitro maturation of oocytes on aneuploidy rate. | Female fertility | 2009 | Female fertility;IVF clinical | |
|
The luteal phase after 3 decades of IVF: what do we know? | 2009 | ||
| The p53 codon 72 single nucleotide polymorphism lacks a significant effect on implantation rate in fresh in vitro fertilization cycles: an analysis of 1,056 patients | Female fertility | 2009 | Female fertility;IVF clinical | |
|
The role of preimplantation genetic diagnosis in diagnosing embryo aneuploidy. | IVF clinical | 2009 | IVF clinical;Female fertility |
|
A luteal estradiol protocol for poor-responders improves embryo number and quality. | Female fertility | 2008 | Female fertility;IVF clinical |
|
Air bubble location inside the uterus after transfer: is the embryo really there? | 2008 | ||
| Alternative splicing of the mouse embryonic poly(A) binding protein (ePAB) RNA is regulated by an exonic splicing enhancer: a model for post-transcriptional control of gene expression in the oocyte. | Technology development | 2008 | Technology development;Female fertility | |
|
Amenorrhea. The National Medical Series for Independent Study. | Female fertility | 2008 | Female fertility;Reproductive disorders;IVF laboratory |
|
Assessment of embryo viability in ART: shortcomings of current approaches and the emerging role of metabolomics. | IVF laboratory | 2008 | IVF laboratory;IVF clinical |
| Birth of a healthy boy after a double factor PGD in a couple carrying a genetic disease and at risk for aneuploidy. | Female fertility | 2008 | Female fertility;Pre-implantation genetics | |
|
CB1 expression is attenuated in Fallopian tube and decidua of women with ectopic pregnancy | 2008 | ||
|
Cigarette Smoking and IVF | Female fertility | 2008 | Female fertility;Male fertility |
|
Cigarette smoking and reproductive function | Female fertility | 2008 | Female fertility;Male fertility |
| Clinical factors affecting endometrial receptiveness in oocyte donation cycles | Endometrial receptivity | 2008 | Endometrial receptivity;Female fertility | |
|
Community acquired clostridium difficile in Vhembe district, South Africa: Studies using molecular biology methods for the detection of Triose phosphate isomerase (tpi), Toxin A (tcdA), Toxin B (tcdB), Binary Toxin (cdtA, cdtB) and tcdC genes. | Immunology | 2008 | Immunology;Female fertility;Male fertility |
|
Comparative protein-profile analysis of implanted versus non-implanted human blastocysts | 2008 | ||
| Comparison of concomitant outcome achieved with fresh and cryopreserved donor oocytes vitrified by the Cryotop method | 2008 | |||
| Comprehensive molecular cytogenetic analysis of the human blastocyst stage. | Female fertility | 2008 | Female fertility;IVF clinical | |
| Contribution of sperm molecular features to embryo quality and assisted reproduction success | Male fertility | 2008 | Male fertility;Female fertility;IVF clinical | |
| Controlled ovarian stimulation induces a functional genomic delay of the endometrium with potential clinical implications | 2008 | |||
| CXCL10 and IL-6 induce chemotaxis in human trophoblast cell lines | 2008 | |||
| Effect of different cryopreservation protocols on the metaphase II spindle in human oocytes | 2008 | |||
| Effects of men and recipients' age on the reproductive outcome of an oocyte donation program | 2008 | |||
|
Efficient method for slow cryopreservation of human embryonic stem cells in xeno-free conditions | 2008 | ||
|
Endocrine modifications associated with final oocyte maturation with gonadotropin-releasing hormone agonists vs. human chorionic gonadotropin in women undergoing intrauterine insemination | 2008 | ||
|
Endometrial receptivity and implantation are not affected by the presence of uterine intramural leiomyomas: a clinical and functional genomics analysis | Endometrial receptivity | 2008 | Endometrial receptivity;IVF clinical |
|
Estradiol supplementation during the luteal phase of IVF-ICSI patients: a randomized, controlled trial | IVF clinical | 2008 | IVF clinical;Female fertility |
| Evaluation of embryo quality by Metabolomics: A new strategy to aid single embryo transfer. | Technology development | 2008 | Technology development;Female fertility;Pre-implantation genetics;IVF laboratory | |
|
Fertility preservation options for women with non-gynecologic cancers. | Cryobiology | 2008 | Cryobiology;Female fertility |
| Functional localization of DNA damage to pore complex bound to Slx5/8 SUMO-dependent E3 ligase | Technology development | 2008 | Technology development;Female fertility;IVF clinical | |
|
Gene expression profiling of human oocytes at different maturational stages and after in vitro maturation. | Female fertility | 2008 | Female fertility;IVF clinical |
| Highly purified hMG versus recombinant FSH in ovarian hyperstimulation with GnRH antagonists--a randomized study | IVF clinical | 2008 | IVF clinical;Female fertility | |
|
Human immunodeficiency type-1 virus (HIV-1) infection in serodiscordant couples (SDCs) does not have an impact on embryo quality or intracytoplasmic sperm injection (ICSI) outcome | IVF clinical | 2008 | IVF clinical;Female fertility;Technology development;IVF laboratory;IVF clinical |
| Identification and characterization of human embryonic poly(A) binding protein (ePAB). | Technology development | 2008 | Technology development;Female fertility | |
| Identification and in vitro characterization of Follicle Stimulating Hormone (FSH) Receptor variants associated with abnormal ovarian response to FSH. | Female fertility | 2008 | Female fertility;IVF clinical | |
|
In Vitro Fertilization and Adverse Pregnancy Outcome. | IVF clinical | 2008 | IVF clinical;IVF laboratory;IVF laboratory |
|
Infertility. | IVF laboratory | 2008 | IVF laboratory;IVF clinical |
| Influence of paternal age on assisted reproduction outcome | Aging and rejuvenation | 2008 | Aging and rejuvenation;Female fertility | |
|
Introducción a los fármacos biológicos. | IVF clinical | 2008 | IVF clinical;Female fertility |
|
Is teratoma formation in stem cell research a characterization tool or a window to developmental biology? | 2008 | ||
|
Leukemia inhibitory factor induces cumulus expansion in immature human and mouse oocytes and improves mouse two-cell rate and delivery rates when it is present during mouse in vitro oocyte maturation. | Female fertility | 2008 | Female fertility;IVF clinical |
| Light exposure and sperm nuclear DNA damage in ICSI Procedures | Male fertility | 2008 | Male fertility;IVF laboratory;IVF clinical | |
|
Low dose aspirin use does not improve in vitro fertilization outcomes in poor responders. | IVF clinical | 2008 | IVF clinical;Female fertility;IVF clinical |
|
Male age negatively impacts embryo development and reproductive outcome in donor oocyte ART cycles. | Aging and rejuvenation | 2008 | Aging and rejuvenation;IVF clinical;IVF clinical |
| Maternal serum ghrelin levels in early IVF pregnancies: lack of prognostic value for viable pregnancy and altered post-prandial responses | 2008 | |||
|
Metabolomic profiling of embryo culture media to predict IVF outcome. | Female fertility | 2008 | Female fertility;IVF clinical |
|
Metabolomics and its application for non-invasive embryo assessment in IVF. | Female fertility | 2008 | Female fertility;IVF clinical |
|
Morphological selection of gametes. | 2008 | ||
| MUC1 in human testis and ejaculated spermatozoa and its relationship to male fertility status | Male fertility | 2008 | Male fertility;IVF clinical | |
| New options in assisted reproduction technology: the Cryotop method of oocyte vitrification | 2008 | |||
|
New perspectives in medically assisted procreation | 2008 | ||
|
Non-invasive metabolomic profiling of embryo culture media using proton NMR correlates with reproductive potential of embryos in women undergoing in vitro fertilization. | Technology development | 2008 | Technology development;Female fertility |
| Noninvasive metabolomic profiling of human embryo culture media using Raman spectroscopy predicts embryonic reproductive potential: a prospective blinded pilot | Technology development | 2008 | Technology development;IVF clinical | |
|
Pelvic Pain. The National Medical Series for Independent Study | Female fertility | 2008 | Female fertility;Reproductive disorders;IVF laboratory |
|
Presente y futuro de las técnicas de reproducción asistida en España | Reproductive disorders | 2008 | Reproductive disorders;IVF clinical;IVF laboratory |
|
PSA in the new millennium: a powerful predictor of prostate cancer prognosis and radical prostatectomy outcomes--results from the SEARCH database | Male fertility | 2008 | Male fertility;IVF clinical |
| Quality specifications based on clinicians’ opinion. | IVF clinical | 2008 | IVF clinical;IVF laboratory | |
| Soluble vascular endothelial-cadherin levels correlate with clinical and biological aspects of severe ovarian hyperstimulation syndrome | Female fertility | 2008 | Female fertility;IVF clinical;Pre-implantation genetics | |
| Successful pregnancy and childbirth after intracytoplasmic sperm injection with calcium ionophore oocyte activation in a globozoospermic patient | 2008 | |||
|
Systemic methotrexate to treat ectopic pregnancy does not affect ovarian reserve | Female fertility | 2008 | Female fertility;IVF clinical;IVF clinical |
|
Targeting the vascular endothelial growth factor system to prevent ovarian hyperstimulation syndrome | IVF clinical | 2008 | IVF clinical;Female fertility |
| Técnica de B-Lynch en el control de la hemorragia posparto Progresos de Obstetricia | Female fertility | 2008 | Female fertility;IVF clinical;Pre-implantation genetics | |
|
The effect of cancer on sperm DNA fragmentation as measured by the sperm chromatin dispersion test | Male fertility | 2008 | Male fertility;IVF clinical;IVF laboratory;Cryobiology |
|
The Menstrual Cycle. The National Medical Series for Independent Study. | Female fertility | 2008 | Female fertility;IVF clinical |
|
The predictive value for IVF delivery rates is greatly impacted by the method used to select the threshold between normal and elevated basal FSH. | Female fertility | 2008 | Female fertility;IVF clinical;IVF clinical |
| The role of thrombophilia and thyroid autoimmunity in unexplained infertility, implantation failure and recurrent spontaneous abortion | IVF clinical | 2008 | IVF clinical;Immunology | |
|
The significance of sperm DNA oxidation in embryo development and reproductive outcome in an oocyte donation program: a new model to study a male infertility prognostic factor | Male fertility | 2008 | Male fertility;Female fertility;Reproductive disorders |
| The Valencia Programme for Fertility Preservation | 2008 | |||
|
The value of the short-term fetal heart rate variation for timing the delivery of growth-retarded fetuses | Female fertility | 2008 | Female fertility;IVF clinical |
| Unique pharmacology of KAR-2, a potential anti-cancer agent: absorption modeling and selective mitotic spindle targeting. | Technology development | 2008 | Technology development;Female fertility | |
|
Use of comprehensive chromosomal screening for embryo assessment: microarrays and CGH. | Technology development | 2008 | Technology development;IVF clinical |
|
Use of letrozole in assisted reproduction: a systematic review and meta-analysis | 2008 | ||
|
Vitrification of preimplantation genetically diagnosed human blastocysts and its contribution to the cumulative ongoing pregnancy rate per cycle by using a closed device | 2008 | ||
| Vitrification: an effective new approach to oocyte banking and preserving fertility in cancer patients | 2008 | |||
| [Clinical factors associated with the outcome of oocyte donation] | IVF clinical | 2007 | IVF clinical;Female fertility | |
|
A role for tachykinins in the regulation of human sperm motility | 2007 | ||
|
Abdominal pregnancy, cesarean scar pregnancy, and heterotopic pregnancy. | Female fertility | 2007 | Female fertility;IVF clinical |
|
Age adjusted prostate specific antigen and prostate specific antigen velocity cut points in prostate cancer screening. | Male fertility | 2007 | Male fertility;IVF clinical |
|
An update of luteal phase support in stimulated IVF cycles. | 2007 | ||
|
Artículo de revisión "Diagnóstico por imagen” | Pre-implantation genetics | 2007 | Pre-implantation genetics |
|
Cancer treatment and fertility: a time to reassess realistic opportunities | 2007 | ||
|
Cigarette smoking affects uterine receptiveness | Female fertility | 2007 | Female fertility |
| CLIMATERIO | Female fertility | 2007 | Female fertility;Male fertility | |
| Disruption of apical-basal polarity of human embryonic stem cells enhances hematoendothelial differentiation | 2007 | |||
|
Donantes de semen: análisis comparativo de las recomensaciones de diferentes sociedades científicas. Reflexiones sobre la evaluación de donantes de gametos y embriones. | Male fertility | 2007 | Male fertility;IVF clinical |
| Dopamine agonist cabergoline reduces hemoconcentration and ascites in hyperstimulated women undergoing assisted reproduction | 2007 | |||
|
Early pregnancy loss in women stimulated with gonadotropin-releasing hormone antagonist protocols according to oral contraceptive pill pretreatment | Female fertility | 2007 | Female fertility;IVF clinical;IVF clinical |
|
Ectopic Pregnancies in Unusual Locations. | Female fertility | 2007 | Female fertility |
| Effect of a sharp serum oestradiol fall before HCG administration during ovarian stimulation in donors | 2007 | |||
|
Effect of oral administration of dydrogestrone versus vaginal administration of natural micronized progesterone on the secretory transformation of endometrium and luteal endocrine profile in patients with premature ovarian failure: a proof of concept. | 2007 | ||
| Embryonic adhesion is not affected by endometrial leptin receptor gene silencing | 2007 | |||
| Estrogen increases apoptosis in a murine atherosclerosis model. | Female fertility | 2007 | Female fertility | |
|
Extended embryo culture to increase implantation rate | Immunology | 2007 | Immunology;Female fertility |
| Facteurs cliniques et résultats du don d’ovocytes. | Female fertility | 2007 | Female fertility;IVF clinical | |
| Fresh human orthotopic ovarian cortex transplantation: long-term results | 2007 | |||
| Fresh human orthotopic ovarian córtex transplantation: long-term results. | Reproductive disorders | 2007 | Reproductive disorders | |
|
Future genetic and other technologies for assessing embryos. | Technology development | 2007 | Technology development;IVF clinical;IVF laboratory |
|
GnRH-agonist vs. GnRH-antagonist in elective single blastocyst transfer IVF cycles | 2007 | ||
|
Human chorionic gonadotropin administration vs. luteinizing monitoring for intrauterine insemination timing, after administration of clomiphene citrate: a meta-analysis | 2007 | ||
|
Identification, characterization and co-localization of label-retaining cell population in mouse endometrium with typical undifferentiated markers | 2007 | ||
| Impact of chromosomal abnormalities on preimplantation embryo development | 2007 | |||
|
Implantation is apparently unaffected by the dopamine agonist Cabergoline when administered to prevent ovarian hyperstimulation syndrome in women undergoing assisted reproduction treatment: a pilot study | Female fertility | 2007 | Female fertility;IVF clinical |
|
Improvements achieved in an oocyte donation program over a 10-year period: sequential increase in implantation and pregnancy rates and decrease in high-order multiple pregnancies | 2007 | ||
|
Is ovarian stimulation detrimental to the endometrium? | 2007 | ||
|
Live birth rates after transfer of equal number of blastocysts or cleavage-stage embryos in IVF. A systematic review and meta-analysis. | 2007 | ||
|
Maternal age-related differential global expression profiles observed in human oocytes. | Female fertility | 2007 | Female fertility;Aging and rejuvenation |
|
Molecular biology of the gamete. | Male fertility | 2007 | Male fertility;Female fertility |
| Molecular methods for selection of the ideal oocyte. | IVF clinical | 2007 | IVF clinical;IVF laboratory | |
|
Non-Invasive metabolomic profiling of human embryo culture media using Raman and near infrared spectroscopy correlates with reproductive potential of embryos in women undergoing in vitro fertilization. | Technology development | 2007 | Technology development;Female fertility |
| Obesity and poor reproductive outcome: the potential role of the endometrium | Female fertility | 2007 | Female fertility;Reproductive disorders | |
|
Ovarian stimulation length, number of follicles higher than 17 mm and estradiol on the day of human chorionic gonadotropin administration are risk factors for multiple pregnancy in intrauterine insemination | Female fertility | 2007 | Female fertility;IVF clinical |
|
Patient-friendly IVF: how should it be defined? | IVF clinical | 2007 | IVF clinical |
| Prostate-specific antigen (PSA) and PSA velocity for prostate cancer detection in men aged <50 years. | Male fertility | 2007 | Male fertility;IVF clinical | |
|
Removal of 2 cells from cleavage stage embryos is likely to reduce the efficacy of chromosomal tests that are used to enhance implantation rates. | Female fertility | 2007 | Female fertility;IVF laboratory |
| Safety of sperm for use in ICSI. | IVF laboratory | 2007 | IVF laboratory;Male fertility | |
|
Salpingectomy increases peri-implantation endometrial HOXA10 expression in women with hydrosalpinx. | Female fertility | 2007 | Female fertility;Reproductive disorders;IVF clinical |
| Selection of viable embryos and gametes by rapid, non-invasive metabolomic profiling of oxidative stress biomarkers. | Female fertility | 2007 | Female fertility;Male fertility | |
| Serum interleukin-6 levels are elevated in women with minimal-mild endometriosis | Reproductive disorders | 2007 | Reproductive disorders;Female fertility;IVF clinical | |
|
Single cell diagnosis using comparative genomic hybridization after preliminary DNA amplification still needs more tweaking: too many miscalls. | Pre-implantation genetics | 2007 | Pre-implantation genetics;Female fertility |
| Single embryo transfer in preimplantation genetic diagnosis cycles for women <36 years does not reduce delivery rate. | 2007 | |||
|
Sperm DNA and embryo development. | IVF clinical | 2007 | IVF clinical;Female fertility |
| Sperm selection by swim-up in terms of deoxyribonucleic acid fragmentation as measured by the sperm chromatin dispersion test is altered in heavy smokers | Male fertility | 2007 | Male fertility;IVF laboratory;Pre-implantation genetics | |
| The human sperm glutathione system: a key role in male fertility and successful cryopreservation | Male fertility | 2007 | Male fertility;Cryobiology;IVF laboratory;IVF clinical | |
|
The luteal phase of recombinant follicle-stimulating hormone/gonadotropin-releasing hormone antagonist in vitro fertilization cycles during supplementation with progesterone or progesterone and estradiol. | 2007 | ||
|
Thyroid disease and pregnancy: degrees of knowledge. | Female fertility | 2007 | Female fertility;IVF laboratory |
|
Treatment of anorexia nervosa is associated with increases in bone mineral density, and recovery is a biphasic process involving both nutrition and return of menses. | Reproductive disorders | 2007 | Reproductive disorders |
|
Trying to avoid the transmission of human immunodeficiency virus particles in sperm ejaculates | 2007 | ||
|
Uterine receptivity and the ramifications of ovarian stimulation on endometrial function | 2007 | ||
|
Vascular endothelial cadherin regulates vascular permeability: Implications for ovarian hyperstimulation syndrome | IVF clinical | 2007 | IVF clinical;Female fertility;IVF laboratory |
|
Wide genomic analysis of human endometrial receptivity: new times, new opportunities | 2007 | ||
|
A successful strategy for Preimplantation Genetic Diagnosis of betathalassemia and simultaneous detection of Down's syndrome using multiplex fluorescent PCR. | Female fertility | 2006 | Female fertility;Pre-implantation genetics;IVF laboratory |
|
Active CMOS array sensor for time-resolved fluorescence detection. | Technology development | 2006 | Technology development;Female fertility;IVF clinical |
| Addition of estradiol to progesterone for luteal supplementation in patients stimulated with GnRH antagonist/rFSH for IVF: a randomized controlled trial. | 2006 | |||
|
Adjuvant therapy enhances endometrial receptivity in patients undergoing assisted reproduction. | Endometrial receptivity | 2006 | Endometrial receptivity;Female fertility;IVF clinical |
|
Aromatase inhibitors in ovarian stimulation | Female fertility | 2006 | Female fertility;IVF clinical;IVF clinical |
| Aumento de la fragmentación del ADN espermático en los fumadores tras la capacitación mediante swim-up. | Male fertility | 2006 | Male fertility;IVF clinical;IVF clinical | |
| Characterization of a human Bid homologue protein from Gallus gallus. | Reproductive disorders | 2006 | Reproductive disorders;IVF clinical | |
|
Coasting for the prevention of ovarian hyperstimulation syndrome: much ado about nothing? | 2006 | ||
| Complete cytogenetic investigation of oocytes from a young cancer patient with the use of comparative genomic hybridisation reveals meiotic errors. | Female fertility | 2006 | Female fertility;IVF clinical;IVF laboratory;Female fertility | |
|
Crossmodal audio-visual interactions in the primary visual cortex of the visually deprived cat: a physiological and anatomical study. | Technology development | 2006 | Technology development |
| De la fragmentación del DNA espermático en los fumadores tras la capacitación mediante swim-up. | Male fertility | 2006 | Male fertility;IVF laboratory;IVF clinical | |
|
Delaying the initiation of progesterone supplementation until the day of fertilization does not compromise cycle outcome in patients receiving donated oocytes: a randomized study | IVF clinical | 2006 | IVF clinical;Female fertility |
|
Derivation and characterization of three new Spanish human embryonic stem cell lines (VAL -3 -4 -5) on human feeder and in serum-free conditions | 2006 | ||
|
Derivation of clinical-grade human embryonic stem cells | 2006 | ||
|
Doubtful association between TAR syndrome and increased nuchal translucency in the first trimester of pregnancy | Female fertility | 2006 | Female fertility;IVF laboratory |
| E.coli multiresistant meningitis after transrectal prostate biopsy. | Male fertility | 2006 | Male fertility | |
| Early pregnancy loss is significantly higher after day 3 single embryo transfer than after day 5 single blastocyst transfer in GnRH antagonist stimulated IVF cycles. | 2006 | |||
| Effect of an intrauterine device on the gene expression profile of the endometrium | 2006 | |||
| Effect of sperm glutathione peroxidases 1 and 4 on embryo asymmetry and blastocyst quality in oocyte donation cycles | Male fertility | 2006 | Male fertility;Female fertility;IVF laboratory | |
|
Embryo-endometrial interaction | 2006 | ||
| Estradiol increases apoptosis in cultured human coronary artery endothelial cells (HCAEC) by up-regulating Fas expression. | IVF clinical | 2006 | IVF clinical;Female fertility | |
| Estudio comparativo de dos medios de cultivo HTF e ISM-1: implicaciones en el fenotipo embrionario y resultados clínicos. | Female fertility | 2006 | Female fertility;IVF clinical;IVF laboratory;IVF clinical;Pre-implantation genetics | |
| Examination of the fetal brain by transabdominal three-dimensional ultrasound: potential for routine neurosonographic studies | Technology development | 2006 | Technology development;Female fertility;IVF laboratory | |
| Existe relación entre el riesgo ocupacional y la calidad seminal?. | Male fertility | 2006 | Male fertility;IVF clinical;IVF laboratory | |
| Expression of KiSS-1 in rat ovary: putative local regulator of ovulation? | 2006 | |||
| Genetic Markers linked to Rheumatoid Arthritis are also strongly associated with Articular Manifestations in Ulcerative Colitis Patients. | Immunology | 2006 | Immunology | |
| Heteroparental blastocyst production from microsurgically corrected tripronucleated human embryos | Pre-implantation genetics | 2006 | Pre-implantation genetics;IVF clinical | |
| Heteroparental blastocyst production from microsurgically corrected tripronucleated human embryos. | Pre-implantation genetics | 2006 | Pre-implantation genetics;IVF clinical | |
| High incidence of chromosomal abnormalities in large-headed and multiple-tailed spermatozoa | 2006 | |||
|
Human embryo culture | 2006 | ||
|
Human embryonic stem cell derivation: from the IVF perspective to therapeutic applications | 2006 | ||
|
Implantation in IVF | 2006 | ||
|
Implantation of the human embryo: research lines and models. From the implantation research network 'Fruitful' | 2006 | ||
| Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles | 2006 | |||
|
Increased susceptibility to maternal aneuploidy demonstrated by comparative genomic hybridization analysis of human MII oocytes and first polar bodies. | Female fertility | 2006 | Female fertility;IVF clinical |
| Influence of analytical and biological variation on the clinical interpretation of seminal parameters. | Male fertility | 2006 | Male fertility;IVF clinical | |
| Interactions of the hormones leptin, ghrelin, adiponectin, resistin, and PYY3-36 with the reproductive system | Female fertility | 2006 | Female fertility;IVF clinical | |
| Interleukin-10 haplotypes in Celiac Disease in the Spanish population. | Immunology | 2006 | Immunology | |
|
Interpretation of sperm morphology analysis in gynecological practice for infertility. | Male fertility | 2006 | Male fertility;IVF laboratory;IVF laboratory;IVF clinical |
| J.Ultrastructure of preimplantation genetic diagnosis-derived human blastocysts grown in a coculture system after vitrification. | Pre-implantation genetics | 2006 | Pre-implantation genetics;IVF clinical | |
|
Long-term pituitary down-regulation before in vitro fertilization (IVF) for women with endometriosis | Female fertility | 2006 | Female fertility;IVF clinical |
|
Low-dose dopamine agonist administration blocks vascular endothelial growth factor (VEGF)-mediated vascular hyperpermeability without altering VEGF receptor 2-dependent luteal angiogenesis in a rat ovarian hyperstimulation model | 2006 | ||
|
Metazoan oocyte and early embryo development program: a progression through translation regulatory cascades. | Female fertility | 2006 | Female fertility;IVF laboratory |
| Obesity and assisted reproductive technology outcomes | Female fertility | 2006 | Female fertility;IVF clinical | |
| Organización y recursos físicos de los laboratorios de FIV de los centros de reproducción asistida. | IVF laboratory | 2006 | IVF laboratory;IVF clinical | |
| Plasma levels of soluble vascular endothelial growth factor receptor-1 may determine the onset of early and late ovarian hyperstimulation syndrome | Female fertility | 2006 | Female fertility;IVF clinical | |
| Positive correlation between the expression of X-chromosome RBM genes (RBMX, RBM3, RBM10) and the proapoptotic Bax gene in human breast cancer. | Female fertility | 2006 | Female fertility | |
| Potential pitfalls in fetal neurosonography | Female fertility | 2006 | Female fertility;IVF clinical | |
|
Preimplantation genetic diagnosis (PGD) of monogenic disease: PCR-based methods for the identification of mutations single cells. | Female fertility | 2006 | Female fertility;IVF clinical |
|
Prenatal management of placental chorioangioma: value of the middle cerebral artery peak systolic velocity. | Pre-implantation genetics | 2006 | Pre-implantation genetics;IVF clinical |
|
Pulse current-mode signalling for nearly speed-of-light intrachip communcations | Technology development | 2006 | Technology development |
| Sperm cryopreservation in oncological patients: a 14-year follow-up study | 2006 | |||
|
Stem cells and fertility: what does the future hold? | Stem cells | 2006 | Stem cells;IVF clinical |
|
The effectiveness of modified sperm washes in severely oligoasthenozoospermic men infected with human immunodeficiency and hepatitis C viruses | Male fertility | 2006 | Male fertility;IVF laboratory;IVF laboratory;IVF clinical |
| The role of the leptin in reproduction | 2006 | |||
| The significance of premature luteinization in an oocyte-donation programme | Female fertility | 2006 | Female fertility;IVF clinical;IVF laboratory;Female fertility | |
|
Ultrastructure of preimplantation genetic diagnosis-derived human blastocysts grown in a coculture system after vitrification | 2006 | ||
|
Use of Real-Time Polymerase Chain Reaction to Measure Gene Expression in Single Cells. | Technology development | 2006 | Technology development;Female fertility;Pre-implantation genetics;IVF laboratory |
|
Use of washed sperm for assisted reproduction in HIV-positive males without checking viral absence. A risky business? | Male fertility | 2006 | Male fertility;IVF laboratory;IVF laboratory |
|
Vaginal cytology following primary hysterectomy for cervical cancer: is it useful? | Female fertility | 2006 | Female fertility;IVF clinical |
| Value of the sperm chromatin dispersion test in predicting pregnancy outcome in intrauterine insemination: a blind prospective study | Male fertility | 2006 | Male fertility;IVF clinical | |
|
Value of the sperm deoxyribonucleic acid fragmentation level, as measured by the sperm chromatin dispersion test, in the outcome of in vitro fertilization and intracytoplasmic sperm injection | Male fertility | 2006 | Male fertility;IVF clinical |
|
Value of the sperm deoxyribonucleic acid fragmentation level, as measured by the sperm chromatin dispersion test, in the outcome of in vitro fertilization and intracytoplasmic sperm injection. | Male fertility | 2006 | Male fertility;IVF clinical |
|
Vascular endothelial cadherin regulates vascular permeability: Implications for ovarian hyperstimulation syndrome. | IVF clinical | 2006 | IVF clinical;Female fertility;IVF laboratory |
| Age and uterine receptiveness: predicting the outcome of oocyte donation cycles | Aging and rejuvenation | 2005 | Aging and rejuvenation;Female fertility | |
| An embryonic poly(A)-binding protein (ePAB) is expressed in mouse oocytes and early preimplantation embryos. | Technology development | 2005 | Technology development;Female fertility;IVF laboratory | |
| Aneuploidy 12 in a Robertsonian (13;14) carrier: Case report. | Female fertility | 2005 | Female fertility;IVF clinical | |
|
Association of abnormal morphology and altered gene expression in human preimplantation embryos. | IVF clinical | 2005 | IVF clinical;Pre-implantation genetics;IVF laboratory |
| Effect of controlled ovarian hyperstimulation in IVF on endometrial gene expression profiles | 2005 | |||
|
Effect of repeated assisted reproduction techniques on the ovarian response | IVF clinical | 2005 | IVF clinical;Female fertility |
|
E-learning in reproductive medicine | 2005 | ||
|
E-learning in reproductive medicine. | IVF clinical | 2005 | IVF clinical;Technology development;Male fertility |
| Embryo aneuploidy screening for unexplained recurrent miscarriage: a minireview | 2005 | |||
|
Embryonic implantation and leukocyte transendothelial migration: different processes with similar players? | 2005 | ||
| Endometrioma Ovárico en postmenopausia no relacionado con neoplasia ni hormonoterapia exógena. | Female fertility | 2005 | Female fertility | |
|
Estrogen and folliculogenesis: is one necessary for the other? | 2005 | ||
|
Etiologia, diagnostico y manejo del hidrops fetal: revision de 140 casos | Pre-implantation genetics | 2005 | Pre-implantation genetics |
|
Evidence-based medicine is gaining momentum | IVF clinical | 2005 | IVF clinical;Female fertility |
|
Expression of genes regulating chromosome segregation, the cell cycle and apoptosis during human preimplantation development. | IVF clinical | 2005 | IVF clinical;Pre-implantation genetics;Pre-implantation genetics |
|
Fertility preservation options for female patients with malignancies. | Cryobiology | 2005 | Cryobiology;Female fertility |
|
First derivation in Spain of human embryonic stem cell lines: use of long-term cryopreserved embryos and animal-free conditions | 2005 | ||
| First trimester biochemical screening for Down's syndrome in singleton pregnancies conceived by assisted reproduction | Female fertility | 2005 | Female fertility;IVF clinical | |
| First-trimester diagnosis of thrombocytopenia-absent radius (TAR) syndrome in a triplet pregnancy | Female fertility | 2005 | Female fertility;IVF clinical | |
| FISH screening of aneuploidies in preimplantation embryos to improve IVF outcome | 2005 | |||
|
GnRH antagonist in the adjuvant treatment of a recurrent ovarian granulosa cell tumor: A case report | 2005 | ||
|
How would revealing the identity of gamete donors affect current practice? | IVF clinical | 2005 | IVF clinical;IVF clinical;IVF laboratory |
|
Impact of endometrioma resection prior to IVF/ICSI cycles | Female fertility | 2005 | Female fertility;IVF laboratory;Female fertility |
| Isolated unilateral pulmonary agenesis. Early prenatal diagnosis and long-term follow up. | Pre-implantation genetics | 2005 | Pre-implantation genetics;Female fertility;IVF clinical | |
|
Leptin system in embryo development and implantation: a protein in search of a function | 2005 | ||
|
Medical treatment of endometriosis. | Reproductive disorders | 2005 | Reproductive disorders;Female fertility |
|
Mifepristone is an effective oral alternative for the prevention of premature luteinizing hormone surges and/or premature luteinization in women undergoing controlled ovarian hyperstimulation for in vitro fertilization | 2005 | ||
|
Near Speed-of-Light On-Chip Interconnects Using Pulsed Current-Mode Signaling. | Technology development | 2005 | Technology development;Pre-implantation genetics;IVF laboratory |
|
New trends in IVF. Is there any evidence? | IVF clinical | 2005 | IVF clinical;IVF laboratory;Female fertility |
|
Obesity does not impact implantation rates of pregnancy outcome in women attempting conception through oocyte donation | Female fertility | 2005 | Female fertility;IVF clinical;IVF clinical |
|
Progesterone Versus Progesterone Combined With Estradiol as Luteal Support in Cycles Stimulated With GnRH Antagonist/rec-FSH for IVF: A Randomized Clinical Trial. | 2005 | ;IVF clinical | |
| Proteomic analysis of the Gallus gallus embryo at stage-29 of development. | Female fertility | 2005 | Female fertility;IVF clinical;Female fertility | |
| Quality specifications for seminal parameters on the state of the ART. | Male fertility | 2005 | Male fertility;IVF clinical | |
| Removal of hydrosalpinges increases endometrial leukemia inhibitory factor (LIF) expression at the time of implantation window. | Female fertility | 2005 | Female fertility;IVF clinical;IVF clinical | |
| Rotura Uterina en Gestación a Término tras metroplastia Histeroscópica. | Female fertility | 2005 | Female fertility | |
| Semen characteristics in human immunodeficiency virus (HIV)- and hepatitis C (HCV)-seropositive males: predictors of the success of viral removal after sperm washing | 2005 | |||
|
Serum luteinizing hormone in patients undergoing ovarian stimulation with gonadotropin-releasing hormone antagonists and recombinant follicle-stimulating hormone and its relationship with cycle outcome | 2005 | ||
|
Similar endometrial development in oocyte donors treated with either high- or standard-dose GnRH antagonist compared to treatment with a GnRH agonist or in natural cycles | Female fertility | 2005 | Female fertility;IVF clinical |
| Smoking habits of parents and male: female ratio in spermatozoa and preimplantation embryos | 2005 | |||
| Son peores los resultados perinatales en las gestaciones únicas conseguidas mediante técnicas de reproducción Asistida?. | Reproductive disorders | 2005 | Reproductive disorders | |
|
Spermatozoal nuclear determinants of reproductive outcome: implications on ART. | Male fertility | 2005 | Male fertility;IVF clinical;IVF clinical |
|
Successful treatment of an aggressive recurrent post-menopausal endometriosis with an aromatase inhibitor. | 2005 | ||
|
The aromatase inhibitor letrozole increases the concentration of intraovarian androgens and improves in vitro fertilization outcome in low responder patients: a pilot study | Female fertility | 2005 | Female fertility;IVF clinical;IVF clinical |
|
The female athlete and menstrual function | Female fertility | 2005 | Female fertility;IVF laboratory |
|
The implantation of every embryo facilitates the chances of the remaining embryos to implant in an IVF programme: a mathematical model to predict pregnancy and multiple pregnancy rates | 2005 | ||
|
The Italian law on assisted reproduction: a view from Spain | 2005 | ||
| The significance of sperm nuclear DNA strand breaks on reproductive outcome. | Male fertility | 2005 | Male fertility;IVF clinical;Female fertility | |
| The singleton, term gestation, and live birth rate per cycle initiated: a 1-year experience in in vitro fertilization cycles with native and donated oocytes | IVF clinical | 2005 | IVF clinical;Female fertility;IVF laboratory;Pre-implantation genetics | |
|
Typical isolated ectrodactyly of hands and feet: early antenatal diagnosis | Reproductive disorders | 2005 | Reproductive disorders |
| Value of the sperm chromatin dispersion test in predicting pregnancy outcome in intrauterine insemination: a blind prospective study. | Male fertility | 2005 | Male fertility;IVF clinical | |
|
A Fully Integrated On-Chip DC-DC Conversion and Power Management System. | Technology development | 2004 | Technology development;Female fertility |
|
A new follicle aspiration set is equally effective and as well tolerated as the standard needle when used in a prospective randomized trial in a large in vitro fertilization program. | Technology development | 2004 | Technology development;Female fertility;IVF clinical;IVF laboratory |
|
A proteomic approach to study Salmonella typhi periplasmic proteins altered by a lack of the DsbA thiol: disulfide isomerase. | Technology development | 2004 | Technology development;Immunology |
| Actualizaciones del laboratorio clínico. | IVF clinical | 2004 | IVF clinical;IVF clinical;Immunology | |
|
Administration of low-dose LH induces ovulation and prevents vascular hyperpermeability and vascular endothelial growth factor expression in superovulated rats | 2004 | ||
|
Advances in preimplantation genetic diagnosis. | IVF clinical | 2004 | IVF clinical;Pre-implantation genetics |
| Affecting the Results in a Program of Artificial Insemination With Donor Sperm. A 12-year Retrospective Review of More Than 1800 Cycles. | Male fertility | 2004 | Male fertility;IVF clinical | |
| An anatomical fetal brain structure and a normal variant mimicking anomalies on routine neurosonographic imaging: report of two cases | Reproductive disorders | 2004 | Reproductive disorders | |
|
An experimental bagatelle or a wrong mistake? Reply of the authors. | Endometrial receptivity | 2004 | Endometrial receptivity;Female fertility;IVF clinical;IVF laboratory |
| Análisis de 2304 ciclos de Inseminación Artificial Intrauterina. | Reproductive disorders | 2004 | Reproductive disorders | |
| Analysis of chromosomal abnormalities in testicular and epididymal spermatozoa from azoospermic ICSI patients by fluorescence in-situ hybridization | 2004 | |||
| Aneuploidy study of human oocytes first polar body comparative genomic hybridization and metaphase II fluorescence in situ hybridization analysis. | IVF clinical | 2004 | IVF clinical;Female fertility;IVF laboratory;IVF clinical | |
|
Assessment of Ovarian reserve. Is there still a role for ovarian biopsy? First do no harm! | Female fertility | 2004 | Female fertility;IVF clinical;IVF laboratory |
| Assisted reproduction in HIV and HCV infected men of serodiscordant couples | Male fertility | 2004 | Male fertility;IVF clinical | |
|
BMI--the fragility of fertility | 2004 | ||
|
BMI--the fragility of fertility. | Male fertility | 2004 | Male fertility;Female fertility;IVF laboratory |
| Ca+2 and cholesterol and mitochondrial activity in sperm from fertile and infertile men. | Male fertility | 2004 | Male fertility;IVF clinical | |
|
Can antenatal steroids be considered a fetal "stress" test in cases of severe placental insufficiency? | 2004 | ||
|
Can antepartum computerized cardiotocography predict the evolution of intrapartum acid-base status in normal fetuses? | 2004 | ||
| Células madre espermatogonias. | Male fertility | 2004 | Male fertility;IVF clinical;Female fertility | |
| Coasting acts through downregulation of VEGF gene expression and protein secretion | Female fertility | 2004 | Female fertility | |
|
Comparison of two different starting multiple dose gonadotropin-releasing hormone antagonist protocols in a selected group of in vitro fertilization-embryo transfer patients | 2004 | ||
| Concentration of glutathione and expression of glutathione peroxidases 1 and 4 in fresh sperm provide a forecast of the outcome of cryopreservation of human spermatozoa | 2004 | |||
| Consentimientos informados de reproducción asistida y legibilidad lingüística. | Female fertility | 2004 | Female fertility;IVF clinical;IVF clinical;IVF laboratory | |
| Control de calidad en el estudio espermático”. | Male fertility | 2004 | Male fertility;IVF clinical;IVF laboratory | |
| De embriones sobrantes a ovocitos sobrantes. | Female fertility | 2004 | Female fertility;IVF clinical;IVF clinical | |
| Determinants of endometrial receptivity | 2004 | |||
|
Diminished ovarian reserve and access to care. | Female fertility | 2004 | Female fertility;Aging and rejuvenation |
|
Embryo Morphology. Results of a multicentric evaluation”. | Female fertility | 2004 | Female fertility;IVF clinical |
| Embryonic chromosomal abnormalities obtained after rescue intracytoplasmic sperm injection of 1-day-old unfertilized oocytes | 2004 | |||
| Endometrial leptin and leptin receptor expression in women with severe/moderate endometriosis | 2004 | |||
|
Endometrial thickness cannot predict ongoing pregnancy achievement in cycles stimulated with clomiphene citrate for intrauterine insemination | 2004 | ||
|
Evidence based diagnosis and treatment of tubal factor infertility. | Female fertility | 2004 | Female fertility;IVF clinical |
|
Expression profiles of individual human oocytes using microarray technology. | Technology development | 2004 | Technology development;Female fertility;IVF laboratory |
| Extended coasting duration exerts a negative impact on IVF cycle outcome due to premature luteinization | Female fertility | 2004 | Female fertility;IVF clinical | |
| Eyaculación retrógrada e inseminación artificial, apropósito de un caso. | Male fertility | 2004 | Male fertility | |
| Gene expression pattern and immunoreactive protein localization of LGR7 receptor in human endometrium throughout the menstrual cycle | 2004 | |||
| Global gene expression profiling of human endometrial receptivity | 2004 | |||
|
High-throughput asynchronous datapath with software-controlled voltage scaling. | Technology development | 2004 | Technology development;IVF clinical |
|
Immunology of endometriosis and immunotherapy. | Immunology | 2004 | Immunology;Reproductive disorders |
|
Impact of obesity on spontaneous abortion | 2004 | ||
|
Isolation and characterization of two families of satellite DNA with repetitive units of 135 bp and 2.5 Kb in the ant Monomorium subopacum Hymenoptera, Formicidae). | Technology development | 2004 | Technology development |
| Microarrays for Analysis and Diagnosis of Human Embryos | Technology development | 2004 | Technology development;Female fertility;IVF laboratory | |
| mRNA expression of the angiogenesis markers VEGF and CD105 (endoglin) in human breast cancer. | Female fertility | 2004 | Female fertility;IVF clinical | |
| MUC1 e IL-6: posibles marcadores de fertilidad en reproducción humana. | Reproductive disorders | 2004 | Reproductive disorders;Female fertility | |
| Nup88 mRNA overexpression is associated with high aggressiveness of breast cancer. | Female fertility | 2004 | Female fertility | |
| Parameters affecting the results in a program of artificial insemination with donor sperm. A 12-year retrospective review of more than 1800 cycles | 2004 | |||
|
Pregnancy after cryopreservation of donor oocytes and preimplantation genetic diagnosis of embryos in a patient with premature ovarian failure. | Cryobiology | 2004 | Cryobiology;Female fertility |
| Pro-oxidative and anti-oxidative imbalance in human semen and its relation with male fertility | 2004 | |||
| Recursos humanos en el laboratorio de reproducción asistida. análisis comparativo de guidelines de sociedades científicas. | IVF clinical | 2004 | IVF clinical;IVF laboratory;Female fertility | |
|
Relationship among standard semen parameters, glutathione peroxidase/glutathione reductase activity, and mRNA expression and reduced glutathione content in ejaculated spermatozoa from fertile and infertile men | Male fertility | 2004 | Male fertility;IVF clinical |
|
Relationship between standard semen parameters, calcium, cholesterol contents, and mitochondrial activity in ejaculated spermatozoa from fertile and infertile males | 2004 | ||
| Reliability of comparative genomic hybridization to detect chromosome abnormalities in first polar bodies and metaphase II oocytes. | IVF clinical | 2004 | IVF clinical;Pre-implantation genetics | |
| Removal of endometriomas before in vitro fertilization does not improve fertility outcomes: a matched, case-control study | Surgery | 2004 | Surgery;IVF clinical | |
| Report of the results of a 2 year programme of sperm wash and ICSI treatment for human immunodeficiency virus and hepatitis C virus serodiscordant couples | Male fertility | 2004 | Male fertility;IVF laboratory | |
|
Reproductive issues for persons with HIV | Male fertility | 2004 | Male fertility;Female fertility |
| Resultados de nuestro programa de IAC en función de la causa de esterilidad. | 2004 | |||
| Resultados peri natales en los embarazos conseguidos con TRA en el periodo 2000-2003. | Reproductive disorders | 2004 | Reproductive disorders | |
| Role of cholesterol, calcium, and mitochondrial activity in the susceptibility for cryodamage after a cycle of freezing and thawing | Cryobiology | 2004 | Cryobiology;IVF clinical | |
|
Surgery for the removal of endometriomas before in vitro fertilization does not increase implantation and pregnancy rates | Surgery | 2004 | Surgery;IVF clinical |
| Testicular sperm extraction (TESE) and intracytoplasmic sperm injection (ICSI) in hypogonadotropic hypogonadism with persistent azoospermia after hormonal therapy | Reproductive disorders | 2004 | Reproductive disorders;Male fertility | |
|
The extent of nuclear DNA damage in ejaculated spermatozoa impacts on blastocyst development after IVF. | Male fertility | 2004 | Male fertility;Female fertility;IVF clinical |
|
The leptin system during human endometrial receptivity and preimplantation development | 2004 | ||
| The presence of abnormal spermatozoa in the ejaculate: Did apoptosis fail? | Male fertility | 2004 | Male fertility;IVF clinical | |
|
Treatment of PCOS with metformin and other insulin sensitizing agents | Female fertility | 2004 | Female fertility;IVF clinical |
|
Value of basal FSH: prognostic implications for pregnancy outcome. | Female fertility | 2004 | Female fertility;IVF clinical |
|
A combined approach for gene discovery identifies insulin-like growth factor-binding protein-related protein 1 as a new gene implicated in human endometrial receptivity | 2003 | ||
|
A cross-talk between hypoxia and TGF-? orchestrates erytropoietin gene regulation through SP1 and SMADS. | Reproductive disorders | 2003 | Reproductive disorders |
| Abnormal spermatozoa in the ejaculate: abortive apoptosis and faulty nuclear remodeling during spermatogenesis. | Male fertility | 2003 | Male fertility;IVF clinical | |
|
Administration of moderate and high doses of gonadotropins to female rats increases ovarian vascular endothelial growth factor (VEGF) and VEGF receptor-2 expression that is associated to vascular hyperpermeability | 2003 | ||
|
Administration of recombinant human FSH (solution in cartridge) with a pen device in women undergoing ovarian stimulation | Female fertility | 2003 | Female fertility;IVF clinical |
|
Apoptosis and the pathogenesis of endometriosis | Reproductive disorders | 2003 | Reproductive disorders;Female fertility;IVF laboratory |
|
Asynchronous datapath with software-controlled on-chip adaptive voltage scaling for multirate signal processing applications. | Technology development | 2003 | Technology development;IVF laboratory |
|
Bilateral partial oophorectomy in the management of severe ovarian hyperstimulation syndrome (OHSS): ovarian mutilating surgery is not an option in the management of severe OHSS | Surgery | 2003 | Surgery;Female fertility;IVF laboratory |
|
BRCA1/2 Mutation Status Influences Somatic Genetic Progression in Inherited and Sporadic Epithelial Ovarian Cancer Cases. | Female fertility | 2003 | Female fertility;Reproductive disorders |
| Chromosomal abnormalities and embryo development in recurrent miscarriage couples | 2003 | |||
|
Clinical experience and perinatal outcome of blastocyst transfer after coculture of human embryos with human endometrial epithelial cells: a 5-year follow-up study | IVF laboratory | 2003 | IVF laboratory;IVF clinical |
|
Clomiphene citrate versus letrozole for ovarian stimulation: a pilot study. | 2003 | ||
|
Culture conditions affecting biodegradation components of the brown-rot fungus: Gloeophyllum trabeum. | 2003 | ||
|
Cytogenetics in reproductive medicine: The contribution of comparative genomic hybridization (CGH). | Technology development | 2003 | Technology development;IVF clinical |
|
Detailed investigation of factors influencing amplification efficiency and allele drop-out in single cell PCR: implications for preimplantation genetic diagnosis. | IVF clinical | 2003 | IVF clinical;Pre-implantation genetics |
|
Diagnóstico Genético de Pré-implantação: A Visão do Clinico. | IVF laboratory | 2003 | IVF laboratory;IVF clinical |
| Early maternal hypothyroxinemia alters histogenesis and cerebral cortex cytoarchitecture of the progeny. | Reproductive disorders | 2003 | Reproductive disorders | |
|
Endometriosis: Interaction of immune and endocrine systems. | Immunology | 2003 | Immunology;Reproductive disorders |
|
Exercise-induced endocrine pathologies. | Female fertility | 2003 | Female fertility;IVF clinical;IVF clinical |
| Factors that determine discordant outcome from shared oocytes | Female fertility | 2003 | Female fertility;IVF clinical | |
| First-trimester reversed end-diastolic flow in the umbilical artery is not always an ominous sign | Reproductive disorders | 2003 | Reproductive disorders;IVF laboratory | |
| Gene expression profiling of human endometrial receptivity on days LH+2 versus LH+7 by microarray technology | 2003 | |||
| High frequency of chromosomal abnormalities in embryos obtained from oocyte donation cycles | 2003 | |||
| Hormonal and embryonic regulation of chemokine receptors CXCR1, CXCR4, CCR5 and CCR2B in the human endometrium and the human blastocyst | Female fertility | 2003 | Female fertility;IVF clinical;IVF clinical | |
|
How does endometriosis affect infertility? | 2003 | ||
|
Human endometrial receptivity: a genomic approach | 2003 | ||
|
Human immunodeficiency virus (HIV) and Hepatitis C virus (HCV) presence in washed semen: are they absent or present although non-infective. | Male fertility | 2003 | Male fertility;IVF laboratory;IVF clinical;IVF laboratory |
| Impact of preimplantation genetic diagnosis on IVF outcome in implantation failure patients | 2003 | |||
|
Implantation rates after two, three, or five days of embryo culture | 2003 | ||
| Improved accuracy of hysteroembryoscopic biopsies for karyotyping early missed abortions | 2003 | |||
| Increased frequency of chromosome abnormalities in embryos obtained from oocyte donation cycles. | Female fertility | 2003 | Female fertility;IVF clinical;IVF clinical | |
| Intravenous albumin does not prevent moderate-severe ovarian hyperstimulation syndrome in high-risk IVF patients: a randomized controlled study | Female fertility | 2003 | Female fertility;IVF clinical;IVF laboratory | |
|
New concepts in the understanding of the ovarian hyperstimulation syndrome | Female fertility | 2003 | Female fertility;IVF clinical |
| Obesity and the risk of spontaneous abortion after oocyte donation | Female fertility | 2003 | Female fertility;IVF clinical;IVF laboratory | |
| Parámetros que afectan a los resultados de la inseminación artificial con semen de donante. | IVF clinical | 2003 | IVF clinical;IVF laboratory | |
| Preimplantation genetic diagnosis by fluorescence in situ hybridization: clinical possibilities and pitfalls | 2003 | |||
| Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome | 2003 | |||
|
Premio al mejor artículo original publicado en la Revista Iberoamericana de Fertilidad. TGF-?1 regula in vitro a la mucina endometrial humana MUC1 durante la implantación embrionaria. | Female fertility | 2003 | Female fertility;IVF clinical |
|
Questions concerning the suitability of comparative genomic hybridization for preimplantation genetic diagnosis. | Female fertility | 2003 | Female fertility;IVF clinical;IVF laboratory |
|
Rabbit and pig ear skin sample cryobanking: effects of storage time and temperature of the whole ear extirpated immediately after death. | Pre-implantation genetics | 2003 | Pre-implantation genetics |
| Recombinant vs. urinary follicle-stimulating hormone in couples undergoing intrauterine insemination. A randomized study | IVF clinical | 2003 | IVF clinical;IVF laboratory | |
|
Regulation of embryonic implantation | 2003 | ||
| Resultados de un ensayo piloto para un “programa nacional de control de calidad externo del laboratorio de fiv”. | IVF laboratory | 2003 | IVF laboratory;IVF clinical;IVF clinical;IVF laboratory | |
|
Single-cell sequencing and mini-sequencing for preimplantation genetic diagnosis. | IVF clinical | 2003 | IVF clinical;Pre-implantation genetics |
| Testicular sperm extraction (TESE) and ICSI in patients with permanent azoospermia after chemotherapy | Reproductive disorders | 2003 | Reproductive disorders;Male fertility | |
|
The chemokine connection: hormonal and embryonic regulation at the human maternal-embryonic interface--a review | 2003 | ||
|
The effect of pH and oxalate on hydroquinone-derived hydroxyl radical formation in brown-rot wood degradation | 2003 | ||
| The effect of pronuclear morphology on early development and chromosomal abnormalities in cleavage-stage embryos | 2003 | |||
| The origin of biochemical pregnancies: lessons learned from preimplantation genetic diagnosis | 2003 | |||
|
The role of estrogen in uterine receptivity and blastocyst implantation | 2003 | ||
|
To the editor, regarding Williams et al., | Female fertility | 2003 | Female fertility |
|
Transmembrane and truncated (SEC) isoforms of MUC1 in the human endometrium and Fallopian tube | Female fertility | 2003 | Female fertility;Reproductive disorders |
|
Uterine and ovarian function in endometriosis | Reproductive disorders | 2003 | Reproductive disorders;Female fertility;IVF clinical;Technology development |
|
Vitrification of in vitro cultured rabbit morulae | IVF clinical | 2003 | IVF clinical;IVF laboratory;IVF laboratory |
|
Whole genome amplification and comparative genomic hybridization (CGH). | Technology development | 2003 | Technology development;IVF clinical |
|
Whole genome amplification/hybridization following ooplasmic aspiration reveals no evidence of genomic DNA disturbance | Female fertility | 2003 | Female fertility;IVF clinical;IVF clinical |
|
Whole-genome amplification. | Technology development | 2003 | Technology development;IVF clinical |
| A. Gender selection: ethical, scientific, legal, and practical issues | IVF clinical | 2002 | IVF clinical | |
|
An experimental bagatelle or a wrong mistake? | 2002 | ||
| Análise do DNA do espermatozóide humano por citometria de fluxo (CF) | Male fertility | 2002 | Male fertility;IVF clinical | |
| Comparison of polymerase chain reaction-dependent methods for determining the presence of human immunodeficiency virus and hepatitis C virus in washed sperm | 2002 | |||
| Comparison of polymerase chain reaction–dependent methods for determining the presence of human immunodeficiency virus and hepatitis C virus in washed sperm. | IVF laboratory | 2002 | IVF laboratory;Male fertility;Reproductive disorders | |
|
Elevated soluble Fas ligand levels may suggest a role for apoptosis in women with endometriosis | Reproductive disorders | 2002 | Reproductive disorders;Female fertility;IVF laboratory |
|
Erectile dysfunction after radical prostatectomy: hemodynamic profiles and their correlation with the recovery of erectile function | Male fertility | 2002 | Male fertility;Surgery |
|
Estradiol down-regulates MCP-1 expression in human coronary artery endothelial cells. | Female fertility | 2002 | Female fertility;IVF clinical |
|
Estrogen levels and thrombophilia--an intervening variable or a confounder? | 2002 | ||
| Estrogen suppresses vascular monocyte chemotactic protein-1 expression during early atherogenesis. | Female fertility | 2002 | Female fertility;IVF clinical | |
|
Ethics of oocyte cryopreservation in Spain | 2002 | ||
|
Expression and function of 3beta hydroxisteroid dehydrogenase (3beta HSD) type II and corticosteroid binding globulin (CBG) in granulosa cells from ovaries of women with and without endometriosis | 2002 | ||
|
Extracellular matrix-dependent regulation of Fas ligand expression in human endometrial stromal cells | Female fertility | 2002 | Female fertility;IVF clinical |
| Factor Masculino y. Técnicas de Reproducción Asistida. | Male fertility | 2002 | Male fertility;IVF clinical | |
| Factores influyentes en los resultados de la congelación y descongelación del semen humano. | Male fertility | 2002 | Male fertility;IVF clinical | |
|
First clinical application of comparative genomic hybridization and polar body testing for preimplantation genetic diagnosis of aneuploidy. | IVF clinical | 2002 | IVF clinical;Pre-implantation genetics;IVF laboratory |
| Flow cytometry in human reproductive biology | IVF clinical | 2002 | IVF clinical;IVF laboratory | |
| Gender selection: ethical, scientific, legal, and practical issues | 2002 | |||
| Hormonal and embryonic regulation of chemokines IL-8, MCP-1 and RANTES in the human endometrium during the window of implantation | Female fertility | 2002 | Female fertility;IVF clinical;IVF clinical | |
| Human endometrial receptivity: gene regulation | 2002 | |||
|
In vitro fertilization with intracytoplasmic sperm injection for human immunodeficiency virus-1 serodiscordant couples | 2002 | ||
|
Modulation of the immune system by sex steroids. | Immunology | 2002 | Immunology;Female fertility |
|
Modulation of vascular immune function and atherosclerosis by reproductive hormones. | Immunology | 2002 | Immunology;IVF clinical |
|
Molecular basis of implantation | 2002 | ||
|
New techniques on embryo manipulation | 2002 | ||
|
New techniques on embryo manipulation. | Pre-implantation genetics | 2002 | Pre-implantation genetics;IVF laboratory |
| Oocyte and embryo quality after coasting: the experience from oocyte donation | Female fertility | 2002 | Female fertility;IVF clinical | |
|
Optimizing ovulation induction in women with polycystic ovarian syndrome. | Reproductive disorders | 2002 | Reproductive disorders;IVF clinical |
|
Paracrine dialogue in implantation | 2002 | ||
|
Paracrine interactions during human implantation | 2002 | ||
| Preimplantation genetic diagnosis for single gene disorders: experience with five single gene disorders. | Pre-implantation genetics | 2002 | Pre-implantation genetics;Female fertility | |
|
Preimplantation genetic diagnosis: an alternative to prenatal diagnosis. | Pre-implantation genetics | 2002 | Pre-implantation genetics;IVF clinical |
|
Proven and potential benefits of metformin in women with polycystic ovarian syndrome. | Reproductive disorders | 2002 | Reproductive disorders;Female fertility;IVF clinical |
|
Regulation of fas ligand expression by IL-8 in human endometrium | Female fertility | 2002 | Female fertility;IVF clinical |
|
Rescue IVF and coasting with the use of a GnRH antagonist after ovulation induction. | 2002 | ||
| Resultados de 451 ciclos de inseminación artificial realizados en 2001. | 2002 | |||
| Seguimiento de 237 pacientes incluidas en nuestro programa de inseminación artificial. | Reproductive disorders | 2002 | Reproductive disorders;IVF clinical | |
|
Sex steroids and the immune system. | Female fertility | 2002 | Female fertility;Male fertility |
| Sperm and oocyte donor selection and management: experience of a 10 year follow-up of more than 2100 candidates | 2002 | |||
| Testicular sperm extraction (TESE) and intracytoplasmic sperm injection (ICSI) results in secondary azoospermic patients after chemotherapy. | Male fertility | 2002 | Male fertility;Reproductive disorders | |
|
The "vanishing embryo" phenomenon in an oocyte donation programme | Female fertility | 2002 | Female fertility;IVF clinical;Pre-implantation genetics;Technology development |
|
The "vanishing embryo" phenomenon in an oocyte donation programme. | Female fertility | 2002 | Female fertility;IVF clinical;Pre-implantation genetics;Technology development |
| The endometrium versus embryonic quality in endometriosis-related infertility | Reproductive disorders | 2002 | Reproductive disorders;Female fertility;Female fertility | |
|
The reproductive system from an immunological perspective. | Immunology | 2002 | Immunology;IVF clinical |
| The role of endothelial cells in the pathogenesis of ovarian hyperstimulation syndrome | Female fertility | 2002 | Female fertility;IVF clinical;IVF clinical | |
|
Towards a comprehensive analysis of chromosomes and DNA sequences in human embryos. | Pre-implantation genetics | 2002 | Pre-implantation genetics;Female fertility;IVF clinical |
| Transabdominal ultrasound-guided embryo transfer does not increase pregnancy rates in oocyte recipients | IVF clinical | 2002 | IVF clinical;Female fertility | |
| Transabdominal ultrasound-guided embryo transfer does not increase pregnancy rates in oocyte recipients. | IVF clinical | 2002 | IVF clinical;Female fertility | |
|
Unprocessed proinsulin promotes cell survival during neurulation in the chick embryo. | Female fertility | 2002 | Female fertility;IVF clinical |
|
Vascular endothelial growth factor receptor-2 activation induces vascular permeability in hyperstimulated rats, and this effect is prevented by receptor blockade | 2002 | ||
|
Viable offspring derived from cryopreserved haploid rabbit parthenotes | Pre-implantation genetics | 2002 | Pre-implantation genetics;IVF clinical |
|
Vitrification and rapid freezing of rabbit fetal tissues and skin samples from rabbits and pigs. | Pre-implantation genetics | 2002 | Pre-implantation genetics;IVF clinical |
|
What are the implications for the next delivery in primigravidae who have an elective caesarean section for breech presentation? | 2002 | ||
|
A successful strategy for preimplantation genetic diagnosis of myotonic dystrophy using multiplex fluorescent PCR. | IVF clinical | 2001 | IVF clinical;Pre-implantation genetics |
| Acrocentric chromosome disomy is increased in spermatozoa from fathers of Turner syndrome patients | Male fertility | 2001 | Male fertility;Pre-implantation genetics;IVF laboratory | |
|
Aminopeptidase N activity in human endometrium. | Female fertility | 2001 | Female fertility;IVF clinical;IVF laboratory |
| An analysis of spontaneous hatching in a human endometrial epithelial coculture system: is assisted hatching justified? | 2001 | |||
|
Analysis of SAW properties of epitaxial ZnO films grown on R-Al2O3 substrates. | Technology development | 2001 | Technology development |
|
Blastocyst transfer: does it really affect the outcome? | 2001 | ||
|
Comparison of the effect of two different handling media on rabbit zygote developmental ability | Pre-implantation genetics | 2001 | Pre-implantation genetics |
|
Controlled ovarian hyperstimulation does not adversely affect endometrial receptivity in in vitro fertilization cycles. | Endometrial receptivity | 2001 | Endometrial receptivity;IVF clinical |
| Detección del virus de la Hepatitis C en semen lavado de varones seropositivos para su posterior uso en reproducción asistida: resultados preliminares. | Male fertility | 2001 | Male fertility;IVF clinical;Female fertility | |
|
Diagnosis of single gene defects. | Female fertility | 2001 | Female fertility;ivf lab |
| Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation. | Female fertility | 2001 | Female fertility;IVF clinical;IVF laboratory;IVF clinical | |
|
Embryo effects in human implantation: embryonic regulation of endometrial molecules in human implantation | 2001 | ||
| Endocrinological and ultrasonographic variations after immature oocyte retrieval in a natural cycle | 2001 | |||
| Endometrial quality in infertile women with endometriosis | Reproductive disorders | 2001 | Reproductive disorders;Female fertility | |
|
Endometrial receptivity in terms of pinopode expression is not impaired in women with endometriosis in artificially prepared cycles | Endometrial receptivity | 2001 | Endometrial receptivity;Female fertility;IVF clinical |
| Es segura la utilización del semen de donante? Seguimiento de enfermedades infecciosas y desórdenes hereditarios en la población de donantes de semen y el programa de IAD; experiencia de 10 años | Male fertility | 2001 | Male fertility;IVF clinical;IVF clinical | |
|
Esterilidad e infertilidad humana: abordaje y tratamiento. | Female fertility | 2001 | Female fertility;IVF clinical |
| Estrogen inhibits monocyte chemotactic protein-1 production in human coronary artery smooth muscle cells: A mechanism for its anti-atherogenic effect. | Female fertility | 2001 | Female fertility;IVF clinical;Reproductive disorders | |
|
Expression of Pleurotus eryngii aryl-alcohol oxidase in Aspergillus nidulans: purification and characterization of the recombinant enzyme. | Immunology | 2001 | Immunology |
|
Expression, production, and secretion of vascular endothelial growth factor and interleukin-6 by granulosa cells is comparable in women with and without endometriosis | Reproductive disorders | 2001 | Reproductive disorders;Female fertility |
|
Future developments in preimplantation genetic diagnosis. | Pre-implantation genetics | 2001 | Pre-implantation genetics;Technology development |
|
Genetic alterations in gastric cancers from British patients. | IVF clinical | 2001 | IVF clinical;Pre-implantation genetics;IVF clinical |
| Human endometrial mucin MUC1 is up-regulated by progesterone and down-regulated in vitro by the human blastocyst | Female fertility | 2001 | Female fertility;IVF clinical;Reproductive disorders;Technology development | |
| Human ovarian steroid secretion in vivo: effects of GnRH agonist versus antagonist (cetrorelix) | Female fertility | 2001 | Female fertility;IVF clinical | |
| Incidence of sperm chromosomal abnormalities in a risk population: relationship with sperm quality and ICSI outcome | 2001 | |||
| Increasing levels of estradiol are deleterious to embryonic implantation because they directly affect the embryo | 2001 | |||
| Molecular Cytogenetic Comparison of Apocrine Hyperplasia and Apocrine Carcinoma of the Breast. | Female fertility | 2001 | Female fertility;IVF clinical | |
|
MUC1, glycans and the cell-surface barrier to embryo implantation | Female fertility | 2001 | Female fertility;IVF clinical |
| Numerical chromosome abnormalities in the spermatozoa of the fathers of children with trisomy 21 of paternal origin: generalised tendency to meiotic non-disjunction. | Male fertility | 2001 | Male fertility;Pre-implantation genetics | |
|
Obstetric significance of anti-Jr(a) antibody. | Female fertility | 2001 | Female fertility;IVF clinical |
|
PGD protocols using multiplex fluorescent PCR. | IVF clinical | 2001 | IVF clinical;Pre-implantation genetics |
|
Preimplantation genetic diagnosis: applications for molecular medicine. | IVF clinical | 2001 | IVF clinical;Pre-implantation genetics |
|
Preimplantation genetic diagnostic protocols for alpha- and beta-thalassaemias using multiplex fluorescent PCR. | IVF clinical | 2001 | IVF clinical;Pre-implantation genetics |
|
Reconstruction of the heteroparental diploid condition in rabbit zygotes by nuclear transfer. | 2001 | ||
|
Reproductive outcome in patients with diminished ovarian reserve. | Female fertility | 2001 | Female fertility;IVF clinical |
|
Role of thyroid hormones in the maturation and organisation of rat barrel cortex. | Female fertility | 2001 | Female fertility |
| Silver-Russell syndrome associated to Mayer-Rokitansky-Kuster-Hauser syndrome, diabetes and hirsutism. | Reproductive disorders | 2001 | Reproductive disorders;Female fertility;IVF clinical | |
| The effect of repeated controlled ovarian stimulation in donors | 2001 | |||
|
The effectiveness and safety of recombinant human LH to support follicular development induced by recombinant human FSH in WHO group I anovulation: evidence from a multicentre study in Spain | 2001 | ||
|
Two-step metalorganic chemical vapor deposition growth of piezoelectric ZnO thin film on SiO2/Si substrate. | Technology development | 2001 | Technology development |
| Use of fluorescence in situ hybridization to assess the chromosomal status of embryos obtained from cryopreserved oocytes | 2001 | |||
|
A successful strategy for preimplantation diagnosis of medium-chain acyl-CoA dehydrogenase (MCAD) deficiency. | Pre-implantation genetics | 2000 | Pre-implantation genetics;Female fertility;IVF clinical;IVF laboratory;Cryobiology |
|
Analysis of temperature compensated SAW modes in ZnO/SiO2/Si multilayer structures | Technology development | 2000 | Technology development;IVF clinical |
|
Aryl-alcohol oxidase protein sequence: a comparison with glucose oxidase and other FAD oxidoreductases. | Technology development | 2000 | Technology development |
|
Basal antral follicle number and mean ovarian diameter predict cycle cancellation and ovarian responsiveness in assisted reproductive technology cycles. | Female fertility | 2000 | Female fertility;IVF clinical |
|
Biochemical characterization, cDNA cloning and protein crystallization of aryl-alcohol oxidase from Pleurotus pulmonarius. Biochim. | Immunology | 2000 | Immunology;IVF clinical;IVF laboratory |
|
Blastocyst transfer for couples with multiple IVF failures? | 2000 | ||
| Clinical experience employing co-culture of human embryos with autologous human endometrial epithelial cells | Female fertility | 2000 | Female fertility;IVF clinical | |
| Comparative Genomic Hybridization Analysis of Myoepithelial Carcinoma of the Breast. | Female fertility | 2000 | Female fertility | |
|
Comparative Genomic Hybridization Reveals Extensive Variation Among Different MCF-7 Cell Stocks. | Pre-implantation genetics | 2000 | Pre-implantation genetics;Technology development |
|
Comprehensive chromosomal analysis of human preimplantation embryos using whole genome amplification and single cell comparative genomic hybridization. | Pre-implantation genetics | 2000 | Pre-implantation genetics;Female fertility;IVF laboratory |
|
Cytokines in the peritoneal environment. | Immunology | 2000 | Immunology;Reproductive disorders |
|
Deletion and duplication of the adenomatous polyposis coli gene resulting from an interchromosomal insertion involving 5 (q22q23.3) in the father. | Pre-implantation genetics | 2000 | Pre-implantation genetics;Technology development |
|
Diagnostic accuracy of sonohysterography, transvaginal sonography and hysteroscopy in uterine cavity diseases. | Reproductive disorders | 2000 | Reproductive disorders;Female fertility |
| Effect of injected spermatozoa morphology on the outcome of intracytoplasmic sperm injection in humans | 2000 | |||
| Effects of prandial glycemic changes on objective fetal heart rate parameters | Reproductive disorders | 2000 | Reproductive disorders | |
| Embryo reduction of multifetal pregnancies following assisted reproduction treatment: a modification of the transvaginal ultrasound-guided technique | 2000 | |||
| Embryonic regulation of endometrial epithelial apoptosis during human implantation | 2000 | |||
| Embryonic regulation of endometrial molecules in human implantation | Female fertility | 2000 | Female fertility;IVF clinical | |
|
Empty follicle syndrome: evidence for recurrence | Reproductive disorders | 2000 | Reproductive disorders;Female fertility |
|
Empty follicle syndrome: evidence for recurrence. | Reproductive disorders | 2000 | Reproductive disorders;Female fertility |
|
Endogenous LH surge detection versus administration of HCG to correctly time intrauterine insemination: which provides a better pregnancy rate? | Female fertility | 2000 | Female fertility;IVF clinical |
|
Evaluation of basal estradiol levels in assisted reproductive technology cycles. | Female fertility | 2000 | Female fertility;IVF clinical |
| Follicular hormonal environment and embryo quality in women with endometriosis | Female fertility | 2000 | Female fertility;Reproductive disorders | |
|
High doses of gonadotrophins combined with stop versus non-stop protocol of GnRH analogue administration in low responder IVF patients: a prospective, randomized, controlled trial | Female fertility | 2000 | Female fertility;IVF clinical |
|
High doses of gonadotrophins combined with stop versus non-stop protocol of GnRH analogue administration in low responder IVF patients: a prospective, randomized, controlled trial. | Female fertility | 2000 | Female fertility;IVF clinical |
| Impact of stage III-IV endometriosis on recipients of sibling oocytes: matched case-control study | 2000 | |||
|
In vivo regulation of cell death by embryonic (pro)insulin and the insulin receptor during early retinal neurogenesi | Female fertility | 2000 | Female fertility;IVF clinical |
| Increased adhesiveness in cultured endometrial-derived cells is related to the absence of moesin expression | Female fertility | 2000 | Female fertility;IVF clinical | |
| Indicaciones clínicas de la microinyección intracitoplasmática de espermatozoides. | Male fertility | 2000 | Male fertility;IVF clinical;IVF laboratory | |
|
Influence of sequence duration and number of electrical pulses upon rabbit oocyte activation and parthenogenetic in vitro development. | Technology development | 2000 | Technology development;IVF laboratory |
| Intracytoplasmic sperm injection with cryopreserved testicular spermatozoa | 2000 | |||
| Is there a place for preimplantation genetic diagnosis screening in recurrent miscarriage patients? | 2000 | |||
| Leptin and leptin receptor are expressed in the human endometrium and endometrial leptin secretion is regulated by the human blastocyst | 2000 | |||
| Leptin and reproduction | 2000 | |||
|
Paracrine regulators of implantation | 2000 | ||
|
Presence of Fas-Fas ligand system and bcl-2 gene products in cells and fluids from gonadotropin-stimulated human ovaries | 2000 | ||
|
Regulation of fas ligand expression in breast cancer cells by estrogen: functional differences between estradiol and tamoxifen. | Female fertility | 2000 | Female fertility;IVF clinical |
| Screening for AZF deletion in a large series of severely impaired spermatogenesis patients | 2000 | |||
|
Southern blot screening for lignin peroxidase and aryl-alcohol oxidase genes in 30 fungal species | Technology development | 2000 | Technology development;IVF clinical |
| The effect of intercourse on pregnancy rates during assisted human reproduction | 2000 | |||
| The human blastocyst regulates endometrial epithelial apoptosis in embryonic adhesion | 2000 | |||
| The pathophisiology of endometriosis-associated infertility: follicular environment and embryo quality. | Female fertility | 2000 | Female fertility;Reproductive disorders;IVF clinical | |
| The pathophysiology of endometriosis-associated infertility: follicular environment and embryo quality | 2000 | |||
| The potential use of maturation in vitro of human oocytes in low responder patients | 2000 | |||
|
Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial. The European Orgalutran Study Group | 2000 | ||
|
Triplets: outcomes of expectant management versus multifetal reduction for 127 pregnancies. | Female fertility | 2000 | Female fertility;IVF clinical;Cryobiology |
|
Use of a variable electrical pulsing sequence in rabbit oocyte activation. | Technology development | 2000 | Technology development |
|
Vitrification and rapid-freezing of cumulus cells from rabbits and pigs. | Pre-implantation genetics | 2000 | Pre-implantation genetics;IVF laboratory;IVF clinical |
|
A prospective, randomized, double-blind clinical trial to study the efficacy and efficiency of a fixed dose of recombinant follicle stimulating hormone (Puregon) in women undergoing ovarian stimulation. | Female fertility | 1999 | Female fertility;IVF clinical |
|
Antithyroid antibodies do not affect pregnancy outcome in women undergoing assisted reproduction. | Female fertility | 1999 | Female fertility;IVF clinical;IVF clinical |
|
Chemokines and human reproduction. | Female fertility | 1999 | Female fertility;IVF clinical;IVF clinical;IVF laboratory |
|
Chronology of venous leak development following radical prostatectomy. | Male fertility | 1999 | Male fertility;Surgery |
| Coculture of human embryos with autologous human endometrial epithelial cells in patients with implantation failure. | Female fertility | 1999 | Female fertility;IVF clinical | |
| Cytokines in older patients undergoing in vitro fertilization: the relationship to the response to controlled ovarian hyperstimulation. | Female fertility | 1999 | Female fertility;IVF clinical;Female fertility | |
|
Detailed chromosomal and molecular genetic analysis of single cells by whole genome amplification and comparative genomic hybridisation. | Technology development | 1999 | Technology development;IVF clinical |
| El endotelio como origen de la OHSS | Female fertility | 1999 | Female fertility;IVF clinical | |
|
Electroactivation of rabbit oocytes in an hypotonic pulsing medium and parthenogenetic in vitro development without cytochalasin B-diploidizing pretreatment. | Technology development | 1999 | Technology development |
| Genomic instability in gadd45-deficient mice. | Technology development | 1999 | Technology development;IVF clinical;IVF laboratory | |
|
Human embryo fragmentation in vitro and its implications for pregnancy and implantation | Female fertility | 1999 | Female fertility;IVF clinical;Reproductive disorders |
|
Increased prevalence of antithyroid antibodies in women with recurrent pregnancy loss but not in women undergoing assisted reproduction. | Female fertility | 1999 | Female fertility;IVF clinical;IVF laboratory |
|
Interleukin-8 expression in endometrial stromal cells is regulated by integrin-dependent cell adhesion. | Female fertility | 1999 | Female fertility;IVF clinical;IVF clinical |
|
Interleukin-8 stimulates the adhesion of endometrial stromal cells to fibronectin. | Female fertility | 1999 | Female fertility;IVF clinical |
|
Is the endometrium or oocyte/embryo affected in endometriosis? | Female fertility | 1999 | Female fertility;Reproductive disorders |
|
Macrophage derived growth factors modulate Fas ligand expression in cultured endometrial stromal cells: a role in endometriosis. | Female fertility | 1999 | Female fertility;IVF clinical;IVF laboratory |
| Microambiente autocrino y paracrino folicular y calidad embrionaria en mujeres con endometriosis. | Female fertility | 1999 | Female fertility;Reproductive disorders | |
|
Microdose follicular phase gonadotropin-releasing hormone agonist (GnRh-a) compared with luteal phase GnRh-a for ovarian stimulation at in vitro fertilization. | Female fertility | 1999 | Female fertility;IVF clinical |
|
Molecular cloning of aryl-alcohol oxidase from the fungus Pleurotus eryngii, an enzyme involved in lignin degradation. | Technology development | 1999 | Technology development |
| Monocyte chemotactic protein-1 expression in human corpus luteum. | Female fertility | 1999 | Female fertility | |
| O-126. Embryonic regulation of MCP-1 in human endometrial epithelial cells. | Female fertility | 1999 | Female fertility;IVF clinical | |
| Positive outcome after preimplantation diagnosis of aneuploidy in human embryos. | Female fertility | 1999 | Female fertility;Pre-implantation genetics | |
|
Pretreatment evaluation and screening for ART. | IVF clinical | 1999 | IVF clinical;Female fertility |
|
Prospective, randomized, crossover study to evaluate the benefit of human chorionic gonadotropin-timed versus urinary luteinizing hormone-timed intrauterine inseminations in clomiphene citrate-stimulated treatment cycles. | Female fertility | 1999 | Female fertility;IVF clinical |
| Rapid visualization of metaphase chromosomes in single human blastomeres after fusion with in-vitro matured bovine eggs. | Female fertility | 1999 | Female fertility;IVF clinical | |
|
Recent advances and future developments in PGD. | IVF clinical | 1999 | IVF clinical;IVF laboratory |
|
Regulation of monocyte chemotactic protein-1 expression in human endometrial cells by integrin-dependent cell adhesion. | Female fertility | 1999 | Female fertility;IVF clinical;Reproductive disorders |
|
Regulation of monocyte chemotactic protein-1 expression in human endometrial stromal cells by estrogen and progesterone. | Female fertility | 1999 | Female fertility;IVF clinical |
|
Unicornuate uterus with a rudimentary horn and ovarian dysgerminoma. A case report. | Female fertility | 1999 | Female fertility;Reproductive disorders;Female fertility |
|
Women with declining ovarian reserve may demonstrate a decrease in day 3 serum inhibin B before a rise in day 3 follicle-stimulating hormone. | Female fertility | 1999 | Female fertility;IVF clinical |
|
A prospective, randomized trial of nifedipine vs. ritodrine in threatened preterm labor | Female fertility | 1998 | Female fertility;IVF clinical;Technology development |
|
Basic fibroblast growth factor: peritoneal and follicular fluid levels and its effect on the early embryonic development. | Female fertility | 1998 | Female fertility;IVF clinical |
|
First pregnancies after preconception diagnosis of translocations of maternal origin. | Female fertility | 1998 | Female fertility;IVF clinical |
|
Flow cytometric analysis of whole organs and embryos. | Female fertility | 1998 | Female fertility;IVF clinical |
| Follicular fluid of women with endometriosis stimulates the proliferation of endometrial stromal cells. | Female fertility | 1998 | Female fertility;IVF clinical | |
|
Hysterosalpingo contrast sonography (HyCoSy) for the assessment of tubal patency | Technology development | 1998 | Technology development;Female fertility |
|
Increasing the length of the middle crura for better tip projection in primary rhinoplasty. | Reproductive disorders | 1998 | Reproductive disorders |
| Increasing uterine receptivity by decreasing estradiol levels during the preimplantation period in high responders with the use of a follicle-stimulating hormone step-down regimen. | Female fertility | 1998 | Female fertility;IVF clinical | |
| Interleukin-8 in the human endometrium. | Female fertility | 1998 | Female fertility;IVF clinical;IVF clinical | |
|
Interleukin-8 induces proliferation of endometrial stromal cells: A potential autocrine growth factor. | Female fertility | 1998 | Female fertility;IVF clinical;IVF clinical |
| Midtrimester urine human chorionic gonadotropin b-subunit core fragment levels and the subsequent development of preeclampsia. | Female fertility | 1998 | Female fertility;Reproductive disorders;Technology development | |
|
Modulation of the chaperone heat shock cognate 70 by embryonic (pro)insulin correlates with prevention of apoptosis. | Female fertility | 1998 | Female fertility;IVF clinical;IVF laboratory |
|
MUC1 and endometrial receptivity. | Endometrial receptivity | 1998 | Endometrial receptivity;Female fertility |
| Mutations of adenomatous polyposis coli (APC) gene are uncommon in sporadic desmoid tumours. | Female fertility | 1998 | Female fertility | |
| Ooplasmic transfer in mature human oocytes. | Female fertility | 1998 | Female fertility;IVF clinical | |
|
Potential implications of chemokines in reproductive function: an attractive idea. | Female fertility | 1998 | Female fertility |
|
Preimplantation genetic diagnosis of cancer: familial adenomatous polyposis coli (FAPC). | Pre-implantation genetics | 1998 | Pre-implantation genetics;IVF clinical;Pre-implantation genetics;IVF laboratory |
|
Proinsulin and insulin-like growth factor I complementary expression and roles in early development. | Female fertility | 1998 | Female fertility;IVF clinical;Reproductive disorders;IVF clinical |
|
Response to Letters to the Editor. A negative study with power. | Female fertility | 1998 | Female fertility;Female fertility;Reproductive disorders |
|
Rupture of an ovarian endometrioma during the first trimester of pregnancy. | Female fertility | 1998 | Female fertility;IVF clinical |
| Spontaneous abortions are reduced after preconception diagnosis or translocations. | Female fertility | 1998 | Female fertility;Female fertility | |
|
Strategies for preimplantation genetic diagnosis of single gene disorders by DNA amplification. | Pre-implantation genetics | 1998 | Pre-implantation genetics;IVF clinical;IVF clinical |
|
Synthesis and differentially regulated processing of proinsulin in developing chick pancreas, liver and neuroretina. | Reproductive disorders | 1998 | Reproductive disorders |
|
The detection of diminished ovarian reserve in infertile women. | Female fertility | 1998 | Female fertility;IVF clinical;Technology development |
|
The effect of monocyte chemotactic protein-1 in intraperitoneal adhesion formation in a mice model. | Female fertility | 1998 | Female fertility |
|
The peritoneal fluid levels of Interleukin-12 in women with endometriosis. | Reproductive disorders | 1998 | Reproductive disorders;Female fertility |
|
The role of monocyte chemotactic protein-1 in intraperitoneal adhesion formation. | Female fertility | 1998 | Female fertility;IVF clinical |
|
Virtual Reality Training for the Diagnosis of Prostate Cancer. | Male fertility | 1998 | Male fertility;Reproductive disorders |
|
Antiphospholipid antibodies and pregnancy rates and outcome in IVF patients. | Female fertility | 1997 | Female fertility;IVF clinical |
|
Birth of infant after transfer of anucleate donor oocyte cytoplasm into recipient eggs. | Female fertility | 1997 | Female fertility;IVF clinical;Reproductive disorders |
|
Clinical markers of gametogenic failure. Perimenopause | Female fertility | 1997 | Female fertility;IVF clinical;IVF clinical |
|
Cryopreservation of single human spermatozoa. | Cryobiology | 1997 | Cryobiology;Female fertility |
| Detection of haemoglobinopathies and chromosome aneuploidy from minute DNA samples using multiplex PCR. | Pre-implantation genetics | 1997 | Pre-implantation genetics;Female fertility | |
| Endometrial thickness and serum oestradiol concentrations as predictors of outcome in oocyte donation. | Female fertility | 1997 | Female fertility;IVF clinical;IVF laboratory | |
|
Evaluation of the prognostic significance of day 3 E2 levels in in vitro fertilization. | Female fertility | 1997 | Female fertility;IVF clinical |
|
Evaluation of the prognostic significance of day 3 FSH:LH ratios in in vitro fertilization. | Female fertility | 1997 | Female fertility;IVF clinical;IVF laboratory;Cryobiology |
| Expression of bax mRNA associated with apoptosis in human oocytes and embryos. | Female fertility | 1997 | Female fertility;IVF clinical | |
|
Genetic diagnosis before implantation. | Pre-implantation genetics | 1997 | Pre-implantation genetics;IVF clinical |
| Growth-regulated a expression in human preovulatory follicles and ovarian cells. | Female fertility | 1997 | Female fertility;IVF clinical | |
| Leukemia inhibitory factor expression in human follicular fluid and ovarian cells. | Female fertility | 1997 | Female fertility;IVF clinical | |
| Myoadenylate deaminase deficiency myopathy in pregnancy | Female fertility | 1997 | Female fertility;Reproductive disorders;IVF clinical | |
|
Oocyte Donation. | Female fertility | 1997 | Female fertility;IVF clinical |
| Oocyte quality in polycystic ovaries revisited: identification of a particular subgroup of women. | Reproductive disorders | 1997 | Reproductive disorders;Female fertility | |
|
Ovarian reserve screening. | Technology development | 1997 | Technology development;Female fertility |
|
Pregnancy after recovery of five testicular sperm cell cryopreserved under empty zona pellucida. | Male fertility | 1997 | Male fertility;Female fertility;IVF laboratory |
|
Single cell detection of beta-thalassaemia mutations using silver stained SSCP analysis: an application for preimplantation diagnosis. | Female fertility | 1997 | Female fertility;Reproductive disorders;IVF laboratory |
|
Structure and chromosomal mapping of the mouse P2X3 gene. | Female fertility | 1997 | Female fertility;Reproductive disorders |
|
Use of anucleate donor oocyte cytoplasm in recipient eggs. | Female fertility | 1997 | Female fertility;IVF clinical |
| APC gene mutation and DNA microsatellite instability in pancreatic cancers of UK origin. | Female fertility | 1996 | Female fertility;Pre-implantation genetics | |
|
Characteristics of gonadotropin response, follicular development, and endometrial growth and maturation across consecutive cycles of clomiphene citrate treatment. | Female fertility | 1996 | Female fertility;IVF clinical |
| Complementary roles of the insulin family of factors and receptors in early development and neurogenesis. | Female fertility | 1996 | Female fertility;IVF clinical;IVF clinical | |
| Cytokines-adhesion molecules-invasive proteinases. The missing paracrine/autocrine link in embryonic implantation? | Female fertility | 1996 | Female fertility;IVF clinical | |
|
Differential and tissue-specific regulation of (pro)insulin and insulin-like growth factor-I mRNAs and levels of thyroid hormones in growth-retarded embryos. | Female fertility | 1996 | Female fertility;IVF clinical;Male fertility;Technology development |
|
Efficacy of selection criteria for ovarian reserve screening using the clomiphene citrate challenge test in a tertiary fertility center population. | Female fertility | 1996 | Female fertility;IVF clinical;IVF clinical |
|
Endometrial thickness is predictive of histologic endometrial maturation in women undergoing hormone replacement for ovum donation. | Female fertility | 1996 | Female fertility;IVF clinical;IVF laboratory |
|
Evaluation and treatment of low responders. | Female fertility | 1996 | Female fertility;IVF clinical |
|
Four novel germline mutations of the APC gene. | Male fertility | 1996 | Male fertility;Female fertility |
|
Growth-regulated gene a expression in human peritoneal environment with endometriosis. | Female fertility | 1996 | Female fertility;Reproductive disorders;Surgery |
|
Human guanylate kinase (GUK1): cDNA sequence, expression and chromosomal localisation. | Female fertility | 1996 | Female fertility |
|
In vitro fertilization outcome in women with hydrosalpinx. | Reproductive disorders | 1996 | Reproductive disorders;Female fertility |
|
Infertility after age 35: Diagnostic strategies. | Female fertility | 1996 | Female fertility;Aging and rejuvenation;IVF clinical |
|
Intraobserver, interobserver variation of sperm critical morphology: comparison of examiner and computer-assisted analysis. | Male fertility | 1996 | Male fertility;IVF clinical;Aging and rejuvenation |
|
Maternal serum creatine kinase: a possible predictor of tubal pregnancy? | Female fertility | 1996 | Female fertility;IVF clinical |
|
Not all assays are equal. Response to Letters-to-the-Editor | IVF clinical | 1996 | IVF clinical;IVF clinical |
|
Preimplantation genetic diagnosis of beta-thalassaemia. | Pre-implantation genetics | 1996 | Pre-implantation genetics;IVF clinical;IVF clinical;IVF laboratory |
|
Premature luteinization during controlled ovarian hyperstimulation for in vitro fertilization-embryo transfer has no impact in pregnancy outcome. | Female fertility | 1996 | Female fertility;IVF clinical;Surgery |
| Repercusión of estrogenotherapy whit and whithout oppsosition of progesteronq therapy in the blood pressure. | Female fertility | 1996 | Female fertility | |
| Repercusión of the hormonal substitute therapy in the antitrombin III. | Reproductive disorders | 1996 | Reproductive disorders;Aging and rejuvenation | |
|
Reply to the letter to the editor. How much is left in the tank - can we tell? | IVF laboratory | 1996 | IVF laboratory;IVF clinical |
|
Correlation of loss of heterozygosity with cytogenetic analysis using g-banding and fluorescence in situ hybridization in aneuploid cultures from two human testicular germ-cell tumors. | Pre-implantation genetics | 1995 | Pre-implantation genetics;Female fertility |
|
Differential down regulation of gonadotrope responsiveness following pulsatile GnRH-agonist administration in the presence and absence of long term GnRH-antagonist therapy. | Female fertility | 1995 | Female fertility;IVF clinical |
|
Epidermal growth factor (EGF), transforming growth factor-alpha (TGF-alpha), and their common (EGF) receptor. Potential relevance of this growth factor receptor system in normal human endometrium. | Female fertility | 1995 | Female fertility;IVF clinical |
|
Evaluation of the reproductive performance of women with elevated day 10 progesterone levels during ovarian reserve screening. | Female fertility | 1995 | Female fertility;IVF clinical |
|
Life table analysis of cumulative pregnancy rates based on the results of ovarian reserve screening and patient age in a general infertility population. | Female fertility | 1995 | Female fertility;IVF clinical |
| Localisation of the gene encoding diacylglycerol kinase 3 (DAGK3) to human chromosome 3q27-28 and mouse chromosome 16. | Female fertility | 1995 | Female fertility | |
|
Measures of Association - Smoking and Fecundity. | Male fertility | 1995 | Male fertility;Female fertility |
| Papel del antígeno de células escamosas (SCC-Ag) en el diagnóstico y tratamiento del cáncer de cervix uterino. | Female fertility | 1995 | Female fertility;IVF clinical | |
|
Prognostic assessment of ovarian reserve. | Female fertility | 1995 | Female fertility;IVF clinical |
|
Prognostic assessment of ovarian reserve. | Female fertility | 1995 | Female fertility;IVF clinical |
|
Rapid detection of rare variants and common polymorphisms in the APC gene by PCR-SSCP for presymptomatic diagnosis and showing allele loss. | Female fertility | 1995 | Female fertility;Pre-implantation genetics |
|
Relationship between circulating hCG levels and premature luteinization in cycles of controlled ovarian hyperstRelationship between circulating hCG levels and premature luteinization in cycles of controlled ovarian hyperstimulation. | Female fertility | 1995 | Female fertility;IVF clinical |
|
Response to the Letter to the Editor "Screening for Ovarian Reserve". | Female fertility | 1995 | Female fertility;IVF clinical |
|
Tru-Trax in vitro cervical mucus penetration test in predicting fertilization and pregnancy rates in in vitro fertilization. | Technology development | 1995 | Technology development;IVF clinical |
|
Use of the GnRH-agonist stimulation test in the diagnosis of ovarian remnant syndrome. | Technology development | 1995 | Technology development;IVF clinical |
|
Age related decline in Female fertility is not due to diminished capacity of the uterus to sustain embryo implantation. | Female fertility | 1994 | Female fertility;Aging and rejuvenation |
|
Bleeding patterns in postmenopausal women taking continuous combined or sequential regimens of conjugated estrogens with medroxyprogesterone acetate | Female fertility | 1994 | Female fertility;Aging and rejuvenation |
|
Cigarette smoking accelerates the development of diminished ovarian reserve as evidenced by the clomiphene citrate challenge test (CCCT). | Female fertility | 1994 | Female fertility;IVF clinical |
| Clinical experience with preimplantation diagnosis of sex by dual fluorescent in situ hybridization. | Female fertility | 1994 | Female fertility;IVF clinical | |
|
Comparison of leuprolide acetate and hCG for the induction of ovulation in clomiphene citrate stimulated cycles. | Female fertility | 1994 | Female fertility;IVF clinical |
|
Enhancement of ovarian responsiveness with micro-doses of GnRH-agonist during ovulation induction for in vitro fertilization. | Female fertility | 1994 | Female fertility;IVF clinical |
|
Evaluation of the significance of a poor estradiol response during the clomiphene citrate challenge test. | Female fertility | 1994 | Female fertility;IVF clinical |
|
Gonadotropin releasing hormone antagonist administration enhances gonadotrope responsiveness at doses inadequate to suppress circulating immunoassayable gonadotropin levels. | Immunology | 1994 | Immunology;Female fertility |
|
Immunohistochemical localization of transforming growth factor- in human implantation sites. | Female fertility | 1994 | Female fertility;IVF clinical |
|
In vivo effects of potent GnRH antagonist ORG 30850; Physiologic evidence that down-regulation of GnRH receptors does not occur. | Female fertility | 1994 | Female fertility;IVF clinical |
|
Incidence of endometrial hyperplasia in postmenopausal women taking conjugated estrogens (Premarin) with medroxyprogesterone acetate or conjugated estrogens alone. | Aging and rejuvenation | 1994 | Aging and rejuvenation;Female fertility |
| Localisation of the human blue cone pigment gene to chromosome band 7q31.3-32. | Female fertility | 1994 | Female fertility | |
|
Penetration of human spermatozoa through the zona pellucida of non-viable human oocytes. | Female fertility | 1994 | Female fertility;Male fertility |
|
Progress in biopulping of non-woody materials: Chemical, enzymatic and ultrastructural aspects of wheat straw dlignification with ligninolytic fungy from the genus Pleurotus. | Reproductive disorders | 1994 | Reproductive disorders |
|
Regionally clustered APC mutations are associated with a severe phenotype and occur at a high frequency in new mutation cases of adenomatous polyposis coli. | Female fertility | 1994 | Female fertility;Reproductive disorders |
|
The assisted reproductive technologies in the treatment of male factor infertility. | Male fertility | 1994 | Male fertility;IVF clinical |
| The embryo, the endometrium and the patient. Perspectives on Assisted Reproduction. | Female fertility | 1994 | Female fertility;IVF clinical | |
|
The use of oil overlay for in vitro fertilization and culture. | IVF clinical | 1994 | IVF clinical;IVF laboratory |
|
Tru-trax in vitro cervical mucus penetration testing | Technology development | 1994 | Technology development;IVF clinical |
|
Ultrasongoraphic evaluation of the endometrium during ovulation induction cycles. | Female fertility | 1994 | Female fertility;IVF clinical |
|
Ultrasound monitoring of Controlled Ovarian Hyperstimulation. | Female fertility | 1994 | Female fertility;IVF clinical |
|
A prospective evaluation of clomiphene citrate challenge test screening in the general infertility population. | Female fertility | 1993 | Female fertility;IVF clinical |
| Determinación de CEA, Ca 125, SCC, CA 15,3, Ca 19.9 en cáncer de endometrio. | Female fertility | 1993 | Female fertility | |
|
Establishment of An Assisted Reproduction Program in the Armed Forces. | IVF clinical | 1993 | IVF clinical |
|
Et al. IGF-I and the IGF-I receptor in development of nonmammalian vertebrates. | Female fertility | 1993 | Female fertility |
|
Evaluation of the impact of intra-observer variability on endometrial dating and the diagnosis of luteal phase defects. | Female fertility | 1993 | Female fertility;IVF clinical |
|
Germline rearrangement of MCC and APC detected by pulsed field gel electrophoresis and fluorescent in situ hybridization. | Female fertility | 1993 | Female fertility;Male fertility |
|
Gonadotropin responsiveness to ultra low dose leuprolide acetate administration in baboons. | Female fertility | 1993 | Female fertility;IVF clinical |
|
Immunohistochemical localization of transforming growth factor- in human endometrium, decidua, and trophoblast. | Female fertility | 1993 | Female fertility |
|
Letter to the Editor regarding "Establishment of An Assisted Reproduction Program in the Armed Forces". | IVF clinical | 1993 | IVF clinical |
| Miastenia Gravis y embarazo (a propósito de 3 casos). | Female fertility | 1993 | Female fertility | |
| Papel del SCC como marcador tumoral en el cáncer invasivo de Cervix Uterino. | Female fertility | 1993 | Female fertility | |
|
The duration of leuprolide acetate administration prior to ovulation induction does not impact ovarian responsiveness to exogenous gonadotropins. | Female fertility | 1993 | Female fertility;IVF clinical |
|
Transforming growth factor-in human implantation trophoblast: Immunohistochemical evidence for autocrine/paracrine function. | Female fertility | 1993 | Female fertility;IVF clinical |
|
Ultrasound monitoring. Ovarian Stimulation Monitoring: A roundtable review by L. Bonaventura. | Female fertility | 1993 | Female fertility;IVF clinical |
|
Angioedema and rash related to sublingual Captopril in a postpartum pre-eclampsia syndrome | Female fertility | 1992 | Female fertility |
|
Common errors in hysterosalpingography | Female fertility | 1992 | Female fertility;IVF clinical |
|
Creatine kinase as a marker for preterm labor. | Female fertility | 1992 | Female fertility;IVF clinical |
|
Endometrial Ablation. | Female fertility | 1992 | Female fertility;IVF clinical |
|
Epidermal growth factor and its receptor in human implantation trophoblast: immunohistochemical evidence for autocrine/paracrine function. | Female fertility | 1992 | Female fertility;Endometrial receptivity |
|
A human in vivo model for the luteo-placental shift. | Female fertility | 1991 | Female fertility;IVF clinical |
|
Embryo quality and pregnancy rates in patients attempting pregnancy through in vitro fertilization. | Female fertility | 1991 | Female fertility;IVF clinical |
|
Immunohistochemical localization of epidermal growth factor (EGF) in human endometrium, decidua and placenta. | Female fertility | 1991 | Female fertility;IVF clinical |
|
Pharmacokinetics of percutaneous estradiol: A crossover study using a gel and a transdermal system in comparison with oral micronized estradiol. | Female fertility | 1991 | Female fertility;IVF clinical |
|
Results of a prenatal screening program for the human immunodeficiency virus in a cross-sectional population. | Female fertility | 1991 | Female fertility;IVF clinical |
|
The window of embryo transfer and the efficiency of human conception in vitro. | Female fertility | 1991 | Female fertility;IVF clinical |
|
Acute Changes in serum estradiol concentrations do no elicit changes in serum osteocalcin concentrations. | Female fertility | 1990 | Female fertility;IVF clinical |
|
Effects of leuprolide acetate on follicular fluid hormone composition at oocyte retrieval for in vitro fertilization. | Female fertility | 1990 | Female fertility;IVF clinical |
|
GnRH antagonists: New developments for indications in reproductive medicine. | Female fertility | 1990 | Female fertility;IVF clinical |
|
Hemizona assay: Assessment of human spermatozoa dysfunction and its correlation with in vitro fertilization results. | Male fertility | 1990 | Male fertility;Technology development |
|
Immunoreactive epidermal growth factor concentrations in follicular fluid obtained from in vitro fertilization. | Immunology | 1990 | Immunology;Female fertility |
|
Intercycle variability of day 3 follicle-stimulating hormone levels and its effect on stimulation quality in in vitro fertilization. | Female fertility | 1990 | Female fertility;IVF clinical |
|
Non-functional cysts do not affect ipsilateral or contralateral ovarian performance during in-vitro fertilization. | Female fertility | 1990 | Female fertility;IVF clinical |
|
Pituitary luteinizing hormone (LH) secretion: Effect of different concentrations of serum 17ß-estradiol in postmenopausal women. | Female fertility | 1990 | Female fertility;IVF clinical |
|
Primary amenorrhea. | Female fertility | 1990 | Female fertility;Reproductive disorders |
|
Response to the editor. | Female fertility | 1990 | Female fertility;IVF clinical |
|
Role of spermatozoa cryopreservation in assisted reproduction. | Male fertility | 1990 | Male fertility;IVF clinical |
|
Spermatozoa motile fraction separation. | Male fertility | 1990 | Male fertility;IVF clinical |
|
The ovarian follicle: Life cycle of a pelvic clock. | Female fertility | 1990 | Female fertility;IVF clinical |
|
The relationship between serum estradiol-17ß concentrations and induced pituitary luteinizing hormone (LH) surges in post- menopausal women. | Female fertility | 1990 | Female fertility;IVF clinical |
|
Transplacental transfer of zidovudine (AZT) in the near term pregnant baboon. | Female fertility | 1990 | Female fertility;IVF clinical |
|
A prospective randomized comparison of single and double lumen needles for transvaginal follicular aspiration. | Female fertility | 1989 | Female fertility;IVF clinical |
|
Assisted reproduction in the diagnosis and treatment of the male factor. | Male fertility | 1989 | Male fertility;IVF clinical |
|
Correlation of follicular diameter with oocyte recovery and maturity at the time of transvaginal aspiration | Female fertility | 1989 | Female fertility;IVF clinical |
|
Critical assessment of sperm morphology before and after double swim-up preparation for in vitro fertilization. | Male fertility | 1989 | Male fertility;IVF clinical |
|
Effects of clomiphene citrate on episodic luteinizing hormone secretion throughout the menstrual cycle. | Female fertility | 1989 | Female fertility;IVF clinical |
|
Effects of the severity of tubo-ovarian disease and previous tubal surgery on the results of in vitro fertilization and embryo transfer. | Reproductive disorders | 1989 | Reproductive disorders;Female fertility |
|
Follicle stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome. | Female fertility | 1989 | Female fertility;IVF clinical |
|
Hemizona assay (HZA): Assessment of sperm dysfunction and prediction of in vitro fertilization (IVF) outcome. | IVF clinical | 1989 | IVF clinical;IVF laboratory |
|
Hormonal manipulation of endometrial manipulation. | Female fertility | 1989 | Female fertility;IVF clinical |
|
Maternal height and weight gain as risk factors for cesarean section. | Female fertility | 1989 | Female fertility;IVF clinical |
|
Ovulation induction for assisted reproduction. | Female fertility | 1989 | Female fertility;IVF clinical |
|
The incidence of hyperprolactinemia in gonadotropin stimulated cycles for in vitro fertilization and its effect on cycle quality and pregnancy outcome. | Female fertility | 1989 | Female fertility;Reproductive disorders |
|
Validation of the hemizona assay (HZA) in a monkey model: Influence of oocyte maturational stages. | Technology development | 1989 | Technology development;Female fertility |
|
Maternal arterial oxygen desaturation with treatment of uterine atony with 15-methyl prostaglandin F2 alpha. | Female fertility | 1988 | Female fertility;IVF clinical |
|
Spontaneous and pharmacologically induced remissions in patients with premature ovarian failure. | Reproductive disorders | 1988 | Reproductive disorders;Female fertility |
|
The effect of interobserver variation in dating endometrial histology in the diagnosis of luteal phase defects. | Reproductive disorders | 1988 | Reproductive disorders;Female fertility |
|
Transdermal estrogen replacement in ovarian failure for ovum donation. | Female fertility | 1988 | Female fertility;IVF clinical; |
| Names | Title | Area | Year | Area |
